Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 1.1.1.49 - glucose-6-phosphate dehydrogenase (NADP+)

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
5'-nucleotidase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt.
[Hemolytic anemias caused by erythrocyte enzyme disorders]
6-phosphogluconolactonase deficiency
6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.
Abortion, Habitual
[Glucose-6-phosphate dehydrogenase in couples with habitual abortion]
Abortion, Septic
Pancreatitis in acute hemolysis.
Abortion, Spontaneous
Hofbauer cell activation and its increased glucose-6-phosphate dehydrogenase activity in second trimester-spontaneous abortion: an ultrastructural dual staining enzyme-cytochemical study.
Prenatal selection and fetal development disturbances occurring in carriers of G6PD deficiency.
[Role of disorders of pentosephosphate pathway of glucose oxidation in the pathogenesis of the arrest of fetal development in miscarriage]
Acatalasia
A DUAL HEREDITARY RED BLOOD CELL DEFECT IN ONE FAMILY: HYPOCATALASEMIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Activities of catalase in leucocytes and glucose-6-phosphate dehydrogenase in erythrocytes of hypocatalasemia and acatalasemia.
[Glucose-6-phosphate dehydrogenase activity in the red blood cell in hypo-catalasemia and acatalasemia]
acetylcholinesterase deficiency
Paroxysmal nocturnal hemoglobinuria (PNH) as a clonal disorder.
Acidosis
Alterations of rat kidney, liver and erythrocytes glucose 6-phosphate dehydrogenase activity by chronic acidosis.
Patients with genetic defects in the gamma-glutamyl cycle.
Predictors of Acute Bilirubin Encephalopathy Among Nigerian Term Babies with Moderate-to-severe Hyperbilirubinaemia.
Stimulation of rat-kidney hexose monophosphate shunt dehydrogenase activity by chronic metabolic acidosis.
[Biochemical markers of strophanthin arrhythmia]
[Effect of sodium oxybutyrate on metabolic indices in ischemic hypoxia of muscle tissue]
[Generalized saturnine paralysis. Discovery of a double congenital disease: glucose-6-phosphate dehydrogenase deficiency (new variant) and distal tubular acidosis]
Acidosis, Lactic
Autistic feature as a presentation of Inborn Errors of Metabolism.
Acne Vulgaris
Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne.
Diet in dermatology: revisited.
Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?
[Determination of glucose-6-phosphate dehydrogenase activity in acne vulgaris]
Acquired Immunodeficiency Syndrome
A COMPARISON OF RAPID DIAGNOSTIC TESTING (BY PLASMODIUM LACTATE DEHYDROGENASE), AND QUANTITATIVE BUFFY COAT TECHNIQUE IN MALARIA DIAGNOSIS IN CHILDREN.
G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases.
Purification and characterization of glucose-6-phosphate dehydrogenase from Cryptococcus neoformans: identification as "nothing dehydrogenase".
Acrocephalosyndactylia
Apert syndrome with glucose-6-phosphate dehydrogenase deficiency: a case report.
Acrodermatitis
Diet in dermatology: revisited.
Actinomycosis
[Perineogluteal actinomycosis and G6PD deficiency]
Acute Coronary Syndrome
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Impact of glucose-6-phosphate dehydrogenase deficiency on the severity of coronary atherosclerosis in patients with acute coronary syndromes.
Acute Kidney Injury
Acute hemolytic anemia and acute kidney injury induced by non-high-dose ascorbic acid in a Child with glucose-6-phosphate dehydrogenase deficiency.
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute renal failure due to intravascular hemolysis in the North Indian patients.
Acute renal failure following analgesic overdose in G6PD deficiency.
Acute renal failure in a glucose-6-phosphate dehydrogenase deficient individual with infectious mononucleosis.
Acute renal failure in favism revealing familial glucose-6-phosphate dehydrogenase deficiency.
Acute renal failure in glucose-6-phosphate dehydrogenase (G6 P.D.) deficiency.
Acute renal failure in tropical Africa.
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Chloroquine induced haemolysis and acute renal failure in subjects with G-6-PD deficiency.
Detection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency Anemia.
Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia.
Dialytic support in acute renal failure.
Glucose-6-phosphate dehydrogenase deficiency and acute renal failure.
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
Methylene Blue Induced Methemoglobinemia with Acute Kidney Injury in a Glucose-6-Phosphate Dehydrogenase-deficient Patient.
N-acetylcysteine overdose after acetaminophen poisoning.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency.
Severe hyperbilirubinemia and acute renal failure associated with hepatitis E in a patient whose glucose-6-phosphate dehydrogenase levels were normal.
The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats.
[Acute kidney failure and hemolytic anemia caused by erythrocytic G6PD dificit revealed by chloroquine administration]
[Acute renal failure manifest of glucose-6-phosphate dehydrogenase deficiency: severity of iatrogenic hemolysis. Originality of genetic distribution in a family from Sardinia]
[Recurrent acute renal failure during the course of hemolytic crisis in a patient with glucose-6-phosphate dehydrogenase deficiency]
Acute Lung Injury
Acute lung injury after exchange transfusion in two newborns with Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase-derived reactive oxygen species.
Acute Retroviral Syndrome
Acute Retroviral Syndrome Presenting with Hemolytic Anemia Induced by G6PD Deficiency.
Adenocarcinoma
Effect of actinomycin C on glucose-6-phosphate dehydrogenase activity of a human adenocarcinoma growing in a heterologous host.
Effect of estrogen on synthesis of glucose-6-phosphate dehydrogenase in R3230AC mammary tumors and uteri.
Glucose-6-phosphate dehydrogenase from lactating rat mammary gland and R3230AC adenocarcinoma.
Human colon tumors: enzymic and histological characteristics.
Inactivation of metabolic enzymes by photo-treatment with zinc meta N-methylpyridylporphyrin.
Oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity for the detection of (pre)neoplasm in rat liver.
Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents.
Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
[Histocytospectrophotometric characteristics of lung cancer]
[Oxidoreductase activity in the cells of stomach cancer]
Adenocarcinoma of Lung
Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Adenoma
A compound adrenal medullary tumor (pheochromocytoma and ganglioneuroma) and a cortical adenoma in the ipsilateral adrenal gland. A case report with enzyme histochemical and immunohistochemical studies.
Biology of hepatocellular neoplasia in the mouse. II. Sequential enzyme histochemical analysis of BALB/c mouse liver during safrole-induced carcinogenesis.
Comparison of the various forms of glutathione S-transferase with glucose-6-phosphate dehydrogenase and gamma-glutamyltranspeptidase as markers of preneoplastic and neoplastic lesions in rat kidney induced by N-ethyl-N-hydroxyethylnitrosamine.
Enzymatic characteristics of tubular adenomas and carcinomas of the large intestine.
Enzyme patterns and flow cytometric DNA measurements in colorectal hyperplastic polyps and tubular adenomas less than five millimeters.
Epidemiology of polyps in the rectum and sigmoid colon. Size, enzyme levels, DNA distributions, and nuclear diameter in polyps of the large intestine.
Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Histochemical and histoenzymatic action of crinofizin in cystic mastosis and prostate adenoma studied in cell and organotypic cultures.
Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
[Glucose-6-phosphate dehydrogenase and transketolase activity in the blood of neurological oncologic patients preoperatively and in the dynamics of the postoperative period]
Adenoma, Bile Duct
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Adenoma, Liver Cell
Enzyme histochemical and immunohistochemical characterization of oval and parenchymal cells proliferating in livers of rats fed a choline-deficient/DL-ethionine-supplemented diet.
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
adenosine deaminase deficiency
Ultra-performance liquid chromatography-tandem mass spectrometry-based multiplex enzyme assay for six enzymes associated with hereditary hemolytic anemia.
adenylate kinase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
Adrenal Hyperplasia, Congenital
Current and future perspective of newborn screening: an Indian scenario.
Neonatal biochemical screening for disease.
Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in India.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Newborn screening in the Philippines.
Newborn screening: need of the hour in India.
Preliminary report on neonatal screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency: a Chandigarh experience.
The status of neonatal screening in China, 2013.
Adrenal Insufficiency
Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.
Adrenocortical Adenoma
Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid "adenomas".
Adrenocortical Carcinoma
Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
Adrenocortical Hyperfunction
[The glucose-6-phosphate dehydrogenase isoenzyme spectrum of subcellular organ fractions from rabbits with endogenous and exogenous hypercorticism]
Adrenoleukodystrophy
Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
Agammaglobulinemia
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Agranulocytosis
Genetic factors and risk of agranulocytosis from metamizol.
Albinism
Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants.
Alopecia
Activity of glucose-6-phosphate 1-dehydrogenase in hair follicles with male-pattern alopecia.
Histochemical quantification of glucose-6-phosphate dehydrogenase activity in human hair follicles.
alpha-Thalassemia
Alpha-thalassemia in Papua New Guinea.
Anemia in newborn.
Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Clinical and hematological phenotype of homozygous hemoglobin E: revisit of a benign condition with hidden reproductive risk.
Clinical experience with multigene carrier panels in the reproductive setting.
Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates.
Erythrocyte glucose-6-phosphate dehydrogenase and pyruvate kinase activities in hemoglobin H disease.
Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.
G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.
Genetic benefits of consanguinity through selection of genotypes protective against malaria.
Genetic modifiers of severity in sickle cell disease.
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Glucose-6-phosphate dehydrogenase and hemoglobin variants in Kel Kummer Tuareg and related groups. Indirect evidence for alpha-thalassemia trait.
Hematologic disorders and nonimmune hydrops fetalis.
Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives.
Influence of hemoglobin E trait on the severity of Falciparum malaria.
Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia.
Jordan: communities and community genetics.
Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar.
NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites.
Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa.
Pathogenesis of anemia in malaria: a concise review.
Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok.
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi.
Reticulocyte analysis in iron deficiency anemia and hemolytic anemia.
Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.
[Abnormal hemoglobins, alpha thalassemia and erythrocyte G6PD deficiency in newborn infants of the negroid race]
[Favism, hemoglobin H, alpha-thalassemia and hemoglobinopathy in various Sardinian families. Studies on glucose-6-phosphate dehydrogenase]
[G-6-PD deficiency with hemoglobinopathy and alpha-thalassemia]
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
Alzheimer Disease
Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease.
Chromosomal fragility associated with familial Alzheimer's disease.
Evidence of an oxidative challenge in the Alzheimer's brain.
Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer's disease.
Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms.
Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress.
Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.
Amebiasis
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Amyotrophic Lateral Sclerosis
Enzymatic analysis of individual posterior root ganglion cells in olivopontocerebellar atrophy, amyotrophic lateral sclerosis and Duchenne muscular dystrophy.
Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease.
Anaphylaxis
Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Anemia
A COMPARISON OF RAPID DIAGNOSTIC TESTING (BY PLASMODIUM LACTATE DEHYDROGENASE), AND QUANTITATIVE BUFFY COAT TECHNIQUE IN MALARIA DIAGNOSIS IN CHILDREN.
A hematological survey of preschool children of the United Arab Emirates.
A longitudinal study of red cell enzymes in infants of low birth weight.
A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish.
A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency.
A paper-based biosensor for visual detection of glucose-6-phosphate dehydrogenase from whole blood.
A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.
A rare case report of autoimmune haemolytic anemia in a female child due to a Donath-Landsteiner antibody.
ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency presenting as Hydrops Foetalis.
Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological study.
Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency.
Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne.
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease.
Adult-onset Still's disease associated with G6PD deficiency: a case report and literature review.
Age, Ethnicity, Glucose-6-Phosphate Dehydrogenase Deficiency, Micronutrient Powder Intake, and Biomarkers of Micronutrient Status, Infection, and Inflammation Are Associated with Anemia Among Children 6-59 Months in Nepal.
Agriculture-related anaemias.
An experimental study of hemolysis induced by onion (Allium cepa) poisoning in dogs.
Anaemia and antioxidant defence of the red blood cells.
Anaemic crisis in sickle cell disease.
Anemia and the liver. Hepatobiliary manifestations of anemia.
Anemia associated with new-onset diabetes: improvement with blood glucose control.
Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias.
Anemia during actue infections. Role of glucose-6-phosphate dehydrogenase deficiency in Negroes.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Anemia in pregnancy.
Anemia of premature infant: the glucose-6-phosphate dehydrogenase activity in erythrocytes of cmrd blood from premature and full-term infants.
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).
Assessment of potential donors for living related liver transplantation.
Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE).
Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.
Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections.
Association of homozygous sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency.
Association of naphthalene with acute hemolytic anemia.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Behaviour of cell physiological and biochemical indicators of maturation and aging of red blood cells in density fractionated red blood cells during a bleeding anaemia of the rabbit.
Biochemical changes in equine erythrocytes during experimental regenerative anemia.
Biological impact of ? genes, ? haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Ceramide in suicidal death of erythrocytes.
Changing trends in malaria--a decade's experience at a referral hospital.
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature.
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Clinical disorders of the red cell membrane skeleton.
Clinical Manifestations and Therapeutic Findings of the Children with Glucose-6-Phosphate Dehydrogenase Deficiency Presenting Favism.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.
Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices.
Complete repair of tetralogy associated with sickle cell anemia and G-6-PD deficiency.
Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza).
Congenital dyserythropoietic anemia type II associated with G6PD Seattle in a Sicilian child.
Congenital erythrocyte enzyme deficiencies.
Coombs-negative severe hemolysis associated with hepatitis A.
Cost-benefit analysis of G6PD screening in Lebanese newborn males.
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Detection of G6PD and pyruvate kinase deficiencies in reticulocytosis by reference to erythrocyte creatine.
Detection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency Anemia.
DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase.
Diabetic ketoacidosis revealing glucose-6-phosphate dehydrogenase deficiency: description of an adult case.
Does G gamma/A gamma ratio and Hb F level influence the severity of sickle cell anaemia.
Drug-induced anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
DRUG-INDUCED HEMOYTIC ANEMIAS ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY: AGENETICALLY HETEROGENOUS TRAIT.
Effect of alpha thalassaemia, G-6-PD deficiency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia.
Effect of anaemia on red cell metabolism in cattle.
Effect of experimental anaemia on red cell GSH and enzyme activities in guinea-pig and rabbit.
Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study.
Effects of an NADPH-generating system on primaquine degradation by hamster liver fractions.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anaemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia.
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
EP21.21: Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
Erythrocyte programmed cell death.
Erythrocyte reduced glutathione level in sickle cell anaemia and glucose-6-phosphate dehydrogenase deficient Saudi subjects.
Excessive fluoride consumption increases haematological alteration in subjects with iron deficiency, thalassaemia, and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Fatal familial haemolytic anaemia.
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.
Fine Mapping of Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency in a Rural Malaria Area of South West Odisha Using the Clinical, Hematological and Molecular Approach.
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
Frequency of glucose 6 phosphate dehydrogenase deficiency and related hemolytic anemia in Riyadh, Saudi Arabia.
Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii.
Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
G-6-PD Guadalajara. A new mutant associated with chronic nonspherocytic hemolytic anemia.
G6PD deficiency and absence of ?-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.
G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic.
G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia.
G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.
G6PD sumaré: a novel mutation in the G6PD gene (1292 T-->G) associated with chronic nonspherocytic anemia.
G6PD Varadero. A new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD/PK ratio: a reliable parameter to identify glucose-6-phosphate dehydrogenase deficiency associated with microcytic anemia in heterozygous subjects.
G6PD: population genetics and clinical manifestations.
Gd (+) Laguna, a new rare glucose-6-phosphate dehydrogenase variant from Brazil.
General Anesthesia in a Glucose-6-Phosphate Dehydrogenase Deficiency Child: A Case Report.
Genetic compounds--Hb S, thalassaemias and enzymopathies: spectrum of interactions.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Glucose 6 phosphate dehydrogenase deficiency in adults.
Glucose 6-phosphate dehydrogenase and the kidney.
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community.
Glucose 6-phosphate dehydrogenase, hexokinase activities and ATP levels as a function of cell density in thalassemia and iron deficiency anemia.
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Switzerland. Demonstration of a new variant (G-6-PD Aarau) with chronic nonsphaerocytic haemolytic anaemia.
Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil.
Glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Glucose-6-phosphate dehydrogenase deficiency in Sickle-cell anemia. A study in adults.
Glucose-6-phosphate dehydrogenase deficiency in triplets of African-American descent.
Glucose-6-phosphate dehydrogenase deficiency: the added value of cytology.
Glucose-6-phosphate dehydrogenase Jackson. A new variant associated with hemolytic anemia.
Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children.
Glycosylated hemoglobin in Saudi sickle cell patients with glucose-6-phosphate dehydrogenase deficiency.
Growth-and Documentation-Deficits: Where To Start in Helping Families.
Haematological parameters and altered erythrocyte metabolism in anaemic dogs.
Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in a Scandinavian perspective.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.
HbE-beta-thalassemia associated with G6PD deficiency.
Hematological findings and severity of G6PD deficiency in Vataliya Prajapati subjects.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.
Hematological profile in neonatal jaundice.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.
Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin.
Hereditary anaemias and iron deficiency in a tribal population (the Baiga) of central India.
Hereditary anaemias in Portugal: epidemiology, public health significance, and control.
High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.
High prevalence of microcytic anaemia in Omani children: a prospective study.
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
How I do in front of an hemolytic anemia of unknown etiology?
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
Hydroxychloroquine is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients.
Hyperbilirubinemia following hepatitis A in a patient with G6pD deficiency.
Identification of Inflammatory Biomarkers for Pediatric Malarial Anemia Severity using Novel Statistical Methods.
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.
In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients.
Influence of blood group, Glucose-6-phosphate dehydrogenase and Haemoglobin genotype on Falciparum malaria in children in Vihiga highland of Western Kenya.
Interaction between glucose-6-phosphate dehydrogenase deficiency and sickle cell gene in Saudi Arabia.
Interesting case of G6PD deficiency anemia with severe hemolysis.
Jordan: communities and community genetics.
Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria.
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Massive acute haemolysis in neonates with glucose-6-phosphate dehydrogenase deficiency.
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India.
Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.
New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
Nutritional Status of Young Children with Inherited Blood Disorders in Western Kenya.
Oxidative Stress and Suicidal Erythrocyte Death.
Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus.
Pathogenesis, laboratory diagnosis, and clinical implications of erythrocyte enzyme deficiencies in dogs, cats, and horses.
Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.
PGI*3(Israel), a new, unstable allele in the phosphoglucose isomerase system.
Pharmacoanthropology: outline, problems, and the nature of case histories.
Plan and process for hematology laboratory standard in Thailand.
Predictors of Acute Bilirubin Encephalopathy Among Nigerian Term Babies with Moderate-to-severe Hyperbilirubinaemia.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Prevalence of anemia, iron deficiency, thalassemia and glucose-6-phosphate dehydrogenase deficiency among hill-tribe school children in Omkoi District, Chiang Mai Province, Thailand.
Pyruvate kinase deficiency in mice protects against malaria.
Reappraisal of known malaria resistance loci in a large multicenter study.
Red blood cell-derived microparticles: An overview.
Red cell membrane protein in thalassemia and glucose-6-phosphate dehydrogenase deficiency anemia.
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency.
Reticulocyte analysis in iron deficiency anemia and hemolytic anemia.
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status.
Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.
Some observations on glutathione instability and glucose-6-phosphate dehydrogenase deficiency in infants and children having anaemia and jaundice.
SPECIFIC INHIBITION OF HEPATIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN IRON DEFICIENCY ANEMIA IN ALBINO RATS.
Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity.
Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
Study of red cell membrane lipids in glucose-6-phosphate dehydrogenase deficiency anemia.
Study of some erythrocytic enzymes in extracorpuscular hemolytic anemias.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.
Thalassaemia is a tropical disease.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
The effects of glucose-6-phosphate dehydrogenase deficiency on the haematological parameters and clinical manifestations in patients with sickle cell anaemia.
The First Case of a Class I Glucose-6-phosphate Dehydrogenase Deficiency, G6PD Santiago de Cuba (1339 GA), in a Chinese Population as Found in a Survey for G6PD Deficiency in Northeastern and Central China.
The influence of oxidative bursts of phagocytes on red blood cell oxidation in anemic cattle infected with Theileria sergenti.
The investigation of plasma glucose-6-phosphate dehydrogenase, 6-phoshogluconate dehydrogenase, glutathione reductase in premenauposal patients with iron deficiency anemia.
The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
The relationship between red cell aging and enzyme activities in experimental animals.
The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis.
The role of oxidative stress in hemolytic anemia.
Therapeutic potential of manipulating suicidal erythrocyte death.
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Use and safety of elevated dosages of vitamin E in adults.
[A case of falciparum malaria successfully treated with intravenous artesunate]
[A search for glucose-6-phosphate dehydrogenase deficiency, among Toros Seljouck Turks, in both normal and pathological conditions. The explanation of hemolytic anemias seen, in snake bite and poisonous insect bites cases. Three cases of favism and hemolytic syndrome]
[Activities of erythrocyte glucose-6-phosphate dehydrogenase and catalase during pregnancies associated with anemia]
[Activity of glucose-6-phosphate dehydrogenase and glutathione reductase in early anemia of premature infants]
[Activity of the enzymes phosphoglyceraldehyde dehydrogenase, lactate dehydrogenase and glucose-6-phosphate dehydrogenase in the erythrocytes in deficiency anemia]
[Anemia and jaundice caused by hereditary glucose-6-phosphate dehydrogenase deficit.]
[Biology of glucose-6-phosphate dehydrogenase deficiency]
[Case of nonspherocytic anemia complicated by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]
[Chronic haemolytic anemia due to a defect of glucose-6-phosphate dehydrogenase (G6PD) in a Lorraine family. Demonstration of a new type of the enzyme: Gd(-) Nancy]
[CHRONIC HEMOLYTIC NON SPHEROCYTIC ANEMIA SECONDARY TO DEFICIENCY OF ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE. DESCRIPTION OF A CASE.]
[Clinical, erythrokinetic and metabolic aspects of congenital hemolytic non-spherocytic anemia due to erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Common anemias in neonatology]
[Concerning the level of erythrocytic glucose-6-phosphate dehydrogenase in patients with microdrepanocytic anemia]
[Congenital hemolytic anemias with glutatione metabolism disorders (excluding glucose-6-phosphate dehydrogenase deficiency)]
[Congenital hemolytic non-spherocytic anemia caused by glucose-6-phosphate dehydrogenase deficiency (case contribution)]
[Congenital nonspherocytic hemolytic anemias caused by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes in a Japanese family]
[Contribution to the study of hemolysis in Francoi's anemia. Intermediary deficiency of G-6-PD in a male patient]
[Deficiency of glucose-6-phosphate dehydrogenase in a family]
[Density-specific distribution of erythrocytes in different types of anemia]
[Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti]
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
[Etiology of hemolytic anemia]
[Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo)]
[Federal District glucose-6-phosphate dehydrogenase Gd(-). A new variant associated with moderate enzyme deficiency and occasional hemolytic anemia]
[Frequency of G6PD deficiency in a group of preschool-aged children in a centrally located area of Cambodia]
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[Genetic, biochemical, pathogenetic and laboratory aspects of thalassemia. Heterozygote thalassemia in Alghero]
[Glucose-6-phosphate dehydrogenase (G6PD) deficiency--a cause of anaemia in pregnant women]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE AND SURVIVAL OF ERYTHROCYTES IN VARIOUS FORMS OF ANEMIA.]
[Glucose-6-phosphate dehydrogenase type Schwaben. A new enzyme variant with spontaneous hemolytic anemia]
[Haemolytic anemia associated with G-6-PD deficiency]
[Hematologic characteristics in Black Africa]
[Hemolytic anemia after voluntary ingestion of henna (Lawsonia inermis) decoction by a young girl with G6PD deficiency].
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Condition with diagnostic pitfalls].
[HEMOLYTIC ANEMIAS DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic congenital nonspherocytic anemia secondary to an erythrocyte glucose-6-phosphate dehydrogenase deficiency. Description of 2 new variants: Gd (-) Saint-Louis (Paris) and Gd (-) Hayem]
[Hydrops fetalis and G-6-PD deficiency]
[Importance of the determination of glucose-6-phosphate dehydrogenase in the diagnosis of congenital hemolytic anemias]
[Non-spherocytic congenital hemolytic anemias due to G6PD deficiency. Clinical and hematologic aspects and mechanism of hyperhemolysis]
[On congenital hemolytic, nonspherocytic anemias with a deficiency of glucose-6-phosphate dehydrogenase in red blood cells.]
[ON THE SIGNIFICANCE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY IN ERYTHROCYTES FOR THE DIFFERENTIAL DIAGNOSIS OF ANEMIAS.]
[One hundred and twenty-three cases of sickle-cell trait (author's transl)]
[OPEN PROBLEMS IN THE FIELD OF ANEMIAS DUE TO DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.]
[Review of abnormal genes. II. Hereditary enzyme defects in the erythrocytes: drug-induced hemolytic anemia indirectly caused by glucose-6-phosphate dehydrogenase deficiency]
[Screening for hemoglobinopathies and G-6-PD deficiency anemia in school children of a city in the Turin region]
[Sickle-cell anemia and glucose-6-phosphate dehydrogenase deficiency]
[The African variant of glucose-6-phosphate dehydrogenase deficiency as a factor favoring anemia: comparative study of 157 deficient adults and 300 non-deficient adults]
[The behavior of respiration and glucose-6-phosphate dehydrogenase of red blood cells of different ages during hemorrhagic anemia in rabbits.]
[The C1155G mutation of the red blood cell glucose-6-phosphate dehydrogenase gene in a subject with severe hereditary chronic nonspherocytic anaemia]
[The osmotic stability, glucose-6-phosphate dehydrogenase and glutathione reductase activity of the erythrocytes of leukemia and anemia patients]
[The role glucose-6-phosphate dehydrogenase in pathogenesis of anemia in leptospirosis]
Anemia, Aplastic
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
[Macrolides in the treatment of children with Mediterranean spotted fever]
Anemia, Diamond-Blackfan
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Enzymatic Changes in Red Blood Cells of Diamond-Blackfan Anemia.
Anemia, Dyserythropoietic, Congenital
Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).
Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza).
Congenital dyserythropoietic anemia type II associated with G6PD Seattle in a Sicilian child.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
The role of oxidative stress in hemolytic anemia.
Anemia, Hemolytic
'Gd(-) Hôtel Dieu': a new G-6PD variant with chronic hemolysis in a Negro patient from Senegal.
6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.
A case of congenital dyserythropoietic anemia in a male Chinese.
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
A case report of a 4-year-old child with glucose-6-phosphate dehydrogenase deficiency: An evidence based approach to nutritional management.
A comparative study of acute haemolytic anaemia in patients of viral hepatitis in relation to erythrocyte glucose 6-phosphate dehydrogenase deficiency.
A comprehensive analysis of membrane and morphology of erythrocytes from patients with glucose-6-phosphate dehydrogenase deficiency.
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A-c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations.
A glucose 6-phosphate dehydrogenase Gd (-) Castilla variant characterized by mild deficiency associated with drug-induced hemolytic anemia.
A glucose-6-phosphate dehydrogenase variant, Gd(-) Santamaria found in Costa Rica.
A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency. Vicia sativa (Vetch).
A Japanese neonatal case of glucose-6-phosphate dehydrogenase deficiency presenting as severe jaundice and hemolytic anemia without apparent trigger.
A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes.
A new G-6-PD variant associated with chronic non-spherocytic haemolytic anaemia in a negro family.
A new glucose-6-phosphate dehydrogenase variant (G6PD Iwate) associated with congenital non-spherocytic hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant (G6PD Nagano) associated with congenital hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant (G6PD Tsukui) associated with congenital hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant G6PD Sugao (826C-->T) exhibiting chronic hemolytic anemia with episodes of hemolytic crisis immediately after birth.
A new glucose-6-phosphate dehydrogenase variant with congenital nonspherocytic hemolytic anemia (G6PD Genova). Biochemical characterization and mosaicism expression in the heterozygote.
A new glucose-6-phosphate dehydrogenase variant, Gd(-) Tepic, characterized by moderate enzyme deficiency and mild episodes of hemolytic anemia.
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.
A Novel de novo Mutation in the G6PD Gene in a Korean Boy with Glucose-6-phosphate Dehydrogenase Deficiency: Case Report.
A novel G6PD gene variant in a Chinese girl with favism.
A novel G6PD mutation leading to chronic hemolytic anemia.
A novel missense mutation in glucose-6-phosphate dehydrogenase gene causing chronic nonspherocytic hemolytic anemia in an Indian family.
A novel mutation in the glucose-6-phosphate dehydrogenase gene in a subject with chronic nonspherocytic hemolytic anemia--characterization of enzyme using yeast expression system and molecular modeling.
A novel single-base mutation in the glucose 6-phosphate dehydrogenase gene is associated with chronic non-spherocytic haemolytic anaemia.
A practical toxicity bioassay for vicine-convicine levels in faba bean (Vicia faba).
A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.
A Severe Episode of Hemolytic Anemia After Amoxicillin Exposure in A G6PD Deficient Patient.
A simple, rapid fluorometric assay for the determination of glucose 6-phosphate dehydrogenase activity in dried blood spot specimens.
A somatic mosaicism in the G6PD gene inducing a late onset chronic non-spherocytic hemolytic anemia.
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
A typical presentation of dengue fever in a G6PD deficient patient: A case report.
A unique electrophoretic slow-moving glucose 6-phosphate dehydrogenase variant (G6PD Asahikawa) with a markedly acidic pH optimum.
A variant glucose-6-phosphate dehydrogenase Gd(-) Chiapas associated with moderate enzyme deficiency and occasional hemolytic anemia.
Acquired methemoglobinemia presenting to the pediatric emergency department: a clinical challenge.
Activated oxygen generation by a primaquine metabolite: inhibition by antioxidants derived from Chinese herbal remedies.
Acute haemolytic anaemia and myolysis due to G6PD deficiency.
Acute hemolysis in a patient with a newly diagnosed glioblastoma.
Acute hemolytic anaemia due to phenazopyridine hydrochloride in G-6-PD deficient subject.
Acute hemolytic anemia and acute kidney injury induced by non-high-dose ascorbic acid in a Child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Acute Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency Complicated by Ginkgo biloba.
Acute hemolytic anemia induced by a pyrazolonic drug in a child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency.
Acute Retroviral Syndrome Presenting with Hemolytic Anemia Induced by G6PD Deficiency.
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Age-related red cell enzymes in children with transient erythroblastopenia of childhood and with hemolytic anemia.
An audit of the precipitating factors for haemolytic crisis among glucose-6-phosphate dehydrogenase-deficient paediatric patients.
An In vivo Drug Screening Model Using Glucose-6-Phosphate Dehydrogenase Deficient Mice to Predict the Hemolytic Toxicity of 8-Aminoquinolines.
An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.
Anaemia, a common but often unrecognized risk in diabetic patients: A review.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Anesthetic Management in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Coblation Adenoidectomy With Septoplasty and Turbinectomy.
Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review.
Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program.
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
Autoimmune hemolytic anemia.
Automated determination of glucose-6-phosphate dehydrogenase (G6PD) on a SPOTCHECK Microflow analyzer.
B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.
Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert's syndrome.
Biochemical Analysis of Two Single Mutants that Give Rise to a Polymorphic G6PD A-Double Mutant.
Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency.
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
Changes in red blood cell membrane structure in G6PD deficiency: An atomic force microscopy study.
Characteristics of a new abnormal variant of G-6-PD in human red cells.
Characterization of glucose-6-phosphate dehydrogenase in Sardinian children with congenital nonspherocytic haemolytic anaemia.
Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature.
Chronic haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role of vitamin E in its treatment.
Chronic hemolytic anemia is associated with a new glucose-6-phosphate dehydrogenase in-frame deletion in an older woman.
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants.
Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP). Molecular study of a new variant (G6PD Clinic) with markedly acidic pH optimum.
Chronic nonspherocytic hemolytic anemia and G6PD deficiency.
Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi.
Chronic severe hemolytic anemia due to G-6-PD Charleston: a new deficient variant.
Cimetropium bromide, a new antispasmodic agent, has no hemolytic effects in humans.
Ciprofloxacin-induced acute haemolytic anaemia in a patient with glucose-6-phosphate dehydrogenase Mediterranean deficiency: a case report.
Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia.
Clinical consequences of enzyme deficiencies in the erythrocyte.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Combined G-6PD and 6-PGD deficiency in a Hindu boy.
Comparison of serum copper, magnesium, zinc and calcium levels between G6PD deficient and normal Chinese adults.
Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients.
Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza).
Congenital haemolytic anaemia associated with adenylate kinase deficiency.
Congenital nonspherocytic hemolytic anemia associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Japanese child. Clinical and metabolic studies.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase East Harlem: a new deficient variant.
Cooperating G6PD mutations associated with severe neonatal hyperbilirubinemia and cholestasis.
Copper sulfate-induced hemolytic anemia. Inhibition of glucose-6-phosphate dehydrogenase and other possible etiologic mechanisms.
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.
COVID-19 & Hydroxychloroquine side-effects: Glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
Cytomegalovirus infection and hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency.
Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature.
Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Death from drug-induced hemolytic anemia.
Definition of the mutations of G6PD Wayne, G6PD Viangchan, G6PD Jammu, and G6PD 'LeJeune'.
Dental Considerations in Children with Glucose-6-phosphate Dehydrogenase Deficiency (Favism): A Review of the Literature and Case Report.
Depression of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in enteric fever.
Dexmedetomidine-based intravenous anesthesia of a pediatric patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency: A case report.
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency.
Direct detection for G6PD Bangkok and G6PD Bangkok Noi mutations in the families with chronic nonspherocytic hemolytic anemia (CNSHA).
Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs.
Disorders in the metabolism of erythrocytes in a case of congenital nonspherocytic hemolytic anemia with glucose-6-phosphate dehydrogenase deficiency.
Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase.
Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.
DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants.
Drug induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency subjects.
Drug-eluting stents in a patient with favism: is the aspirin administration safe?
Drug-induced hemolytic anemia: Pharmacological aspects.
Drugs in Development for Malaria.
Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency.
Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in northern Italy in the last 15 years.
Epigenetic therapy reprograms hereditary disease.
Equine glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another.
Erythrocyte membrane protein changes in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease: an example of postsynthetic modification of membrane proteins.
Evaluating of ?-carotene role in ameliorating of favism-induced disturbances in blood and testis.
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency.
Evaluation of DNA damage in leukocytes of G6PD-deficient Iranian newborns (Mediterranean variant) using comet assay.
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency.
Ex Vivo Study of Laban's Role in Decreasing Hemolysis Crisis in G6PD-Deficient Patients.
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
Four new electrophoretically slow-moving glucose 6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: Gd(-) Kurume, Gd(-) Fukushima, Gd(-) Yamaguchi and Gd(-) Wakayama.
Frostbite: A Novel Presentation of Glucose-6-Phosphate Dehydrogenase Deficiency?
Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.
G-6-PD Guadalajara. A new mutant associated with chronic nonspherocytic hemolytic anemia.
G-6-PD hemolytic anemia complicating diabetic ketoacidosis.
G-6-PD Long Prairie: a new glucose-6-phosphate dehydrogenase mutant exhibiting normal sensitivity to inhibition by NADPH and accompanied by nonspherocytic hemolytic anemia.
G-6-PD Manchester: a new variant associated with chronic nonspherocytic hemolytic anemia.
G-6-PD Poznań, variant with severe enzyme deficiency.
G-6-PD Walter Reed: possible insight into "structural" NADP in G-6-PD.
G6PD (Dublin): chronic non-spherocytic haemolytic anaemia resulting from glucose-6-phosphate dehydrogenase deficiency in an Irish kindred.
G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6PD deficiency in Vataliya Prajapati community settled in Surat.
G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia.
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
G6PD deficiency: global distribution, genetic variants and primaquine therapy.
G6PD gene mutations in India producing drug-induced haemolytic anaemia.
G6PD Heian, a glucose-6-phosphate dehydrogenase variant associated with hemolytic anemia found in Japan.
G6PD hillbrow: a new variant of glucose-6-phosphate dehydrogenase associated with drug-induced haemolytic anaemia.
G6PD Huntsville: a new glucose-6-phosphate dehydrogenase associated with chronic hemolytic anemia.
G6Pd Kanazawa: a new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD San Francisco: a new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD Sendagi: a new glucose-6-phosphate dehydrogenase variant associated with congenital hemolytic anemia.
G6PD Varadero. A new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
G6PD-Puerto Limón: a new deficient variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
Gas Chromatography/Mass Spectrometry-Based Metabolomic Profiling Reveals Alterations in Mouse Plasma and Liver in Response to Fava Beans.
Gd(-) Carapicuiba, a rare glucose-6-phosphate dehydrogenase variant associated with moderate enzyme deficiency and chronic hemolysis.
Gd(-) Rennes, a new deficient variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia found in France.
Genetic disorders of human red blood cells.
Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency.
Genotype-Phenotype Correlations of Glucose-6-Phosphate-Deficient Variants Throughout an Activity Distribution.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Glucose 6 phosphate dehydrogenase deficiency unmasked by diabetic ketoacidosis: an underrated phenomenon.
Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia.
Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans.
Glucose 6-phosphate dehydrogenase Palermo R257M: a novel variant associated with chronic non-spherocytic haemolytic anaemia.
Glucose 6-phosphate dehydrogenase variants in Japan.
Glucose 6-phosphate dehydrogenase variants: a unique variant (G6PD Kobe) showed an extremely increased affinity for galactose 6-phosphate and a new variant (G6PD Sapporo) resembling G6PD Pea Ridge.
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Switzerland. Demonstration of a new variant (G-6-PD Aarau) with chronic nonsphaerocytic haemolytic anaemia.
Glucose-6-phosphate dehydrogenase (G-6-PD) Hamburg, a new variant with chronic nonspherocytic haemolytic anaemia.
Glucose-6-phosphate dehydrogenase (G6PD) Iserlohn and G6PD Regensburg: two new severe enzyme defects in German families.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase activity of erythrocytes in hemolytic anemia.
Glucose-6-Phosphate Dehydrogenase and Hemolytic Anemia.
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
Glucose-6-phosphate dehydrogenase aveiro: a de novo mutation associated with chronic nonspherocytic hemolytic anemia.
Glucose-6-phosphate dehydrogenase Beaumont: a new variant with severe enzyme deficiency and chronic nonspherocytic hemolytic anemia.
Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.
Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
Glucose-6-phosphate dehydrogenase deficiency in a native Danish family. A new variant.
Glucose-6-phosphate dehydrogenase deficiency in hemolytic anemia.
Glucose-6-phosphate dehydrogenase deficiency in northern Mexico and description of a novel mutation.
Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
Glucose-6-Phosphate Dehydrogenase Deficiency Unveiled by Diabetic Ketoacidosis: A Dual Dilemma.
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency: an unusual cause of acute jaundice after paracetamol overdose.
Glucose-6-phosphate dehydrogenase deficiency: correlation between the genotype, biochemistry and phenotype.
Glucose-6-phosphate dehydrogenase Durham: a de novo mutation associated with chronic hemolytic anemia.
Glucose-6-phosphate dehydrogenase dye test on patients and their family members of acute hemolytic anemia.
Glucose-6-phosphate dehydrogenase Guadalajara--a case of chronic non-spherocytic haemolytic anaemia responding to splenectomy and the role of splenectomy in this disorder.
Glucose-6-phosphate dehydrogenase Jackson. A new variant associated with hemolytic anemia.
Glucose-6-phosphate dehydrogenase Johannesburg: a new variant with reduced activity in a patient with congenital non-spherocytic haemolytic anaemia.
Glucose-6-phosphate dehydrogenase mutations and haplotypes in Mexican Mestizos.
Glucose-6-phosphate dehydrogenase variants: reexamination of G6PD Chicago and Cornell and a new variant (G6PD Pea Ridge) resembling G6PD Chicago.
Glucose-6-phosphate dehydrogenase Velletri.
Glucose-6-phosphate dehydrogenase, reduced glutathione and heinz bodies in congenital haemolytic anaemia.
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases.
Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.
Gold nanostructures for the multiplex detection of glucose-6-phosphate dehydrogenase gene mutations.
Groups at potentially high risk from chlorine dioxide treated water.
HAART has no major impact on hematological and plasma bilirubin changes in HIV-infected patients with congenital G-6-PD deficiency.
Haematological parameters and altered erythrocyte metabolism in anaemic dogs.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Haemolytic anaemia after ingestion of Neem (Azadirachta indica) tea.
Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency.
Haemolytic anaemia due to glucose-6-phosphate dehydrogenase (G6PD) deficiency: demonstration of two new biochemical variants, G6PD Hamm and G6PD Tarsus.
Haemolytic anaemia with massive haemoglobinuria due to glucose-6-phosphate dehydrogenase deficiency in Ceylon.
Haptoglobin therapy for acute favism: a Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara.
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Hemolytic anemia after acetaminophen overdose in patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia and erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia and G-6-PD deficiency.
Hemolytic anemia and G6PD deficiency.
Hemolytic Anemia Associated with Dapsone PCP Prophylaxis in GBM Patients with Normal G6PD Activity.
Hemolytic anemia caused by G-6-PD Carswell, a new variant.
Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient.
Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt.
Hemolytic anemia in two patients with glioblastoma multiforme: A possible interaction between vorinostat and dapsone.
Hemolytic Anemia Induced by Pegloticase Infusion in a Patient With G6PD Deficiency.
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
Henna (Lawsonia inermis Linn.) induced haemolytic anaemia in siblings.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: A biochemical, genetic and clinical overview.
Heterozygous pyruvate kinase deficiency and severe hemolytic anemia in a pregnant woman with concomitant, glucose-6-phosphate dehydrogenase deficiency.
High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
High prevalence of G6PD deficiency in Vataliya Prajapati community in western India.
Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history.
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
Hydroxychloroquine is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients.
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Identification of a single base change in a new human mutant glucose-6-phosphate dehydrogenase gene by polymerase-chain-reaction amplification of the entire coding region from genomic DNA.
Identification of two novel deletion mutations in glucose-6-phosphate dehydrogenase gene causing hemolytic anemia.
Improved quantitative method for G6PD deficiency detection.
In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Increased basal oxidation of peroxiredoxin 2 and limited peroxiredoxin recycling in glucose-6-phosphate dehydrogenase-deficient erythrocytes from newborn infants.
Induction of hemolytic anemia by nonsteroidal antiinflammatory drugs.
Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.
Inhibition of hexose monophosphate shunt in young erythrocytes by pyrimidine nucleotides in hereditary pyrimidine 5' nucleotidase deficiency.
Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Intraerythrocytic distribution of glucose-6-phosphate dehydrogenase (G-6-PD) in haemolytic anaemias.
Intragenic interspecific complementation of glucose 6-phosphate dehydrogenase in human-hamster cell hybrids.
Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells.
Is topical dapsone safe in glucose-6-phosphate dehydrogenase-deficient and sulfonamide-allergic patients?
Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature.
Laparoscopic cholecystectomy and postoperative pain control in a patient with chronic non-spherocytic hemolytic anemia from glucose-6-phosphate dehydrogenase deficiency.
Letters to the editor: Acute hemolytic anemia, G-6PD deficiency and viral hepatitis.
Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.
Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus).
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children.
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Mechanisms of perturbation of erythrocyte calcium homeostasis in favism.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Membrane characteristics and metabolic properties of glucose-6-phosphate dehydrogenase deficient red cells.
Membrane deformability of erythrocytes with glucose-6-phosphate dehydrogenase Hamburg.
Metabolic findings in the erythrocytes of cardiopathic and anaemic dogs.
Metabolism of human erythrocytes. Studies in health and disease.
Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
Metformin-Induced Hemolytic Anemia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency.
Methemoglobinemia and hemolytic anemia after COVID-19 infection without identifiable eliciting drug: A case-report.
Mild hemolysis in a girl with G6PD Sumaré (class I variant) associated with G6PD A-.
Modeling human glucose-6-phosphate dehydrogenase mutations using C. elegans GSPD-1.
Modelling primaquine-induced haemolysis in G6PD deficiency.
Molecular abnormality of a Japanese glucose-6-phosphate dehydrogenase variant (G6PD Tokyo) associated with hereditary non-spherocytic hemolytic anemia.
Molecular basis of chronic non-spherocytic haemolytic anaemia: a new G6PD variant (393 Arg----His) with abnormal KmG6P and marked in vivo instability.
Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.
Molecular characterisation of an Italian G6PD variant responsible for chronic non-spherocytic haemolytic anaemia.
Molecular Characterization of G6PD Deficiency: Report of Three Novel G6PD Variants.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran.
Molecular characterization of glucose-6-phosphate dehydrogenase variants from Brazil.
Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-).
Molecular Epidemiology of G6PD Genotypes in Different Ethnic Groups Residing in Saharan and Sahelian Zones of Mauritania.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Mexico: overall results of a 7-year project.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).
Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
Mutation analysis of glucose-6-phosphate dehydrogenase (G6PD) variants in Costa Rica.
N-acetyl cysteine, L-cysteine, and beta-mercaptoethanol augment selenium-glutathione peroxidase activity in glucose-6-phosphate dehydrogenase-deficient human erythrocytes.
Naphthalene-induced hemolytic anemia in a child with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.
Neonatal cholestasis and glucose-6-P-dehydrogenase deficiency.
Neonatal nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Danish infant.
Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway.
Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.
New glucose-6-phosphate dehydrogenase mutations associated with chronic anemia.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
Not the Typical Pneumonia: An Unusual Case of Rasburicase-induced Methomoglobinemia.
OCT Angiographic Findings in Glucose-6-Phosphate Dehydrogenase Deficiency.
Optimizing Measurement and Interpretation of the G6PD/Hb Ratio.
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation.
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
Ozone: a possible cause of hemolytic anemia in glucose-6-phosphate dehydrogenase deficient individuals.
Pancreatitis in acute hemolysis.
Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.
Pegloticase Induced Hemolytic Anemia in a Patient With G6PD Deficiency.
Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Pharmacogenetic considerations in the treatment of gout.
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Phenazopyridine-induced hemolytic anemia in a patient with G6PD deficiency.
Phenazopyridine-induced hemolytic anemia in G-6-PD deficiency.
Plasma and erythrocyte magnesium, manganese, zinc, and plasma calcium levels in G-6-PD-deficient and normal male children.
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Positive Impact of Clinical Audit on Appropriateness of Laboratory Investigations for Glucose-6-Phosphate Dehydrogenase-Deficient Patients in the Emergency Department.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency.
Possible potentiation of hemolytic anemia by tolbutamide. Report of a patient with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Prediction of functional consequences of the five newly discovered G6PD variations in Taiwan.
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Primaquine overdose in a toddler.
Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Rapid quantitative assays for glucose-6-phosphate dehydrogenase (G6PD) and hemoglobin combined on a capillary-driven microfluidic chip.
Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Rasburicase: a potent uricolytic agent.
Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome.
Reactivity of Blood Samples Spotted onto Filter Papers in the WST-8 Method for Screening of G6PD Deficiency.
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias.
Red cell enzymopathies as a model of inborn errors of metabolism.
Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population.
Relationship between erythrocyte glucose-6-phosphate dehydrogenase and the hemolytic anemia of infection.
Reticulocyte analysis in iron deficiency anemia and hemolytic anemia.
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use.
Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review.
Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in Lam Dong Province in southern Vietnam.
Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Severe hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency and Epstein-Barr virus infection.
Severe hemolytic anemia due to transient acquired G6PD deficiency after ingestion of sodium chlorite.
Severe hemolytic anemia in black children with glucose-6-phosphate dehydrogenase deficiency.
Severe jaundice in a patient with a previously undescribed glucose-6-phosphate dehydrogenase (G6PD) mutation and Gilbert syndrome.
Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).
Single dose primaquine in a preclinical model of G6PD deficiency: implications for use in malaria transmission blocking programs.
Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.
Sporadic G6PD deficiency with haemolytic anaemia in two children of West European ancestry.
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.
Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage.
Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence.
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
The ocular findings in glucose-6-phosphate dehydrogenase deficiency.
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency.
Three new electrophoretically normal glucose-6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: G6PD Ogikubo, Yokohama, and Akita.
Three new exon 10 glucose-6-phosphate dehydrogenase mutations.
Three new variants of glucose-6-phosphate dehydrogenase associated with chronic nonspherocytic hemolytic anemia: G-6-PD Lincoln Park, G-6-PD Arlington Heights, and G-6-PD West Town.
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells.
Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.
Treatment and prevention of malaria in children.
Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.
Two distinct Indian G6PD variants G6PD Jamnagar and G6PD Rohini caused by the same 949 G-->A mutation.
Two new glucose 6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: GD(-) Tokushima and GD(-) Tokyo.
Two new glucose-6 phosphate dehydrogenase (G6PD) variants associated with hemolytic anemia: G6PD Amman-1 and G6PD Amman-2.
Two new glucose-6-phosphate dehydrogenase mutations causing chronic hemolysis.
Two new mutations of the glucose-6-phosphate dehydrogenase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and molecular relationships.
Two new variants of glucose-6-phosphate dehydrogenase associated with hereditary non-spherocytic hemolytic anemia: G6PD Wayne and G6PD Huron.
Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients.
Two novel glucose-6-phosphate dehydrogenase variants found in newborn mass-screening for galactosaemia.
Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
Ultrasound-Guided Regional Anesthesia in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Geriatric Trauma Patient.
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient population.
Viral hepatitis with haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
[A case of acute hemolytic anemia caused by deficiency of glucose-6-phosphate dehydrogenase (G-6-PD) in erythrocytes]
[A case of new glucose 6-phosphate dehydrogenase (G-6-PD) variant with chronic nonspherocytic hemolytic anemia: G-6-PD Maebashi (author's transl)]
[A family of new glucose 6-phosphate dehydrogenase (G 6 PD) variant associated with chronic nonspherocytic hemolytic anemia: G 6 PD Kurume (author's transl)]
[Acute drug-induced hemolytic anemia in persons with congenital glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia after the consumption of fava beans. Familial case study on glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia consequent to administration of nitrofuran and novalgine, in 2 patients with erythrocytic glucose-6-phosphate dehydrogenase]
[Acute hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency (apropos of a case)]
[Acute hemolytic anemia in the course of spesis caused by Proteus morganii in a subject with erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Acute kidney failure and hemolytic anemia caused by erythrocytic G6PD dificit revealed by chloroquine administration]
[Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management]
[CHRONIC HEMOLYTIC ANEMIA WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Clinical Features and Laboratory Data Analysis of Glucose-6- Phosphate Dehydrogenase Deficiency].
[Congenital non spherocytic hemolytic anemia due to G-6PD deficiency: physiological and biochemical study of an unusual variant. Relationship to Benevento G-6PD]
[Congenital non spherocytic hemolytic anemia due to lack of glucose-6-phosphate dehydrogenase (G-6-PD)]
[Congenital nonspherocytic hemolytic anemia resulting from G-6-PD inactivity]
[Congenital nonspherocytic hemolytic anemia with deficiency of glucose-6-phosphate dehydrogenase]
[Congenital nonspherocytic hemolytic anemia, cataract and glucose-6-phosphate dehydrogenase deficiency]
[Consciousness disorders and severe haemolytic anaemia in a patient coming from overseas]
[Detection of a new anomalous variant of glucose-6-phosphate dehydrogenase in human erythrocytes]
[Diagnosis of hemolytic anemia with unstable hemoglobin]
[Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti]
[Early detection of color blindness from the viewpoint of occupational medicine with various references to internistic and human genetic symptom complexes]
[Electrophoretic and kinetic properties of the erythrocyte glucose-6-phosphate dehydrogenase of patients with hemolytic anemia related to a deficit in the activity of that enzyme]
[Enzyme-deficient hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a child of German descent]
[Erythrocytic enzymopathy in Uzbekistan].
[Familial study in a case of congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Federal District glucose-6-phosphate dehydrogenase Gd(-). A new variant associated with moderate enzyme deficiency and occasional hemolytic anemia]
[G-6-PD deficiency hemolytic anemia with abnormal BSP retention]
[G6PD deficiency in females with neonatal revelation. Report of four cases].
[Glucose-6-phosphate dehydrogenase (G6PD) deficiency--a cause of anaemia in pregnant women]
[Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia in a Danish boy]
[Glucose-6-phosphate dehydrogenase deficiency in an 81-year-old]
[Glucose-6-phosphate dehydrogenase deficiency in children: a case report].
[Glucose-6-phosphate dehydrogenase deficiency in Japan].
[Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report]
[Glucose-6-phosphate dehydrogenase deficiency, 1 of the forms of hemolytic anemia (review of the literature)]
[Glucose-6-phosphate dehydrogenase deficiency. Diagnosis during treatment of a mandibular fracture]
[Glucose-6-phosphate dehydrogenase type Schwaben. A new enzyme variant with spontaneous hemolytic anemia]
[Glucose-6-phosphate dehydrogenase]
[Hemolytic anemia after treatment with sulfamethoxypyridazine in a child with temporary G-6-PD deficiency and grave hypothyroidism]
[Hemolytic anemia associated with minor salmonellosis in an HIV positive, G6PD deficient Congolese woman]
[Hemolytic anemia based on congenital glucose-6-phosphate dehydrogenase deficiency in erythrocytes in the Taszhik SSR]
[Hemolytic anemia caused by association of a double anomaly: beta-thalassemia and deficiency of G6PD]
[HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G-6-PD) DEFICIENCY.]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency during typhoid fever]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]
[HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic anemia due to congenital glucose-6-phosphate dehydrogenase deficiency.]
[Hemolytic anemia due to G6PD deficiency. Apropos of 3 cases]
[Hemolytic anemia due to the dysfunction of the protection against oxidative attack]
[Hemolytic anemia in children caused by deficiency of the enzyme glucose-6-phosphate dehydrogenase in erythrocytes]
[Hereditary non-spherocytic hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Formation of an enzyme protein with modified characteristics in the blood cells of a German family]
[II. Chronic hemolytic anemia caused by erythrocytic deficiency of glucose-6-phosphate dehydrogenase (G6PD)]
[Impaired glutathione metabolism in hemolytic anemia]
[Lethal acute hemolytic anemia in viral hepatitis, caused by glucose-6-phosphate dehydrogenase deficiency]
[Letter: Hemolytic anemia after antibilharzia treatment with niridazole in an Antillean with G6PD deficiency]
[Macrolides in the treatment of children with Mediterranean spotted fever]
[Molecular analysis of glucose-6-dehydrogenase deficiency in Spain]
[Molecular-genetic studies of carrier stage of glucose-6-phosphate dehydrogenase deficiency]
[Neonatal hemolytic anemia due to G-6-PD deficiency in a family of the South-West. Detection of a double set of erythrocytes in heterozygotes]
[New anomalous variant of "Kremenchug" glucose-6-phosphate dehydrogenase linked to acute drug-induced hemolytic anemia]
[New variant of glucose-6-phosphate dehydrogenase (G-6-PD "Kaluga") from erythrocytes of a patient with chronic nonspherocytic hemolytic anemia]
[OBSERVATION OF A CASE OF ACUTE HEMOLYTIC ANEMIA RELATED TO A GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[ON A CASE OF HEMOLYTIC ANEMIA DUE TO SULFAMETHOXYPYRIDAZINE IN A SUBJECT WITH ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[On a rare form of glucose-6-phosphate dehydrogenase deficiency with congenital nonspherocytic hemolytic anemia]
[On case histories of acute hemolytic anemia in persons with glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[Plasmodium vivax, a parasite coming out of the shadows].
[Recurrence problems with preventive primaquine treatment in patients with malaria]
[Relations between chronic non-spherocytic hemolytic anemia and neonatal jaundice due to deficiency of glucose-6-phosphate dehydrogenase]
[Review of abnormal genes. II. Hereditary enzyme defects in the erythrocytes: drug-induced hemolytic anemia indirectly caused by glucose-6-phosphate dehydrogenase deficiency]
[Severe hemolytic anemia for the first time in a 42-year-old patient. Homozygote G-6-PD deficiency in a woman]
[Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase]
[The C1155G mutation of the red blood cell glucose-6-phosphate dehydrogenase gene in a subject with severe hereditary chronic nonspherocytic anaemia]
[The glucose-6-phosphate dehydrogenase/6-phosphogluconate dehydrogenase ratio in the identification of glucose-6-phosphate dehydrogenase heterozygosity]
[Tonsillectomy in a 6-year-old child with hemolytic anemia caused by erythrocytic glucose-6-phosphate dehydrogenase deficiency]
Anemia, Hemolytic, Autoimmune
Aortic valve replacement for a patient with glucose-6-phosphate dehydrogenase deficiency and autoimmune hemolytic anemia.
Autoimmune hemolytic anemia in a patient with a deficiency of red cell glucose-6-phosphate dehydrogenase activity.
Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia.
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
Serum ferritin in patients with various haemolytic disorders.
[Considerations on a case of autoimmune hemolytic anemia in the course of malignant granuloma with complete defect of erythrocyte glucose-6-phosphate dehydrogenase]
[Density-specific distribution of erythrocytes in different types of anemia]
Anemia, Hemolytic, Congenital
A new glucose-6-phosphate dehydrogenase variant (G6PD Nagano) associated with congenital hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant (G6PD Tsukui) associated with congenital hemolytic anemia.
A new variant of glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia, G6PD Cornell: erythrocyte, leukocyte, and platelet studies.
Congenital erythrocyte enzyme deficiencies.
G6PD Sendagi: a new glucose-6-phosphate dehydrogenase variant associated with congenital hemolytic anemia.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NONSPHEROCYTIC CONGENITAL HEMOLYTIC ANEMIA.
Hereditary hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency (Mediterranean type).
HEREDITARY HEMOLYTIC ANEMIA DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY; IMPROVEMENT FOLLOWING SPLENECTOMY AND FOLIC ACID THERAPY.
Hereditary hemolytic anemia due to glucose-6-phosphate dehydrogenase Torrance: a new variant.
Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Intra-erythrocytary enzymes before and after splenectomy.
Molecular aspects of erythroenzymopathies associated with hereditary hemolytic anemia.
Nonspherocytic congenital hemolytic anemia due to a new G-6-pd variant: g-6-pd alhambra.
Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.
[CONGENITAL HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Congenital hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Congenital hemolytic anemias with glutatione metabolism disorders (excluding glucose-6-phosphate dehydrogenase deficiency)]
[Electrophoretic and kinetic properties of the erythrocyte glucose-6-phosphate dehydrogenase of patients with hemolytic anemia related to a deficit in the activity of that enzyme]
[Glucose-6-phosphate dehydrogenase deficiency and hereditary hemolytic anemia]
[Glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia (author's transl)]
[Glucose-6-phosphate dehydrogenase deficiency in Japan].
[Hereditary hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency discovered in a 6-year-old child]
[Importance of the determination of glucose-6-phosphate dehydrogenase in the diagnosis of congenital hemolytic anemias]
[Non-spherocytic congenital hemolytic anemias due to G6PD deficiency. Clinical and hematologic aspects and mechanism of hyperhemolysis]
[Pathophysiology and laboratory tests of hemolytic anemia: with special reference to erythroenzymopathies]
Anemia, Hemolytic, Congenital Nonspherocytic
'Gd(-) Hôtel Dieu': a new G-6PD variant with chronic hemolysis in a Negro patient from Senegal.
A new glucose-6-phosphate dehydrogenase variant with congenital nonspherocytic hemolytic anemia (G6PD Genova). Biochemical characterization and mosaicism expression in the heterozygote.
Congenital nonspherocytic hemolytic anemia associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Japanese child. Clinical and metabolic studies.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase East Harlem: a new deficient variant.
Disorders in the metabolism of erythrocytes in a case of congenital nonspherocytic hemolytic anemia with glucose-6-phosphate dehydrogenase deficiency.
Four new electrophoretically slow-moving glucose 6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: Gd(-) Kurume, Gd(-) Fukushima, Gd(-) Yamaguchi and Gd(-) Wakayama.
G6Pd Kanazawa: a new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD San Francisco: a new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD Varadero. A new variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
G6PD-Puerto Limón: a new deficient variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia.
Gd(-) Rennes, a new deficient variant of glucose-6-phosphate dehydrogenase associated with congenital nonspherocytic hemolytic anemia found in France.
Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).
Three new electrophoretically normal glucose-6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: G6PD Ogikubo, Yokohama, and Akita.
Two new glucose 6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: GD(-) Tokushima and GD(-) Tokyo.
[Congenital nonspherocytic hemolytic anemia resulting from G-6-PD inactivity]
[Congenital nonspherocytic hemolytic anemia with deficiency of glucose-6-phosphate dehydrogenase]
[Congenital nonspherocytic hemolytic anemia, cataract and glucose-6-phosphate dehydrogenase deficiency]
[Familial study in a case of congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[On a rare form of glucose-6-phosphate dehydrogenase deficiency with congenital nonspherocytic hemolytic anemia]
Anemia, Hypochromic
Activity of glucose-6-phosphate dehydrogenase among Indians living in a malarial region of Mato Grosso and its implication to the Indian-mixed populations in Brazil.
Anemia, Iron-Deficiency
A hematological survey of preschool children of the United Arab Emirates.
Glucose 6-phosphate dehydrogenase, hexokinase activities and ATP levels as a function of cell density in thalassemia and iron deficiency anemia.
Growth-and Documentation-Deficits: Where To Start in Helping Families.
Plan and process for hematology laboratory standard in Thailand.
Prevalence of thalassaemia, iron-deficiency anaemia and glucose-6-phosphate dehydrogenase deficiency among Arab migrating nomad children, southern Islamic Republic of Iran.
Reticulocyte analysis in iron deficiency anemia and hemolytic anemia.
SPECIFIC INHIBITION OF HEPATIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN IRON DEFICIENCY ANEMIA IN ALBINO RATS.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
The investigation of plasma glucose-6-phosphate dehydrogenase, 6-phoshogluconate dehydrogenase, glutathione reductase in premenauposal patients with iron deficiency anemia.
[Density-specific distribution of erythrocytes in different types of anemia]
Anemia, Megaloblastic
Death from drug-induced hemolytic anemia.
Anemia, Pernicious
[Glucose-6-phosphate dehydrogenase activity of erythrocytes in pernicious anemia.]
[The importance of determination of ferritin levels in erythrocytes]
Anemia, Refractory
[Glucose-6-phosphate dehydrogenase activity in hemolytic and refractory anemias]
Anemia, Sickle Cell
50 Years Ago in The Journal of Pediatrics: The Hemolytic Crisis of Sickle Cell Disease: The Role of Glucose-6-Phosphate Dehydrogenase Deficiency.
A clinician's view of the mass screening of the newborn for inherited diseases: current practice and future considerations.
A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.
A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.
Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood.
Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological study.
Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.
Anemia and the liver. Hepatobiliary manifestations of anemia.
Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.
Association of homozygous sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency.
Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.
Biological impact of ? genes, ? haplotypes, and G6PD activity in sickle cell anemia at baseline and with hydroxyurea.
Birth control necessary to limit family size in tribal couples with aberrant heterosis of G-6-PD deficiency and sickle cell disorders in India: an urgency of creating awareness and imparting genetic counseling.
Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Campaign to control genetic blood diseases in Bahrain.
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Changing trends in malaria--a decade's experience at a referral hospital.
Clinical disorders of the red cell membrane skeleton.
Clinical significance of glucose-6-phosphate dehydrogenase deficiency in Nigerian patients with sickle cell disease.
Clinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices.
Complete repair of tetralogy associated with sickle cell anemia and G-6-PD deficiency.
Component therapy.
Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Does G gamma/A gamma ratio and Hb F level influence the severity of sickle cell anaemia.
Effect of alpha thalassaemia, G-6-PD deficiency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia.
Effect of G-6 PD deficiency on sickle cell disease in Saudi Arabia.
Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anaemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia.
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte ion channels in regulation of apoptosis.
Erythrocyte oxidative stress markers in children with sickle cell disease.
Erythrocyte reduced glutathione level in sickle cell anaemia and glucose-6-phosphate dehydrogenase deficient Saudi subjects.
Etiology and Outcomes of Thrombotic Microangiopathies.
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia.
G6PD deficiency and absence of ?-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.
G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.
Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift ?-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].
Genetic Blood Disorders Survey in the Sultanate of Oman.
Genetic compounds--Hb S, thalassaemias and enzymopathies: spectrum of interactions.
Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.
Glucose 6 phosphate dehydrogenase deficiency and hemoglobinopathy in South Western Region Nepal: a boon or burden.
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency in sickle cell disease by DNA analysis.
Glycosylated hemoglobin in Saudi sickle cell patients with glucose-6-phosphate dehydrogenase deficiency.
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.
Hereditary red blood cell disorders in middle eastern patients.
High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.
How I do in front of an hemolytic anemia of unknown etiology?
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.
Impaired pentose phosphate shunt function in sickle cell disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation.
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Interaction between glucose-6-phosphate dehydrogenase deficiency and sickle cell gene in Saudi Arabia.
Jordan: communities and community genetics.
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.
Management of Athletes With G6PD Deficiency: Does Missing an Enzyme Mean Missing More Games?
Mandibular nerve neuropathy in sickle cell disease. Local factors.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population.
Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.
Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE).
Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa.
Oxidative Stress and Suicidal Erythrocyte Death.
Pharmacoanthropology: outline, problems, and the nature of case histories.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.
Priapism in hematological and coagulative disorders: an update.
Pyruvate kinase deficiency in mice protects against malaria.
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method.
Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease.
Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam.
Red blood cell-derived microparticles: An overview.
Red cell genetic disorders and plasma lipids.
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
Sickle cell disease and glucose-6-phosphate dehydrogenase.
Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Sickle cell disease, G-6-PD deficiency, and jaundice.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.
Some roles of free radicals in malaria.
Thalassaemia is a tropical disease.
The burden of genetic disorders in India and a framework for community control.
The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease.
The effects of glucose-6-phosphate dehydrogenase deficiency on the haematological parameters and clinical manifestations in patients with sickle cell anaemia.
The hemolytic crisis of sickle cell disease: the role of glucose-6-phosphate dehydrogenase deficiency.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.
[Association of a triple genetic erythrocyte defect: thalassemia, sickle cell disease and glucose-6-phosphate dehydrogenase deficiency in a child of Calabro-Sardinian origin]
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
[Etiology of hemolytic anemia]
[Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo)]
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population.]
[Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote]
Anemia, Sideroblastic
Hereditary sideroblastic anemia and glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Sideroblastic anemia segregating with glucose-6-phosphate dehydrogenase deficiency.
Aneurysm
Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
[Enzyme activity in post-infarct aneurysm and in the myocardial zone outside the infarct in experimental infarct in rats]
Antiphospholipid Syndrome
The epidemiology of recurrent pregnancy loss.
Aortic Coarctation
Influence of aortic coarctation on myocardial glucose-6-phosphate dehydrogenase.
Apnea
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Arnold-Chiari Malformation
G6PD Deficiency with Arnold-Chiari Malformation.
Arrhythmias, Cardiac
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
[Biochemical markers of strophanthin arrhythmia]
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Arsenic Poisoning
[Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity in arsenic poisoning and in hypoxemia caused by sodium nitrite.]
Arteriosclerosis
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
Arthritis
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
Enzyme histochemical reactions in unfixed and undecalcified cryostat sections of mouse knee joints with special reference to arthritic lesions.
Green tea extract improves the oxidative state of the liver and brain in rats with adjuvant-induced arthritis.
Arthritis, Experimental
GdX/UBL4A-knockout mice resist collagen-induced arthritis by balancing the population of Th1/Th17 and regulatory T cells.
Arthritis, Rheumatoid
Effect of 4-Methyl-Phenyl Biguanide on Free Radical Homeostasis and Activity of Oxidative Metabolism Enzymes in Rats with Cardiovascular Pathology Developing against the Background of Rheumatoid Arthritis.
Metabolic alterations in human synovial lining cells in pigmented villonodular synovitis.
Metabolic Insight of Neutrophils in Health and Disease.
Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome.
Ascorbic Acid Deficiency
Phagocytosis and leukocyte enzymes in ascorbic acid deficient guinea pigs.
Asthma
Asthma and oxidant stress: nutritional, environmental, and genetic risk factors.
Differentially expressed serum proteins in children with or without asthma as determined using isobaric tags for relative and absolute quantitation proteomics.
Protein-protein interaction network analysis and identifying regulation microRNAs in asthmatic children.
The effect of dapsone in steroid-dependent asthma.
[Activity of glucose-6-phosphate dehydrogenase in erythrocytes in patients with atopic asthma and allergic rhinitis]
Astrocytoma
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Asymptomatic Infections
Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.
Ataxia Telangiectasia
A case of ataxia telangiectasia with unbalanced glucose 6-phosphate dehydrogenase mosaicism in the granulocytic/monocytic lineages.
Combined metabolic and transcriptional profiling identifies pentose phosphate pathway activation by HSP27 phosphorylation during cerebral ischemia.
Does Ataxia Telangiectasia Mutated (ATM) protect testicular and germ cell DNA integrity by regulating the redox status?
Pentose phosphate pathway activation via HSP27 phosphorylation by ATM kinase: A putative endogenous antioxidant defense mechanism during cerebral ischemia-reperfusion.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Atherosclerosis
Clonal nature of atherosclerotic plaques.
Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity.
Estradiol prevents homocysteine-induced endothelial injury in male rats.
Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes.
Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.
Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases.
Mosaicism in female hybrid hares heterozygous for glucose-6-phosphate dehydrogenase (G-6-PD). I. General properties of a hybrid hare model with special reference to atherogenesis.
Mosaicism in female hybrid hares heterozygous for glucose-6-phosphate dehydrogenase. IV. Aortic atherosclerosis in hybrid hares fed alternating cholesterol-supplemented and nonsupplemented diets.
Population dynamics of arterial cells during atherogenesis. X. Study of monotypism in atherosclerotic lesions of black women heterozygous for glucose-6-phosphate dehydrogenase (G-6-PD).
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects.
Atypical Hemolytic Uremic Syndrome
Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
Autoimmune Diseases
Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.
Avitaminosis
[Erythrocytic G-6-PD activity in experimental avitaminosis C]
Babesiosis
Isoenzyme patterns of glucose-6-phosphate dehydrogenase, malate dehydrogenase and lactate dehydrogenase in Babesia rodhaini and Babesia microti.
Bacteremia
Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Bacterial Infections
A prospective study of the role of bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria.
Bacterial infections in children with glucose-6-phosphate dehydrogenase deficiency.
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function.
Glucose-6-phosphate dehydrogenase deficiency and bacterial infections in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and infection: a study of hospitalized patients in Iran.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Meldola Blue for the cytochemical demonstration of leukocyte dehydrogenases.
Multiple leukocyte abnormalities in chronic granulomatous disease: a familial study.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
The metabolic and phagocytic activities of leukocytes from patients receiving corticosteroid and radiation therapy, and patients with bacterial infections.
[Change of G6PD Activity in Children with Acute Leukemia and Its Clinical Significance].
Bartonella Infections
Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?
beta-Thalassemia
A hematological survey of preschool children of the United Arab Emirates.
Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).
beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants.
Biochemical genetics and mental retardation: a study of hemoglobins, Australia antigen and the enzymes pseudocholinesterase and glucose-6-phosphate dehydrogenase.
Ceramide in suicidal death of erythrocytes.
Coinheritance of Rotor syndrome, G-6-PD deficiency, and heterozygous beta thalassemia: a possible genetic interaction.
Distribution of beta-thalassemia trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency in the Markham River Valley of New Guinea.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Elevated red blood cell 2,3-diphosphoglycerate levels in black blood donors.
Eryptosis: Ally or Enemy.
Erythrocyte programmed cell death.
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Genetic resistance to malaria, oxidative stress and hemoglobin oxidation.
HbE-beta-thalassemia associated with G6PD deficiency.
Hematologic genetic disorders among Southeast Asian refugees.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Hemoglobin A2, E and F levels and the incidence of hemoglobin E, beta-thalassemia, and glucose-6-phosphate dehydrogenase deficiency in lymphoma.
Hemolysis following transfusion of erythrocytes from a donor with G6PD deficiency and beta-thalassemia minor.
Hereditary red cell disorders in Southeast Asian refugees and the effect on the prevalence of thalassemia disorders in the United States.
Inborn defects in the antioxidant systems of human red blood cells.
Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives.
Influence of hemoglobin E trait on the severity of Falciparum malaria.
Innate resistance to malaria: the intraerythrocytic cycle.
Jordan: communities and community genetics.
Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Occupational lead exposure, G-6PD deficiency and beta-thalassemia trait.
Osmotic hemolysis is a donor-specific feature of red blood cells under various storage conditions and genetic backgrounds.
Pathogenesis of anemia in malaria: a concise review.
Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews.
Progressive peroneal muscular atrophy (Charcot-Marie-Tooth disease) associated with beta-thalassemia trait and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. A clinical and nerve biopsy case.
Pyruvate kinase deficiency in mice protects against malaria.
Red blood cell-derived microparticles: An overview.
Red cell acid phosphatase activity in carriers of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency.
Red cell membrane protein in thalassemia and glucose-6-phosphate dehydrogenase deficiency anemia.
Redox and energetic state of red blood cells in G6PD deficiency, heterozygous beta-thalassemia and the combination of both.
Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray.
Sickle cell hemoglobin, beta-thalassemia and G6PD deficiency in tribes of Maharashtra, India.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
The interaction between beta-thalassemia, G-6-PD deficiency, and favism.
Use and safety of elevated dosages of vitamin E in adults.
X-linked dyskeratosis congenita with pancytopenia.
[Aspects of the decrease of some enzyme activities in erythrocytes of subjects with beta-thalassemia]
[Beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency]
[CONGENITAL AND RECESSIVE METHEMOGLOBINEMIA. ITS ASSOCIATION WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THALASSEMIA MINOR.]
[Detection of combined forms of hemoglobino- and enzymopathies in newborns]
[Genetico-epidemiological and molecular investigation of G-6-PD deficiency in a Brazilian community]
[Hemolytic anemia caused by association of a double anomaly: beta-thalassemia and deficiency of G6PD]
[Incidence of beta-thalassemia carriers and those deficient in erythrocyte glucose-6-phosphate dehydrogenase in the greater Buenos Aires area]
[Interrelation between beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency and characteristics of the clinico-hemato-logic indices when the 2 are combined]
[Study of the enzymatic activities in the erythrocytes and platelets of subjects with Mediterranean anemia. V. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities of thalassemic platelets]
[The importance of determination of ferritin levels in erythrocytes]
Biotinidase Deficiency
Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
Neonatal biochemical screening for disease.
bisphosphoglycerate mutase deficiency
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Blackwater Fever
Blackwater fever at the Kenyatta National Hospital in Kenya: a case report.
Falciparum malaria--present day problems. An experience with 425 cases.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.
The role of glucose-6-phosphate dehydrogenase deficiency in blackwater fever.
Blast Crisis
Red cell enzymopathies in leukemias.
Blepharitis
Epidemiology and Associated Morbidity of Pterygium: A Large, Community-Based Case-Control Study.
Blindness
Close linkage of fragile X-mental retardation syndrome to haemophilia B and transmission through a normal male.
Genetic linkage between X-chromosome markers and bipolar affective illness.
Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X.
Minireview: Molecular genetics in affective illness.
New linkage data for the X-linked types of muscular dystrophy and G6PD variants, colour blindness, and Xg blood groups.
Xq28: epidemiology and sex-linkage between red-green colour blindness and G6PD deficiency.
[Geographic distribution maps of human genes in China]
Blister
Blister and bite cells in G6PD deficiency.
New Diagnosis of G6PD Deficiency Presenting as Severe Rhabdomyolysis.
Blood Group Incompatibility
Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.
Comprehensive newborn screening program: ARAMCO experience, the national need and recommendations.
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.
Evaluation of a new end-tidal carbon monoxide monitor from the bench to the bedside.
Genetic polymorphisms in Thai neonates with hyperbilirubinemia.
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Prenatal Training Improves New Mothers' Understanding of Jaundice.
Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
Bone Resorption
Microcytophotometric analysis of human osteoclast metabolism: lack of activity in certain oxidative pathways indicates inability to sustain biosynthesis during resorption.
Boutonneuse Fever
Glucose-6-phosphate dehydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia.
Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency.
[Malignant mediterranean boutonneuse fever in a patient with partial glucose-6-phosphate dehydrogenase deficiency]
Bradycardia
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Brain Diseases
Autistic feature as a presentation of Inborn Errors of Metabolism.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Viral hepatitis with extreme hyperbilirubinemia, massive hemolysis and encephalopathy in a patient with a new G6PD variant.
Brain Injuries
G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway.
Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway.
Brain Ischemia
G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: The pros and cons.
Pentose phosphate pathway activation via HSP27 phosphorylation by ATM kinase: A putative endogenous antioxidant defense mechanism during cerebral ischemia-reperfusion.
Redistribution of glucose-6-phosphate dehydrogenase in response to cerebral ischemia in rat brain.
[Glucose-6-phosphate dehydrogenase and catalase in the erythrocytes of patients with cerebral ischemia attacks]
Brain Neoplasms
Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Breast Diseases
Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours.
Breast Neoplasms
Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Characterization of epithelial cell islets in primary monolayer cultures of human breast carcinomas by the tetrazolium reaction for glucose 6-phosphate dehydrogenase.
Effect of branched-chain fatty acids on fatty acid biosynthesis of human breast cancer cells.
Effect of oxygen on the tetrazolium reaction for glucose 6-phosphate dehydrogenase in cryosections of human breast carcinoma, fibrocystic disease and normal breast tissue.
Effects of 17 beta-estradiol and R5020 on glucose-6-phosphate dehydrogenase activity in MCF-7 human breast cancer cells: a cytochemical assay.
Erythrocyte antioxidant enzyme activity in CMF treated breast cancer patients.
Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Estradiol receptors and glucose-6-phosphate dehydrogenase activity in human breast tumors.
Estrogenic effects of phenolic compounds on glucose-6-phosphate dehydrogenase in MCF-7 cells and uterine glutathione peroxidase in rats.
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
G6PD deficiency and breast cancer.
Glucose-6-phosphate dehydrogenase activity and estrogen receptors in human breast cancer.
Glucose-6-phosphate dehydrogenase activity in human breast cancer. Lack of association with oestrogen receptor content.
Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell metabolic reprogramming and correlate with poor patient outcome.
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Glycolaldehyde induces apoptosis in a human breast cancer cell line.
Glycolytic enzymes in human breast carcinoma cytosols: the influence of commonly used reference parameters.
Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism.
Identification of malignant cells in primary monolayer cultures of human breast tumors.
Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease.
P-cadherin induces anoikis-resistance of matrix-detached breast cancer cells by promoting pentose phosphate pathway and decreasing oxidative stress.
Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours.
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.
Relative value of oestrogen receptor assay, lactoferrin content, and glucose-6-phosphate dehydrogenase activity as prognostic indicators in primary breast cancer.
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report.
Safe neoadjuvant trastuzumab-based treatment in HER2?+?inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.
Sex steroid hormone modulation of NADPH pathways in MCF-7 cells.
Stimulatory effect of 1,25-dihydroxyvitamin D3 on the glucose-6-phosphate dehydrogenase activity in the MCF-7 human breast cancer cell line.
Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance.
The correlation of cytologic degree of differentiation of infiltrative ductal breast carcinoma and cytochemical activity of glucose-6-phosphate dehydrogenase.
Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.
[A study on the relationship among estrogen receptor, progesterone receptor and glucose-6-phosphate dehydrogenase activity in primary breast cancer]
[Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase in breast tumors]
[Histo- and cytochemical enzymatic characteristics of breast cancer]
Bronchial Spasm
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies.
Bronchopneumonia
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Brucellosis
Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Burkitt Lymphoma
Glucose-6-phosphate dehydrogenase (G-6-PD) markers in Burkitt lymphoma and other malignancies.
Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma.
[Hematologic characteristics in Black Africa]
Candidiasis, Oral
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Carcinogenesis
A new lease of life for an old enzyme.
Adaptational changes in kinetic parameters of G6PDH but not of PGDH during contamination-induced carcinogenesis in livers of North Sea flatfish.
Arginase and glucose-6-phosphate dehydrogenase activities in spontaneous mammary carcinogenesis.
c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity.
Colorectal Cancer Mortality in Relation to Glucose - 6 - Phosphate Dehydrogenase Deficiency and Consanguinity in Sardinia: A Spatial Correlation Analysis
Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity.
Development of oxygen insensitivity of the quantitative histochemical assay of G6PDH activity during colorectal carcinogenesis.
Early lesions during pancreatic carcinogenesis induced in Syrian hamster by DHPN or DOPN. I. Histologic, histochemical and radioautographic findings.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice.
Immunohistochemical demonstration of increased glucose-6-phosphate dehydrogenase in preneoplastic and neoplastic lesions induced by propylnitrosamines in F344 rats and Syrian hamsters.
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides.
Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance.
Investigation of Pokemon-regulated proteins in hepatocellular carcinoma using mass spectrometry-based multiplex quantitative proteomics.
LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis.
Long-term dehydroepiandrosterone and 16alpha-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats.
miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Premorphological metabolic changes in human breast carcinogenesis.
Rhubarb granule promotes diethylnitrosamine-induced liver tumorigenesis by activating the oxidative branch of pentose phosphate pathway via G6PD in rats.
Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
Studies of tumor cell origins in mosaics.
Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway.
Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Carcinoma
5' structure and expression of human glucose-6-phosphate dehydrogenase mRNA.
A cytochemical study of the livers of rats treated with diethylnitrosamine/phenobarbital, with benzidine/phenobarbital, with phenobarbital, or with clofibrate.
Adaptational changes in kinetic parameters of G6PDH but not of PGDH during contamination-induced carcinogenesis in livers of North Sea flatfish.
Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation.
Carbohydrate metabolism in human renal clear cell carcinomas.
Characterization of epithelial cell islets in primary monolayer cultures of human breast carcinomas by the tetrazolium reaction for glucose 6-phosphate dehydrogenase.
Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma.
Clonal xenobiotic resistance during pollution-induced toxic injury and hepatocellular carcinogenesis in liver of female flounder (Platichthys flesus (L.)).
Combined efficacy of tamoxifen and coenzyme Q10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer.
Comparison of enzyme phenotypes in human bladder tumours and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder. A combined histochemical and immunohistochemical approach.
Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.
Correlative histochemical studies on preneoplastic and neoplastic lesions in the kidney of rats treated with nitrosamines.
Cytochemical assay of glucose-6-phosphate dehydrogenase in koilocytes.
DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma.
Effect of Semecarpus anacardium Linn. nut milk extract on glutathione and its associated enzymes in experimentally induced mammary carcinoma.
Enzymatic characteristics of tubular adenomas and carcinomas of the large intestine.
Enzyme activities and level of SH groups in breast carcinomas.
Enzyme activities in human breast tumours.
Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines.
Focal hepatic glycogenosis.
G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS?MAPK axis pathway.
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3.
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?
Genetic variants of glucose-6-phosphate dehydrogenase in the study of carcinoma of the cervix.
Glucose-6-phosphate dehydrogenase (G6PD) activity in tumoral tissues of G6PD-deficient subjects affected by larynx carcinoma.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase and lactate dehydrogenase isoenzynes in rodent mammary carcinomas and the effect of oophorectomy.
Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Glucose-6-phosphate dehydrogenase: a possible clinical indicator for prostatic carcinoma.
Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis.
Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
Histochemistry and cytochemistry of glucose-6-phosphate dehydrogenase.
Histogenesis of dieldrin and DDT-induced hepatocellular carcinoma in Balb/c mice.
Inhibition of glucose-6-phosphate dehydrogenase from Ehrlich ascites carcinoma by ATP.
Loss of peroxisomes causes oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity to detect cancer cells.
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.
Multiple molecular forms of glucose-6-phosphate dehydrogenase in normal, preneoplastic, and neoplastic mammary tissues of mice.
Multiple molecular forms of lactate dehydrogenase and glucose 6-phosphate dehydrogenase in normal and abnormal human breast tissues.
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Novel evidence for oncogenic piRNA-823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Reactive oxygen species in cancer, too much or too little?
Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species.
Renal cell carcinoma and oxidative stress: The lack of peroxisomes.
Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast.
Sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine.
Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
The correlation of membranous glycoprotein-gp-170, cytoplasmic glutathione and glucose-6-phosphate dehydrogenase levels with multidrug resistance in transitional cell carcinoma cell lines of the urinary tract.
The effect of low temperature on the enzyme activities and the level of SH groups in benign gastric ulcer and gastric carcinoma.
The histochemical G6PDH reaction but not the LDH reaction with neotetrazolium is suitable for the oxygen sensitivity test to detect cancer cells.
[Clinical studies on glucose-6-phosphate dehydrogenase in women with carcinoma of the cervix]
[Effects of glucose-6-phosphate dehydrogenase expression down-regulation on cell apoptosis and invasion ability in cutaneous squamous cell carcinoma A431 cells].
[Glucose-6-phosphate dehydrogenase and succinate dehydrogenase in metastatic cells of Lewis lung carcinoma]
[Histochemical and biochemical comparative study of glucose-6-phosphate dehydrogenase in cutaneous epitheliomas. Preliminary note]
[Histocytospectrophotometric characteristics of lung cancer]
[Histoenzymatic studies of cervical carcinoma. II. Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, TPN diaphorase and DPN diaphorase]
Carcinoma, Basal Cell
Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma.
Carcinoma, Ductal
Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast.
Carcinoma, Ehrlich Tumor
Enzyme activities of six different dehydrogenases in Ehrlich ascites cells measured by flow cytometry.
Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development.
Carcinoma, Hepatocellular
A case of minimal deviation hepatoma in man with elevated liver-type pyruvate kinase isozyme.
BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas.
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Control of the NADPH supply for oxidative stress handling in cancer cells.
Cross-reacting material to monoclonal anti-G6PD in the absence of catalytic activity.
Distribution and partial purification of a liver membrane protein capable of inactivating cytosol enzymes.
Ecotoxicological evaluation of diethanolamine using a battery of microbiotests.
Elevated activity of the oxidative and non-oxidative pentose phosphate pathway in (pre)neoplastic lesions in rat liver.
Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
Examination of HeLa cell contamination of human cell lines derived from primary hepatomas using glucose-6-phosphate dehydrogenase and lactate dehydrogenase isozymes.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
Glucose-6-phosphate dehydrogenase activity in a hepatoma cell line: preliminary evidence for negative genetic control.
Glucose-6-phosphate dehydrogenase deficiency and malignant hepatoma in a Bantu population.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
Hepatic preneoplasia in hepatitis B virus transgenic mice.
Increased glucose 6-phosphate dehydrogenase concentration in hepatoma 3924A: enzymic and immunological evidence.
Metabolic adaptations in rat hepatomas. V. Reciprocal relationship between threonine dehydrase and glucose-6-phosphate dehydrogenase.
miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell.
Overexpression of glucose-6-phosphate-dehydrogenase in rat hepatic preneoplasia and neoplasia.
Post-translational regulation of glucose-6-phosphate dehydrogenase activity in (pre)neoplastic lesions in rat liver.
Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers.
Reactive oxygen species in cancer, too much or too little?
Subchromosomal localization and order of GLA, PGK1, HPRT, and G6PD loci on the X chromosome of the American mink (Mustela vison).
The associated reactivation of two X-linked genes. The spontaneous and azacytidine-induced reexpression of ornithine transcarbamoylase and glucose-6-phosphate dehydrogenase in a rat hepatoma.
Uridine and cytidine nucleotide synthesis in renal hypertrophy: biochemical differences in response to the growth stimulus of diabetes and unilateral nephrectomy.
[Activities of dehydrogenases of the pentose phosphate pathway and transketolase in transplanted mouse hepatomas with different growth rates and in organs of tumor carriers]
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
[Glucose-6-phosphate dehydrogenase isoenzymes in the liver and hepatomas of mice]
[Properties of glucose-6-phosphate dehydrogenase of the liver tissue of intact rats and rats with Zaidel ascitic hepatoma]
Carcinoma, Lewis Lung
[Glucose-6-phosphate dehydrogenase and succinate dehydrogenase in metastatic cells of Lewis lung carcinoma]
Carcinoma, Medullary
Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma.
Carcinoma, Merkel Cell
Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Carcinoma, Non-Small-Cell Lung
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer.
The TGF?1-FOXM1-HMGA1-TGF?1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression.
Carcinoma, Pancreatic Ductal
Enhanced citrate synthase activity in human pancreatic cancer.
Carcinoma, Renal Cell
Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation.
Characterization of an established cell line from human renal carcinoma.
G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS?MAPK axis pathway.
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3.
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Silent information regulator 2 promotes clear cell renal cell carcinoma progression through deacetylation and small ubiquitin-related modifier 1 modification of glucose 6-phosphate dehydrogenase.
Carcinoma, Small Cell
[Histocytospectrophotometric characteristics of lung cancer]
Carcinoma, Squamous Cell
Glucose-6-phosphate dehydrogenase and the histogenesis of epidermoid carcinoma of the cervix.
[Effects of glucose-6-phosphate dehydrogenase expression down-regulation on cell apoptosis and invasion ability in cutaneous squamous cell carcinoma A431 cells].
[Histocytospectrophotometric characteristics of lung cancer]
Carcinoma, Transitional Cell
Comparison of enzyme phenotypes in human bladder tumours and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder. A combined histochemical and immunohistochemical approach.
The correlation of membranous glycoprotein-gp-170, cytoplasmic glutathione and glucose-6-phosphate dehydrogenase levels with multidrug resistance in transitional cell carcinoma cell lines of the urinary tract.
Cardiac Tamponade
Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency.
Cardiomegaly
Glucose-6-phosphate dehydrogenase is critical for suppression of cardiac hypertrophy by H
Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice.
Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart.
Cardiomyopathies
Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice.
The NADPH metabolic network regulates human ?B-crystallin cardiomyopathy and reductive stress in Drosophila melanogaster.
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart.
Cardiomyopathy, Alcoholic
Effect of chronic ethanol treatment under partial catalase inhibition on the activity of enzymes related to peroxide metabolism in rat liver and heart.
Cardiomyopathy, Dilated
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart.
Cardiotoxicity
Protective role of DLalpha-lipoic acid against adriamycin-induced cardiac lipid peroxidation.
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.
Cardiovascular Diseases
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is linked with cardiovascular disease.
Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGF?/NADPH Oxidases/ROS Signaling Pathway.
Glucose-6-phosphate dehydrogenase deficiency and metabolic profiling in adolescence from the Chinese birth cohort: "Children of 1997".
Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study.
Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.
Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases.
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms.
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.
Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency.
Occupational lead exposure and screening of glucose-6-phosphate dehydrogenase polymorphism: useful prevention or nonvoluntary discrimination?
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects.
Superoxide Production by NAD(P)H oxidase and Mitochondria is Increased in Genetically Obese and Hyperglycemic Rat Heart and Aorta Prior to Cardiac ...
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.
[Glucose-6-phosphate-dehydrogenase deficiency management in western countries. A literature review].
Castleman Disease
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Cataract
Alphab-crystallin-assisted reactivation of glucose-6-phosphate dehydrogenase upon refolding.
Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Bilateral cataracts associated with glucose-6-phosphate dehydrogenase deficiency.
Blood and lens lipid peroxidation and antioxidant status in normal individuals, senile and diabetic cataractous patients.
Cataracts in glucose-6-phosphate dehydrogenase deficiency.
Cataracts in Glucose-6-phosphate Dehydrogenase Deficiency.
Changes in erythrocyte glucose-6-phosphate dehydrogenase (G6PD) and reduced glutathione (GSH) activities in the development of senile and diabetic cataracts.
Changes in glutathione, glutathione-linked enzymes and hexose monophosphate shunt enzymes in senile cataract.
Decreased Glucose-6-PhosphateDehydrogenase (G6PD) Activity and Risk of Senile Cataract in Taiwan.
Effects of antioxidant supplementation on mRNA expression of glucose-6-phosphate dehydrogenase, ?-actin and 18S rRNA in the anterior capsule of the lens in cataract patients.
Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies.
Erythrocyte glutathione concentrations in diabetics with cataracts, with and without glucose-6-phosphate dehydrogenase deficiency.
Fructose induced deactivation of glucose-6-phosphate dehydrogenase activity and its prevention by pyruvate: implications in cataract prevention.
G6PD deficiency in senile cataracts.
Genetic localization and phenotypic expression of X-linked cataract (Xcat) in Mus musculus.
Glucose 6-phosphate dehydrogenase deficiency and cataract of patients in northern Sardinia.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part I.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part II.
Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency and senile cataract in a Sardinian male population, Italy.
Glucose-6-phosphate dehydrogenase deficiency and cataracts.
Glucose-6-phosphate dehydrogenase deficiency and idiopathic presenile cataract in Dalmatia, Croatia.
Glucose-6-phosphate dehydrogenase deficiency and incidence of cataract in Sicily.
Glucose-6-phosphate dehydrogenase deficiency with bilateral cataract.
Grape seed extract and Zinc containing nutritional food supplement delays onset and progression of Streptozocin-induced diabetic cataract in Wistar rats.
GSSG-reducing activity in lenses deficient in glucose-6-phosphate dehydrogenase.
Increased incidence of cataracts in male subjects deficient in glucose-6-phosphate dehydrogenase.
India-US case-control study of age-related cataracts. India-US Case-Control Study Group.
Letter: cataracts with a glucose-6-phosphate dehydrogenase variant.
Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes.
Quantitative cytochemistry of enzymes in the epithelium of ageing rat lenses.
Recent epidemiologic studies on nutrition and cataract in India, Italy and the United States.
Red blood cells and serum antioxidant defense systems of galactosaemic children.
Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. The Italian-American Cataract Study Group.
Senile cataract and glucose-6-phosphate dehydrogenase deficiency in Indians.
The effect of diabetes mellitus and diabetic therapy on cataract formation.
The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study.
The study of G6PD in erythrocyte and lens in senile and presenile cataract.
[Cataract and glucose-6-phosphate dehydrogenase deficiency in Sardinians]
[Congenital nonspherocytic hemolytic anemia, cataract and glucose-6-phosphate dehydrogenase deficiency]
Catatonia
Catatonia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Report of Two Cases and a Review.
Cerebral Infarction
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.
Cerebral Palsy
Anaesthetic management in a child with an atypical triad for reconstructive scoliosis surgery.
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Cerebrovascular Disorders
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration.
Cervical Intraepithelial Neoplasia
Cytochemical assay of glucose-6-phosphate dehydrogenase in koilocytes.
Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia.
Chagas Disease
Comparative study of enzymes in testes and ovaries from adult Dipetalogaster maximus (Uhler) and triatoma infestans (Klug) (Hemiptera: Reduviidae). correlation with fine structural organization.
Development of Selective Steroid Inhibitors for the Glucose-6-phosphate Dehydrogenase from Trypanosoma cruzi.
Discovery of new uncompetitive inhibitors of glucose-6-phosphate dehydrogenase.
The identification by isoenzyme patterns of two distinct strain-groups of Trypanosoma cruzi, circulating independently in a rural area of Brazil.
Chalazion
Epidemiology and Associated Morbidity of Pterygium: A Large, Community-Based Case-Control Study.
Charcot-Marie-Tooth Disease
Progressive peroneal muscular atrophy (Charcot-Marie-Tooth disease) associated with beta-thalassemia trait and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. A clinical and nerve biopsy case.
CHARGE Syndrome
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
Chediak-Higashi Syndrome
A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndrome.
Congenital disorders of the function of polymorphonuclear neutrophils.
Chemical and Drug Induced Liver Injury
[Catalytic properties of 6-phosphogluconate dehydrogenase from rat liver in normal state and during toxic hepatitis]
[Regulatory properties of glucose-6-phosphate dehydrogenase from rat liver under conditions of the intensification of free-radical oxidation stimulated by toxic hepatitis]
[Thioctic acid action on glutathione-dependent antioxidant system functioning at toxic hepatitis of rats]
Chickenpox
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Cholangiocarcinoma
Intestinal metaplasia and altered enzyme expression in propylnitrosamine-induced Syrian hamster cholangiocellular and gallbladder lesions.
Cholecystitis
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report.
Cholecystolithiasis
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report.
Cholelithiasis
Effects of variant UDP-glucuronosyltransferase 1A1 gene, glucose-6-phosphate dehydrogenase deficiency and thalassemia on cholelithiasis.
Gilbert syndrome.
Increased prevalence of glucose-6-phosphate dehydrogenase deficiency in patients with cholelithiasis.
Cholestasis
Assessment of potential donors for living related liver transplantation.
Cooperating G6PD mutations associated with severe neonatal hyperbilirubinemia and cholestasis.
Jaundice associated with lobar pneumonia. A clinical, laboratory and histological study.
Metabolic changes in rat brain histaminergic neurons during subhepatic cholestasis.
STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis.
Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.
[Activity of carbohydrate metabolism enzyme activity in normal and pathologic parodontal tissues]
Cholestasis, Extrahepatic
[Concentration of components of the adenylate system in the liver during cholestasis]
Cholestasis, Intrahepatic
Glucose-6-phosphate dehydrogenase deficiency and lobar pneumonia. Fine structure of the liver.
Cholesteatoma
A comparative study of enzyme histochemical features in the gerbilline and human cholesteatoma.
Ciliary Motility Disorders
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Cleidocranial Dysplasia
Genetic disorders in Southern Africa.
coagulation factor ixa deficiency
Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site.
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree.
The human genes for hemophilia A and hemophilia B flank the X chromosome fragile site at Xq27.3.
Coinfection
Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Colitis
Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Colitis, Ulcerative
In vivo effects of curcumin on the paraoxonase, carbonic anhydrase, glucose-6-phosphate dehydrogenase and ?-glucosidase enzyme activities in dextran sulphate sodium-induced ulcerative colitis mice.
Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
Colonic Neoplasms
Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity.
Modulation of pentose phosphate pathway during cell cycle progression in human colon adenocarcinoma cell line HT29.
NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism.
PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth.
[Effects of miR-335-5p targeting G6PD on proliferation and apoptosis of colon cancer cells].
Color Vision Defects
A case-control study of primary hepatocellular carcinoma in Taiwan.
Congenital X-linked incomplete achromatopsia. Evidence for slow progression, carrier fundus findings, and possible genetic linkage with glucose-6-phosphate dehydrogenase locus.
Evidence against close linkage of unipolar affective illness to human chromosome 11p markers HRAS1 and INS and chromosome Xq marker DXS52.
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree.
Genetic studies of the Seneca Indians: haptoglobins, transferrins, G-6-PD deficiency, hemoglobinopathy, color blindness, morphological traits and dermatoglyphics.
Linkage analysis of bipolar illness with X-chromosome DNA markers: a susceptibility gene in Xq27-q28 cannot be excluded.
Linkage disequilibrium between glucose-6-phosphate dehydrogenase deficiency and congenital color blindness in Turkish population.
Old and new genetics help ordering loci at the telomere of the human X-chromosome long arm.
Studies on hemophilia A in Sardinia bearing on the problems of multiple allelism, carrier detection, and differential mutation rate in the two sexes.
The ocular findings in glucose-6-phosphate dehydrogenase deficiency.
Triplo-X constitution of mother explains apparent occurrence of two recombinants in sibship segregating at two closely X-linked loci (G6PD and deutan).
X-chromosome markers and manic-depressive illness. Rejection of linkage to Xq28 in nine bipolar pedigrees.
[Frequency of color blindness and glucose-6-phosphate dehydrogenase enzyme deficiency in non-industrialized populations in the state of Nuevo León, México]
Colorectal Neoplasms
Aspirin inhibits glucose?6?phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites.
Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy.
c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration.
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Prognostic estimation of survival of colorectal cancer patients with the quantitative histochemical assay of G6PDH activity and the multiparameter classification program CLASSIF1.
Coma
[Energy metabolic changes and nerve cell damage in rats exposed to multiple administration of large-dose insulin].
Communicable Diseases
Community-acquired acute kidney injury in Asia.
Dental Considerations in Children with Glucose-6-phosphate Dehydrogenase Deficiency (Favism): A Review of the Literature and Case Report.
Glucose-6-phosphate dehydrogenase deficiency.
How I do in front of an hemolytic anemia of unknown etiology?
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors.
[Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management]
Condylomata Acuminata
Viral "tumorigenesis" in man: cell markers in condylomata acuminata.
Confusion
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects.
Congenital Abnormalities
Congenital defects of the central nervous system associated with hyperendemic goiter in a neolithic highland society of Netherlands New Guinea II. Glucose-6-phosphate dehydrogenase in the mulia population.
Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
Congenital Hypothyroidism
A neonatal screening in Lebanon: Results of five years' experience.
Adequacy and pitfalls of G6PD deficiency counseling in Hong Kong.
Alpha-1-antitrypsin deficiency in babies with prolonged jaundice.
Comprehensive newborn screening program: ARAMCO experience, the national need and recommendations.
Current and future perspective of newborn screening: an Indian scenario.
Neonatal screening and monitoring system in Taiwan.
Neonatal screening in Hong Kong and Macau.
Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in India.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Newborn screening in the Philippines.
Newborn screening: need of the hour in India.
Preliminary report on neonatal screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency: a Chandigarh experience.
Prevention of intellectual and other disabilities: the Singapore experience.
The status of neonatal screening in China, 2013.
[Congenital hypothyroidism missed on newborn screening: report of two cases]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Cloning and biochemical characterization of three glucose?6?phosphate dehydrogenase mutants presents in the Mexican population.
Congenital X-linked incomplete achromatopsia. Evidence for slow progression, carrier fundus findings, and possible genetic linkage with glucose-6-phosphate dehydrogenase locus.
Coproporphyria, Hereditary
[Hereditary coproporphyria with grand mal epilepsy, glucose-6-phosphate dehydrogenase deficiency and phenobarbital tolerance]
Coronary Artery Disease
Impact of glucose-6-phosphate dehydrogenase deficiency on the severity of coronary atherosclerosis in patients with acute coronary syndromes.
Coronary Disease
Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease.
Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits.
[Disorders of myocardial metabolism in sudden coronary death in the presence of coronary atherosclerosis: findings of quantitative histoenzymologic studies]
Coronavirus Infections
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Cough
Community-acquired Acinetobacter pneumonia: a case report.
COVID-19
"Hemolysis, or not Hemolysis, that is the Question". Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency.
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
COVID-19 & Hydroxychloroquine side-effects: Glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients.
Evaluation of glucose-6-phosphate dehydrogenase (G6PD) status in US military and VA patients with COVID-19 infection.
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost.
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana.
Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
Glucose-6-phosphate dehydrogenase deficiency and COVID-19 mortality.
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.
The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution.
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
Crigler-Najjar Syndrome
Phenotype heterogeneity of hyperbilirubinemia condition: the lesson by coinheritance of glucose-6-phosphate dehydrogenase deficiency and Crigler-Najjar syndrome type II in an Italian patient.
Crohn Disease
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
Crohn's disease and G-6-PD deficiency.
G-6-pd deficiency and Crohn's disease.
Regional enteritis and glucose-6-phosphate dehydrogenase deficiency.
Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Cryptorchidism
Gene mapping and serendipity. The locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430, Mckusick) is at Xq28, distal to the G6PD locus.
Cystic Fibrosis
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
A Rare Case of Short-Chain Acyl-COA Dehydrogenase Deficiency: The Apparent Rarity of the Disorder Results in Under Diagnosis.
Adaptations of Pseudomonas aeruginosa to the cystic fibrosis lung environment can include deregulation of zwf, encoding glucose-6-phosphate dehydrogenase.
Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Clinical experience with multigene carrier panels in the reproductive setting.
Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs.
Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?
Genetic screening for low-penetrance variants in protein-coding genes.
Gilbert syndrome.
Glucose 6-phosphate dehydrogenase deficiency and cystic fibrosis.
Jordan: communities and community genetics.
Neonatal biochemical screening for disease.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Understanding human disease mutations through the use of interspecific genetic variation.
Cysts
Growth performance, meat quality and activities of glycolytic enzymes in the blood and muscle tissue of calves infected with Sarcocystis cruzi.
Histoenzymological study of selected dehydrogenase enzymes in Pneumocystis carinii.
Some glucose metabolic enzymes in various fractions of sarcocysts of Sarcocystis fusiformis of buffalo (Bubalus bubalis).
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
[Periapical odontogenic processes of inflammatory origin. Enzyme activity]
cytochrome-b5 reductase deficiency
Red cell enzymes.
The laboratory use of butylnitrite for the production of methemoglobin.
Cytomegalovirus Infections
Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency.
Cytomegalovirus infection and hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency.
Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Deafness
Glucose 6-phosphate dehydrogenase deficiency with kernicterus: progressive late recovery from profound deafness.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
[Infantile transitory distal renal tubular acidosis with bicarbonate loss]
Deficiency Diseases
Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.
Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review.
Reference levels for glucose-6-phosphate dehydrogenase enzyme activity in infants 7-90 days old in Taiwan.
Dehydration
Changes in globus pallidus with (pre)term kernicterus.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Neurological complications of kernicterus.
The role of glutathione in yeast dehydration tolerance.
The subfornical organ: biochemical and neuroendocrine comparisons with the hypothalamo-neurohypophysial system.
Therapeutic potential of manipulating suicidal erythrocyte death.
[Effect of dehydration on lipid metabolism]
[The hormonal status and carbohydrate-energy metabolism of rats after the long-term action of low doses of ionizing radiation and heat]
Delirium
Glucose-6-phosphate dehydrogenase deficiency with psychosis.
Dementia
Acute Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency Complicated by Ginkgo biloba.
Glucose-6-phosphate dehydrogenase a novel hope on a blood-based diagnosis of Alzheimer's disease.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Dengue
A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD São Paulo) and polymorphic G6PD variants in São Paulo State, Brazil.
A typical presentation of dengue fever in a G6PD deficient patient: A case report.
Atypical dengue Fever in a splenectomized boy with glucose-6- phosphodehydrogenase deficiency and thalassemia intermedia.
Comments on Sameed Ullah Qureshi et al (J Pak Med Assoc. 2019 69:1553-1556) A typical presentation of dengue fever in a G6PD deficient patient: A case report.
Dengue Virus Type 2 (DENV2)-Induced Oxidative Responses in Monocytes from Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient and G6PD Normal Subjects.
Development of a Method to Control the RNA Extraction and Reverse Transcription Steps for the Detection of Dengue Virus Present in Human Blood Samples.
Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever.
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency.
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.
Response to Comments on Sameed Ullah Qureshi et al (J Pak Med Assoc. 2019 69:1553-1556) A typical presentation of dengue fever in a G6PD deficient patient: A case report.
Dental Caries
Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates.
Dermatitis, Allergic Contact
Diet in dermatology: revisited.
Dermatitis, Atopic
Diet in dermatology: revisited.
[Activity of pyruvate kinase and glucose-6-phosphate dehydrogenase in polymorphonuclear granulocytes of patients with atopic dermatitis in the active stage and in remission]
Dermatofibrosarcoma
[Enzyme patterns in connective tissue proliferations (author's transl)]
Diabetes Complications
Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice.
Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
Molecular chaperones protect against glycation-induced inactivation of glucose-6-phosphate dehydrogenase.
Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.
Diabetes Mellitus
Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice.
Assessment of potential donors for living related liver transplantation.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus in ethnic groups of Singapore.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus.
Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency.
Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.
Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus.
Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another.
Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies.
Epidemiology of clinical hyperbilirubinaemia in Al Ain, United Arab Emirates.
Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes.
Erythrocyte Glucose-6-Phosphate Dehydrogenase Level in Type 2 Diabetes Male.
Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.
Further studies of haemoglobin glycosylation: influence of diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency in Nigerians.
G6PD deficiency and diabetes mellitus in northern Sardinian subjects.
G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus.
Genetic disorders in Southern Africa.
Glucose-6-Phosphate Dehydrogenase Activity and Protein Oxidative Modification in Patients with Type 2 Diabetes Mellitus.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus.
Glucose-6-Phosphate Dehydrogenase Deficiency Diagnosed in an Adolescent with Type 1 Diabetes Mellitus and Hemoglobin A1c Discordant with Blood Glucose Measurements.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
[Features of disruption of certain components of carbohydrate metabolism in a combination of pulmonary tuberculosis and diabetes mellitus in people with haptoglobin phenotypes]
[Lactate dehydrogenase and glucose-6-phosphate dehydrogenase activity in the erythrocytes in diabetes mellitus]
[On the activity of erythrocyte glucose-6-phosphate dehydrogenase in diabetes mellitus]
[The regulation of glucose-6-phosphate dehydrogenase and glycogen synthase activities by insulin superfamily peptides in myometrium of pregnant women and its impairments under different types of diabetes mellitus]
Diabetes Mellitus, Experimental
Effect of alloxan diabetes and cortisol on glucose-6-phosphate dehydrogenase and transketolase in rabbit liver mitochondria.
The effects of alloxan diabetes, insulin and epinephrine on glucose-6-phosphate dehydrogenase from rat liver and brain.
Tissue distribution of glucose-6-phosphate dehydrogenase isoenzymes and the effect of alloxan diabetes and insulin.
[Activity of hexokinase and glucose-6-phosphate dehydrogenase in hemopoietic cells of the bone marrow in normal rabbits and after hydrocortisone administration during starvation and alloxan diabetes]
[Isoenzymic composition of glucose-6-phosphate dehydrogenase of subcellular fractions of rabbit tissues under alloxan diabetes]
Diabetes Mellitus, Type 1
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency.
Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs.
Glucose-6-Phosphate Dehydrogenase Deficiency Diagnosed in an Adolescent with Type 1 Diabetes Mellitus and Hemoglobin A1c Discordant with Blood Glucose Measurements.
Glucose-6-phosphate dehydrogenase deficiency induced haemolysis in a woman with newly diagnosed diabetes after normalisation of hyperglycaemia.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
Neonatal hyperbilirubinaemia is associated with a subsequent increased risk of childhood-onset type 1 diabetes.
[The regulation of glucose-6-phosphate dehydrogenase and glycogen synthase activities by insulin superfamily peptides in myometrium of pregnant women and its impairments under different types of diabetes mellitus]
Diabetes Mellitus, Type 2
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus in ethnic groups of Singapore.
Caveolin-1 upregulation in diabetic fibroblasts and wounded tissues: implication for understanding the underlying mechanisms of non-healing diabetic ulcers.
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
Diet, diabetes, hypertension and blacks.
Erythrocyte Glucose-6-Phosphate Dehydrogenase Level in Type 2 Diabetes Male.
Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.
G6PD up-regulation promotes pancreatic beta-cell dysfunction.
Glucose-6-Phosphate Dehydrogenase Activity and Protein Oxidative Modification in Patients with Type 2 Diabetes Mellitus.
Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes.
Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.
High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.
Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.
Real-time monitoring of glucose-6-phosphate dehydrogenase activity using liquid droplet arrays and its application to human plasma samples.
Superoxide Production by NAD(P)H oxidase and Mitochondria is Increased in Genetically Obese and Hyperglycemic Rat Heart and Aorta Prior to Cardiac ...
Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
[The regulation of glucose-6-phosphate dehydrogenase and glycogen synthase activities by insulin superfamily peptides in myometrium of pregnant women and its impairments under different types of diabetes mellitus]
Diabetes, Gestational
Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes.
[The regulation of glucose-6-phosphate dehydrogenase and glycogen synthase activities by insulin superfamily peptides in myometrium of pregnant women and its impairments under different types of diabetes mellitus]
Diabetic Ketoacidosis
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Diabetic ketoacidosis revealing glucose-6-phosphate dehydrogenase deficiency: description of an adult case.
Diabetic Ketoacidosis Revealing Severe Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D) Deficiency with Methemoglobinemia: A Case Report.
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES.
G-6-PD hemolytic anemia complicating diabetic ketoacidosis.
G6PD deficiency-induced hemolysis in a Chinese diabetic patient: a case report with clinical and molecular analysis.
Glucose-6-Phosphate Dehydrogenase Deficiency Unveiled by Diabetic Ketoacidosis: A Dual Dilemma.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency.
[Erythrocytic glucose-6-phosphate dehydrogenase deficiency, hemolysis and diabetic ketoacidosis]
Diabetic Nephropathies
Glucose 6-phosphate dehydrogenase and the kidney.
Diabetic Retinopathy
Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy.
Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
DiGeorge Syndrome
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
Disseminated Intravascular Coagulation
Consumption coagulopathy following haemolytic crisis in glucose-6-phosphate dehydrogenase deficient subjects.
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
Diverticulum
Enzymatic and histopathologic biomarkers as indicators of contaminant exposure and effect in Asian clam (Potamocorbula amurensis).
Down Syndrome
Alpha-1-antitrypsin deficiency in babies with prolonged jaundice.
Congenital disorders of the function of polymorphonuclear neutrophils.
Glucose-6-phosphatedehydrogenase is also increased in erythrocytes from adolescents with Down syndrome.
Leucocyte alkaline phosphatase and erythrocyte glucose-6-phosphate dehydrogenase in Down's Syndrome.
Neonatal jaundice associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a non-Mediterranean Caucasian infant with trisomic Down's Syndrome.
Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
The burden of genetic disorders in India and a framework for community control.
[A 12-week physical activity program increases glucose-6-phosphate-dehydrogenase activity in Down syndrome adolescents]
[Cellular enzymes and mongolism. Study on the glucose-6-phosphate dehydrogenase erythrocytes activity]
[Thermal sensitivity of enzymes in trisomy 21 leukocytes]
Drug Eruptions
Diet in dermatology: revisited.
Drug-Related Side Effects and Adverse Reactions
Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency.
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Drug-induced hemolytic anemia: Pharmacological aspects.
Duodenal Ulcer
Glucose-6-phosphate dehydrogenase deficiency and duodenal ulcer.
[Characteristics of the pentose phosphate pathway of carbohydrate metabolism in the gastric mucosa of persons with peptic ulcer]
Dysautonomia, Familial
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Dyslipidemias
The impact of hydroxycitric acid on the lipid metabolism profile under experimental insulin resistance syndrome of Syrian hamsters.
Dyspnea
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
Precautionary Measures for Successful Open Heart Surgery in G6PD Deficient Patient- A Case Report.
Dystonia
Anesthetic Management of a Child With Severe Dystonia and G6PD Deficiency for Deep Brain Stimulation.
Ectodermal Dysplasia
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
X-mapping in man: evidence against measurable linkage between anhidrotic ectodermal dysplasia and G6PD deficiency.
Ectodermal Dysplasia 1, Anhidrotic
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Elliptocytosis, Hereditary
Abnormal haemoglobin, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in North Sumatra, Indonesia.
Abnormal hemoglobins, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Dayaks of Sarawak.
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Ok Tedi impact region of Papua New Guinea.
Hemoglobinopathies, G6PD deficiency, and hereditary elliptocytosis in Bahrain.
Hereditary elliptocytosis (the first report in Thailand) in association with erythrocyte glucose-6-phosphate dehydrogenase deficiency and hemoglobin E.
Hereditary spherocytosis is associated with decreased pyruvate kinase activity due to impaired structural integrity of the red blood cell membrane.
Red blood cell-derived microparticles: An overview.
Endocarditis
Clonal structure of Streptococcus sanguinis strains isolated from endocarditis cases and the oral cavity.
Endometrial Neoplasms
The effects of medroxyprogesterone acetate on enzyme activities in human endometrial carcinoma.
Endotoxemia
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.
Endotoxin stimulates the expression of glucose-6-phosphate dehydrogenase in Kupffer and hepatic endothelial cells.
Enterocolitis
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Enterocolitis, Necrotizing
Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis?
Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
Epilepsy
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
[Genetic questionnaire. Genetic counseling for a patient with the complex association of G-6-PD deficiency, Gronblad-Strandberg syndrome (pseudo-xanthoma elasticum) and epilepsy]
[Hereditary coproporphyria with grand mal epilepsy, glucose-6-phosphate dehydrogenase deficiency and phenobarbital tolerance]
Epilepsy, Tonic-Clonic
[Hereditary coproporphyria with grand mal epilepsy, glucose-6-phosphate dehydrogenase deficiency and phenobarbital tolerance]
Epstein-Barr Virus Infections
Severe hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency and Epstein-Barr virus infection.
Erythema
Epidermal changes in human skin following irradiation with either UVB or UVA.
Erythema Infectiosum
[Aplastic crisis due to human parvovirus B19 infection in glucose-6-phosphate dehydrogenase deficiency]
Esophageal Neoplasms
Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice.
Esophageal Squamous Cell Carcinoma
DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.
Essential Hypertension
An increase in a circulating inhibitor of Na+,K+-dependent ATPase: a possible link between salt intake and the development of essential hypertension.
Effect of hemicholinium-3 on the hypothalamic concentration of a cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating substance.
Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension.
The relation of the natriuretic hormone to essential hypertension.
[Intraerythrocyte levels of glucose-6-phosphate dehydrogenase in patients with essential arterial hypertension and persons with normal blood pressure. Modifications after nifedipine therapy]
Fabry Disease
Fabry Disease and G6PD in Three Family Members with Priapism: Is the Nitric Oxide Pathway to Blame?
Reexpression of HPRT activity following cell fusion with polyethylene glycol.
Familial Mediterranean Fever
Clinical experience with multigene carrier panels in the reproductive setting.
Jordan: communities and community genetics.
Familial Primary Pulmonary Hypertension
Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
Fanconi Anemia
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Superoxide dismutase and other biochemical disorders in a family with Fanconi's anemia.
Fatty Liver
Assessment of potential donors for living related liver transplantation.
Biochemical changes associated with the fatty liver syndrome in cows.
Biochemical changes in liver and blood during liver fattening in rats.
Some lipogenic enzyme activities in rat livers in which an excessive fat accumulation occurred due to feeding low-level amino acid mixture diets.
Favism
A comprehensive study on the major mutations in glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in the coastal provinces of Caspian Sea in the north of Iran.
A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism.
A novel G6PD gene variant in a Chinese girl with favism.
A practical toxicity bioassay for vicine-convicine levels in faba bean (Vicia faba).
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency.
Acute renal failure in favism revealing familial glucose-6-phosphate dehydrogenase deficiency.
Ahaptoglobinemia in Favism patients from Iran.
An unusual syncope cause in the ED: Favism.
Association between ACP(1) genetic polymorphism and favism.
At least five polymorphic mutants account for the prevalence of glucose-6-phosphate dehydrogenase deficiency in Algeria.
Biochemical characterization of a glucose-6-phosphate dehydrogenase variant with favism: G-6-PD Zähringen.
Clinical Manifestations and Therapeutic Findings of the Children with Glucose-6-Phosphate Dehydrogenase Deficiency Presenting Favism.
Common G6PD variant from Saudi population and its prevalence.
Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs.
Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.
Evaluating of ?-carotene role in ameliorating of favism-induced disturbances in blood and testis.
Ex Vivo Study of Laban's Role in Decreasing Hemolysis Crisis in G6PD-Deficient Patients.
Family investigations of erythrocyte glucose-6-phosphate dehydrogenase in favism.
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.
Favism in a female newborn infant whose mother ingested fava beans before delivery.
Favism in a Portuguese family due to a deficient glucose-phosphate dehydrogenase variant (Canton) or (cpanton-like) type.
Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-).
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Favism-induced methemoglobinemia in a G6PD deficient male with a subsequent hemolytic cascade, a therapeutic challenge: Case report and review of literature.
Favism: divicine hemotoxicity in the rat.
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
G6PD Aures: a new mutation (48 Ile-->Thr) causing mild G6PD deficiency is associated with favism.
G6PD deficiency and fava bean consumption do not produce hemolysis in Thailand.
G6PD deficiency and favism in the island of Rhodes (Greece).
G6PD deficiency: An update.
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
Gas Chromatography/Mass Spectrometry-Based Metabolomic Profiling Reveals Alterations in Mouse Plasma and Liver in Response to Fava Beans.
Gd(-) Muret and gd(-) Colomiers, two new variants of glucose-6-phosphate dehydrogenase associated with favism.
Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism.
Glucose-6-phosphate dehydrogenase activity during cytodifferentiation of the haemopoietic system. Studies on red and white cells in patients with favism.
Glucose-6-phosphate dehydrogenase deficiency in Sicily. Incidence, biochemical characteristics and clinical implications.
Glucose-6-phosphate dehydrogenase variants associated with favism in thai children.
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases.
Haemopexin behaviour in an acute hyperhaemolytic crisis secondary to favism (erythrocyte glucose-6-phosphate dehydrogenase deficiency).
Haptoglobin therapy for acute favism: a Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara.
Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism.
Hemolytic crises of favism in Sicilian females heterozygous for G-6-PD deficiency.
Hepatic transcriptional profiling response to fava bean-induced oxidative stress in glucose-6-phosphate dehydrogenase-deficient mice.
Heterogeneity of "Mediterranean type" glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain and description of two new variants associated with favism.
Heterozygote detection in glucose-6-phosphate dehydrogenase deficiency: limitation of hair follicle analysis.
High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms.
Identification of Mediterranean mutation in Egyptian favism patients.
Independent origin of single and double mutations in the human glucose 6-phosphate dehydrogenase gene.
Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism.
Leucocyte glucose-6-phosphate dehydrogenase (g-6-pd) activity in g-6-pd deficient subjects.
Malaria, favism and glucose-6-phosphate dehydrogenase deficiency.
Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.
Mechanism of action of divicine in a cell-free system and in glucose-6-phosphate dehydrogenase-deficient red cells.
Mechanisms of perturbation of erythrocyte calcium homeostasis in favism.
Medical expenses of patients with Favism admitted to 17th Shahrivar Hospital compared to G6PD enzyme screening cost, in north of Iran.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran.
Molecular genetics of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Spain: identification of two new point mutations in the G6PD gene.
Molecular heterogeneity underlying the G6PD Mediterranean phenotype.
Molecular identification of mutations in G6PD gene in patients with favism in Iran.
Neonatal jaundice in Saudi newborns with G6PD Aures.
Oxidative stress and antioxidant defense in Egyptian favism patients.
Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency.
Possible fenugreek induced haemolysis in a patient with previously unknown G6PD deficiency.
Prevalence of Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Population of Western Turkey.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.
Supplementation of ?-Tocopherol Attenuates Minerals Disturbance, Oxidative Stress and Apoptosis Occurring in Favism.
Tf, Gc and Cp phenotypes in favism and G-6-PD deficiency.
The erythroenzymopathies. With particular reference to glucose-6-phosphate dehydrogenase deficiency and favism.
The interaction between beta-thalassemia, G-6-PD deficiency, and favism.
The ocular findings in glucose-6-phosphate dehydrogenase deficiency.
The Protective Role of Anise Oil in Oxidative Stress and Genotoxicity Produced in Favism.
Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran.
Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy.
[A cytochemical study of the enzyme glucose-6-phosphate dehydrogenase in favism]
[A search for glucose-6-phosphate dehydrogenase deficiency, among Toros Seljouck Turks, in both normal and pathological conditions. The explanation of hemolytic anemias seen, in snake bite and poisonous insect bites cases. Three cases of favism and hemolytic syndrome]
[ACTION OF THE STROMA ON ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN NORMAL HUMAN SUBJECTS AND SUBJECTS WITH A HISTORY OF FAVISM.]
[Biochemical characterization of a new variant of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency with favism: G-6-PD Bielefeld (author's transl)]
[Broad beans as a cause of acute hemolytic anemia]
[Deficiency of the enzyme glucose-6-phosphate dehydrogenase, favism, malario-resistance and the pathogenesis of certain types of jaundice.]
[Determination of glucose-6-phosphate dehydrogenase (G6PD) in the thrombocytes of children with ictero-hemoglobinuric favism]
[Family studies of erythrocyte glucose-6-phosphate dehydrogenase in favism]
[Favism (study of 8 families)]
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. FURTHER OBSERVATIONS IN ANOTHER SPANISH FAMILY.]
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. STUDY OF THIS ENZYMATIC DISTURBANCE IN A SPANISH FAMILY.]
[FAVISM IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE INACTIVITY. REPORT ON 3 CASES OBSERVED IN GERMANY.]
[Favism, hemoglobin H, alpha-thalassemia and hemoglobinopathy in various Sardinian families. Studies on glucose-6-phosphate dehydrogenase]
[Favism, hemolytic attacks caused by drugs and grave neonatal jaundice in populations with high incidence of G-6-PD deficiency]
[Favism, hemolytic crises and severe jaundice of the newborn infant in the population with increased G-6-PD deficiency]
[Favism: hemolytic crisis due to glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[Favism]
[Gene Mutants and Their Clinical Characteristics of G6PD Deficiency Among Children in Luzhou Area].
[Glucose-6-phosphate dehydrogenase activity in the erythrocytes of children with favism, during and at various intervals after the hemolytic attack]
[Glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type B minus. 1. Favism in childhood]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. APROPOS OF A CASE OF FAVISM.]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]
[Hereditary transmission of glucose-6-phosphate dehydrogenase deficiency (G-6-PD) in the granulocytes and erythrocytes of 3 Sardinian families with a history of favism]
[Molecular analysis of glucose-6-dehydrogenase deficiency in Spain]
[New aspects of the biochemical alterations in the erythrocytes of patients with favism; almost complete absence of glucose-6-phosphate dehydrogenase.]
[New contributions on the subject of the bio-enzymology of ictero-hemoglobinuric favism. Note 3. Glucose-6-phosphate dehydrogenase activity of the hepatic parenchyma.]
[Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism]
[Study of the relationships between hereditary transmission of the erythrocytic thrombocytic deficiency of glucose-6-phosphate dehydrogenase in Sardinian subjects with favism]
[Variations in enzymatic patterns in G6PD deficiency and favism]
Febrile Neutropenia
Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Fetal Diseases
Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.
Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Oxidative damage in chemical teratogenesis.
Fetal Growth Retardation
Antioxidants activities and concentration of selenium, zinc and copper in preterm and IUGR human placentas.
Fetal Hypoxia
[Antioxidant enzymes activity of erythrocytes and indicators of blood hemodynamics of normal and hypoxic newborns in their first day of life]
Fetal Macrosomia
Epigenetic modification of the pentose phosphate pathway and the IGF-axis in women with gestational diabetes mellitus.
Fetal Resorption
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
Fetomaternal Transfusion
Hematologic disorders and nonimmune hydrops fetalis.
Fibroadenoma
Relative value of oestrogen receptor assay, lactoferrin content, and glucose-6-phosphate dehydrogenase activity as prognostic indicators in primary breast cancer.
Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast.
Fibroma
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
[Enzyme patterns in connective tissue proliferations (author's transl)]
Filariasis
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
Foot Rot
Reference gene selection for quantitative PCR studies in sheep neutrophils.
Fragile X Syndrome
Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?
Fragile X syndrome: search for phenotypic manifestations at loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase.
Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.
Galactosemias
A Rare Case of Short-Chain Acyl-COA Dehydrogenase Deficiency: The Apparent Rarity of the Disorder Results in Under Diagnosis.
Detection of inborn errors of metabolism in 1,117 patients studied because of suspected inherited disease.
Diet in dermatology: revisited.
False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency.
Multiplex tandem mass spectrometry assay for newborn screening of X-linked adrenoleukodystrophy, biotinidase deficiency, and galactosemia with flexibility to assay other enzyme assays and biomarkers.
Neonatal biochemical screening for disease.
Neonatal screening and monitoring system in Taiwan.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Newborn screening in the Philippines.
Screening for galactosemia and glucose-6-phosphate dehydrogenase deficiency in newborn infants.
Two novel glucose-6-phosphate dehydrogenase variants found in newborn mass-screening for galactosaemia.
[Congenital hypothyroidism missed on newborn screening: report of two cases]
[Hereditary galactosemia in rats: biochemical mechanisms of the disease]
Gallstones
Gall stones, G-6PD deficiency and Wilson's disease.
Gallstones due to hereditary spherocytosis with glucose-6-phosphate dehydrogenase deficiency.
Ganglion Cysts
Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats.
Gardner Syndrome
Multiclonal origin of polyps in Gardner syndrome.
Gastroesophageal Reflux
Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.
Gastrointestinal Neoplasms
Antioxidant enzyme levels in cases with gastrointesinal cancer.
Gaucher Disease
Genetic screening for low-penetrance variants in protein-coding genes.
Genetic Diseases, Inborn
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Abnormal haemoglobins, thalassaemia and G-6-PD enzyme deficiency in Rajasthan (western-India).
Adverse effects of herbal or dietary supplements in G6PD deficiency: A systematic review.
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Antioxidant vitamins and glucose-6-phosphate dehydrogenase deficiency in full-term neonates.
Cation channels, cell volume and the death of an erythrocyte.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Chemical toxicity of red cells.
Cost-benefit analysis of G6PD screening in Lebanese newborn males.
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Different effects of 26-week dietary intake of rapeseed oil and soybean oil on plasma lipid levels, glucose-6-phosphate dehydrogenase activity and cyclooxygenase-2 expression in spontaneously hypertensive rats.
Differentiation of hair growth cycle from scalp hair roots for the diagnosis of glucose-6-phosphate dehydrogenase deficiency in neonates.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Epigenetic therapy reprograms hereditary disease.
Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?
G6PD deficiency: An update.
G6PD deficiency: the genotype-phenotype association.
Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.
Glucose-6-phosphate dehydrogenase deficiency in internationally adopted children.
Glucose-6-phosphate dehydrogenase deficiency--a genetic disorder of red cell metabolism.
Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hereditary disorders in the Eastern Mediterranean Region.
High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
Human red blood cell polymorphisms prevalent in Colombian population and its protective role against malaria.
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Insertion/Deletion polymorphisms do play any role in G6PD deficiency individuals in the Kingdom of the Saudi Arabia.
Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C.
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Methemoglobinemia in an elderly patient with glucose-6-phosphate dehydrogenase deficiency: a case report.
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Multiplex primer extension reaction screening and oxidative challenge of glucose-6-phosphate dehydrogenase mutants in hemizygous and heterozygous subjects.
Neonatal screening program for G6PD deficiency in India: need and feasibility.
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.
Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus.
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Present status of understanding on the G6PD deficiency and natural selection.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method.
Reappraisal of known malaria resistance loci in a large multicenter study.
Red cell genetic disorders and plasma lipids.
Severe Rhabdomyolysis in Glucose-6-Phosphate Dehydrogenase Deficiency.
Sickle cell haemoglobin, thalassaemia and G-6-PD enzyme deficiency genes in Garasiya tribe inhabited malaria endemic areas of Sirohi District, Rajasthan (India).
Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females.
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Two novel glucose 6-phosphate dehydrogenase deficiency mutations and association of such mutations with F8C/G6PD haplotype in Chinese.
Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[PCR-single-strand conformation (SSCP), DNA direct sequencing analysis in detecting mutation in exon 2 of g6pd gene]
[Research Progress in Acute Hemolysis and Safe Blood Transfusion of Glucose-6-Phosphate Dehydrogenase Deficiency-Review].
[The client's viewpoint on genetic counseling. Acceptability of the service in an Oristanese community (Cabras)]
Gilbert Disease
Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert's syndrome.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus-normal neonates.
Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.
Gilbert syndrome.
Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.
Gilbert's syndrome associated with glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome: a gene interaction underlies severe jaundice without severe hemolysis.
Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome.
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Severe jaundice in a patient with a previously undescribed glucose-6-phosphate dehydrogenase (G6PD) mutation and Gilbert syndrome.
Study of a family in the province of Matera presenting with glucose-6-phosphate dehydrogenase deficiency and Gilbert's syndrome.
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.
The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels.
[Glucose-6-phosphate dehydrogenase deficiency, neonatal hyperbilirubinemia and Gilbert syndrome]
Glioblastoma
Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.
PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3.
Glioma
ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.
Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.
Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels.
Enzymes related to energy metabolism in human gliomas.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin ?-2 Expression, and Induce Antitumor Effects against Human Glioma.
Histochemical evaluation of energy metabolism in rat glioma.
HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.
Inhibition of IRE1 modifies hypoxic regulation of G6PD, GPI, TKT, TALDO1, PGLS and RPIA genes expression in U87 glioma cells.
Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure.
Regulation of the pentose phosphate pathway in human astrocytes and gliomas.
Glomerulonephritis
Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature.
Dialytic support in acute renal failure.
Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria.
[Arterial hypertension in glomerulonephritis]
Glucose Intolerance
Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle.
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis.
Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action.
Intracellular metabolism in biopsies from the aorta in patients undergoing coronary bypass surgery.
Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
"COMPLETE" ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
"Hemolysis, or not Hemolysis, that is the Question". Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency.
'Gd(-) Hôtel Dieu': a new G-6PD variant with chronic hemolysis in a Negro patient from Senegal.
(TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates.
(TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates.
1376G-->T mutation of G6PD gene in Han and Li nationalities in Hainan, China.
16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity.
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
3'-UTR variations and G6PD deficiency.
50 Years Ago in The Journal of Pediatrics: The Hemolytic Crisis of Sickle Cell Disease: The Role of Glucose-6-Phosphate Dehydrogenase Deficiency.
50 Years Ago in The Journal of Pediatrics: The Relationship of Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency to Hyperbilirubinemia in Negro Premature Infants.
59Fe study of red blood cells life span in glucose-6-phosphate dehydrogenase deficiency heterozygote.
6-Phosphogluconate dehydrogenase deficiency in an Italian family.
6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.
?-Lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.
A belated diagnosis of G6PD deficiency in an 81-year-old woman.
A benign sickle-cell disease in a Saudi subject with beta zero-thalassemia and glucose-6-phosphate dehydrogenase deficiency.
A case of black water fever treated with peritoneal dialysis and artemether (quinghaosu derivative).
A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency.
A case of congenital dyserythropoietic anemia in a male Chinese.
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.
A case of kernicterus in New Zealand: a predictable tragedy?
A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?
A case report of a 4-year-old child with glucose-6-phosphate dehydrogenase deficiency: An evidence based approach to nutritional management.
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
A case-control study of primary hepatocellular carcinoma in Taiwan.
A challenge to the concept of selection by malaria in glucose-6-phosphate dehydrogenase deficiency.
A child with xeroderma pigmentosum and G6PD deficiency.
A clinician's view of the mass screening of the newborn for inherited diseases: current practice and future considerations.
A combined system for the study of glutathione metabolism in erythrocytes.
A community-based study of common hereditary blood disorders in Oman.
A comparative study of acute haemolytic anaemia in patients of viral hepatitis in relation to erythrocyte glucose 6-phosphate dehydrogenase deficiency.
A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct.
A comparison among quantitative, dye reduction and fluorescent spot tests for G-6-PD deficiency.
A comparison of the two-generation and three-generation methods of estimating linkage values on the X chromosome in man with special reference to the loci determining the Xg blood group and glucose-6-phosphate dehydrogenase deficiency.
A comprehensive analysis of membrane and morphology of erythrocytes from patients with glucose-6-phosphate dehydrogenase deficiency.
A comprehensive study on the major mutations in glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in the coastal provinces of Caspian Sea in the north of Iran.
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A-c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations.
A controlled study of polymorphisms in serum globulin and glucose-6-phosphate dehydrogenase deficiency in leprosy.
A correlative study of A B O blood groups, sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency as genetic marker in Mahar community of rural population of Wardha District in Maharashtra.
A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency.
A DUAL HEREDITARY RED BLOOD CELL DEFECT IN ONE FAMILY: HYPOCATALASEMIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
A genetic profile of the South African Ashkenazi Jewish population.
A genetic study among the Lepchas of the Darjeeling area of eastern India.
A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.
A glucose 6-phosphate dehydrogenase Gd (-) Castilla variant characterized by mild deficiency associated with drug-induced hemolytic anemia.
A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency.
A glucose-6-phosphate dehydrogenase stain for frozen human skeletal muscle biopsy specimens. A sensitive indicator of fiber degeneration.
A greater awareness of children with glucose-6-phosphate dehydrogenase deficiency is imperative in western countries.
A hematological survey of preschool children of the United Arab Emirates.
A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency. Vicia sativa (Vetch).
A Japanese neonatal case of glucose-6-phosphate dehydrogenase deficiency presenting as severe jaundice and hemolytic anemia without apparent trigger.
A large, systematic molecular-genetic study of G6PD in Indian populations identifies a new non-synonymous variant and supports recent positive selection.
A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish.
A new glucose-6-phosphate dehydrogenase deficiency variant, G6PD Mizushima, showing increases in serum ferritin and cytosol leucine aminopeptidase levels.
A new glucose-6-phosphate dehydrogenase variant (G6PD Nagano) associated with congenital hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-->Gly), is the major polymorphic variant in tribal populations in India.
A new lease of life for an old enzyme.
A new mutation responsible for severe G6PD deficiency in two ethnic Chinese with different clinical presentations: determination by a direct PCR sequencing technique.
A new paper-based analytical device for detection of Glucose-6-phosphate dehydrogenase deficiency.
A new simple screening method for glucose 6-phosphate dehydrogenase deficiency.
A new variant of glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia, G6PD Cornell: erythrocyte, leukocyte, and platelet studies.
A note on oseltamivir treatment in a boy with G6PD deficiency.
A Novel A1088T Mutation in the Glucose-6-Phosphate Dehydrogenase Gene Detected by RT-PCR Combined with DNA Sequencing.
A novel C to T substitution at nucleotide 1360 of cDNA which abolishes a natural Hha I site accounts for a new G6PD deficiency gene in Chinese.
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.
A Novel de novo Mutation in the G6PD Gene in a Korean Boy with Glucose-6-phosphate Dehydrogenase Deficiency: Case Report.
A novel G473A mutation in the glucose-6-phosphate dehydrogenase gene.
A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency.
A novel G6PD mutation leading to chronic hemolytic anemia.
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices.
A novel mutation of the ITGB2 gene in a Chinese Zhuang minority patient with leukocyte adhesion deficiency type 1 and glucose-6-phosphate dehydrogenase deficiency.
A novel R198H mutation in the glucose-6-phosphate dehydrogenase gene in the tribal groups of the Nilgiris in Southern India.
A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic Activity.
A Pale Baby With Blue Blood.
A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.
A preliminary survey for glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in Ethiopia.
A prolonged neonatal jaundice associated with a rare G6PD mutation.
A prospective study of the role of bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria.
A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
A rapid screening dye test for the detection of glucose-6-phosphate dehydrogenase deficiency in red cells.
A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands.
A RE-EVALUATION OF THE RELATIONSHIP BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE BEHAVIORAL MANIFESTATIONS OF SCHIZOPHRENIA.
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
A review of G6PD deficiency in Pakistani perspective.
A review of Orang Asli newborns admitted to a neonatal unit in a Malaysian general hospital.
A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.
A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency.
A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency.
A Severe Episode of Hemolytic Anemia After Amoxicillin Exposure in A G6PD Deficient Patient.
A simple and rapid dye test for glucose-6-phosphate dehydrogenase deficiency for routine use.
A simple fluorimetric assay for pyridoxamine phosphate oxidase in erythrocyte haemolysates: effects of riboflavin supplementation and of glucose 6-phosphate dehydrogenase deficiency.
A simple laboratory procedure for the recognition of A - (African type) G-6PD deficiency in acute haemolytic crisis.
A SIMPLE MICROMETHOD FOR THE DETECTION OF ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
A simple screening procedure for adenylate kinase, hexokinase and glucose-6-phosphate dehydrogenase deficiencies.
A simple visual screening test for glucose-6-phosphate dehydrogenase deficiency employing ascorbate and cyanide.
A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
A single mutation is responsible for the high prevalence of G6PD deficiency in the Vataliya Prajapatis--an endogamous caste group from Western India.
A study of nine polymorphic systems in the population of the Po Delta.
A study of some genetic characteristics of the Fur and Baggara tribes of the Sudan.
A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes.
A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: investigation of platelet enzymes.
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
A survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Rumania.
A survey of glucose-6-phosphate dehydrogenase deficiency & sickle-cell trait on a local population of Tirupati.
A survey of glucose-6-phosphate dehydrogenase deficiency and some of its correlates in a Maharashtra village.
A Survey of Practice and Knowledge of Refugee and Migrant Pregnant Mothers Surrounding Neonatal Jaundice on the Thailand-Myanmar Border.
A survey of the incidence of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Zambia.
A tetrazolium-linked cytochemical method for estimation of glucose-6-phosphate dehydrogenase activity in individual erythrocytes: applications in the study of heterozygotes for glucose-6-phosphate dehydrogenase deficiency.
A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.
A typical presentation of dengue fever in a G6PD deficient patient: A case report.
A vegetable-induced hemolytic crisis in a G6PD deficient person: a case report.
ABNORMAL HAEMOGLOBIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN MALAYAN ABORIGINES.
Abnormal haemoglobin, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in North Sumatra, Indonesia.
Abnormal haemoglobin, thalassaemia and G-6-PD deficiency in Libya.
Abnormal hemoglobins, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Dayaks of Sarawak.
Abnormal hemoglobins, thalasemia trait & G6PD deficiency in young Pakistani males.
ABNORMAL ORAL GLUCOSE TOLERANCE RESPONSE IN ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency presenting as Hydrops Foetalis.
Abrogation of red blood cell G6PD enzyme activity through Heat treatment: development of survey material for the UK NEQAS G6PD scheme.
Absence of parvovirus and cytomegalovirus in red-cell aplastic crises in glucose-6-phosphate dehydrogenase deficiency.
Acalypha indica induced haemolysis in G6PD deficiency.
Acalypha indica-Induced Hemolysis and Methemoglobinemia in a Child With G6PD Deficiency.
Access to orphan drugs in the Middle East: Challenge and perspective.
Acetamonophen and G-6-PD deficiency.
Active transport of nitrofurantoin into human milk.
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency.
Activity of glucose-6-phosphate dehydrogenase among Indians living in a malarial region of Mato Grosso and its implication to the Indian-mixed populations in Brazil.
Acute episodic hemolysis in the African black rhinoceros as an analogue of human glucose-6-phosphate dehydrogenase deficiency.
Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency.
Acute haemolysis with Ambilhar treatment in glucose-6-phosphate dehydrogenase deficiency.
Acute haemolytic anaemia and myolysis due to G6PD deficiency.
Acute haemolytic crisis in a Thai patient with homozygous haemoglobin Constant Spring (Hb CS/CS): a case report.
Acute hemolysis in a patient with a newly diagnosed glioblastoma.
Acute hemolytic anemia and acute kidney injury induced by non-high-dose ascorbic acid in a Child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Acute Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency Complicated by Ginkgo biloba.
Acute hemolytic anemia induced by a pyrazolonic drug in a child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency.
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency.
Acute Kidney Injury following Ingestion of Henna Leaf Extract: A Case Report from Myanmar.
Acute lung injury after exchange transfusion in two newborns with Glucose-6-phosphate dehydrogenase deficiency.
Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency.
Acute renal failure following analgesic overdose in G6PD deficiency.
Acute renal failure in favism revealing familial glucose-6-phosphate dehydrogenase deficiency.
Acute renal failure in north Indian children.
Acute renal failure in tropical Africa.
Acute Retroviral Syndrome Presenting with Hemolytic Anemia Induced by G6PD Deficiency.
Acute reversible renal failure and Stevens-Johnson syndrome in a patient having glucose-6-phosphate dehydrogenase deficiency.
Acute rhabdomyolysis induced by tonic-clonic epileptic seizures in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis with severe hyperbilirubinemia and massive hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Acyanotic Hypoxia in a Febrile Child.
Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne.
Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency.
Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.
Adequacy and pitfalls of G6PD deficiency counseling in Hong Kong.
Adult T-cell leukemia/lymphoma and Glucose-6-phosphate dehydrogenase deficiency rapidly diagnosed through blood smear examination.
Adult-onset Still's disease associated with G6PD deficiency: a case report and literature review.
Advanced glycation end products inhibit glucose-6-phosphate dehydrogenase activity and expression in human umbilical vein endothelial cells.
Adverse effects of herbal or dietary supplements in G6PD deficiency: A systematic review.
African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.
Agar in control of hyperbilirubinemia of full-term newborn infants with erythrocyte G-6-PD deficiency.
Age, Ethnicity, Glucose-6-Phosphate Dehydrogenase Deficiency, Micronutrient Powder Intake, and Biomarkers of Micronutrient Status, Infection, and Inflammation Are Associated with Anemia Among Children 6-59 Months in Nepal.
Agriculture-related anaemias.
Alcoholic liver disease in black men with G6PD deficiency.
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.
Alpha-1-antitrypsin deficiency in babies with prolonged jaundice.
alpha-Thalassaemia and hyperbilirubinaemia in G-6-PD-deficient newborns.
Alpha-thalassemia in Papua New Guinea.
Alpha-thalassemia minor and neonatal hyperbilirubinemia.
Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency.
Alternatives to currently used antimalarial drugs: in search of a magic bullet.
Amino acid conservation and clinical severity of human glucose-6-phosphate dehydrogenase mutations.
Amoxycillin in treatment of typhoid fever in patients with haematological contraindications to chloramphenicol.
Amyl Nitrite-Induced Hemolytic Anemia: Acute Therapy and Prevention.
An anthropological perspective on the epidemiology of hemoglobin defects and glucose-6-phosphate dehydrogenase deficiencies in the northern half of the African continent.
An Ashkenazi Jewish woman presenting with favism.
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
An epidemiological study of G-6-PD deficiency, sickle cell haemoglobin, and ABO blood groups in relation to malaria incidence in Muslim and Christian communities of Kheda, Gujarat, (India).
An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire.
An evaluation of screening procedures for red cell glucose-6-phosphate dehydrogenase deficiency in the newborn infant.
An evaluation of the dorset sheep as a predictive animal model for the response of G-6-PD deficient human erythrocytes to a proposed systemic toxic ozone intermediate, methyl oleate hydroperoxide.
An evaluation of the dorset sheep as a predictive animal model for the response of glucose-6-phosphate dehydrogenase-deficient human erythrocytes to a proposed systemic toxic ozone intermediate, methyl oleate ozonide.
An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency.
An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency.
An In vivo Drug Screening Model Using Glucose-6-Phosphate Dehydrogenase Deficient Mice to Predict the Hemolytic Toxicity of 8-Aminoquinolines.
An intriguing case of Prurigo pigmentosa in a Sicilian young patient.
An investigation into the riboflavin status of young Egyptians from the oasis with glucose-6-phosphate dehydrogenase deficiency.
An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
An optimised system for refolding of human glucose 6-phosphate dehydrogenase.
An unusual distribution of glucose-6-phosphate dehydrogenase deficiency of south Indian newborn population.
An unusual syncope cause in the ED: Favism.
An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates.
Anaemia, a common but often unrecognized risk in diabetic patients: A review.
Anaemic crisis in sickle cell disease.
Anaesthesia and glucose-6-phosphate dehydrogenase deficiency. A case report and review of the literature.
Anaesthesia Management of a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Total Thyroidectomy.
Anaesthetic management in a child with an atypical triad for reconstructive scoliosis surgery.
Anaesthetic management in patients with glucose-6-phosphate dehydrogenase deficiency undergoing neurosurgical procedures.
Analysis of common mutations and associated haplotypes in Chinese patients with glucose-6-phosphate dehydrogenase deficiency.
Analysis of G6PD enzyme deficiency in Saudi population.
Analysis of genotype distribution of thalassemia and G6PD deficiency among Hakka population in Meizhou city of Guangdong Province.
Analysis of Glucose-6-Phosphate Dehydrogenase Genetic Polymorphism in the Hakka Population in Southern China.
Analysis of malaria associated genetic traits in Cabo Verde, a melting pot of European and sub Saharan settlers.
Anemia and the liver. Hepatobiliary manifestations of anemia.
Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias.
Anemia during actue infections. Role of glucose-6-phosphate dehydrogenase deficiency in Negroes.
Anemia in adolescence. 2. Hemoglobinopathies and other causes.
Anemia in newborn.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Anemia in pregnancy.
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Anemia-induced liver injury: A rare case revealing glucose-6-phosphate dehydrogenase deficiency.
Anesthesia and glucose-6-phosphate dehydrogenase deficiency in a child with congenital heart disease.
Anesthetic Management in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Coblation Adenoidectomy With Septoplasty and Turbinectomy.
Anesthetic Management of a Child With Severe Dystonia and G6PD Deficiency for Deep Brain Stimulation.
Angiographic preoperative bowel segment localization using methylene blue, isosulfan blue, and fluorescein.
Aniline-induced methaemoglobinaemia in a glucose-6-phosphate dehydrogenase enzyme deficient patient.
Antimalarial NADPH-Consuming Redox-Cyclers as Superior G6PD Deficiency Copycats.
Antimalarial red cells.
Antioxidant enzymatic systems and oxidative stress in erythrocytes with G6PD deficiency: effect of deferoxamine.
Antioxidant vitamins and glucose-6-phosphate dehydrogenase deficiency in full-term neonates.
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.
Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists.
Aortic valve replacement for a patient with glucose-6-phosphate dehydrogenase deficiency and autoimmune hemolytic anemia.
Apert syndrome with glucose-6-phosphate dehydrogenase deficiency: a case report.
Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review.
Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program.
Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis.
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Ascorbic-acid-induced haemolysis in G-6-PD deficiency.
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.
Aspects of sickle cell gene in Saudi Arabia--interaction with glucose-6-phosphate dehydrogenase deficiency.
ASPECTS OF THE POPULATION DYNAMICS OF THE ABNORMAL HEMOGLOBIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY GENES.
Aspects of tropical paediatrics.
Aspirin and glucose-6-phosphate dehydrogenase deficiency.
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).
Assessment of G6PD screening program in premature infants in a NICU.
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Assessment of potential donors for living related liver transplantation.
Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency: a preliminary study.
Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea.
Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.
Association between ACP(1) genetic polymorphism and favism.
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.
Association Between G6PD Deficiency and Hyperbilirubinemia in Neonates: A Meta-Analysis.
Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors.
Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.
Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis.
Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus in ethnic groups of Singapore.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus.
Association of homozygous sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency.
Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
Association of naphthalene with acute hemolytic anemia.
Association of red cell glucose-6-phosphate dehydrogenase with haemoglobinopathies.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study.
Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study.
At least five polymorphic mutants account for the prevalence of glucose-6-phosphate dehydrogenase deficiency in Algeria.
Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Atypical dengue Fever in a splenectomized boy with glucose-6- phosphodehydrogenase deficiency and thalassemia intermedia.
Audit of birth defects in 34,109 deliveries in a tertiary referral center.
Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
Autistic feature as a presentation of Inborn Errors of Metabolism.
Autoimmune hemolytic anemia.
Automated determination of glucose-6-phosphate dehydrogenase (G6PD) on a SPOTCHECK Microflow analyzer.
Automated fluorometric method for screening for erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Automated-red cell exchange for methaemoglobinaemia in a G6PD-deficient patient.
B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.
Bacterial infections in children with glucose-6-phosphate dehydrogenase deficiency.
Barriers to routine G6PD testing prior to treatment with primaquine.
Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.
Berberine-induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases.
Beta-thalassaemia, G-6-PD deficiency, and atypical cholinesterase in Cyprus.
beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants.
Bilateral cataracts associated with glucose-6-phosphate dehydrogenase deficiency.
Bilateral pulmonary edema after endoscopic sympathectomy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
Bilirubin crystals were detected in peripheral blood neutrophils in newborn with sepsis and G6PD deficiency.
Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert's syndrome.
Bimodal distribution of erythrocytes in heterozygotes for strong Mediterranean glucose-6-phosphate dehydrogenase deficiency.
Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency.
Biochemical changes caused by glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Biochemical genetics and mental retardation: a study of hemoglobins, Australia antigen and the enzymes pseudocholinesterase and glucose-6-phosphate dehydrogenase.
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency.
Biogenetical studies of Nagas: glucose-6-phosphate dehydrogenase deficiency in Angami Nagas.
Birth control necessary to limit family size in tribal couples with aberrant heterosis of G-6-PD deficiency and sickle cell disorders in India: an urgency of creating awareness and imparting genetic counseling.
Blackwater fever at the Kenyatta National Hospital in Kenya: a case report.
Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases.
Blackwater fever: the rise and fall of an exotic disease.
Blister and bite cells in G6PD deficiency.
Blood cell parameters for screening and diagnosis of hereditary spherocytosis.
Blood genetic markers in the Chinese of two eastern provinces.
Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency.
Blood groups and types, hemoglobin variants, and G-6-PD deficiency among Abu Dhabians in the United Arab Emirates.
Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency.
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency.
Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype.
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.
Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
Brilliant cresyl blue screening test for demonstrating glucose-6-phosphate dehydrogenase deficiency in red cells.
Brown recluse spider bites.
Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Burden of genetic disorders in India.
Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Calcium activated neutral protease & calcium ATPase in glucose-6-phosphate dehydrogenase deficiency hemizygotes.
Campaign to control genetic blood diseases in Bahrain.
Can African-variant G6PD deficiency trigger hemolysis in DKA?
Can elevated levels of copper in drinking water precipitate aucte hemolysis in G-6-PD deficient individuals?
Can glucose-6-phosphate dehydrogenase deficiency be correlated with ABO blood type?
Can severe neonatal jaundice be prevented by neonatal screening for glucose-6-phosphate dehydrogenase deficiency?--a review of evidence.
Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.
Cardiac failure associated with G6PD deficiency.
Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Case studies on haemoglobin S heterozygotes with severe clinical manifestations.
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Cataracts in glucose-6-phosphate dehydrogenase deficiency.
Cataracts in Glucose-6-phosphate Dehydrogenase Deficiency.
Catatonia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Report of Two Cases and a Review.
Cation channels, cell volume and the death of an erythrocyte.
Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.
Cell-Derived Microparticles in Blood Products from Blood Donors Deficient in Glucose-6-Phosphate Dehydrogenase.
Central Nervous System Symptoms Due to Transient Methemoglobinemia in a Child With G6PD Deficiency.
Central retinal vein occlusion in an Army Ranger with glucose-6-phosphate dehydrogenase deficiency.
Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency.
Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
Cerebellar Toxoplasmosis in an Immunocompetent Patient with G6PD Deficiency.
Certain red cell genetic factors and prevalence of chloroquine-induced pruritus.
Changes in globus pallidus with (pre)term kernicterus.
Changes in incidence and sex ratio of glucose-6-phosphate dehydrogenase deficiency by population drift in Taiwan.
Changes in red blood cell membrane structure in G6PD deficiency: An atomic force microscopy study.
Changing trends in malaria--a decade's experience at a referral hospital.
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
Characteristics of a new abnormal variant of G-6-PD in human red cells.
Characterization of abnormal glucose-6-phosphate dehydrogenase variants.
Characterization of G6PD deficiency and thalassaemia in Papua New Guinea.
Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.
Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.
Characterization of G6PD Rohini--a new class III Indian variant.
Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress.
Characterization of glucose-6-phosphate dehydrogenase deficiency and identification of a novel haplotype 487G>A/IVS5-612(G>C) in the Achang population of Southwestern China.
Chemical toxicity of red cells.
Chemotherapeutic malaria control as a selective primary health care activity in the Solomon Islands.
Chemotherapy in a Patient With G6PD Deficiency and Advanced Testicular Cancer.
Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017.
Chloramine-induced haemolysis presenting as erythropoietin resistance.
Chloramphenicol-induced hemolysis in Caucasian glucose-6-phosphate dehydrogenase deficiency.
Chloroquine induced haemolysis and acute renal failure in subjects with G-6-PD deficiency.
Cholinsalicylate gel induced oral lesion: report of case.
Chronic granulomatous disease with leukocytic glucose-6-phosphate dehydrogenase deficiency in a 28-month-old girl.
Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature.
Chronic haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
CHRONIC HEMOLYSIS ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role of vitamin E in its treatment.
Chronic hemolytic anemia is associated with a new glucose-6-phosphate dehydrogenase in-frame deletion in an older woman.
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants.
Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP). Molecular study of a new variant (G6PD Clinic) with markedly acidic pH optimum.
Chronic nonspherocytic hemolytic anemia and G6PD deficiency.
Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi.
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants.
Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia.
Clinical and hematological phenotype of homozygous hemoglobin E: revisit of a benign condition with hidden reproductive risk.
Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.
Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia.
Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.
Clinical consequences of enzyme deficiencies in the erythrocyte.
Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre.
Clinical disorders of the red cell membrane skeleton.
Clinical examination and hematological data in asymptomatic & apparently healthy school children in a boarding school in a tribal area.
Clinical experience with multigene carrier panels in the reproductive setting.
Clinical experience with phototherapy.
Clinical implications of glucose-6-phosphate dehydrogenase deficiency.
Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients.
Clinical Manifestations and Therapeutic Findings of the Children with Glucose-6-Phosphate Dehydrogenase Deficiency Presenting Favism.
Clinical mutants of human glucose 6-phosphate dehydrogenase: impairment of NADP(+) binding affects both folding and stability.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Clinical rounds in the well-baby nursery: treating jaundiced newborns.
Clinical significance of glucose-6-phosphate dehydrogenase deficiency in Nigerian patients with sickle cell disease.
Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Clinical Spectrum of Primaquine-induced Hemolysis in G6PD Deficiency: A Nine-Year Hospitalization-Based Study from the Brazilian Amazon.
Clinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India.
Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield.
Clonorchiasis: treatment with praziquantel in 50 cases.
Clostridium difficile infection precipitating hemolysis in glucose-6-phosphate dehydrogenase-deficient preterm twins causing severe neonatal jaundice.
Co-evolution of glucose-6-phosphate dehydrogenase deficiency and quinine taste sensitivity.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Co-inheritance of Southeast Asian Ovalocytosis (SAO) and G6PD deficiency associated with acute hemolysis in a Thai patient.
Co-occurrence of biphenotypic acute leukaemia, glucose 6-phosphate dehydrogenase deficiency and haemoglobin E trait in a single child.
Co-trimoxazole in the treatment of typhoid fever in children with glucose-6-phosphate dehydrogenase deficiency.
Co-trimoxazole-induced severe haemolysis: the experience of a large general hospital in Hong Kong.
Coexistence of five G6PD variants indicates ethnic complexity of Phuket islanders, Southern Thailand.
Coinheritance of Rotor syndrome, G-6-PD deficiency, and heterozygous beta thalassemia: a possible genetic interaction.
Coinheritance of variant UDP-glucuronosyl transferase 1A1 gene and glucose-6-phosphate dehydrogenase deficiency in adults with hyperbilirubinemia.
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.
Colorectal Cancer Mortality in Relation to Glucose - 6 - Phosphate Dehydrogenase Deficiency and Consanguinity in Sardinia: A Spatial Correlation Analysis
Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.
Combined erythrocyte glucosephosphate isomerase (GPI) and glucose-6-phosphate dehydrogenase (G6PD) deficiency in an Italian family.
Combined erythrocyte phosphohexose isomerase and glucose-6-phosphate dehydrogenase deficiency.
Combined G-6PD and 6-PGD deficiency in a Hindu boy.
Combined glucose phosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of erythrocytes.
Combined glucosephosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of the erythrocytes: a new haemolytic syndrome.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Community-acquired acute kidney injury in Asia.
Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.
Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices.
Comparative analysis of glucose-6-phosphate dehydrogenase levels in pre-term and term babies delivered at University of Ilorin Teaching Hospital.
Comparison between G6PD-Deficient and Normal Individuals after Eccentric Exercise.
Comparison between the chromate inhibition test and a cytochemical method for the determination of glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Comparison for functional aberration of G-6-PD deficiency variants with exon 10 mutations.
Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
Comparison of molecular mutations of G6PD deficiency gene between icteric and nonicteric neonates.
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.
Comparison of serum copper, magnesium, zinc and calcium levels between G6PD deficient and normal Chinese adults.
Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females.
Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
Complete molecular characterisation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a group of Malaysian Chinese neonates.
Complete repair of tetralogy associated with sickle cell anemia and G-6-PD deficiency.
Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment.
Component therapy.
Computer simulation of evolutionary trends in an X linked trait. Application to glucose-6-phosphate dehydrogenase deficiency in man.
Congenital disorders of the function of polymorphonuclear neutrophils.
Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza).
Congenital erythrocyte enzyme deficiencies.
Congenital haemolytic anaemia associated with adenylate kinase deficiency.
Congenital nonspherocytic hemolytic anemia associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Japanese child. Clinical and metabolic studies.
Congenital nonspherocytic hemolytic disease secondary to glucose-6-phosphate dehydrogenase deficiency: report of three cases.
Congenital nonspherocytic hemolytic disease. With erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.
Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study.
Consideration of ethics in primaquine therapy against malaria transmission.
Control and elimination of Plasmodium vivax.
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene.
Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Controlled reversible assembly of gold nanoparticles as a new colorimetric and sensitive detection of glucose-6-phosphate dehydrogenase deficiency.
Cord blood G-6-PD activity by quantitative enzyme assay and fluorescent spot test in Chinese neonates.
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.
Correction: Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
Correlation of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and sickle cell trait (Hb-AS).
CORRELATION OF S HEMOGLOBIN WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND ITS SIGNIFICANCE.
Corrigendum to 'Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients' [Clin. Biochem. 49 (2016) 808-810].
Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Corrigendum: Genetic Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in the Arab World.
Cortisol levels in glucose-6-phosphate dehydrogenase deficiency.
Cortisol metabolism in glucose-6-phosphate dehydrogenase deficiency.
Cost-benefit analysis of G6PD screening in Lebanese newborn males.
Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.
COVID-19 & Hydroxychloroquine side-effects: Glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients.
Crohn's disease and G-6-PD deficiency.
Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests.
Current and future perspective of newborn screening: an Indian scenario.
Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency.
Current prevalence of intestinal parasitic infections and their impact on hematological and nutritional status among Karen hill tribe children in Omkoi District, Chiang Mai Province, Thailand.
Cyanosis Due to Methemoglobinemia as the Presenting Sign of Glucose-6-Phosphate Dehydrogenase Deficiency in a Child: Diagnostic and Clinical Implications.
Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Cytokine responses of TNF-?, IL-6, and IL-10 in G6PD-deficient infants.
Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency.
Cytomegalovirus infection and hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency.
D-Glucaric acid excretion in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
Dapsone for immune thrombocytopenic purpura in children and adults.
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Dapsone intoxication: two case reports.
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Dapsone: An Old but Effective Therapy in Pediatric Refractory Immune Thrombocytopenia.
Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.
Decreased erythrocyte nucleoside transport and hENT1 transporter expression in glucose 6-phosphate dehydrogenase deficiency.
Decreased Glucose-6-PhosphateDehydrogenase (G6PD) Activity and Risk of Senile Cataract in Taiwan.
Decreased Glutathione S-transferase Level and Neonatal Hyperbilirubinemia Associated with Glucose-6-phosphate Dehydrogenase Deficiency: A Perspective Review.
Decreased survival in vivo of diamide-incubated dog erythrocytes. A model of oxidant-induced hemolysis.
Deep Hypothermic Circulatory Arrest in a Patient With Severe G6PD Deficiency.
Deep vein thrombosis in association with acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency: a unique case.
Defects in the oxidative killing of microorganisms by phagocytic leukocytes.
Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
Deficiency of glucose-6-phosphate dehydrogenase found in a case of hepatic fructose-1,6-diphosphatase deficiency.
Definition of the mutations of G6PD Wayne, G6PD Viangchan, G6PD Jammu, and G6PD 'LeJeune'.
Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity.
Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates.
Denaturing high-performance liquid chromatography technique platform applied to screen G6PD deficient variants.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Dental Considerations in Children with Glucose-6-phosphate Dehydrogenase Deficiency (Favism): A Review of the Literature and Case Report.
Depression of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in enteric fever.
Description of a novel missense mutation of glucose-6-phosphate dehydrogenase gene associated with asymptomatic high enzyme deficiency.
Detection of glucose-6-phosphate dehydrogenase deficiency in erythrocytes: a spectrophotometric assay and a fluorescent spot test compared with a cytochemical method.
Detection of glucose-6-phosphate dehydrogenase deficiency in the newborn using blood specimens dried on filter paper.
Detection of inborn errors of metabolism in 1,117 patients studied because of suspected inherited disease.
Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants.
Detection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency Anemia.
Detection of three common G6PD gene mutations in Chinese individuals by probe melting curves.
Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.
Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor.
Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism.
Development of a novel mouse model of severe glucose-6-phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of hemolytic toxicity to red blood cells.
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Development of allelic discrimination assay to detect Mediterranean G6PD mutation and its linked inheritance with normal vision and/colorblindness loci for 4 generations among Egyptian and Emirati families.
Development of suitable external quality control material for G6PD deficiency screening with the fluorescent spot test.
Dexmedetomidine-based intravenous anesthesia of a pediatric patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency: A case report.
Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another.
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Diabetic ketoacidosis revealing glucose-6-phosphate dehydrogenase deficiency: description of an adult case.
Diabetic Ketoacidosis Revealing Severe Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D) Deficiency with Methemoglobinemia: A Case Report.
Diagnosis and management of G6PD deficiency.
Diagnosis and treatment of Plasmodium vivax malaria.
Diagnosis of erythrocyte glucose-6-phosphate dehydrogenase deficiency in the negro male despite hemolytic crisis.
Diagnosis of glucose-6-phosphate dehydrogenase (G6PD) mutations by DNA amplification and allele-specific oligonucleotide probes.
Diagnosis of red cell G-6-PD deficiency in a Chinese neonate.
Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping.
Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.
Diagnostic Practices and Treatment for P. vivax in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods Study.
Diagnostic problems in severe neonatal jaundice and G6PD deficiency in Greece.
Dialytic support in acute renal failure.
Diet in dermatology: revisited.
Diet, diabetes, hypertension and blacks.
Dietary alterations modulate susceptibility to Plasmodium infection.
Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency.
Differential fertility as a mechanism maintaining balanced polymorphisms in Sardinia.
Differentiation of hair growth cycle from scalp hair roots for the diagnosis of glucose-6-phosphate dehydrogenase deficiency in neonates.
Diminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells.
Diminished response to cytotoxic therapy in G-6-PD deficiency.
Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.
Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs.
Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases.
Disorders in the metabolism of erythrocytes in a case of congenital nonspherocytic hemolytic anemia with glucose-6-phosphate dehydrogenase deficiency.
Distance and sequence of the loci for protan and deutan defects and for glucose-6-phosphate dehydrogenase deficiency.
Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase.
Distribution of ABO and Rhesus blood groups in G6PD deficient Chinese and Malay newborns.
Distribution of ABO blood groups, G6PD deficiency, and abnormal haemoglobins in leprosy.
Distribution of beta-thalassemia trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency in the Markham River Valley of New Guinea.
Distribution of Gd- alleles in some ethnic groups of the USSR.
Distribution of red cell G6PD and 6PGD phenotypes in Saudi Arabia.
Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.
Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymorphism in Taiwan.
Diversity in expression of glucose-6-phosphate dehydrogenase deficiency in females.
DNA damage and apoptosis in mononuclear cells from glucose-6-phosphate dehydrogenase-deficient patients (G6PD Aachen variant) after UV irradiation.
DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.
DNA haplotypes in the G6PD gene cluster studied in the Chinese Li population and their relationship to G6PDCanton.
DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants.
Do all patients with acquired methemoglobinemia need treatment? A lesson learnt.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs.
Does G gamma/A gamma ratio and Hb F level influence the severity of sickle cell anaemia.
Does G6PD deficiency protect against cancer? A critical review.
DOES GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY MODIFY THE COURSE OF LEPROSY OR ITS TREATMENT.
Does Ibuprofen increase neonatal hyperbilirubinemia?
Does the history before blood transfusion identify donors who are glucose-6-phosphate dehydrogenase (G-6-PD) deficient?
Dominance of high-producing interleukin 6 and low-producing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenase-deficient trauma patients.
Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia.
Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.
Double heterozygosity for glucose-6-phosphate dehydrogenase deficiency.
Double phototherapy in jaundiced term infants with hemolysis.
Drug induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency subjects.
Drug-eluting stents in a patient with favism: is the aspirin administration safe?
Drug-induced anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Drug-induced glucose-6-phosphate dehydrogenase deficiency-related hemolysis risk assessment.
Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency.
Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
DRUG-INDUCED HEMOYTIC ANEMIAS ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY: AGENETICALLY HETEROGENOUS TRAIT.
Drug-induced red cell dyscrasias.
Drugs in Development for Malaria.
Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.
Dubin-Johnson syndrome coexisting with glucose-6-phosphate dehydrogenase deficiency presenting after acute viral hepatitis.
Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition.
Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
Economic evaluation of point of care universal newborn screening for glucose-6-Phosphate dehydrogenase deficiency in United States.
Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults.
Effect of alpha thalassaemia, G-6-PD deficiency and Hb F on the nature of sickle cell anaemia in south-western Saudi Arabia.
Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.
Effect of desferrioxamine B on hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency.
Effect of exercise on oxidative stress in individuals with glucose-6-phosphate dehydrogenase deficiency.
Effect of G-6 PD deficiency on sickle cell disease in Saudi Arabia.
Effect of gamma irradiation on blood from glucose 6 phosphate dehydrogenase deficient blood donors.
Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function.
Effect of glucose-6-phosphate dehydrogenase deficiency on reduced and oxidized glutathione and lipid peroxide levels in the blood of African-Americans.
Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes.
Effect of glucose-6-phosphate dehydrogenase deficiency on the benz(a)pyrene toxicity for in vitro cultured human skin fibroblasts.
Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study.
Effect of orotic acid upon serum bilirubin in newborn infants with erythrocyte G-6-PD deficiency.
Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever.
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.
Effectiveness of doxycycline combined with primaquine for malaria prophylaxis.
Effects of environmental oxidant stressors on individuals with a G-6-PD deficiency with particular reference to an animal model.
Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies.
Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Effects of Glucose 6-Phosphate Dehydrogenase Deficiency on the Metabolic and Cardiac Responses to Obesogenic or High Fructose Diets.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anaemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon the host and upon host-drug-malaria parasite interactions.
Effects of Hb types and G-6-PD deficiency on height, weight and skinfolds: a study on Indian population.
Effects of Single and Double Mutants in Human Glucose-6-Phosphate Dehydrogenase Variants Present in the Mexican Population: Biochemical and Structural Analysis.
Effects of variant UDP-glucuronosyltransferase 1A1 gene, glucose-6-phosphate dehydrogenase deficiency and thalassemia on cholelithiasis.
Efficacy and Safety of a Naphthoquine-Azithromycin Co-Formulation for Malaria Prophylaxis in Southeast Asia: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial.
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
Efficacy of phototherapy in neonatal hyperbilirubinaemia associated with glucose-6-phosphate dehydrogenase deficient status.
Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.
Engraftment of umbilical cord blood with glucose 6-phosphate dehydrogenase deficiency after double-unit unrelated cord blood transplantation.
Enhanced binding of FAD to glutathione reductase in G6PD deficiency.
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts.
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Environmental quality induced predicted by evolutionary theory.
Enzyme activity of glucose-6-phosphate dehydrogenase-deficient Malaysian neonates during the first 10 days of life.
Enzyme cytochemistry of blood and marrow cells.
Enzyme deficiencies in neonates with jaundice.
Enzyme kinetics and molecular modeling studies of G6PD(Mahidol) associated with acute hemolytic anemia.
ENZYMES AND DRUG SENSITIVITY. GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
EP21.21: Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Epidemiological, clinical and laboratory profile of glucose-6-phosphate dehydrogenase deficiency in the middle and north of Iraq: a comparative study.
Epidemiology and Associated Morbidity of Pterygium: A Large, Community-Based Case-Control Study.
Epidemiology and clinical features of Mediterranean spotted fever in Italy.
Epidemiology and Control of Plasmodium vivax in Afghanistan.
Epidemiology of clinical hyperbilirubinaemia in Al Ain, United Arab Emirates.
Epidemiology of Plasmodium vivax in Indonesia.
Epidemiology of Plasmodium vivax Malaria in Peru.
Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations.
Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.
Equine glucose-6-phosphate dehydrogenase deficiency.
Ernest Beutler: his life and contribution to medical science.
Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Erthrocyte glucose-6-phosphate dehydrogenase deficiency: precautions for dental treatment.
Erythrocyte (Ca+2 + Mg+2)-ATPase activity: increased sensitivity to oxidative stress in glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte acid phosphomonesterase and glucose-6-phosphate dehydrogenase deficiency in Caucasians.
Erythrocyte enzyme abnormalities in leukemias.
Erythrocyte enzyme disorders in children.
Erythrocyte enzymes in neonatal juandice.
Erythrocyte G-6-PD and 6-PGD genetic polymorphisms in South African Negroes, with a note on G-6-PD and the malaria hypothesis.
Erythrocyte G-6-PD deficiency among Chinese and Malays of Singapore.
Erythrocyte glucose 6-phosphate dehydrogenase deficiency (G6PD type A-) and neonatal jaundice.
Erythrocyte glucose-6-phosphate dehydrogenase and pyruvate kinase activities in hemoglobin H disease.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency & thalassaemic genes in the scheduled castes of Rajasthan.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency does not pose an increased risk for black Americans exposed to oxidant gases in the workplace or general environment.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Aleppo.
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN CHINESE.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in diabetes (maturity onset).
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in New Guinea and New Britain.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Poland--a study on the 563 and 1311 mutations of the G6PD gene.
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN TURKEY.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Uganda.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in West Africa.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait.
Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Erythrocyte glucose-6-phosphate dehydrogenase status of newborns and adults in eastern Libya.
Erythrocyte glutathione concentrations in diabetics with cataracts, with and without glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte glutathione determination in the diagnosis of glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte glutathione reductase in gout and in glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another.
Erythrocyte ion channels in regulation of apoptosis.
Erythrocyte membrane abnormalities in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean and A-types.
Erythrocyte membrane ATPase activity of G6PD-deficient individuals and the effect of primaquine metabolite(s) on membrane ATPase enzymes.
Erythrocyte pyridoxamine phosphate oxidase activity: a potential biomarker of riboflavin status?
Erythrocyte pyruvate kinase deficiency: 11 new cases.
Erythrocyte superoxide dismutase, catalase and glutathione peroxidase in glucose-6-phosphate dehydrogenase deficiency.
Erythrocytic enzymes decomposing reactive oxygen species and glucose 6-phosphate dehydrogenase deficiency.
Erythrocytic glucose 6-phosphate dehydrogenase deficiency in thalassaemia syndromes--a cytochemical study.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency amongst non tribal population of Orissa.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency and its significance with special emphasis on malaria.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency as a problem in the selection of blood donors.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency at Varanasi.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency in the Bania community of Punjab.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency.
Estimated disease burden and lost economic productivity due to glucose-6-phosphate dehydrogenase deficiency in Nigerian newborns.
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
Estimation of risk of glucose 6-phosphate dehydrogenase-deficient red cells to ozone and nitrogen dioxide.
Estrogen binding by leukocytes during phagocytosis,.
Etiology and Outcomes of Thrombotic Microangiopathies.
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.
Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia.
Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia.
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency.
Evaluation of a flow cytometric test for G6PD-deficient erythrocytes.
Evaluation of a micromethod for detection of G-6-PD deficiency.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency.
Evaluation of DNA damage in leukocytes of G6PD-deficient Iranian newborns (Mediterranean variant) using comet assay.
Evaluation of glucose-6-phosphate dehydrogenase activity in two different ethnic groups using a kit employing the haemoglobin normalization procedure.
Evaluation of glucose-6-phosphate dehydrogenase deficiency without hemolysis in icteric newborns at Mazandaran province, Iran.
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Evaluation of liver and kidney function in favism patients.
Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency.
Evaluation of neonatal jaundice in the Makkah region.
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection.
Evaluation of the blue formazan spot test for screening glucose 6 phosphate dehydrogenase deficiency.
Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Evaluation of the Diagnostic Accuracy of the CareStart™ Glucose-6-Phosphate Dehydrogenase Deficiency Rapid Diagnostic Test among Chinese Newborns.
Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency.
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency.
Evidence for balancing selection from nucleotide sequence analyses of human G6PD.
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree.
Ex Vivo Study of Laban's Role in Decreasing Hemolysis Crisis in G6PD-Deficient Patients.
Exaggeration of hypoxic lung injury in a patient with glucose-6-phosphate dehydrogenase deficiency.
Excess release of ferriheme in G6PD-deficient erythrocytes: possible cause of hemolysis and resistance to malaria.
Excessive fluoride consumption increases haematological alteration in subjects with iron deficiency, thalassaemia, and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital.
Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan, Iran.
Exchange transfusion in neonatal hyperbilirubinemia.
Exercise and Redox Status Responses Following Alpha-Lipoic Acid Supplementation in G6PD Deficient Individuals.
Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review.
Exercise-induced oxidative stress in G6PD-deficient individuals.
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
Expression and biochemical characterization of human glucose-6-phosphate dehydrogenase in Escherichia coli: a system to analyze normal and mutant enzymes.
External quality assessment program for detection of glucose-6-phosphate dehydrogenase deficiency in the Guangxi region.
External quality assurance programme for newborn screening of glucose-6-phosphate dehydrogenase deficiency.
Extramedullary blast crisis and hemolytic anemia in a patient with t(3p+;4q-) and rapidly evolving myelogenous leukemia.
Extreme Hyperbilirubinemia and G6PD Deficiency With No Laboratory Evidence of Hemolysis.
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.
Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.
Falciparum malaria and beta-thalassaemia trait in northern Liberia.
Falciparum malaria--present day problems. An experience with 425 cases.
False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency.
Familial Hirschsprung's disease: report of autosomal dominant and probable recessive X-linked kindreds.
Familial hypohaptoglobinemia. A genetically determined trait segragating from glucose-6-phosphate dehydrogenase deficiency.
Fast hemoglobin and glucose-6-phosphate dehydrogenase deficiency as artefacts imputable to an anticoagulant added to the blood sample.
Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.
Fatal familial haemolytic anaemia.
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
Fatal hemolysis from mafenide treatment of burns in a patient with glucose-6-phosphate dehydrogenase deficiency. Case report.
Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality.
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.
Favism in a female newborn infant whose mother ingested fava beans before delivery.
Favism in a Portuguese family due to a deficient glucose-phosphate dehydrogenase variant (Canton) or (cpanton-like) type.
Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-).
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
Fertility and malaria in Sardinia.
Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.
Fetal Hemoglobin Modulators May Be Associated With Symptomology of Football Players with Sickle Cell Trait.
Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.
Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria.
Fine Mapping of Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency in a Rural Malaria Area of South West Odisha Using the Clinical, Hematological and Molecular Approach.
First episode of acute hemolysis due to G6PD deficiency in a middle-aged woman and transmission of the enzymatic defect through bone marrow transplant.
First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in-silico.
Five novel glucose-6-phosphate dehydrogenase deficiency haplotypes correlating with disease severity.
Flow cytofluorometric analysis of enzyme reactions based on quenching of fluorescence by the final reaction product: detection of glucose-6-phosphate dehydrogenase deficiency in human erythrocytes.
Fluorescent spot test for screening erythrocyte glucose-6-phosphate dehydrogenase deficiency in newborn babies.
Foetal loss & family size in neonatal jaundice due to ABO-HDN, G-6-PD deficiency & low birth weight.
Food-borne nitrates and nitrites as a cause of methemoglobinemia.
Fractionation of serum bilirubin conjugates in the exploration of the pathogenesis of significant neonatal bilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency.
Fragmentation and myelin formation in hereditary xerocytosis and other hemolytic anemias.
Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya.
Frequencies of some human genetic markers and their association with Plasmodium falciparum malaria in the Niger Delta, Nigeria.
Frequency and origin of G-6-PD deficiency among icteric newborns in the metropolitan area of Monterrey, Nuevo León, Mexico.
Frequency of ABO blood groups, sickle-cell haemoglobin, G-6-PD deficiency and their relation with malaria in scheduled castes and scheduled tribes of Kheda District, Gujarat.
Frequency of G-6-PD deficiency among some Iranian ethnic groups.
Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.
Frequency of glucose 6 phosphate dehydrogenase deficiency and related hemolytic anemia in Riyadh, Saudi Arabia.
Frequency of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Tanzanian males with typhoid fever.
Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii.
Frequency of Glucose-6-Phosphate dehydrogenase deficiency in Egyptian infants.
Frequency of glucose-6-phosphate dehydrogenase deficiency in individuals with normal and sickle cell haemoglobin--a preliminary study.
Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude: a malaria hypothesis.
Frequency of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease. A study in Saudi Arabia.
Frequency of glucose-6-phosphate dehydrogenase deficiency in some ethnic groups of Pakistan.
Frequency of glucose-6-phosphate dehydrogenase phenotypes and deficiency in Al-Baha.
Frequency of glucose-6-phosphate dehydrogenase, pyruvate kinase and hexokinase deficiency in the Saudi population.
Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service.
Frequency of glutathione reductase, pyruvate kinase and glucose-6-phosphate dehydrogenase deficiency in a Spanish population.
FREQUENCY OF HAEMOGLOBIN S AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN SOUTHERN TANZANIA.
Frequency of Haemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency in Southern Tanzania.
Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra.
Frequency of Inborn Errors of Metabolism in a Northeastern Iranian Sample with High Consanguinity Rates.
Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan.
Frequency of Mediterranean mutation among a group of Saudi G6PD patients in Western region-Jeddah.
Frequency of thalassemia and G6PD deficiency in five provinces of Spain.
From prejudice to evidence: the case of rhizoma coptidis in singapore.
Frostbite: A Novel Presentation of Glucose-6-Phosphate Dehydrogenase Deficiency?
Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency.
Functional analysis of polymorphonuclear leukocytes in siblings of glucose-6-phosphate dehydrogenase deficiency.
Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.
Functional and structural analysis of double and triple mutants reveals the contribution of protein instability to clinical manifestations of G6PD variants.
Further data from Greece on recombination between the Xg blood group and glucose-6-phosphate dehydrogenase deficiency.
Further evidence for heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea.
Further Molecular Analysis of G6PD Deficiency Variants in Southern Vietnam and a Novel Variant Designated as G6PD Ho Chi Minh (173 A>G; 58 Asp>Gly): Frequency Distributions of Variants Compared with Those in Other Southeast Asian Countries.
Further studies of haemoglobin glycosylation: influence of diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency in Nigerians.
Further studies on glucose-6-phosphate dehydrogenase deficiency in Chinese subjects.
G 6 PD deficiency induced hemolysis in diabetic twins.
G-6-PD and haemoglobin variants among twelve endogamous Dhangar castes of Maharashtra, India.
G-6-PD deficiency and abnormal hemoglobins in a Brazilian population.
G-6-pd deficiency and Crohn's disease.
G-6-PD deficiency and hyperbilirubinemia; in black American full-term infants.
G-6-PD deficiency and malaria in Black Americans in Vietnam.
G-6-PD deficiency and physiopathologic processes.
G-6-PD deficiency and primaquine.
G-6-PD deficiency as the cause of isolated peripheral retinal ischemia.
G-6-PD deficiency gene dynamics in a Brazilian population.
G-6-PD deficiency in neonates in relation to religion of parents.
G-6-PD deficiency in newborns.
G-6-PD deficiency in the Pootai and the So communities in northeast Thailand.
G-6-PD deficiency, sickle cell trait, and acute hemolysis after bronchography.
G-6-PD Deficiency.
G-6PD deficiency in malaria endemic areas of Udaipur District in Rajasthan.
G6PD (Dublin): chronic non-spherocytic haemolytic anaemia resulting from glucose-6-phosphate dehydrogenase deficiency in an Irish kindred.
G6PD A- Deficiency and Severe Malaria in The Gambia: Heterozygote Advantage and Possible Homozygote Disadvantage.
G6PD A- is the major cause of G6PD deficiency among the Siddis of Karnataka, India.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
G6PD Aures: a new mutation (48 Ile-->Thr) causing mild G6PD deficiency is associated with favism.
G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
G6PD deficiency and absence of ?-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.
G6PD deficiency and aluminum phosphide poisoning.
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
G6PD deficiency and breast cancer.
G6PD deficiency and chronic hemolysis: four new mutants--relationships between clinical syndrome and enzyme kinetics.
G6PD deficiency and diabetes mellitus in northern Sardinian subjects.
G6PD deficiency and fava bean consumption do not produce hemolysis in Thailand.
G6PD deficiency and favism in the island of Rhodes (Greece).
G6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus.
G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.
G6PD deficiency and malaria in India.
G6PD deficiency and malaria selection.
G6PD Deficiency and Priapism: Is There a Link Between the Two Entities?
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
G6PD deficiency and stroke in the CSSCD.
G6PD Deficiency as a predisposing factor for attention deficit/hyperactivity disorder: a hypothesis.
G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A-.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6pd Deficiency Does Not Affect the Cytosolic Glutathione or Thioredoxin Antioxidant Defense in Mouse Cochlea.
G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients.
G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors.
G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic.
G6PD deficiency in an unselected Brazilian population.
G6pd deficiency in Asian children.
G6PD deficiency in autism : A case-series from Saudi Arabia.
G6PD deficiency in blood donors of Manaus, Amazon Region, northern Brazil.
G6PD Deficiency in Children: From Clinical Auditing to Optimizing Care.
G6PD deficiency in females screened at tertiary care hospital.
G6PD deficiency in Latin America: systematic review on prevalence and variants.
G6PD deficiency in malaria endemic areas of Nepal.
G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study.
G6PD deficiency in neonates: a prospective study.
G6PD deficiency in newborn infants.
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.
G6PD deficiency in senile cataracts.
G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost.
G6PD deficiency in two autochthonous Croatian families.
G6PD deficiency in Vataliya Prajapati community settled in Surat.
G6PD deficiency is not an uncommon cause of pigment nephropathy.
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
G6PD Deficiency Prevalence as a Cause of Neonatal Jaundice in a Neonatal Ward in Dohuk, Iraq.
G6PD deficiency shifts polarization of monocytes/macrophages towards a proinflammatory and profibrotic phenotype.
G6PD Deficiency with Arnold-Chiari Malformation.
G6PD deficiency with Gd(-)A like variant in a Chinese family from Cambodia.
G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia.
G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.
G6PD deficiency, distribution and variants in Saudi Arabia: an overview.
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
G6PD deficiency-induced hemolysis in a Chinese diabetic patient: a case report with clinical and molecular analysis.
G6PD deficiency.
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria.
G6PD Deficiency: A Possible Cardiovascular Risk Factor in Older People.
G6PD deficiency: An update.
G6PD deficiency: global distribution, genetic variants and primaquine therapy.
G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus.
G6PD deficiency: the genotype-phenotype association.
G6PD diaxBox: Digital image-based quantification of G6PD deficiency.
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.
G6PD Enzyme Deficiency in Neonatal Pathologic Hyperbilirubinemia in Yazd.
G6PD genetic variations in neonatal Hyperbilirubinemia in Indonesian Deutromalay population.
G6PD Genotype and Its Associated Enzymatic Activity in a Chinese Population.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews.
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
G6PD Ube, a glucose-6-phosphate dehydrogenase variant found in four unrelated Japanese families.
G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
G6PD Viangchan and G6PD Mediterranean are the main variants in G6PD deficiency in the Malay population of Malaysia.
G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
G6PD-deficient donor blood as a cause of hemolysis in two preterm infants.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
G6PD-MutDB: a mutation and phenotype database of glucose-6-phosphate (G6PD) deficiency.
G6PD/PK ratio: a reliable parameter to identify glucose-6-phosphate dehydrogenase deficiency associated with microcytic anemia in heterozygous subjects.
G6PD: population genetics and clinical manifestations.
G6PDdb, an integrated database of glucose-6-phosphate dehydrogenase (G6PD) mutations.
Galactitol accumulation by glucose-6-phosphate deficient fibroblasts: a cellular model for resistance to the complications of diabetes mellitus.
Gall stones, G-6PD deficiency and Wilson's disease.
Gallstones due to hereditary spherocytosis with glucose-6-phosphate dehydrogenase deficiency.
Gene symbol: G6PD. Disease: Glucose-6-phosphate dehydrogenase deficiency.
Gene-nutrient interactions in G6PD-deficient subjects--implications for cardiovascular disease susceptibility.
General Anesthesia in a Glucose-6-Phosphate Dehydrogenase Deficiency Child: A Case Report.
Genes and people in the Caspian Littoral: a population genetic study in Northern Iran.
Genetic analysis of the glucose-6-phosphate dehydrogenase deficiency in a southern Croatia.
Genetic association in infertility: ABO, Rh (subtypes), Lea blood groups, G6PD deficiency and haemoglobin types.
Genetic association in myocardial infarction. Ethnicity; ABO, Rh, Le, Xg blood groups; G6PD deficiency; and abnormal haemoglobins.
Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift ?-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].
Genetic benefits of consanguinity through selection of genotypes protective against malaria.
Genetic Blood Disorders Survey in the Sultanate of Oman.
Genetic components in susceptibility to nasopharyngeal carcinoma.
Genetic compounds--Hb S, thalassaemias and enzymopathies: spectrum of interactions.
Genetic control of resistance to human malaria.
Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya.
Genetic disorders and malaria in Indo-China region.
Genetic disorders in Southern Africa.
Genetic disorders of glutathione and sulfur amino-acid metabolism. New biochemical insights and therapeutic approaches.
Genetic disorders of human red blood cells.
Genetic distances among the five tribal populations of Andhra, Pradesh, South India.
Genetic diversity among the Arabs.
Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.
Genetic diversity of the "Mediterranean" glucose-6-phosphate dehydrogenase deficiency phenotype.
Genetic factors and malaria in the Temuan.
Genetic factors related to unconjugated hyperbilirubinemia amongst adults.
Genetic heterogeneity and pathophysiology of G6PD deficiency.
Genetic heterogeneity at the glucose-6-phosphate dehydrogenase locus in southern Italy: a study on a population from the Matera district.
Genetic heterogeneity of glucose 6-phosphate dehydrogenase deficiency in Sardinia.
Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency in south-east Sicily.
Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis.
Genetic implications of G-6-PD deficiency.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Genetic linkage between X-chromosome markers and bipolar affective illness.
Genetic marker profile of primitive Kutia Kondh tribal population of Phulbani district (Orissa).
Genetic modifiers of severity in sickle cell disease.
Genetic polymorphism of G6PD in a Bulgarian population.
Genetic polymorphisms among Bukharan and Georgian Jews in Israel.
Genetic polymorphisms among Iranian Jews in Israel.
Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.
Genetic polymorphisms in Thai neonates with hyperbilirubinemia.
Genetic Profiles of Korean Patients With Glucose-6-Phosphate Dehydrogenase Deficiency.
Genetic red cell disorders and severity of falciparum malaria in Myanmar.
Genetic screening for hypersusceptibles in industry.
Genetic screening for low-penetrance variants in protein-coding genes.
Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.
Genetic structure of Rajaka caste and affinities with other caste populations of Andhra Pradesh, India.
Genetic studies among endogamous groups of Saraswats in Western India.
Genetic studies among the endogamous groups of Lohanas of North and West India.
Genetic studies among the Nagas and Hmars of eastern India.
Genetic studies of the Seneca Indians: haptoglobins, transferrins, G-6-PD deficiency, hemoglobinopathy, color blindness, morphological traits and dermatoglyphics.
Genetic study of retinitis pigmentosa in China.
Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection.
Genetical linkage between the loci for glucose-6-phosphate dehydrogenase deficiency and colour-blindness in American Negroes.
Genetically determined deficiency of glucose 6-phosphate dehydrogenase (type-A-) is expressed in the liver.
Genetics of glucose-6-phosphate dehydrogenase deficiency in Saudi patients.
Genotype and phenotype correlation in glucose-6-phosphate dehydrogenase deficiency.
Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency.
Genotype-Phenotype Correlations of Glucose-6-Phosphate-Deficient Variants Throughout an Activity Distribution.
Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria.
Genotyping of Malaysian G6PD-deficient neonates by reverse dot blot flow-through hybridisation.
Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana.
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.
Gilbert syndrome.
Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.
Gilbert's syndrome associated with glucose-6-phosphate dehydrogenase deficiency.
Global burden of genetic disease and the role of genetic screening.
Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia.
Glucose 6 phosphate dehydrogenase deficiency and hemoglobinopathy in South Western Region Nepal: a boon or burden.
Glucose 6 phosphate dehydrogenase deficiency in adults.
Glucose 6 phosphate dehydrogenase deficiency unmasked by diabetic ketoacidosis: an underrated phenomenon.
Glucose 6-phosphate dehydrogenase activity in membranes of erythrocytes from normal individuals and subjects with Mediterranean G6PD deficiency.
Glucose 6-phosphate dehydrogenase and the kidney.
Glucose 6-phosphate dehydrogenase deficiency and cataract of patients in northern Sardinia.
Glucose 6-phosphate dehydrogenase deficiency and cystic fibrosis.
Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.
Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia.
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part I.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part II.
Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans.
Glucose 6-Phosphate dehydrogenase deficiency genetic, pathophysiological and therapeutic aspects.
Glucose 6-phosphate dehydrogenase deficiency in Africa--review.
Glucose 6-phosphate dehydrogenase deficiency in an elite long-distance runner.
Glucose 6-phosphate dehydrogenase deficiency in Muslim community settled in Jaunpur district.
Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure.
Glucose 6-phosphate dehydrogenase deficiency with kernicterus: progressive late recovery from profound deafness.
Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype.
Glucose 6-phosphate dehydrogenase knockdown enhances IL-8 expression in HepG2 cells via oxidative stress and NF-?B signaling pathway.
Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.
Glucose-6 phosphate dehydrogenase deficiency and psychotic illness.
Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
Glucose-6 phosphate dehydrogenase deficiency: an easy and sensitive quantitative assay for the detection of female heterozygotes in red blood cells.
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. II. Incidence of G-6-PD deficiency in Japanese.
Glucose-6-phosphate dehydrogenase (G-6-PD) levels in jaundiced neonates in Calabar.
Glucose-6-phosphate dehydrogenase (G6PD) activity and deficiency in a population of Nigerian males resident in Jos.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency and senile cataract in a Sardinian male population, Italy.
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in Greek newborns: The Mediterranean C563T mutation screening.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a study on the population of the Cosenza province.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Yogyakarta and its surrounding areas.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina Faso.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and UDP-glucuronosyltransferase promoter polymorphism among G6PD deficient Kuwaitis.
Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population.
Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population.
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese.
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient infants: Enzyme activity and gene variants as risk factors for phototherapy in the first week of life.
Glucose-6-Phosphate Dehydrogenase - Beyond the Realm of Red Cell Biology.
Glucose-6-phosphate dehydrogenase activity in bipolar disorder and schizophrenia: Relationship to mitochondrial impairment.
Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
Glucose-6-phosphate dehydrogenase activity in male premature and term neonates.
Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia.
Glucose-6-phosphate dehydrogenase activity, structure, molecular characteristics and role in neonatal hyperbilirubinemia in cord blood in Cukurova region.
Glucose-6-phosphate dehydrogenase and its relationship to mental retardation.
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
Glucose-6-phosphate dehydrogenase deficiency & neonatal hyperbilirubinaemia.
Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis.
Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.
Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGF?/NADPH Oxidases/ROS Signaling Pathway.
Glucose-6-phosphate dehydrogenase deficiency allelic variants and their prevalence in malaria patients in Eritrea.
Glucose-6-phosphate dehydrogenase deficiency among children attending the Emergency Paediatric Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Glucose-6-phosphate dehydrogenase deficiency among ethnic groups in Iraq.
Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.
Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
Glucose-6-Phosphate Dehydrogenase Deficiency among Male Blood Donors in Sana'a City, Yemen.
Glucose-6-phosphate dehydrogenase deficiency among three national minorities in Hainan Island, China.
Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Glucose-6-phosphate dehydrogenase deficiency and abnormal hemoglobins in mexican newborns with jaundice.
Glucose-6-phosphate dehydrogenase deficiency and acute renal failure.
Glucose-6-phosphate dehydrogenase deficiency and adrenal hemorrhage in a filipino neonate with hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
Glucose-6-phosphate dehydrogenase deficiency and bacterial infections in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and blood groups in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and blood transfusion.
Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study.
Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants.
Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery.
Glucose-6-phosphate dehydrogenase deficiency and cataracts.
Glucose-6-phosphate dehydrogenase deficiency and chronic haemolysis in an English family.
Glucose-6-phosphate dehydrogenase deficiency and colour-vision studies in Indian Muslims.
Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
Glucose-6-phosphate dehydrogenase deficiency and COVID-19 mortality.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus.
Glucose-6-phosphate dehydrogenase deficiency and duodenal ulcer.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND FALCIPARUM MALARIA.
Glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome: a gene interaction underlies severe jaundice without severe hemolysis.
Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
Glucose-6-phosphate dehydrogenase deficiency and haemoglobin level in Jamaican children.
Glucose-6-phosphate dehydrogenase deficiency and haemolytic disease of the newborn in Israel.
Glucose-6-phosphate dehydrogenase deficiency and haptoglobin polymorphism among Rajput and Brahmin children in Himachal Pradesh.
Glucose-6-phosphate dehydrogenase deficiency and hematopoietic stem cell transplantation.
Glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Ok Tedi impact region of Papua New Guinea.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica.
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Glucose-6-phosphate dehydrogenase deficiency and hyperbilirubinemia in the newborn.
Glucose-6-phosphate dehydrogenase deficiency and idiopathic presenile cataract in Dalmatia, Croatia.
Glucose-6-phosphate dehydrogenase deficiency and incidence of cataract in Sicily.
Glucose-6-phosphate dehydrogenase deficiency and infection: a study of hospitalized patients in Iran.
Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
Glucose-6-phosphate dehydrogenase deficiency and its variants in India.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND JAUNDICE IN NEWBORN INFANTS IN NORTHERN THAILAND.
Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia.
Glucose-6-phosphate dehydrogenase deficiency and lobar pneumonia. Fine structure of the liver.
Glucose-6-phosphate dehydrogenase deficiency and lung cancer: a hospital based case-control study.
Glucose-6-phosphate dehydrogenase deficiency and malaria--a study on north Madras population.
Glucose-6-phosphate dehydrogenase deficiency and malaria.
Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women.
Glucose-6-phosphate dehydrogenase deficiency and malignant hepatoma in a Bantu population.
Glucose-6-phosphate dehydrogenase deficiency and Mediterranean fever in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and mental retardation.
Glucose-6-phosphate dehydrogenase deficiency and metabolic profiling in adolescence from the Chinese birth cohort: "Children of 1997".
Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and myelofibrosis.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice among population groups of Cape Town.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Al-Hofuf area.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN NIGERIA: THEIR RELATION TO THE USE OF PROPHYLACTIC VITAMIN K.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN SOUTH AFRICAN BANTU INFANTS.
Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NONSPHEROCYTIC CONGENITAL HEMOLYTIC ANEMIA.
Glucose-6-phosphate dehydrogenase deficiency and osteoarthritis in men of Northern Sardinia.
Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence.
Glucose-6-phosphate Dehydrogenase Deficiency and Pre-eclampsia: Possibility of Treatment.
Glucose-6-phosphate dehydrogenase deficiency and red cell glutathione peroxidase.
Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Glucose-6-phosphate dehydrogenase deficiency and related disorders of the pentose phosphate pathway.
Glucose-6-phosphate dehydrogenase deficiency and Rh factor.
Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study.
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study.
Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.
Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior.
Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell genes in Bisha.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell genes in two regions of western Saudi Arabia.
Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana.
Glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia.
Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes.
Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE INCIDENCE OF CANCER.
Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.
Glucose-6-phosphate dehydrogenase deficiency and the sickle cell gene in Makkah, Saudi Arabia.
Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs.
Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes.
Glucose-6-phosphate dehydrogenase deficiency as a cause of drug-induced hemolysis with renal shut down and kernicterus.
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
Glucose-6-phosphate dehydrogenase deficiency associated with hemogobin H disease.
Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Glucose-6-Phosphate Dehydrogenase Deficiency Diagnosed in an Adolescent with Type 1 Diabetes Mellitus and Hemoglobin A1c Discordant with Blood Glucose Measurements.
Glucose-6-phosphate dehydrogenase deficiency does not increase the susceptibility of sperm to oxidative stress induced by H2O2.
Glucose-6-phosphate dehydrogenase deficiency does not result from mutations in the promoter region of the G6PD gene.
Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection.
Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.
Glucose-6-Phosphate Dehydrogenase Deficiency Genetic Variants in Malaria Patients in Southwestern Ethiopia.
Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia.
Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN BRUNEI, SABAH AND SARAWAK.
Glucose-6-phosphate dehydrogenase deficiency in a community with a high incidence of the mutant gene.
Glucose-6-phosphate dehydrogenase deficiency in a dog.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN A DUTCH FAMILY.
Glucose-6-phosphate dehydrogenase deficiency in a native Danish family. A new variant.
Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study.
Glucose-6-phosphate dehydrogenase deficiency in a rural Saudi population.
Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in manaus: a cross-sectional survey in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase deficiency in an XO individual.
Glucose-6-phosphate dehydrogenase deficiency in blood donors.
Glucose-6-phosphate dehydrogenase deficiency in blood donors: screening by micromethaemoglobin reduction test.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Glucose-6-phosphate dehydrogenase deficiency in Canadian Negroes.
Glucose-6-phosphate dehydrogenase deficiency in children in Zulfi (Riyadh) area - needs immediate attention.
Glucose-6-phosphate dehydrogenase deficiency in Chinese.
Glucose-6-phosphate dehydrogenase deficiency in congenital hemolytic disease. A review.
Glucose-6-phosphate dehydrogenase deficiency in Cukurova Province, Turkey.
Glucose-6-phosphate dehydrogenase deficiency in dermatology.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN DIFFERENT ETHNIC GROUPS IN THAILAND.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN EAST AFRICANS.
Glucose-6-Phosphate dehydrogenase deficiency in Egypt: with a note on the methemoglobin reduction test.
Glucose-6-phosphate dehydrogenase deficiency in erythrocytes in sheep and goats.
Glucose-6-phosphate dehydrogenase deficiency in ethnic minorities in Britain.
Glucose-6-phosphate dehydrogenase deficiency in ethnic minorities in The Netherlands.
Glucose-6-phosphate dehydrogenase deficiency in female heterozygotes and the X-inactivation hypothesis.
Glucose-6-phosphate dehydrogenase deficiency in female octogenarians, nanogenarians, and centenarians.
Glucose-6-phosphate dehydrogenase deficiency in females, diagnosed by partial inhibition of glutathione reductase activity in the erythrocytes after incubation with chromate.
Glucose-6-phosphate dehydrogenase deficiency in Greece.
Glucose-6-phosphate dehydrogenase deficiency in health and disease.
Glucose-6-phosphate dehydrogenase deficiency in healthy Nepalese patients.
Glucose-6-phosphate dehydrogenase deficiency in hemolytic anemia.
Glucose-6-phosphate dehydrogenase deficiency in human platelets and its effect on platelet aggregation.
Glucose-6-phosphate dehydrogenase deficiency in immigrant greek infants.
Glucose-6-phosphate dehydrogenase deficiency in India and its clinical significance.
Glucose-6-phosphate dehydrogenase deficiency in India.
Glucose-6-phosphate dehydrogenase deficiency in internationally adopted children.
Glucose-6-phosphate dehydrogenase deficiency in Iraq.
Glucose-6-phosphate dehydrogenase deficiency in Italian blood donors: prevalence and molecular defect characterization.
Glucose-6-phosphate dehydrogenase deficiency in Italy. A study of the distribution and severity of the enzymatic defect.
Glucose-6-phosphate dehydrogenase deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon.
Glucose-6-phosphate dehydrogenase deficiency in Kuwait.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN MALAYANS.
Glucose-6-phosphate dehydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia.
Glucose-6-phosphate dehydrogenase deficiency in Maltese newborn infants.
Glucose-6-phosphate Dehydrogenase Deficiency in Marfan's Syndrome.
Glucose-6-phosphate dehydrogenase deficiency in military recruits.
Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinaemia: Hacettepe exper?ence.
Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia in a south Indian referral hospital.
Glucose-6-phosphate Dehydrogenase Deficiency in Neonatal Indirect Hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency in neonates.
Glucose-6-phosphate dehydrogenase deficiency in newborn infants.
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency in northern Mexico and description of a novel mutation.
Glucose-6-phosphate dehydrogenase deficiency in northern Vietnam.
Glucose-6-phosphate dehydrogenase deficiency in Orissa.
Glucose-6-phosphate dehydrogenase deficiency in Pakistani males.
Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea using a simple methylene blue reduction test.
Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea. The description of 13 new variants.
Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.
Glucose-6-phosphate dehydrogenase deficiency in pleiotropic carbohydrate-negative mutant strains of Rhizobium meliloti.
Glucose-6-phosphate dehydrogenase deficiency in Portugal: biochemical and mutational profiles, heterogeneity, and haplotype association.
Glucose-6-phosphate dehydrogenase deficiency in pregnancy.
Glucose-6-phosphate dehydrogenase deficiency in Project Head Start children.
Glucose-6-phosphate dehydrogenase deficiency in red blood cells of East Africans.
Glucose-6-phosphate dehydrogenase deficiency in red cells.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN RED CELLS. INCIDENCE IN THE CURA CAO POPULATION, ITS CLINICAL AND GENETIC ASPECTS.
Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia.
Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. A study in Al-Ula.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN SAUDI ARABIA: A SURVEY.
Glucose-6-phosphate dehydrogenase deficiency in Sicily. Incidence, biochemical characteristics and clinical implications.
Glucose-6-phosphate dehydrogenase deficiency in sickle cell disease by DNA analysis.
Glucose-6-phosphate dehydrogenase deficiency in Sickle-cell anemia. A study in adults.
Glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease.
Glucose-6-phosphate dehydrogenase deficiency in Singapore.
Glucose-6-phosphate dehydrogenase deficiency in South Vietnamese.
Glucose-6-phosphate dehydrogenase deficiency in Southeast Asian refugees entering the United States.
Glucose-6-phosphate dehydrogenase deficiency in Taiwan.
Glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Glucose-6-phosphate dehydrogenase deficiency in Thailand: the influence on the clinical presentation of malaria in male adult patients.
Glucose-6-phosphate dehydrogenase deficiency in Thailand; its significance in the newborn.
Glucose-6-phosphate dehydrogenase deficiency in the Bhanushali community--a survey.
Glucose-6-phosphate dehydrogenase deficiency in the Dr. Cipto Mangunkusumo General Hospital.
Glucose-6-phosphate dehydrogenase deficiency in the Greek population of Cape Town.
Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution.
Glucose-6-phosphate dehydrogenase deficiency in the newborn and its relation to serum bilirubin.
Glucose-6-phosphate dehydrogenase deficiency in the newborn: its prevalence and relation to neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency in the Parsee community, Bombay.
Glucose-6-phosphate dehydrogenase deficiency in the peoples of the Niger Delta.
Glucose-6-phosphate dehydrogenase deficiency in the Philippines: report of a new variant--G6PD Panay.
Glucose-6-phosphate dehydrogenase deficiency in the Sudan.
Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks.
Glucose-6-phosphate dehydrogenase deficiency in triplets of African-American descent.
Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association.
Glucose-6-phosphate dehydrogenase deficiency in Tunisian jaundiced neonates.
Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
Glucose-6-phosphate dehydrogenase deficiency in two siblings of a Chinese family.
Glucose-6-Phosphate dehydrogenase deficiency incidence in a Hispanic population.
Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion: Protective role of l-cysteine.
Glucose-6-phosphate dehydrogenase deficiency induced haemolysis in a woman with newly diagnosed diabetes after normalisation of hyperglycaemia.
Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum.
Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.
Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Glucose-6-phosphate dehydrogenase deficiency is associated with lower fibrosis score in non-progressive HBsAg-positive subjects.
Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
Glucose-6-phosphate dehydrogenase deficiency mutations in Papua New Guinea.
Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening.
Glucose-6-phosphate dehydrogenase deficiency presented with convulsion: a rare case.
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.
Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-phosphate dehydrogenase deficiency screening in Madeira.
Glucose-6-phosphate dehydrogenase deficiency severely restricts the biotransformation of daunorubicin in human erythrocytes.
Glucose-6-phosphate dehydrogenase deficiency trait in Nigeria.
Glucose-6-Phosphate Dehydrogenase Deficiency Unveiled by Diabetic Ketoacidosis: A Dual Dilemma.
Glucose-6-phosphate dehydrogenase deficiency with bilateral cataract.
Glucose-6-phosphate dehydrogenase deficiency with psychosis.
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Glucose-6-phosphate dehydrogenase deficiency, haemoglobin variants, and blood groups distribution in a Liberian sample.
Glucose-6-phosphate dehydrogenase deficiency, hemoglobin and haptoglobin types in Mexicans and American Negroes.
Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis.
Glucose-6-phosphate dehydrogenase deficiency, thalassaemia & abnormal haemoglobins in Bohra Muslims.
Glucose-6-phosphate dehydrogenase deficiency, the sickling trait, and malaria in Saudi Arab children.
Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency, vitamin K, and ambiguity in medical textbooks.
Glucose-6-phosphate dehydrogenase deficiency--report of 4 cases.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Glucose-6-phosphate dehydrogenase deficiency.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-Phosphate Dehydrogenase Deficiency.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency. A new aetiological factor of severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency. Diagnosis, clinical and genetic implications.
Glucose-6-phosphate dehydrogenase deficiency. Part 1: Tropical Africa.
Glucose-6-phosphate dehydrogenase deficiency. Part 2. Tropical Asia.
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Glucose-6-phosphate dehydrogenase deficiency: a brief review.
Glucose-6-phosphate dehydrogenase deficiency: a contraindication for living donor liver transplantation?
Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a historical perspective.
Glucose-6-phosphate dehydrogenase deficiency: a new hypothesis for an old disease.
Glucose-6-phosphate dehydrogenase deficiency: a novel role for thyroxine in peroxide-induced hemolysis.
Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation.
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
Glucose-6-phosphate dehydrogenase deficiency: an unusual cause of acute jaundice after paracetamol overdose.
Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis?
Glucose-6-phosphate dehydrogenase deficiency: biochemical and histochemical studies on hair roots for carrier detection.
Glucose-6-phosphate dehydrogenase deficiency: correlation between the genotype, biochemistry and phenotype.
Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits.
Glucose-6-phosphate dehydrogenase deficiency: genetic heterogeneity in Sardinia.
Glucose-6-phosphate dehydrogenase deficiency: mechanisms of drug-induced hemolysis.
Glucose-6-phosphate dehydrogenase deficiency: molecular heterogeneity in southeast Asian countries.
Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males.
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever.
Glucose-6-phosphate dehydrogenase deficiency: pre-natal and post-natal implications.
Glucose-6-phosphate dehydrogenase deficiency: screening of 200 Zambian newborn.
Glucose-6-phosphate dehydrogenase deficiency: some biological implications.
Glucose-6-phosphate dehydrogenase deficiency: the added value of cytology.
Glucose-6-phosphate dehydrogenase deficiency: why girls are affected?
Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase is indispensable in embryonic development by modulation of epithelial-mesenchymal transition via the NOX/Smad3/miR-200b axis.
Glucose-6-phosphate dehydrogenase isoenzyme pattern and evaluation of screening methods for G-6-PD deficiency in neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase isozymes in Jordan Valley.
Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.
Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis.
Glucose-6-phosphate dehydrogenase mutations and haplotypes in Mexican Mestizos.
Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.
Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar.
Glucose-6-phosphate dehydrogenase of malaria parasite Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.
Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.
Glucose-6-phosphate dehydrogenase red blood cell phenotype in GdMediterranean heterozygous females and hemizygous males at birth.
Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates.
Glucose-6-phosphate dehydrogenase screening of babies born in a tertiary care hospital in West Bengal.
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
Glucose-6-phosphate dehydrogenase variants and sickle cell genes in Al-Qunfuda, Saudi Arabia.
Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong, China.
Glucose-6-phosphate dehydrogenase variants from Italian subjects associated with severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.
Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria.
Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.
Glucose-6-phosphate metabolism in Plasmodium falciparum.
Glucose-6-phosphate-dehydrogenase deficiency and haematopoietic stem cell transplantation in Chinese patients.
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium.
Glucotoxicity and oxidative hemolysis in G-6-PD deficiency.
Glutathione and glucose-6-phosphate dehydrogenase deficiency can increase protein glycosylation.
Glutathione reductase activity and its relationship to pyridoxine phosphate activity in G6PD deficiency.
Glutathione reductase deficiency in association with sickle cell and thalassaemia genes in Saudi populations.
Glutathione reductase in the south-western province of Saudi Arabia--genetic variation vs. acquired deficiency.
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.
Glycosylated haemoglobin in glucose-6-phosphate dehydrogenase deficiency.
Glycosylated hemoglobin in Saudi sickle cell patients with glucose-6-phosphate dehydrogenase deficiency.
Grand rounds, University Hospital. G6PD deficiency.
Green Tea Polyphenol Epigallocatechin-3-gallate Protects Cells against Peroxynitrite-Induced Cytotoxicity: Modulatory Effect of Cellular G6PD Status.
Groups at potentially high risk from chlorine dioxide treated water.
GSSG-reducing activity in lenses deficient in glucose-6-phosphate dehydrogenase.
HAART has no major impact on hematological and plasma bilirubin changes in HIV-infected patients with congenital G-6-PD deficiency.
Haematological study in Cabo Delgado province, Mozambique; sickle cell trait and G6PD deficiency.
Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population.
Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria.
Haemoglobin and erythrocytic glucose-6-phosphate dehydrogenase variants among selected tribes in Western Saudi Arabia.
Haemoglobin disorders: a pattern for thalassaemia and haemoglobinopathies in Arabia.
Haemoglobin O Arab, beta-thalassaemia and glucose-6-phosphate dehydrogenase deficiency in a Hungarian family.
Haemoglobin variants, beta-thalassaemia and G-6-PD types in Liberia.
Haemoglobin, serum iron, transferrin, ferritin concentrations and total iron-binding capacity in erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in a Scandinavian perspective.
Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Eastern Libya.
Haemoglobinopathies, glucose-6-phosphate dehydrogenase deficiency and allied problems in the Indian subcontinent.
Haemoglobinopathies, thalassaemias and enzymopathies in Saudi Arabia: the present status.
Haemoglobinopathy survey in an Eti-Turk village.
Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.
Haemoglobinuria among adult Nigerians due to glucose-6-phosphate dehydrogenase deficiency with drug sensitivity.
Haemoglobinuria and haptoglobin in G6PD deficiency.
Haemolysis complicating acute viral hepatitis in patients with normal or deficient glucose-6-phosphate dehydrogenase activity.
Haemolysis complicating fulminant hepatitis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Haemolysis complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Haemolysis due to glucose-6-phosphate dehydrogenase deficiency in Malaya.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases.
Haemolysis in a G6PD-deficient child induced by eating unripe peaches.
Haemolysis in typhoid fever in children with G-6-PD deficiency.
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency.
Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency.
Haemolytic anaemia after ingestion of Neem (Azadirachta indica) tea.
Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency.
Haemolytic anaemia after oral self-giving of naphthalene-containing oil.
Haemolytic anaemia associated with Nigerian barbecued meat (red suya).
Haemolytic anaemia with massive haemoglobinuria due to glucose-6-phosphate dehydrogenase deficiency in Ceylon.
Haemolytic crises caused by Hoya carnosa in a patient with G6PD deficiency.
Haemolytic crises due to glucose-6-phosphate dehydrogenase deficiency in the mid-southern region of Turkey.
Haemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait.
Haemolytic effect of trimethoprim-sulphamethoxazole in G-6-PD deficiency.
Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Hair root versus red cell individual phenotype in Sardinian heterozygotes for G6PD deficiency (Mediterranean type).
Hairy-cell leukemia and glucose-6-phosphate dehydrogenase deficiency in two brothers.
Haptoglobin therapy for acute favism: a Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara.
Haptoglobin, hemopexin, hemoglobin and hematocrit in newborns with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review.
Hb Belfast (beta 15 (A 12) Trp leads to Arg) in combination with G6PD deficiency in an Italian carrier.
Hb Buffalo [alpha89(FG1)His-->Gln (alpha1)], observed solely and in the presence of an Hb S [beta6(A3)Glu-->Val] heterozygosity.
HB H disease with homozygosity for red cell G6PD deficiency in a Turkish female.
HbA1c levels in diabetic Sardinian patients with or without G6PD deficiency.
HbE-beta-thalassemia associated with G6PD deficiency.
Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice.
Hematologic disorders and nonimmune hydrops fetalis.
Hematologic findings in Southeast Asian immigrants with particular reference to hemoglobin E.
Hematologic genetic disorders among Southeast Asian refugees.
Hematologic problems in pregnancy. 3. Glucose-6-phosphate dehydrogenase deficiency.
Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Hematological findings and severity of G6PD deficiency in Vataliya Prajapati subjects.
Hematological findings in neonatal hyperbilirubinemia due to G6PD deficiency.
Hematological parameters and red blood cell morphological abnormality of Glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.
Hematological profile in neonatal jaundice.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).
Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism.
Hemoglobin A2, E and F levels and the incidence of hemoglobin E, beta-thalassemia, and glucose-6-phosphate dehydrogenase deficiency in lymphoma.
Hemoglobin C trait and glucose-6-phosphate dehydrogenase deficiency.
Hemoglobin E and glucose-6-phosphate deficiency in the Khmer Air Force (Cambodia).
Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh.
Hemoglobin H disease in the Al-Qatif Region of Saudi Arabia.
Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria.
Hemoglobin variants in India.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in one of the regions of Azerbaijan: mass screening and laboratory investigations.
Hemoglobinopathies in relation to the erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemoglobinopathies, G6PD deficiency, and hereditary elliptocytosis in Bahrain.
Hemolysis after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia.
Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip.
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Hemolysis as a potential complication of acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolysis caused by G-6PD deficiency after a difficult and prolonged therapeutic endoscopic retrograde cholangiopancreatography.
Hemolysis due to G-6-PD deficiency induced by endoscopic sphincterotomy.
Hemolysis following transfusion of erythrocytes from a donor with G6PD deficiency and beta-thalassemia minor.
Hemolysis in G6PD deficiency in Qatif, Saudi Arabia.
Hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia after acetaminophen overdose in patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.
Hemolytic anemia and erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia and G-6-PD deficiency.
Hemolytic anemia and G6PD deficiency.
Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient.
Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Hemolytic Anemia Induced by Pegloticase Infusion in a Patient With G6PD Deficiency.
Hemolytic anemia.
Hemolytic anemias and erythrocyte enzymopathies.
Hemolytic anemias due to erythrocyte enzyme deficiencies.
Hemolytic anemias. Diagnosis and management.
Hemolytic crises of favism in Sicilian females heterozygous for G-6-PD deficiency.
Hemolytic crisis after excessive ingestion of fava beans in a male infant with G6PD Canton.
Hemolytic crisis following acetaminophen overdose in a patient with G6PD deficiency.
Hemolytic Crisis following Naphthalene Mothball Ingestion in a 21-Month-Old Patient with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.
Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin.
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
Hemolytic crisis in G6PD-deficient individuals in the occupational setting.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn.
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report.
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report: Retraction.
Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice.
Henna (Lawsonia inermis Linn.) induced haemolytic anaemia in siblings.
Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Henna causes life-threatening hyperbilirubinaemia in glucose-6-phosphate dehydrogenase deficiency.
Henna-induced Hemolysis and Acute Kidney Injury in an 85-year-old Man; a Case Report.
Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia.
Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hepatitis A infection related haemophagocytic syndrome: a case report and systematic review.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hepatitis E virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase deficiency.
Hepatitis E with Intravascular Hemolysis in Beta Thalassemia Trait: A Rare Association or Coincidence.
Hereditary anaemias and iron deficiency in a tribal population (the Baiga) of central India.
Hereditary anaemias in Portugal: epidemiology, public health significance, and control.
Hereditary characteristics of enzyme deficiency and dermatoglyphics in congenital color blindness.
Hereditary disorders in the Eastern Mediterranean Region.
Hereditary elliptocytosis (the first report in Thailand) in association with erythrocyte glucose-6-phosphate dehydrogenase deficiency and hemoglobin E.
Hereditary hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency (Mediterranean type).
HEREDITARY HEMOLYTIC ANEMIA DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY; IMPROVEMENT FOLLOWING SPLENECTOMY AND FOLIC ACID THERAPY.
HEREDITARY HEMOLYTIC DISEASE SECONDARY TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY: REPORT OF THREE CASES WITH SPECIAL EMPHASIS ON ATP METABOLISM.
Hereditary hemolytic disorders among the Ashram school children in Mayurbhanj district of Orissa.
Hereditary red blood cell disorders in middle eastern patients.
Hereditary red cell disorders in Southeast Asian refugees and the effect on the prevalence of thalassemia disorders in the United States.
Hereditary sideroblastic anemia and glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Hereditary spherocytosis and glucose-6-phosphate dehydrogenase deficiency.
Hereditary spherocytosis in association with severe G6PD deficiency: report of an unusual case.
Heterogeneity and variation of clinical and haematological expression of haemoglobin S in Saudi Arabs.
Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions.
Heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Algeria. Study in Northern Algeria with description of five new variants.
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.
Heterozygote detection in glucose-6-phosphate dehydrogenase deficiency: limitation of hair follicle analysis.
Heterozygous pyruvate kinase deficiency and severe hemolytic anemia in a pregnant woman with concomitant, glucose-6-phosphate dehydrogenase deficiency.
Hidden risks: early discharge and bilirubin toxicity due to glucose 6-phosphate dehydrogenase deficiency.
High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis.
High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.
High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon.
High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria.
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis.
High incidence of 3-thalassemia, hemoglobin E, and glucose-6-phosphate dehydrogenase deficiency in populations of malaria-endemic southern Shan State, Myanmar.
High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.
High Incidence of Malaria Along the Sino-Burmese Border Is Associated With Polymorphisms of CR1, IL-1A, IL-4R, IL-4, NOS, and TNF, But Not With G6PD Deficiency.
High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.
High prevalence of G6PD deficiency in Vataliya Prajapati community in western India.
High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
High prevalence of microcytic anaemia in Omani children: a prospective study.
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency.
Histochemistry and cytochemistry of glucose-6-phosphate dehydrogenase.
HLA-DRB1 and DQB1 allele distribution in the Muong population exposed to malaria in Vietnam.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Homozygous G6PD deficiency and propacetamol induced hemolysis.
Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case.
Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea.
Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission.
Host factors against Salmonella typhi in children with glucose-6-phosphate dehydrogenase deficiency.
Host-targeted Interventions as an Exciting Opportunity to Combat Malaria.
How malaria has affected the human genome and what human genetics can teach us about malaria.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Human embryonic stem cells derived from abnormal blastocyst donated by glucose-6-phosphate dehydrogenase deficiency patient.
Human erythrocyte G6PD deficiency: pathophysiology, prevalence, diagnosis, and management.
Human genetic factors related to susceptibility to mild malaria in Gabon.
Human genetics and malaria resistance.
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency.
Human hair follicles may be used for population screening of heterozygotes of glucose-6-phosphate dehydrogenase deficiency.
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history.
Human red blood cell polymorphisms prevalent in Colombian population and its protective role against malaria.
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid.
Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
Hydroxychloroquine is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients.
Hyperbilirubinaemia and erythrocytic glucose 6 phosphate dehydrogenase deficiency in Malaysian children.
Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome.
Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
Hyperbilirubinemia following hepatitis A in a patient with G6pD deficiency.
Hyperbilirubinemia in black infants. Role of glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome.
Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.
Hyperlactatemia and hemolysis in G6PD deficiency after nitrofurantoin ingestion.
Hyperlipidemia in acute hemolysis.
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Hypoxic Activation of G6PD Controls the Expression of Genes Involved in the Pathogenesis of Pulmonary Hypertension Through the Regulation of DNA Methylation.
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
Ichthyosis accompanied by neurological symptoms with special reference to epilepsy.
Identification of a case of glucose-6-phosphate dehydrogenase deficiency with G6PD mediterranean-middle east subtype in China.
Identification of Genetic Risk Factors for Neonatal Hyperbilirubinemia in Fujian Province, Southeastern China: A Case-Control Study.
Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia.
Identification of Inflammatory Biomarkers for Pediatric Malarial Anemia Severity using Novel Statistical Methods.
Identification of Mutation of Glucose-6-Phosphate Dehy-drogenase (G6PD) in Iran: Meta- analysis Study.
Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights.
Identifying risk of neonatal hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns in Singapore.
If Vitamins Could Kill: Massive Hemolysis Following Naturopathic Vitamin Infusion.
Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.
Impact of G6PD status on red cell storage and transfusion outcomes.
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.
Impact of glucose-6-phosphate dehydrogenase deficiency on the severity of coronary atherosclerosis in patients with acute coronary syndromes.
Impact of Hemoglobin S Trait on Cell Surface Antibody Recognition of Plasmodium falciparum-Infected Erythrocytes in Pregnancy-Associated Malaria.
Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis.
Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolism.
Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX/p38 MAPK/AP-1 redox signaling.
Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency.
Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes.
Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States.
Implementation of G6PD testing and primaquine for P. vivax radical cure: Operational perspectives from Thailand and Cambodia.
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh.
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency.
Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis.
Improved quantitative method for G6PD deficiency detection.
In the Light of Evolution IV: The Human Condition Sackler Colloquium: Gene-culture coevolution in the age of genomics.
In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Inborn defects in the antioxidant systems of human red blood cells.
Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants.
Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
Incidence and characteristics of glucose-6-phosphate dehydrogenase variants in Japan.
Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations.
Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency.
Incidence and molecular analysis of glucose-6-phosphate dehydrogenase deficiency in the province of Denizli, Turkey.
Incidence and molecular characterization of Glucose-6-Phosphate Dehydrogenase deficiency among neonates for newborn screening in Chaozhou, China.
Incidence and mutation analysis of glucose-6-phosphate dehydrogenase deficiency in eastern Indonesian populations.
Incidence of abnormal haemoglobins and G-6-PD deficiency in school children of Udaipur (Rajasthan), India.
Incidence of Chronic Bilirubin Encephalopathy in Canada, 2007-2008.
Incidence of erythrocyte glucose-6-phosphate dehydrogenase deficiency among different ethnic groups of India.
Incidence of G-6-PD deficiency and abnormal haemoglobins in the indigenous and immigrant tribes of the Sudan.
Incidence of G6PD deficiency in patients of three different ethnic groups suffering from pulmonary tuberculosis.
Incidence of glucose 6-phosphate dehydrogenase deficiency and some observations in patients with haemoglobinuria.
Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants.
Incidence of glucose-6-phosphate dehydrogenase deficiency and haemoglobinopathies in Bhil tribe of Udaipur District.
Incidence of glucose-6-phosphate dehydrogenase deficiency in a hospital population of Delhi.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Egypt.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Jabalpur area.
Incidence of glucose-6-phosphate dehydrogenase deficiency in jaundiced punjabi neonates.
Incidence of glucose-6-phosphate dehydrogenase deficiency in three Gujarati populations.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Zimbabwe.
Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984.
Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns.
Increase of F cells during acute hemolysis in glucose-6-phosphate dehydrogenase-deficient males.
Increased basal oxidation of peroxiredoxin 2 and limited peroxiredoxin recycling in glucose-6-phosphate dehydrogenase-deficient erythrocytes from newborn infants.
Increased bilirubin production, ceruloplasmin concentrations and hyperbilirubinaemia in full-term newborn infants.
Increased erythrocyte deformability in fetal erythropoiesis and in erythrocytes deficient in glucose-6-phosphate dehydrogenase and other glycolytic enzymes.
Increased incidence of cataracts in male subjects deficient in glucose-6-phosphate dehydrogenase.
Increased incidence of hyperbilirubinaemia in 'unchallenged' glucose-6-phosphate dehydrogenase deficiency in term Saudi newborns.
Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients.
Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient.
Increased morbidity following acute viral hepatitis in children with glucose-6-phosphate dehydrogenase deficiency.
Increased morbidity in acute viral hepatitis with glucose-6-phosphate dehydrogenase deficiency.
Increased prevalence of glucose-6-phosphate dehydrogenase deficiency in patients with cholelithiasis.
Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
Index of suspicion. Case 3. Diagnosis: glucose-6-phosphate dehydrogenase deficiency.
Index of suspicion. Case 3. Kernicterus in a baby girl homozygous for glucose-6-phosphate dehydrogenase deficiency.
Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.
Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study.
Induction of hemolytic anemia by nonsteroidal antiinflammatory drugs.
Infantile pyknocytosis and glucose-6-phosphate dehydrogenase deficiency.
Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization.
Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency.
Infectious hepatitis with excessive hyperbilirubinemia and a hemolytic crisis in an 8-year-old boy. His G6PD deficiency was an aggravating factor.
Influence of blood group, Glucose-6-phosphate dehydrogenase and Haemoglobin genotype on Falciparum malaria in children in Vihiga highland of Western Kenya.
Influence of Changes in the Evaluation of Neonatal Jaundice.
Influence of glucose-6-phosphate dehydrogenase deficiency on the glutathione reductase test for ariboflavinosis.
Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives.
Influence of hemoglobin E trait on the severity of Falciparum malaria.
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia.
Influence of pharmacogenetics on drug disposition and response.
Influence of the Inherited Glucose-6-phosphate Dehydrogenase Deficiency on the Appearance of Neonatal Hyperbilirubinemia in Southern Croatia.
Influenza-induced hemolytic crisis in glucose-6-phosphate dehydrogenase deficiency.
Inheritance of glucose 6-phosphate dehydrogenase deficiency, a study of eight families.
Inherited anaemias in the Greek community of Cape Town.
Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.
Inherited haemolytic states: glucose-6-phosphate dehydrogenase deficiency.
Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.
Inhibition of Glucose-6-Phosphate Dehydrogenase Could Enhance 1,4-Benzoquinone-Induced Oxidative Damage in K562 Cells.
Inhibition of glucose-6-phosphate dehydrogenase protects hepatocytes from aluminum phosphide-induced toxicity.
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Inhibitory effect of a fava bean component on the in vitro development of Plasmodium falciparum in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes.
Insertion/Deletion polymorphisms do play any role in G6PD deficiency individuals in the Kingdom of the Saudi Arabia.
Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C.
Interaction between glucose-6-phosphate dehydrogenase deficiency and sickle cell gene in Saudi Arabia.
Interaction between the glucose-6-phosphate dehydrogenase deficiency and thalassaemia genes at phenotype level.
Interaction of malarial infection and glucose-6-phosphate dehydrogenase deficiency in Muria gonds of district Bastar, central India.
Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon.
Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Interesting case of G6PD deficiency anemia with severe hemolysis.
Internal carotid artery aneurysm: a singular anomaly.
Interplay between glutathione-S-transferase and glucose-6-phosphate dehydrogenase in neonatal cord blood.
Interrelationships of erythrocyte glutathione peroxidase system enzymes in the fasted Beagle.
Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Intraoperative hemolysis. The initial manifestation of glucose-6-phosphate dehydrogenase deficiency.
Intravascular haemolysis and renal insufficiency in children with glucose-6-phosphate dehydrogenase deficiency, following antimalarial therapy.
Intravascular haemolysis due to glucose-6-phosphate dehydrogenase deficiency in a patient with aluminium phosphide poisoning.
Intravascular hemolysis in aluminium phosphide poisoning.
Intravascular Hemolysis in Aluminum Phosphide Poisoning.
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
Intravenous Thrombolysis for Stroke Patients with G6PD Deficiency.
Introduction to discussion of glucose-6-phosphate dehydrogenase deficiency.
Inverse Association between Glucose?6?Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma
Investigation of glucose 6-phosphate dehydrogenase (G6PD) kinetics for normal and G6PD-deficient persons and the effects of some drugs.
Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
Investigation of prolonged neonatal jaundice.
Investigation of the mutation points and effects of some drugs on glucose-6-phosphate dehydrogenase-deficient people in the Erzurum region.
Investigations of the fluorescent spot test for erythrocyte glucose-6-phosphate dehydrogenase deficiency in southeast Thailand.
Investigations regarding glucose-6-phosphate dehydrogenase deficiency in Hungary.
Iron overload, G6PD deficiency, and lead levels on blood smears.
Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells.
Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.
Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure?
Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?
Is testing for glucose-6-phosphate dehydrogenase deficiency before starting sulfa useful in HIV-infected male patients originating from sub-Saharan Africa?
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?
Is there a need for neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Canada?
Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?
Isoflurane Induced Malignant Hyperthermia in a Patient with Glucose 6-Phosphate Dehydrogenase Deficiency and Growth Hormone Abuse.
Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates.
Jaundice associated with lobar pneumonia. A clinical, laboratory and histological study.
Jaundice: a 10 year review of 41,000 live born infants.
Jaundice: clinical practice in 88,000 liveborn infants.
Jordan: communities and community genetics.
Kawasaki disease with G6PD deficiency - Report of one case and literature review.
Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report.
Kelley-Seegmiller syndrome in a patient with complete hypoxanthine-guanine phosphoribosyltransferase deficiency.
Kernicterus and G6PD deficiency--a case series from Oman.
Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature.
Kernicterus in a newborn female with G-6-PD deficiency.
Kinetic analysis in single, intact cells by microspectrophotometry: evidence for two populations of erythrocytes in an individual heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Laboratory and field comparisons of adenosine influx in Plasmodium falciparum and Plasmodium vivax infected erythrocytes with genetic abnormalities from patients in Myanmar.
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
Lack of association between falciparum malaria parasitemia and acute diarrhea in Nigerian children.
Lack of association between glucose-6-phosphate dehydrogenase deficiency and dextromethorphan O-demethylation polymorphism.
Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism.
Laparoscopic cholecystectomy and postoperative pain control in a patient with chronic non-spherocytic hemolytic anemia from glucose-6-phosphate dehydrogenase deficiency.
Large cohort screening of G6PD deficiency and the mutational spectrum in the Dongguan District in Southern China.
Late onset jaundice and urinary tract infection in neonates.
Late-Life Presentation of Unsuspected G6PD Deficiency.
Leg ulcers in a family with both beta thalassaemia and glucose-6-phosphate dehydrogenase deficiency.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Letter to the editor: G6PD deficiency in the Tafenoquine era.
Letter: Ascorbic acid-induced hemolysis in G-6-PD deficiency.
Letter: G-6-PD deficiency in sickle-cell disease.
Letter: Glucose-6-phosphate dehydrogenase deficiency and co-trimoxazole.
Letters to the editor: Acute hemolytic anemia, G-6PD deficiency and viral hepatitis.
Leucocyte glucose-6-phosphate dehydrogenase (G-6-PD) activity in G-6-PD deficient Chinese.
Leucocyte glucose-6-phosphate dehydrogenase (g-6-pd) activity in g-6-pd deficient subjects.
Leucocyte glucose-6-phosphate dehydrogenase deficiency and necrotizing pneumonia.
Leukocytoclastic vasculitis resolution with topical dapsone.
Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications.
Life-threatening haemolysis induced by henna in a Sudanese child with glucose-6-phosphate dehydrogenase deficiency.
Limits to the use of the glucose 6-phosphate dehydrogenase/6-phosphogluconate dehydrogenase index for the detection of glucose 6-phosphate dehydrogenase deficiency.
Linkage between glucose-6-phosphate dehydrogenase deficiency and colour-blindness.
Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis.
Linkage disequilibrium between glucose-6-phosphate dehydrogenase deficiency and congenital color blindness in Turkish population.
Lipid peroxidation and antioxidant capacity of G6PD-deficient patients with A-(202G>A) mutation.
Local swimming pool and G-6-PD deficiency.
Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.
Loss of flaps due to glucose-6-phosphate dehydrogenase deficiency. Case report.
Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania.
Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency.
Low incidence of erythrocyte G-6-PD deficiency in Koreans.
Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria.
Low to Normal Plasma Levels of Marinobufagenin 24 Hours or More after an Ischemic Stroke: A Pilot Study.
Low-grade haemolysis and assessment of iron status during the steady state in G6PD-deficient subjects.
Malaria and diabetes.
Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa.
Malaria and glucose 6-phosphate dehydrogenase deficiency in populations with high and low spleen rates in Madang, Papua New Guinea.
Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia.
MALARIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THAILAND.
Malaria and glucose-6-phosphate dehydrogenase deficiency.
Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border.
Malaria chemoprophylaxis.
Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago.
Malaria in Brent: successful treatment in the community.
Malaria in the Greater Mekong Subregion: Heterogeneity and complexity.
Malaria in the Guangxi Zhuang Autonomous Region in China: A Twelve-Year Surveillance Data Study.
Malaria prophylaxis and treatment in G-6-PD deficiency. An observation on the toxicity of primaquine and chloroquine.
Malaria, favism and glucose-6-phosphate dehydrogenase deficiency.
Malaria, glucose-6-phosphate dehydrogenase deficiency, and Hb S.
Malaysian mothers' knowledge & practices on care of neonatal jaundice.
Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency.
Management of Athletes With G6PD Deficiency: Does Missing an Enzyme Mean Missing More Games?
Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic.
Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
Management of relapsing Plasmodium vivax malaria.
Mandibular nerve neuropathy in sickle cell disease. Local factors.
Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X.
Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.
Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda.
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Mary Lyon and the hypothesis of random X chromosome inactivation.
Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore.
Mass newborn screening in Singapore.
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Mass screening for glucose-6-phosphate dehydrogenase deficiency: improved fluorescent spot test.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Massive acute haemolysis in neonates with glucose-6-phosphate dehydrogenase deficiency.
Massive hemolysis following inhalation of volatile nitrites.
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children.
Maternal Empowerment - an underutilized strategy to prevent kernicterus?
Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in Sardinia.
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal.
Mathematical modelling of energy and redox metabolism of G6PD-deficient erythrocytes.
Mathematical modelling of metabolic pathways affected by an enzyme deficiency. Energy and redox metabolism of glucose-6-phosphate-dehydrogenase-deficient erythrocytes.
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Mechanical membrane properties of human red blood cells and their change due to metabolic disturbance.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Mechanisms underlying glucose-6-phosphate dehydrogenase deficiency: heterogeneity of response to stromal activation in erythrocytes.
Medical genetics in Singapore.
Medical genetics in Thailand.
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Mediterranean G-6-PD deficiency and cerebral involvement. Clinical-electroencephalographic evaluation and follow-up.
Mediterranean glucose 6-phosphate dehydrogenase (G6PD) deficiency--near normal decay of the mutant enzyme protein in circulating erythrocytes.
Membrane deformability of erythrocytes with glucose-6-phosphate dehydrogenase Hamburg.
Membrane elastic shear modulus of red blood cells with glucose-6-phosphate dehydrogenase and pyruvatekinase enzymopathies.
Membrane protein carbonylation of Plasmodium falciparum infected erythrocytes under conditions of sickle cell trait and G6PD deficiency.
Metabolic Insight of Neutrophils in Health and Disease.
Metabolic profiling reveals alterations in the erythrocyte response to fava bean ingestion in G6PD-deficient mice.
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
Metabolism of human erythrocytes. Studies in health and disease.
Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
Metformin-Induced Hemolytic Anemia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency.
Methaemoglobinaemia after cardiac catheterisation: a rare cause of cyanosis.
Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result.
Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
Methaemoglobinaemia with G6PD deficiency; rare cause of persistently low saturations in neonates.
Methemoglobinemia - The Cryptic Cause of Dyspnoea.
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
Methemoglobinemia and intravascular hemolysis in a patient with G6PD deficiency.
Methemoglobinemia associated with massive acetaminophen ingestion: a case series.
Methemoglobinemia in an elderly patient with glucose-6-phosphate dehydrogenase deficiency: a case report.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Methemoglobinemia induced by methylene blue pertubation during laparoscopy.
Methemoglobinemia induced by rasburicase in a pediatric patient: A case report and literature review.
Methemoglobinemia: etiology, pharmacology, and clinical management.
Methylene Blue Induced Methemoglobinemia with Acute Kidney Injury in a Glucose-6-Phosphate Dehydrogenase-deficient Patient.
Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Methylene blue.
Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency.
MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN GREEK MALES.
Military ethics and G-6-PD deficiency.
Military ethics and G6PD deficiency.
Modeling human glucose-6-phosphate dehydrogenase mutations using C. elegans GSPD-1.
Modeling Plasmodium vivax: Relapses, treatment, seasonality, and G6PD deficiency.
Modelling primaquine-induced haemolysis in G6PD deficiency.
Moderate G6PD deficiency increases mutation rates in the brain of mice.
Moderate to severe hemolytic disease of the newborn in a referral centre in Saudi Arabia.
Modification of neonatal screening test for erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts.
Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.
Molecular basis of G6PD deficiency in India.
Molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency in three Taiwan aboriginal tribes.
Molecular basis of glucose-6-phosphate dehydrogenase deficiency among Filipinos.
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population.
Molecular characterisation of red cell glucose-6-phosphate dehydrogenase deficiency in north-west Pakistan.
Molecular characterisation of red cell glucose-6-phosphate dehydrogenase deficiency in Singapore Chinese.
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
Molecular characterization of a German variant of glucose-6-phosphate dehydrogenase deficiency (G6PD Aachen).
Molecular characterization of Chinese G6PD deficiency by using polymerase chain reaction/single strand conformation polymorphism.
Molecular Characterization of Cosenza Mutation among Patients with Glucose-6-Phosphate Dehydrogenase Deficiency in huzestan Province, Southwest Iran.
Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates.
Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Tunisia.
Molecular Characterization of G6PD Deficiency at a North Indian Centre: Implications for Diagnostic Testing Laboratories in Different Regions of India.
Molecular characterization of G6PD deficiency in Cyprus.
Molecular characterization of G6PD deficiency in Oman.
Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity, correlation genotype-phenotype and description of a new variant (G6PD Neapolis).
Molecular Characterization of G6PD Deficiency: Report of Three Novel G6PD Variants.
Molecular characterization of G6PD Insuli--a novel 989 CGC --> CAC (330 Arg --> His) mutation in the Indian population.
Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population.
Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan.
Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency among Jordanians.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Brazil.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Chinese infants with or without severe neonatal hyperbilirubinaemia.
Molecular Characterization of Glucose-6-phosphate Dehydrogenase Deficiency in Families from the Republic of Macedonia and Genotype-phenotype Correlation.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Jeddah, Kingdom of Saudi Arabia.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Pakistani population.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Eastern Province of Saudi Arabia.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Shenzhen Population.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Turkey.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase: Do Single Nucleotide Polymorphisms Affect Hematological Parameters in HIV-Positive Patients?
Molecular epidemiological investigation of G6PD deficiency by a gene chip among Chinese Hakka of southern Jiangxi province.
Molecular Epidemiological Survey of Glucose-6-Phosphate Dehydrogenase Deficiency and Thalassemia in Uygur and Kazak Ethnic Groups in Xinjiang, Northwest China.
Molecular epidemiology and activity of erythrocyte G6PD variants in a homogeneous Nigerian population.
Molecular Epidemiology of G6PD Genotypes in Different Ethnic Groups Residing in Saharan and Sahelian Zones of Mauritania.
Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in a population of newborns from Ivory Coast.
Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in Mexico.
Molecular genetics of the glucose-6-phosphate dehydrogenase (G6PD) Mediterranean variant and description of a new G6PD mutant, G6PD Andalus1361A.
Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese.
Molecular genotyping of G6PD mutations and Duffy blood group in Afro-descendant communities from Brazilian Amazon.
Molecular heterogeneity of G-6-PD deficiency in Mexico.
Molecular heterogeneity of G6PD deficiency in an Amazonian population and description of four new variants.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency among the tribals in Western India.
Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Gaza Strip Palestinians.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Malays in Malaysia.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Mexico: overall results of a 7-year project.
Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population.
Molecular identification of mutations in G6PD gene in patients with favism in Iran.
Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand conformation polymorphism analysis.
Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India.
Molecular variants of red cell glucose-6-phosphate dehydrogenase deficiency in Central Java, Indonesia.
More on the association of glucose-6-phosphate dehydrogenase deficiency with hairy-cell leukemia.
Morphological abnormalities of the red cells during hemolytic episode in a patient with glucose 6-phosphate dehydrogenase deficiency.
MORPHOLOGICAL DEMONSTRATION OF 2 RED CELL POPULATIONS IN HUMAN FEMALES HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency.
Multimodality imaging of a neonatal wandering spleen.
Multiple G6PD mutations are associated with a clinical and biochemical phenotype similar to that of G6PD Mediterranean.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).
Multiplex primer extension reaction screening and oxidative challenge of glucose-6-phosphate dehydrogenase mutants in hemizygous and heterozygous subjects.
Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.
Muscle expression of glucose-6-phosphate dehydrogenase deficiency in different variants.
Muscle G6PD deficiency.
Muscle glucose-6-phosphate dehydrogenase deficiency.
Muscle glucose-6-phosphate dehydrogenase deficiency: restoration of enzymatic activity in hybrid myotubes.
Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: mechanism and implication.
Mutation in the glucose-6-phosphate dehydrogenase gene leads to inactivation of Ku DNA end binding during oxidative stress.
Mutation of glucose-6-phosphate dehydrogenase deficiency in Chinese Han children in eastern Fujian.
Mutations and haplotype diversity in 70 Portuguese G6PD-deficient individuals: an overview on the origin and evolution of mutated alleles.
N-acetyl cysteine, L-cysteine, and beta-mercaptoethanol augment selenium-glutathione peroxidase activity in glucose-6-phosphate dehydrogenase-deficient human erythrocytes.
N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency.
NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites.
NADP+ and NADPH in glucose-6-phosphate dehydrogenase-deficient erythrocytes under oxidative stimulation.
NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Naphthalene Toxicity in a Three-Year-Old Child Complicated by Severe Hemolytic Anemia and Mild Methemoglobinemia: A Case Report.
Naphthalene Toxicity in Clinical Practice.
Naphthalene-induced hemolysis in a black female toddler deficient in glucose-6-phosphate dehydrogenase.
Naphthalene-induced hemolytic anemia in a child with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.
Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn.
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Negro variant of glucose-6-phosphate dehydrogenase deficiency (A-) in man.
Neonatal anti-Kell isoimmune hemolytic disease with spherocytes.
Neonatal bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in preterm and low-birth-weight infants in Israel.
Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.
Neonatal biochemical screening for disease.
Neonatal cholestasis and glucose-6-P-dehydrogenase deficiency.
Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency.
Neonatal exchange transfusion: a Jordanian experience.
Neonatal hyperbilirubinaemia in heterozygous glucose-6-phosphate dehydrogenase deficient females.
Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.
Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes.
Neonatal Hyperbilirubinemia in infants with G6PD c.563C > T Variant.
Neonatal hyperbilirubinemia: don't let glucose-6-phosphate dehydrogenase deficiency off the hook.
Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice among Nigerian preterm infants.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants.
Neonatal jaundice and severity of glucose-6-phosphate dehydrogenase deficiency in Sardinian babies.
Neonatal jaundice associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a non-Mediterranean Caucasian infant with trisomic Down's Syndrome.
Neonatal Jaundice Associated with Familial G6PD Deficiency in Israel.
NEONATAL JAUNDICE DUE TO GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Neonatal jaundice in Asia.
Neonatal jaundice in Qatif: The role of glucose-6-phosphate dehydrogenase deficiency in the etiology among outpatient cases.
Neonatal jaundice in Zaria, Nigeria--a second prospective study.
Neonatal jaundice, aflatoxins and naphthols: report of a study in Ibadan, Nigeria.
Neonatal jaundice--traditional Chinese medicine approach.
Neonatal jaundice. A second 4-year experience in Toa Payoh Hospital (1986-1989).
Neonatal jaundice: two cases associated with glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Neonatal nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Danish infant.
Neonatal nucleated red blood cells in G6PD deficiency.
Neonatal screening and monitoring system in Taiwan.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency fails to detect heterozygote females.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: sex distribution.
Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa.
Neonatal screening in Hong Kong and Macau.
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Khorfakkan, United Arab Emirates.
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia.
Neonatal screening program for G6PD deficiency in India: need and feasibility.
Neonatal screening program in Rajavithi Hospital, Thailand.
Neonatal transfusion malaria requiring exchange transfusion.
Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia.
Neurological complications of kernicterus.
Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency.
New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension.
New considerations on the distribution of malaria, thalassemia, and glucose-6-phosphate dehydrogenase deficiency in Sardinia.
New data on glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. G6PD variants, and the association between enzyme deficiency and hemoglobins S.
New developments in glucose-6-phosphate dehydrogenase deficiency.
New Diagnosis of G6PD Deficiency Presenting as Severe Rhabdomyolysis.
New genetic variants of glucose 6-phosphate dehydrogenase (G6PD) in Italy.
New insights into G6PD deficiency.
New onset diabetes complicated by haemolysis and rhabdomyolysis: a case report and review of the literature.
New stable mutant (Gd(-) variants: G6PD Tashkent and G6PD Nucus. Molecular basis of hereditary enzyme deficiency.
Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in India.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Newborn screening for G6PD deficiency: A 2-year data from North India.
Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay.
Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
Newborn screening in Singapore.
Newborn screening in the Asia Pacific region.
Newborn screening in the Philippines.
Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin.
Non-inactivation of an x-chromosome locus in man.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Novel human pathological mutations. Gene symbol: G6PD. Disease: glucose-6-phosphate dehydrogenase deficiency.
Novel point mutation in exon 12 of the glucose-6- phosphate dehydrogenase gene: G6PD FLORES.
Nucleotide 1376 G-->T mutation in G6PD-deficient Chinese in Malaysia.
Nucleotide variability at G6pd and the signature of malarial selection in humans.
Nutritional Status of Young Children with Inherited Blood Disorders in Western Kenya.
Ob-Gyn Section: G6PD deficiency.
Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
Observations on the inheritance of glucose-6-phosphate dehydrogenase deficiency in erythrocytes and in leucocytes.
Occupational lead exposure, G-6PD deficiency and beta-thalassemia trait.
Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.
Occurrence and clinical implications of red-cell glucose-6-phosphate dehydrogenase deficiency in South African racial groups.
OCT Angiographic Findings in Glucose-6-Phosphate Dehydrogenase Deficiency.
Ocular cicatricial pemphigoid (Review).
Old and new genetics help ordering loci at the telomere of the human X-chromosome long arm.
On the relation between malaria and G-6-PD deficiency.
On the relation between malaria and G-6-PD deficiency: a reply.
Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates.
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.
Optimizing Measurement and Interpretation of the G6PD/Hb Ratio.
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East.
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Oseltamivir and G6PD deficiency.
Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.
Overt hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a survey in general practice.
Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation.
Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells.
Oxidative damage in chemical teratogenesis.
Oxidative haemolysis secondary to high-dose vitamins in a woman with glucose-6-phosphate dehydrogenase deficiency.
Oxidative hemoglobin breakdown induced by a rubber additive.
Oxidative Stress and Suicidal Erythrocyte Death.
Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency.
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
Ozone: a possible cause of hemolytic anemia in glucose-6-phosphate dehydrogenase deficient individuals.
Pancreatitis in acute hemolysis.
Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom.
Parental discussion of G6PD deficiency and child health: implications for clinical practice.
Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.
Paroxysmal Nocturnal Hemoglobinuria with Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Review of the Literature.
Partial exchange transfusion prior to treating cerebral malaria in an African child with glucose-6-phosphate dehydrogenase deficiency.
Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
Parvovirus-associated aplastic crisis in a patient with red blood cell glucose-6-phosphate dehydrogenase deficiency.
Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review.
Pathogenesis of anemia in malaria: a concise review.
Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Pathophysiology of spontaneous neonatal bilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency.
Pathways for the reduction of oxidized glutathione in the Plasmodium falciparum-infected erythrocyte: can parasite enzymes replace host red cell glucose-6-phosphate dehydrogenase?
Patient with toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report.
Patients with genetic defects in the gamma-glutamyl cycle.
Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.
Patterns of sickle cell, thalassaemia and glucose-6-phosphate dehydrogenase deficiency genes in north-western Saudi Arabia.
PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.
Peas, beans, and the Pythagorean theorem - the relevance of glucose-6-phosphate dehydrogenase deficiency in dermatology.
Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency.
Pegloticase Induced Hemolytic Anemia in a Patient With G6PD Deficiency.
Pelvic pain, low blood pressure, and hemolysis after outpatient hysteroscopy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Percentage glycosylated haemoglobin in normal, G6PD deficient and HbSS Saudi Arabs.
Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Periodontal considerations in a patient with glucose-6-phosphate dehydrogenase deficiency with associated pancytopenia: A rare case report.
Periodontal disease and hemolysis in glucose-6-phosphate dehydrogenase deficiency: Is there a nexus?
Perioperative challenges in a patient of severe G6PD deficiency undergoing open heart surgery.
Perioperative management in a case of glucose-6-phosphate dehydrogenase deficiency undergoing orthopaedic surgery.
Perioperative management of glucose 6 phosphate dehydrogenase deficiency. A review of the literature.
Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiency.
Peripheral red blood cell survival invariance during piroxicam treatment in subjects with glucose-6-phosphate dehydrogenase deficiency.
Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
PGI*3(Israel), a new, unstable allele in the phosphoglucose isomerase system.
Pharmacoanthropology: outline, problems, and the nature of case histories.
Pharmacogenetic considerations in the treatment of gout.
Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Pharmacogenetics. Glucose-6-phosphate dehydrogenase deficiency.
Pharmacokinetic Interactions and Safety Evaluations of Coadministered Tafenoquine and Chloroquine in Healthy Subjects.
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria.
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Phenazopyridine-induced hemolytic anemia in a patient with G6PD deficiency.
Phenazopyridine-induced hemolytic anemia in G-6-PD deficiency.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Phenotype heterogeneity of hyperbilirubinemia condition: the lesson by coinheritance of glucose-6-phosphate dehydrogenase deficiency and Crigler-Najjar syndrome type II in an Italian patient.
Phenotypic and genotypic characterization of glucose-6-phosphate dehydrogenase deficiency in Argentina. Retrospective and descriptive study.
Phenotypic variation in red cell G-6PD deficiency in heterozygotes.
Phosphoglycerate kinase deficiency: biochemical studies on hair follicles.
Phospholipid content and phospholipid fatty acid composition of red blood cells in enzyme defect hemolytic anemias.
Phototherapy for neonatal hyperbilirubinemia in mature newborn infants with erythrocyte G-6-PD deficiency.
Phototherapy for neonatal jaundice in erythrocyte glucose-6-phosphate dehydrogenase-deficient infants.
Phototherapy in newborn infants with glucose-6-phosphate dehydrogenase deficiency.
Pityriasis rotunda and G6PD deficiency.
Plan and process for hematology laboratory standard in Thailand.
Plasma and erythrocyte magnesium, manganese, zinc, and plasma calcium levels in G-6-PD-deficient and normal male children.
Plasma cell leukemia revealing a G6PD deficiency.
Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.
Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes.
Platelet-function studies in patients with glucose-6-phosphate dehydrogenase deficiency.
Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study.
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection.
Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies.
Poor iron store recovery in voluntary blood donors in the northern zone of Ghana; a five-month three-centre cohort study.
Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity.
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria.
Population genetic studies in the Congo. II. Effect of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency on mortality and fertility.
Population genetic study among the Orange Asli (Semai Senoi) of Malaysia: Malayan aborigines.
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.
Population genetics of malaria resistance in humans.
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Population screening for glucose-6-phosphate dehydrogenase deficiency on the Baleares.
Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria.
Population study in Assam: ABO blood groups, haemoglobin E and G-6-PD deficiency.
Population study of 1311 C/T polymorphism of Glucose 6 Phosphate Dehydrogenase gene in Pakistan - an analysis of 715 X-chromosomes.
Populations and genetic polymorphisms.
Positive Impact of Clinical Audit on Appropriateness of Laboratory Investigations for Glucose-6-Phosphate Dehydrogenase-Deficient Patients in the Emergency Department.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency.
Possible factors involved in the methemoglobin reduction test for the G-6-PD deficiency.
Possible fenugreek induced haemolysis in a patient with previously unknown G6PD deficiency.
Possible incompatibility of glucose-6-phosphate dehydrogenase deficiency and championship athletic performance.
Possible potentiation of hemolytic anemia by tolbutamide. Report of a patient with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Post-anaesthetic jaundice due to glucose-6-phosphate dehydrogenase deficiency.
Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Potential Risks of Hemolysis after Short-Term Administration of Analgesics in Children with Glucose-6-Phosphate Dehydrogenase Deficiency.
Predicting significant hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns.
Prediction of functional consequences of the five newly discovered G6PD variations in Taiwan.
Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Predictive models for human glucose-6-phosphate dehydrogenase deficiency.
Predictors of Acute Bilirubin Encephalopathy Among Nigerian Term Babies with Moderate-to-severe Hyperbilirubinaemia.
Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses.
Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Preliminary experience with the differential pH technique for glucose-6-phosphate dehydrogenase (G6PD) measurement in whole blood: application to an area with high prevalence of thalassaemia and G6PD deficiency.
Preliminary report on neonatal screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency: a Chandigarh experience.
Preliminary results of a geographic correlation study on G6PD deficiency and cancer.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency.
Prenatal selection and fetal development disturbances occurring in carriers of G6PD deficiency.
Prenatal Training Improves New Mothers' Understanding of Jaundice.
Present and future approaches to the correction of erythrocyte glucose 6-phosphate dehydrogenase deficiency.
Present status of understanding on the G6PD deficiency and natural selection.
Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes.
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Prevalence and Genetic Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in Anemic Subjects from Uttar Pradesh, India.
Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Females from Previously Malaria Endemic Regions in Northeastern Thailand and Identification of a Novel G6PD Variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand.
Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Lue ethnic group of northern Thailand.
Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq.
Prevalence and molecular defect characterization of glucose-6-phosphate dehydrogenase deficiency in Brazilian blood donors.
Prevalence and molecular identification of the mediterranean variant among G6PD-deficient Sistani and Balouch males in Southeastern Iran.
Prevalence and molecular study of G6PD deficiency in Malaysian Orang Asli.
Prevalence and Molecular Study of G6PD Deficiency in the Dai and Jingpo Ethnic Groups in the Dehong Prefecture of the Yunnan Province.
Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
Prevalence and Significance of G6PD Deficiency in Patients of an Urban HIV Clinic.
Prevalence and spectrum of mutations causing G6PD deficiency in Indian populations.
Prevalence of abnormal hemoglobins, thalassaemia and erythrocyte glucose-6-phosphate dehydrogenase deficiency in Kashmiris: a preliminary study.
Prevalence of and mothers' knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study.
Prevalence of anemia, iron deficiency, thalassemia and glucose-6-phosphate dehydrogenase deficiency among hill-tribe school children in Omkoi District, Chiang Mai Province, Thailand.
Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews.
Prevalence of classic erythrocyte polymorphisms among 749 children in southern highland Rwanda.
Prevalence of erythrocyte G6PD deficiency in Sabah.
Prevalence of Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Population of Western Turkey.
Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population.
Prevalence of G-6-PD deficiency and sickle-cell haemoglobin carriers in malaria endemic tribal dominated districts--Mandla and Jabalpur, Madhya Pradesh.
Prevalence of G-6-PD deficiency in a malaria endemic tribal area of Orissa (India).
Prevalence of G-6-PD deficiency in the Croatian Adriatic Coast population.
Prevalence of G6PD deficiency among recruits in the Singapore Armed Forces.
Prevalence of G6PD deficiency and associated haematological parameters in children from Botswana.
Prevalence of G6PD deficiency and knowledge of diagnosis in a sample of previously unscreened Lebanese males: clinical implications.
Prevalence of G6PD deficiency and molecular characterization of G202A, A376G and C563T polymorphisms in newborns in Southeastern Brazil.
Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Prevalence of G6PD deficiency in Children with Hepatitis A.
Prevalence of G6PD deficiency in Iran, a mata-analysis.
Prevalence of G6PD Deficiency in Iran.
Prevalence of G6PD deficiency in Iranian neonates with jaundice: a systematic review and meta-analysis.
Prevalence of G6PD Deficiency in Neonatal Sepsis in Iran.
Prevalence of G6PD deficiency in newborns in the south of Brazil.
Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.
Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency Among Children in Eastern Saudi Arabia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency among neonates at a tertiary care centre in Lebanon.
Prevalence of glucose-6-phosphate dehydrogenase deficiency among schoolboys in Kermanshah, Islamic Republic of Iran.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency and Gametocytemia in a Pre-Elimination, Low Malaria Transmission Setting in Southern Zambia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and the role of the A- variant in a Saudi population.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Northern Greece.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Sichuan, China.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Prevalence of glucose-6-phosphate dehydrogenase deficiency.
Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok.
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.
Prevalence of malaria in Ao Nagas and its association with G6PD and HbE.
Prevalence of neonatal hyperbilirubinaemia and its association with glucose-6-phosphate dehydrogenase deficiency and blood-type incompatibility in sub-Saharan Africa: a systematic review and meta-analysis.
Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.
Prevalence of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency.
Prevalence of thalassaemia, iron-deficiency anaemia and glucose-6-phosphate dehydrogenase deficiency among Arab migrating nomad children, southern Islamic Republic of Iran.
Prevalence of thalassemia and G6PD deficiency in North Cyprus.
Prevalence of Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency in Newborns and Adults at the Ramathibodi Hospital, Bangkok, Thailand.
Prevalence of UGT1A1 (TA)n promoter polymorphism in Panamanians neonates with G6PD deficiency.
Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Prevention of intellectual and other disabilities: the Singapore experience.
Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.
Priapism and glucose-6-phosphate dehydrogenase deficiency: An underestimated correlation?
Priapism in hematological and coagulative disorders: an update.
Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate.
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Primaquine overdose in a toddler.
Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk.
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
Primaquine therapy for malaria.
Primaquine toxicity forestalls effective therapeutic management of the endemic malarias.
Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Primaquine, malaria chemotherapy and G-6-PD deficiency.
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Primaquine: the risks and the benefits.
Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency.
Primary lactase deficiency and past malarial endemicity in Sardinia.
Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Proceedings: Red cell cytochemistry in glucose-6-phosphate dehydrogenase deficiency.
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects.
Prognosis of hemolytic anemia in G6PD- subjects. Multifactorial cluster analysis of biochemical characteristics of red cell age groups.
Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion.
Prolonged indirect hyperbilirubinemia in a moderately preterm boy with Mediterranean glucose-6-phosphate dehydrogenase and glutathione S-transferase Mu 1 null mutations.
Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.
Propofol infusion in an infant with glucose-6-phosphate dehydrogenase deficiency.
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi.
Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria.
Protective Role of G6PD Deficiency in Aluminium Phosphide Poisoning.
Protective role of G6PD deficiency in poisoning by aluminum phosphide; are there possible new treatments?
Protein methylation as a marker of aspartate damage in glucose-6-phosphate dehydrogenase-deficient erythrocytes: role of oxidative stress.
Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B?-mediated cytotoxicity.
Proteomic signature of muscle fibre hyperplasia in response to faba bean intake in grass carp.
Protoporphyrin (proto)-determined hepatopathy in a South African Jewish family.
PSEUDO-MOSAICISM IN MALES WITH MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects.
Pulmonary hypertension in children and young adults with sickle cell disease: Evidence for familial clustering.
Pulmonary toxicity with mefloquine.
Pycnogenol prevents haemolytic injury in G6PD deficient human erythrocytes.
Pyruvate kinase deficiency. Association with G6PD deficiency.
Quality assurance program for neonatal screening of glucose-6-phosphate dehydrogenase deficiency.
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader.
Rapid and label-free single-nucleotide discrimination via an integrative nanoparticle-nanopore approach.
Rapid and reliable detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis.
Rapid detection of common Chinese glucose-6-phosphate dehydrogenase (G6PD) mutations by microarray-based assay.
Rapid detection of G6PD mutations by multicolor melting curve analysis.
Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography.
Rapid detection of twenty-nine common Chinese glucose-6-phosphate dehydrogenase variants using a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay on dried blood spots.
Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.
Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
Rapid genotyping of two common G6PD variants, African (A-) and Mediterranean, by high-resolution melting analysis.
Rapid quantitative assays for glucose-6-phosphate dehydrogenase (G6PD) and hemoglobin combined on a capillary-driven microfluidic chip.
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method.
Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem.
Rasburicase : a review of its use in the management of anticancer therapy-induced hyperuricaemia.
Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency.
Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
Rasburicase-Induced Methemoglobinemia.
Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Rasburicase: a potent uricolytic agent.
Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome.
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies.
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
Rationale for short course primaquine in Africa to interrupt malaria transmission.
Re-evaluation of methaemoglobin reduction as a screening procedure for glucose-6-phosphate dehydrogenase (G6PD).
Re-inventing the wheel; the use of autologous and fresh donor blood in cardiac surgery.
Reactivity of Blood Samples Spotted onto Filter Papers in the WST-8 Method for Screening of G6PD Deficiency.
Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: A hospital-based retrospective study.
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Real-time monitoring of glucose-6-phosphate dehydrogenase activity using liquid droplet arrays and its application to human plasma samples.
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.
Reappraisal of known malaria resistance loci in a large multicenter study.
Reassessing an old claim: Natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.
Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency.
Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice.
Red Blood Cell Enzyme Disorders.
Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease.
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias.
Red blood cell-derived microparticles: An overview.
Red cell acid phosphatase activity in carriers of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Red cell and platelet derived microparticles are increased in g6pd deficient subjects.
Red cell enzyme deficiencies in the tribal population groups of the Bastar District, Madhya Pradesh, India.
Red cell enzymes glucose-6-phosphate dehydrogenase deficiency.
Red cell enzymopathies as a model of inborn errors of metabolism.
Red cell genetic abnormalities and environmental interactions: a study in Tehamat Aseer.
Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia.
Red cell genetic abnormalities, beta-globin gene haplotypes, and APOB polymorphism in the Great Andamanese, a primitive Negrito tribe of Andaman and Nicobar Islands, India.
Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Red cell glucose-6-phosphate dehydrogenase deficiency among Andhras.
Red cell glucose-6-phosphate dehydrogenase deficiency and haemoglobin variants among ten endogamous groups of Maharshtra and West Bengal.
Red cell glucose-6-phosphate dehydrogenase deficiency in ethnic groups in Israel.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland. Characterization of a new variant with severe enzyme deficiency.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland. Further biochemical characterization of G-6-PD Helsinki.
Red cell glucose-6-phosphate dehydrogenase deficiency in Pakistan.
Red cell glucose-6-phosphate dehydrogenase deficiency in the Jammu region of J&K State.
Red cell glucose-6-phosphate dehydrogenase deficiency in Turkey.
Red cell membrane protein in thalassemia and glucose-6-phosphate dehydrogenase deficiency anemia.
Red cell metabolism and severe neonatal jaundice in West Malaysia.
Red cell NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficiency.
Red cell phosphoglucomutase (PGM)-deficiency: hereditary defect of the PGM1-locus.
Red cell proteasome modulation by storage, redox metabolism and transfusion.
Red cell pyruvate kinase deficiency in Southern Sardinia.
Red-cell GSH regeneration and glutathione reductase activity in G6PD variants in the Ferrara area.
Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis.
Redox and energetic state of red blood cells in G6PD deficiency, heterozygous beta-thalassemia and the combination of both.
Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency.
Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.
Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy.
Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns.
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency.
Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Reference levels for glucose-6-phosphate dehydrogenase enzyme activity in infants 7-90 days old in Taiwan.
Refractory Causes of Kernicterus in Developed Countries: Can We Eradicate G6PD Deficiency Triggered and Low-Bilirubin Kernicterus?
Regional enteritis and glucose-6-phosphate dehydrogenase deficiency.
Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.
Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.
Relationship among glucose-6-phosphate dehydrogenase (G-6-PD) activity, G-6-PD variants and reticulocytosis in neonates of northeast Thailand.
Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria.
Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality.
Reliability of quantitative and qualitative tests to identify heterozygotes carrying severe or mild G6PD deficiency.
Reliability of three screening tests in detection of glucose-6-phosphate dehydrogenase deficiency in adults and neonates.
Report of an Italian family carrying a typical Indian variant of the Nilgiris tribal groups resulting from a
Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells.
Resistance to falciparum malaria among adults in central Sudan.
Response to the letter of Morán et al. regarding our use of an inaccurate reference for the maximal dose of vitamin C in G6PD deficiency.
Retinitis Pigmentosa Associated with Glucose-6-Phosphate Dehydrogenase Deficiency.
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
Rhabdomyolysis and hemolysis associated with sickle cell trait and glucose-6-phosphate dehydrogenase deficiency.
Ribose metabolism and nucleic acid synthesis in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes infected with Plasmodium falciparum.
Right Middle Lobe Collapse and Pleural Effusion in an 18-Year-Old Man.
Risk Assessment for Adverse Outcome in Term and Late Preterm Neonates with Bilirubin Values of 20 mg/dL or More.
Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.
Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.
Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals.
Risk Factors for Sensorineural Hearing Loss in Neonatal Hyperbilirubinemia.
Risk of Hyperbilirubinemia in Breast-Fed Infants.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
Role of G6PD, ABO incompatibility, low birth weight and infection in neonatal hyperbilirubinaemia.
Role of genetic factors and ethnicity on the multiplicity of Plasmodium falciparum infection in children with asymptomatic malaria in Yaoundé, Cameroon.
Role of glucose 6-phosphate dehydrogenase (G6PD) deficiency and its association to Autism Spectrum Disorders.
ROLE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN ACUTE HEMOLYTIC CRISIS AND NEONATAL JAUNDICE.
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
Role of vitamin E supplementation on serum levels of copper and zinc in hemolytic anemic patients with G6PD deficiency.
Routine testing for G-6-PD deficiency.
Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use.
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report.
Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Safe neoadjuvant trastuzumab-based treatment in HER2?+?inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.
Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.
Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.
Safety of flurbiprofen in subjects with G-6-PD deficiency. In vivo and in vitro results.
Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review.
Safety of Live Liver Donation by Individuals With G6PD Deficiency: Initial Results and Comparative Study.
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
Safety of vitamin C in sepsis: a neglected topic.
Salicylamide glucuronide formation in newborn babies with G-6-PD deficiency.
Salicylamide glucuronide formation in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Sanfilippo syndrome, glucose-6-phosphate dehydrogenase deficiency and sickle cell/?(+) thalassemia in a child: The burden of consanguinity.
Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
SCIENTIFIC AND PRACTICAL STUDIES OF MALARIA IN THE CIS COUNTRIES AND GEORGIA.
Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China.
Screening for G6PD Deficiency Among Neonates with Neonatal Jaundice Admitted to Tertiary Care Center: A Need in Disguise.
Screening for G6PD Deficiency in Blood Donor Population.
Screening for galactosemia and glucose-6-phosphate dehydrogenase deficiency in newborn infants.
Screening for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency by a simple method.
Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Screening for glucose-6-phosphate dehydrogenase deficiency in a hospital laboratory.
Screening for glucose-6-phosphate dehydrogenase deficiency in blood donors.
Screening for glucose-6-phosphate dehydrogenase deficiency in haemolytic disorders: the methylene blue reduction test.
Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples.
Screening for glucose-6-phosphate dehydrogenase deficiency in newborns-practical considerations.
Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy.
Screening for glucose-6-phosphate dehydrogenase deficiency using a modified formazan method: a pilot study on Filipino male newborns.
Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Screening for glucose-6-phosphate dehydrogenase deficiency.
Screening for haemoglobinopathies and G6PD deficiency among the Mizos of Mizoram: a preliminary study.
Screening for inborn errors of the erythrocyte metabolism in Northwestern Mexico.
Screening of jaundiced neonates for glucose-6-phosphate dehydrogenase deficiency.
Screening of pyruvate kinase deficiency and G6PD deficiency in Chinese newborn in Hong Kong.
Screening of the newborns for glucose-6-phosphate dehydrogenase deficiency.
Screening tests for G-6-PD deficiency.
Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype.
Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.
Senile cataract and glucose-6-phosphate dehydrogenase deficiency in Indians.
Separate detection of glucose-6-phosphate dehydrogenase from 6-phosphogluconate dehydrogenase by DEAE-paper chromatography.
Seroprevalence of Malaria and Hepatitis B Coinfection among Pregnant Women in Tamale Metropolis of Ghana: A Cross-Sectional Study.
Serratia marcescens osteomyelitis in an infant.
Serum and red blood cell magnesium, copper, and zinc content in G6PD deficiency.
Serum bilirubin levels in 1-month-old, healthy, term infants from southern Turkey.
Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Serum lipoproteins in schoolboys in relation to glucose-6-phosphate dehydrogenase deficiency and thalassaemia trait.
Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency.
Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
Severe G6PD Deficiency Due to a New Missense Mutation in an Infant of Northern European Descent.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Severe hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency and Epstein-Barr virus infection.
Severe hemolytic anemia due to transient acquired G6PD deficiency after ingestion of sodium chlorite.
Severe hemolytic anemia in black children with glucose-6-phosphate dehydrogenase deficiency.
Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency.
Severe hyperbilirubinemia in a glucose-6-phosphate dehydrogenase-deficient preterm neonate: could prematurity be the main responsible factor?
Severe hyperbilirubinemia in Thai newborns in association with erythrocyte G6PD deficiency.
Severe infections in thalassaemic patients: prevalence and predisposing factors.
Severe inflammatory reaction following corneal collagen cross-linking in a patient with glucose-6-phosphate dehydrogenase deficiency.
Severe jaundice in a gunshot casualty due to the coexistence of Dubin-Johnson and glucose-6-phosphate dehydrogenase deficiency.
Severe jaundice in a patient with a previously undescribed glucose-6-phosphate dehydrogenase (G6PD) mutation and Gilbert syndrome.
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.
Severe methemoglobinemia and syncope in a patient with glucose-6-phosphate dehydrogenase deficiency.
Severe methemoglobinemia in an infant with glucose-6-phosphate dehydrogenase deficiency.
Severe Methemoglobinemia Secondary to Ferula asafoetida Ingestion in an Infant: A Case Report.
Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
Severe neonatal hyperbilirubinemia in the southeast region of Turkey
Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.
Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.
Severe Plasmodium vivax malaria, HIV, tuberculosis co-infection in a Sri Lankan traveller: case management and challenges during the prevention of malaria reintroduction phase.
Severe Rhabdomyolysis in Glucose-6-Phosphate Dehydrogenase Deficiency.
Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).
Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells.
Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?
Sickle cell anaemia in Jordan and its clinical patterns.
Sickle cell and G-6-PD deficiency gene in cord blood samples: experience at King Khalid University Hospital, Riyadh.
Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.
Sickle cell disease, G-6-PD deficiency, and jaundice.
Sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency among Dhobis of Visakhapatnam, Andhra Pradesh, India.
Sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency among Rellis of Visakhapatnam, Andhra Pradesh, South India.
Sickle cell hemoglobin, beta-thalassemia and G6PD deficiency in tribes of Maharashtra, India.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Sickle cell trait and G6PD deficiency in blood donors in eastern Saudi Arabia.
Sickle cell trait and glucose-6-phosphate dehydrogenase deficiency. Effects on health and military performance in black Navy enlistees.
Sickle cell trait, thalassaemia and glucose-6-phosphate dehydrogenase deficiency in the Bhil tribe of southern Rajasthan.
Sickle cell-thalassemia associated with G6PD deficiency in an African girl in Tanzania.
Sickle haemoglobin, G-6PD deficiency and malaria in western Orissa.
Sickle-cell anaemia in Turkey. Evaluation of 97 cases (with parents' findings).
Sickle-cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency in tribal populations of Andhra Pradesh.
Sickle-cell trait, thalassemia, G-6-PD deficiency and puerperal pulmonary embolism.
Side-effects of henna and semi-permanent 'black henna' tattoos: a full review.
Sideroblastic anemia segregating with glucose-6-phosphate dehydrogenase deficiency.
Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
Single dose primaquine in a preclinical model of G6PD deficiency: implications for use in malaria transmission blocking programs.
Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
Small-Molecule Activators of Glucose-6-phosphate Dehydrogenase (G6PD) Bridging the Dimer Interface.
Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.
Some hereditary red-cell traits in Kalahari Bushmen and Bantu: hemoglobins, glucose-6-phosphate dehydrogenase deficiency, and blood groups.
Some Mexican glucose-6-phosphate dehydrogenase variants revisited.
Some observations on glutathione instability and glucose-6-phosphate dehydrogenase deficiency in infants and children having anaemia and jaundice.
Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency.
Spectrophotometric evaluation of results of the ascorbate and the ascorbate-cyanide screening tests for glucose-6-phosphate dehydrogenase deficiency.
Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
Spectrum of acute cortical necrosis in Indian patients.
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
Spleen size determined by ultrasound in patients with sickle cell trait, HbAC trait and glucose-6-phosphate-dehydrogenase deficiency in a malaria hyperendemic area (Ashanti Region, Ghana).
Splenic visualization in a patient with glucose-6-phosphate dehydrogenase deficiency.
Sporadic G6PD deficiency with haemolytic anaemia in two children of West European ancestry.
Spotlight on rasburicase in anticancer therapy-induced hyperuricemia.
Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer.
Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency.
Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A(-) deficiency.
Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity.
Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-) deficiency.
Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population.
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.
Student screening for inherited blood disorders in Bahrain.
Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates.
Studies of Glucose-6-Phosphate Dehydrogenase Activity of Individual Erythrocytes: The Methemoglobin-Elution Test for Identification of Females Heterozygous for G6PD Deficiency.
Studies of the distribution of haemoglobin E, thalassaemias and glucose-6-phosphate dehydrogenase deficiency in north-eastern Thailand.
Studies on several genetic hematologic traits of Mexicans IX. Abnormal hemoglobins and erythrocytic glucose-6-phosphate dehydrogenase deficiency in several Indian tribes.
STUDIES ON SEVERAL GENETIC HEMATOLOGICAL TRAITS OF THE MEXICAN POPULATION. 8. HEMOGLOBIN S, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, AND OTHER CHARACTERISTICS IN A MALARIAL REGION.
Studies on several genetic hematological traits of the Mexican population. XVI. Hemoglobin, S and glucose-6-phosphate dehydrogenase deficiency in the east coast.
Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain).
STUDIES ON THE CORRELATION OF THE GENETICALLY DETERMINED TRAIT, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, WITH BEHAVIORAL MANIFESTATIONS IN SCHIZOPHRENIA.
STUDIES ON THE DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, THALASSEMIA, AND OTHER GENETIC TRAITS IN THE COASTAL AND MOUNTAIN VILLAGES OF CYPRUS.
Study of a family in the province of Matera presenting with glucose-6-phosphate dehydrogenase deficiency and Gilbert's syndrome.
Study of erythrocyte G6PD deficiency in leprosy.
Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India.
Study of glucose-6-phosphate dehydrogenase (G6PD) in the Kissan tribals of Orissa and the Kannikar tribals of Kerala, India.
Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
Study of glucose-6-phosphate dehydrogenase: history and molecular biology.
Study of red cell membrane lipids in glucose-6-phosphate dehydrogenase deficiency anemia.
Study on glucose-6-phosphate dehydrogenase deficiency in Laos.
STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis.
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana.
Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test.
Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.
Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests.
Superoxide dismutase activity and reduced glutathione content in cataractous lens of patients with glucose-6-phosphate dehydrogenase deficiency.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Fiji.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Hawaii.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Polynesians.
Survey on haemoglobin variants, beta thalassaemia, glucose-6-phosphate dehydrogenase deficiency, and haptoglobin types in Turks from western Thrace.
Survey on haemoglobin variants, beta-thalassaemia, glucose-6-phosphate dehydrogenase deficiency and haptoglobin types in Turkish people living in Manavgat, Serik and Boztepe (Antalya).
SURVIVAL OF 51 CR-LABELLED RED CELLS IN SUBJECTS WITH THALASSAEMIA-TRAIT OR G6PD DEFICIENCY OR BOTH ABNORMALITIES.
Sweat test in patients with glucose-6-phosphate-1-dehydrogenase deficiency.
Sweetened blood cools hot tempers: physiological self-control and aggression.
Synchrony of G6PD activity and RBC fragility under oxidative stress exerted at normal and G6PD deficiency.
Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.
Tafenoquine and G6PD: a primer for clinicians.
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review.
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
Tafenoquine Is a Promising Drug Candidate for the Treatment of Babesiosis.
Tafenoquine: a toxicity overview.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
tert-Butyl Hydroperoxide (tBHP)-Induced Lipid Peroxidation and Embryonic Defects Resemble Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in C. elegans.
Testing the "malaria hypothesis" for the case of Thailand: a genetic appraisal.
Tf, Gc and Cp phenotypes in favism and G-6-PD deficiency.
Thalassaemia and glucose-6-phosphate dehydrogenase deficiency in sickle-cell disorder patients in Taiz, Yemen.
Thalassaemia and glucose-6-phosphate dehydrogenase screening in 13- to 14-year-old students of the Sardinian population: preliminary findings.
THALASSAEMIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, SICKLING, AND MALARIAL ENDEMICITY IN GREECE: A STUDY OF FIVE AREAS.
Thalassemia and G-6-PD deficiency in Chinese-Canadians: admission screening of a hospital population.
Thalassemia and G6PD deficiency in Spanish blood donors.
Thalassemia trait and G6PD deficiency in Thai blood donors.
THALASSEMIAS, ABNORMAL HEMOGLOBINS AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THE ARTA AREA OF GREECE: DIAGNOSTIC AND GENETIC ASPECTS OF COMPLETE VILLAGE STUDIES.
The ascorbate cyanide test and the detection of females heterozygous for glucose-6-phosphate dehydrogenase deficiency.
The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females.
The association between glucose-6-phosphate dehydrogenase deficiency and cancer in American Negroes.
The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia.
The blood groups, serum groups, red-cell isoenzymes and haemoglobins of the Sandawe and Nyaturu of Tanzania.
The burden and consequences of inherited blood disorders among young children in western Kenya.
The burden of genetic disorders in India and a framework for community control.
The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.
THE CLINICAL PICTURE OF GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN EARLY INFANCY.
The clonal organization of the squamous epithelium of the tongue.
The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria.
The coincidence of glucose-6-phosphate dehydrogenase deficiency and hemoglobin S gene in Cukurova Province, Turkey.
The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The detection of glucose-6-phosphate dehydrogenase deficiency in mediterraneans by comparative quantitative enzyme electrophoresis.
The detection of heterozygous G6PD deficiency; similarity between glutathione deficiency and G6PD deficiency.
The detection of heterozygous glucose-6-phosphate dehydrogenase deficiency in Mediterraneans by comparative enzyme assay.
The distribution of glucose-6-phosphate dehydrogenase deficiency in Greece.
The distribution of hereditary erythrocytic disorders associated with malaria, in a lowland area of Nepal: a micro-epidemiological study.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum.
The effect of diabetes mellitus and diabetic therapy on cataract formation.
The effect of glucose-6-phosphate dehydrogenase deficiency on the severity of neonatal jaundice in Cape Town.
The effect of moderate non-hemolytic jaundice and phototherapy on newborn behavior.
The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease.
The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells.
The Effectiveness of Oral Tin Mesoporphyrin Prophylaxis in Reducing Bilirubin Production after an Oral Heme Load in a Transgenic Mouse Model.
The effects of di- and trichloroacetic acid on sheep erythrocytes: an animal model with a glucose-6-phosphate dehydrogenase deficiency.
The effects of glucose-6-phosphate dehydrogenase deficiency on the haematological parameters and clinical manifestations in patients with sickle cell anaemia.
The effects of some antibiotics on sheep lens glucose 6-phosphate dehydrogenase in vitro.
The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern Iran.
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.
The epidemiology of recurrent pregnancy loss.
The erythroenzymopathies. With particular reference to glucose-6-phosphate dehydrogenase deficiency and favism.
The existence of the glucose-6-phosphate dehydrogenase deficiency trait in Nigeria and its clinical implications.
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.
The fatty acid composition of red cells deficient in glucose-6-phosphate dehydrogenase and their susceptibility to lipid peroxidation.
The First Case of a Class I Glucose-6-phosphate Dehydrogenase Deficiency, G6PD Santiago de Cuba (1339 GA), in a Chinese Population as Found in a Survey for G6PD Deficiency in Northeastern and Central China.
The first reported case of G6PD deficiency due to Seoul mutation in Poland.
The frequency of glucose-6-phosphate dehydrogenase deficiency in Colombia.
The frequency of glucose-6-phosphate dehydrogenase deficiency in the newborns and adults in Kuwait.
The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell gene in Al-Qassim.
The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell genes in Al-Qatif oasis.
The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.
The gene spectrum of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Guangdong province, China.
The genetics of glucose-6-phosphate dehydrogenase deficiency.
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
The haematological effects of glucose-6-phosphate dehydrogenase deficiency and thalassaemia trait: interaction between the two genes at the phenotype level.
The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.
The hemolytic crisis of sickle cell disease: the role of glucose-6-phosphate dehydrogenase deficiency.
The HLA system and G6PD deficiency in the Bulgarian population.
The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase.
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study.
The incidence of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Singapore.
The incidence of glucose-6-phosphate dehydrogenase deficiency and thalassaemia in Malta.
The incidence of glucose-6-phosphate dehydrogenase deficiency in a population of Greek, Italian and Yugoslav origin in Australia.
The incorporation of isotopically labelled glycine into glutathione of erythrocytes with glucose-6-phosphate dehydrogenase deficiency.
The influence of G-6-PD activity on the response of erythrocyte glutathione reductase to riboflavin deficiency.
The influence of haemoglobin-S and G6PD deficiency on the activity of the 17 beta-hydroxysteroid dehydrogenase of intact human erythrocytes.
The integrity and stability of specimens under different storage conditions for glucose-6-phosphate dehydrogenase deficiency screening using WST-8.
The interaction between beta-thalassemia, G-6-PD deficiency, and favism.
The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels.
The Interaction between Hb A1C and Selected Genetic Factors in the African American Population in the USA.
The laboratory use of butylnitrite for the production of methemoglobin.
The Le(a) antigen and neonatal hyperbilirubinemia in Taiwan.
THE LYON HYPOTHESIS IN G-6-PD DEFICIENCY.
The methylene blue reduction test: evaluation of a screening method for glucose-6-phosphate dehydrogenase deficiency.
The micro-methemoglobin reduction screening test for G6PD deficiency in childhood.
The micro-methemoglobin reduction test for glucose 6-phosphate dehydrogenase deficiency. A simple field screening procedure.
The molecular basis of glucose-6-phosphate dehydrogenase deficiency.
The molecular biology of G6PD variants and other red cell enzyme defects.
The mortality of exchange transfusions.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
The ocular findings in glucose-6-phosphate dehydrogenase deficiency.
The partial purification and properties of a human erythrocyte 4-nitroacetophenone reductase.
The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution.
The possible role of hypertension in aggravating hemolytic episodes in G-6PD deficient persons.
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.
The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.
The prevalence of G6PD deficiency in blood transfusion recipients.
The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.
The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.
The prevalence of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in Jordanian newborn.
The prevalence of the erythrocyte glucose-6-phosphate dehydrogenase deficiency among Africans in Uganda.
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos.
The Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran.
The reality of using primaquine.
The reduction of methemoglobin in erythrocytes of a patient with congenital methemoglobinemia, subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency, and normal individuals.
The relations between G-6-PD deficiency, thalassemia and malaria. Further analysis of data from Sardinia and the Po Valley.
The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study.
The relationship of erythrocyte glucose-6-phosphate dehydrogenase deficiency to byperbilirubinemia in Negro premature infants.
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
The risk of jaundice in glucose-6-phosphate dehydrogenase deficient babies exposed to menthol.
The role of anti-malarial drugs in eliminating malaria.
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress.
The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis.
The role of glucose-6-phosphate dehydrogenase deficiency in blackwater fever.
The role of haemolysis in neonatal hyperbilirubinaemia as reflected in carboxyhaemoglobin levels.
The role of oxidative stress in hemolytic anemia.
The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal.
The roles of glucose-6-phosphate dehydrogenase deficiency and ventilation support in outcome of carbon monoxide poisoning.
The separation of glucose-6-phosphate dehydrogenase deficient erythrocytes from blood of heterozygotes for glucose-6-phosphate dehydrogenase deficiency.
The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability.
The significance of glucose-6-phosphate dehydrogenase deficiency in pregnancy.
The Spectrum of Hemolytic Disease of the Newborn: Evaluating the Etiology of Unconjugated Hyperbilirubinemia Among Neonates Pertinent to Immunohematological Workup.
The status of neonatal screening in China, 2013.
The study of G6PD in erythrocyte and lens in senile and presenile cataract.
The suitability of saliva for detection of glucose-6-phosphate dehydrogenase deficiency.
The Thai variant and the distribution of alleles of 6-phosphogluconate dehydrogenase and the distribution of glucose 6-phosphate dehydrogenase deficiency in Thailand.
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
The value of a routine screening test for glucose-6-phosphate dehydrogenase deficiency.
The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency.
The value of screening tests for glucose-6-phosphate dehydrogenase deficiency.
Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.
Therapeutic potential of manipulating suicidal erythrocyte death.
Three major G6PD-deficient polymorphic variants identified among the Mauritian population.
Three mutations analysis of glucose-6-phosphate dehydrogenase deficiency in neonates in South-west China.
Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia.
Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.
Topical benzocaine (Hurricaine) induced methemoglobinemia during endoscopic procedures in gastric bypass patients.
Topical herbal medicine causing haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Towards one standard treatment for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria: Perspectives from and for the Peruvian Amazon.
Toxic effects of drugs on erythrocytes.
Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review.
Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients.
Traditional African remedies induce hemolysis in a glucose-6-phopshate dehydrogenase deficient zebrafish model.
Traditional Chinese medicine and treatment of neonatal jaundice.
Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells.
Transcutaneous bilirubin nomogram for Taiwanese newborns - A single center study.
Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units.
Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.
Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.
Transient, acquired glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Treatment and prevention of malaria in children.
Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful?
Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange.
Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin.
Treatment of MRSA Infections in an African-American male with G6PD Deficiency.
Treatment of schistosomiasis mansoni with hycanthone in glucose-6-phosphate dehydrogenase deficiency in St. Lucia.
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.
Trends of Transcutaneous Bilirubin in Neonates Who Develop Significant Hyperbilirubinemia.
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
TRIPLE ERYTHROPOIETIC ANOMALY: PORPHYRIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND HETEROZYGOUS STATE OF HAEMOGLOBIN E.
Triplo-X constitution of mother explains apparent occurrence of two recombinants in sibship segregating at two closely X-linked loci (G6PD and deutan).
Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia.
Two cases of glucose-6-phosphate dehydrogenase-deficient Nepalese belonging to the G6PD Mediterranean-type, not India-Pakistan sub-type but Mediterranean-Middle East sub-type.
Two commonly occurring nucleotide base substitutions in Chinese G6PD variants.
Two new class III G6PD variants [G6PD Tunis (c.920A>C: p.307Gln>Pro) and G6PD Nefza (c.968T>C: p.323 Leu>Pro)] and overview of the spectrum of mutations in Tunisia.
Two new variants of G6PD deficiencies in Singapore.
Two new variants of glucose-6-phosphate dehydrogenase associated with hereditary non-spherocytic hemolytic anemia: G6PD Wayne and G6PD Huron.
Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients.
Two novel glucose 6-phosphate dehydrogenase deficiency mutations and association of such mutations with F8C/G6PD haplotype in Chinese.
Two novel glucose-6-phosphate dehydrogenase variants found in newborn mass-screening for galactosaemia.
Two novel mutations (2976INSA, 4311insA) of ATP7B in a patient with Wilson's disease coexisting with glucose-6-phosphate dehydrogenase deficiency.
Two point mutations are responsible for G6PD polymorphism in Sardinia.
Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.
Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
UGT1A1 Gene Polymorphisms in North Indian Neonates Presenting with Unconjugated Hyperbilirubinemia.
UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia.
UK malaria treatment guidelines 2016.
UK malaria treatment guidelines.
Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
Ultrasound-Guided Regional Anesthesia in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Geriatric Trauma Patient.
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
Underlying etiologies of prolonged icterus in neonates.
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: Evaluation of eryptotic pathway.
Unexpected glucose-6-phosphate dehydrogenase deficiency.
Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system.
Universal Implementation of Newborn Screening in India.
Unnecessary deprivation of common food items in glucose-6-phosphate dehydrogenase deficiency.
Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy.
Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates.
Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.
Urinary acidification in a patient with glucose-6-phosphate dehydrogenase deficiency. A reevaluation of the role of the hexose monophosphate shunt in renal acid secretion.
Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
Use and safety of elevated dosages of vitamin E in adults.
Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency.
Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
Use of nimotuzumab in the patient with G-6-PD deficiency: The first world report.
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Use of tolfenamic acid in febrile children with and without glucose-6-phosphate dehydrogenase deficiency.
Use of trimethoprim-sulfamethoxazole in a patient with G6PD deficiency for treating Pneumocystis jirovecii pneumonia without haemolysis: Case report and literature review.
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Using the fluorescence spot test for neonatal screening of G6PD deficiency.
USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania.
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Variability of red cell phenotypes between and within individuals in an unbiased sample of 77 heterozygotes for G6PD deficiency in Sardinia.
Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
Variants of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) in Bulgarian populations.
Variants of glucose-6-phosphate dehydrogenase (G-6-PD) associated with G-6-PD deficiency in Puerto Ricans.
Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.
Viral hepatitis with haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
Viral infections in G-6-PD deficiency.
Vitamin C and kidney transplantation: Nutritional status, potential efficacy, safety, and interactions.
Vitamin C Inhibits Aggravated Eryptosis by Hydrogen Peroxide in Glucose-6-Phosphated Dehydrogenase Deficiency.
Vitreoretinal hemorrhages after ingestion of fava beans in a G-6-PD-deficient subject.
What has passed is prolog: new cellular and physiological roles of G6PD.
What is the role of the second "structural" NADP+-binding site in human glucose 6-phosphate dehydrogenase?
When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin concentration.
Why G-6-PD deficiency is common in females.
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria.
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
X-linkage and genetic heterogeneity in bipolar-related major affective illness: reanalysis of linkage data.
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.
X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus.
X-mapping in man: evidence against measurable linkage between anhidrotic ectodermal dysplasia and G6PD deficiency.
Xq28: epidemiology and sex-linkage between red-green colour blindness and G6PD deficiency.
Yield of reticulocyte counts and blood smears in term infants.
[2 cases of glucose 6-phosphate dehydrogenase deficiency revealed during treatment with para-amino-salicylic acid]
[A boy with jaundice.]
[A case of acute recurrent benign pericarditis in a patient with glucose-6-phosphate dehydrogenase deficiency, treated with sodium salicylate]
[A case of falciparum malaria successfully treated with intravenous artesunate]
[A case of nt 1004C --> A G6PD gene mutation in Yunnan Han people]
[A case of typhoid fever in a visitor from India with glucose-6-phosphate dehydrogenase deficiency. Remarkable conjugated hyperbilirubinemia probably induced by an analgesic drug (author's transl)]
[A family study of G-6-PD deficiency associated with increased erythrocyte ATPase activities and reduced blood ATP levels]
[A family study of G-6-PD deficiency: report of 13th case in Japan]
[A frequently occurring imported illness, glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[A new reagent for methemoglobin reduction test]
[A search for glucose-6-phosphate dehydrogenase deficiency, among Toros Seljouck Turks, in both normal and pathological conditions. The explanation of hemolytic anemias seen, in snake bite and poisonous insect bites cases. Three cases of favism and hemolytic syndrome]
[A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase]
[A young man with acute generalised jaundice and intermittent epigastric pain]
[Abnormal hemoglobins and glucose-6-phosphate dehydrogenase deficiency in El Salvador]
[Abnormal hemoglobins, alpha thalassemia and erythrocyte G6PD deficiency in newborn infants of the negroid race]
[Acute drug-induced hemolytic anemia in persons with congenital glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[Acute hemolysis after ingestion of glyceryl aminophenaquine in a subject presenting with G6PD deficiency]
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolysis caused by glucose-6-phosphate dehydrogenase deficiency at the outset of myeloma therapy. Role of melphalan?]
[Acute hemolysis due to trinitrotoluene in G6PD deficiency]
[Acute hemolytic anemia after the consumption of fava beans. Familial case study on glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency (apropos of a case)]
[Acute hemolytic anemia in the course of spesis caused by Proteus morganii in a subject with erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Acute myocarditis complicating Mediterranean spotted fever. A case report.]
[Acute post-operative hemolysis related to a G6DP deficiency. Report of one case (author's transl)]
[Acute renal failure manifest of glucose-6-phosphate dehydrogenase deficiency: severity of iatrogenic hemolysis. Originality of genetic distribution in a family from Sardinia]
[An additional argument in favor of the protective effect of glucose 6-phosphate dehydrogenase deficiency against malaria?]
[AN ASHKENAZI FAMILY WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Anaesthetic management of a child with hemoglobinopathy].
[Anesthesia in glucose 6-phosphate dehydrogenase-deficient patient: case report.]
[Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management]
[Antihemolytic action of an extract of Carica papaya bark. Possibilities of use in glucose-6-phosphate dehydrogenase deficiencies]
[Aplastic crisis due to human parvovirus B19 infection in glucose-6-phosphate dehydrogenase deficiency]
[Application of PCR-DGGE technique in G-6-PD deficiency]
[Aregenerative anemia and erythrocytes hemighosts: a case report].
[Association between disturbances in intestinal absorption or glucose and G6PD deficiency in immigrants from Kurdistan]
[Association of a triple genetic erythrocyte defect: thalassemia, sickle cell disease and glucose-6-phosphate dehydrogenase deficiency in a child of Calabro-Sardinian origin]
[Association of hemoglobinosis and glucose-6-phosphate dehydrogenase deficiency]
[Association of heterozygote drepanocytosis and G6PD deficiency: apropos of a case]
[Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine]
[Attempt at characterization of 2 erythrocyte variants of glucose-6-phosphate dehydrogenase in a patient with a partial enzymatic deficit]
[Autointoxication with 'suicide powder'].
[Beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency]
[Biology of glucose-6-phosphate dehydrogenase deficiency]
[Blackwater fever in adults with sickle cell anemia. Two fatal cases]
[Can glucose-6-phosphate dehydrogenase deficiency alone explain neonatal jaundice]
[Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency]
[Case of nonspherocytic anemia complicated by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]
[Catalase activity in red blood cells with glucose-6-phosphate dehydrogenase deficiency]
[Cataract and glucose-6-phosphate dehydrogenase deficiency in Sardinians]
[Changes in the contents of membrane phospholipid and membrane phospholipid asymmetry in glucose-6-phosphate dehydrogenase deficient erythrocyte]
[Changes of erythrocyte membrane lipid in hereditary G6PD deficiency]
[Changes of protein tyrosine phosphorylation in erythrocyte band 3 glucose-6-phosphate dehydrogenase deficiency]
[Characteristics of two new mutant forms of erythrocyte glucose-6-phosphate dehydrogenase: "Kirovograd" G6PD and "Zhitomir" G6PD]
[CHRONIC HEMOLYTIC ANEMIA WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Chronic non-conjugated hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day]
[Clinical evaluation of a melting curve analysis-based PCR assay for glucose phosphate dehydrogenase gene mutation detection].
[Clinical experience of primaquine use for treatment of vivax and ovale malaria in Japanese travelers].
[Clinical Features and Laboratory Data Analysis of Glucose-6- Phosphate Dehydrogenase Deficiency].
[Clinical polymorphism of glucose-6-phosphate dehydrogenase deficiency: the Seattle variant]
[Clinical Significance of Gene Mutation Detection for Female Heterozygotes with Glucose-6-Phosphate Dehydrogenase Deficiency].
[Clinical studies of neonatal hyperbilirubinemia treated with blood exchange transfusion]
[Clinical study on the prevention of kernicterus caused by hereditary glucose-6-phosphate dehydrogenase deficiency]
[Clinical, erythrokinetic and metabolic aspects of congenital hemolytic non-spherocytic anemia due to erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Clinico-biochemical characteristics of patients with congenital glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[Clinico-genetic polymorphism of erythrocytes glucose-6-phosphate dehydrogenase deficiency in Bulgaria]
[Clinico-genetic significance of glucose-6-phosphate dehydrogenase deficiency of erythrocytes]
[Clinico-immunologic characteristics of patients with pulmonary tuberculosis, psychic diseases and a congenital glucose-6-phosphate dehydrogenase deficiency]
[Clinicogenetic studies of a patient with the Corinth type of glucose-6-phosphate dehydrogenase deficiency]
[Common anemias in neonatology]
[Common mutation analysis for patients found in Tianjin area with glucose-6-phosphate dehydrogenase deficiency]
[Comparative study of three common G6PD gene mutations in Yao and Han People in Guangxi]
[Complete glucose-6-phosphate dehydrogenase deficiency associated with Gilbert's familial cholemia in a metropolitan French subject]
[Complex mutations of 1311 C-->T in exon 11 and 93 T-->C in intron 11 in G6PD gene]
[Complicated viral to cholestatic hepatitis in a child with glucose-6-phosphate dehydrogenase deficiency from a high andean region].
[Complications of exchange transfusion in term and preterm newborns]
[CONGENITAL AND RECESSIVE METHEMOGLOBINEMIA. ITS ASSOCIATION WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THALASSEMIA MINOR.]
[CONGENITAL HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Congenital hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Congenital hemolytic non-spherocytic anemia caused by glucose-6-phosphate dehydrogenase deficiency (case contribution)]
[Congenital non spherocytic hemolytic anemia due to G-6PD deficiency: physiological and biochemical study of an unusual variant. Relationship to Benevento G-6PD]
[Congenital non-spherocytic hemolytic jaundice with glucose-6-phosphate dehydrogenase deficiency. 2 cases.]
[Congenital nonspherocytic hemolytic anemia, cataract and glucose-6-phosphate dehydrogenase deficiency]
[Congenital nonspherocytic hemolytic anemias caused by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes in a Japanese family]
[Correlation analysis of genotypes and the enzymatic activities of glucose-6-phosphate dehydrogenase in neonates in Guangzhou].
[Course of epidemic viral hepatitis in subjects with glucose-6-phosphate dehydrogenase deficiency. Apropos of 6 cases]
[Critical observations on the morphological methods used to demonstrate 2 cell populations in heterozygotic women with erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Critical study of various technics of detection and determination of glucose-6-phosphate dehydrogenase deficiency]
[Current clinical approaches and gene mutation study of beta-thalassemia major]
[Current status of readmission of neonates with hyperbilirubinemia and risk factors for readmission].
[Cytogenetic studies on four German patients with G-6-PD deficiency; demonstration of a fresh mutation. Summary]
[Deficiency of glucose-6-phosphate dehydrogenase in a family]
[Dermatoglyphics and creases in a large family with glucose-6-phosphate dehydrogenase deficiency]
[Description of new mutant forms of erythrocyte glucose-6-phosphate dehydrogenase in man]
[Detection of a new anomalous variant of glucose-6-phosphate dehydrogenase in human erythrocytes]
[Detection of female heterozygous glucose-6-phosphate dehydrogenase deficiency]
[Detection of G-6-PD deficiency in children born at the Giannina Gaslini Institute, using a rapid screening method]
[Detection of G6PD deficiency by tests of methemoglobin reduction]
[Detection of gene mutation in glucose-6-phosphate dehydrogenase deficiency by RT-PCR sequencing].
[Determination of glucose-6-phosphate dehydrogenase deficiency to prevent possible drug-induced hemolysis]
[Determination of superoxide dismutase (sod) in erythrocytes in glucose-6-phosphate dehydrogenase deficiency (G6PD-deficiency)]
[Diagnosis of glucose-6-phosphate dehydrogenase deficiency by activation of the erythrocytic redox systems]
[Digitalis intoxication during the neonatal period: role of dehydration]
[Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti]
[Double erythrocyte enzymopathy. Acquired pyruvate kinase and inherited glucose-6-phosphate dehydrogenase deficiencies]
[Double-blind controlled comparison of placebo and paracetamol in patients with G-6-PD deficiency]
[DREPANOCYTEMIA, ERYTHROCYTIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (G-6-PD) AND MALARIA IN THE CUANGO POST (LUNDA-ANGOLA).]
[Drug-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency: an update].
[Drug-induced hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency]
[Drugs and other agents leading to increased hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]
[Early detection of color blindness from the viewpoint of occupational medicine with various references to internistic and human genetic symptom complexes]
[Effect of ethanol on the detoxification of hydrogen peroxide induced by ascorbic acid in normal erythrocytes and those with glucose-6-phosphate dehydrogenase deficiency]
[Effects of Yinzhihuang oral liquid and Lonicera japonica extract on hemolysis and hyperbilirubinemia in rats with glucose-6-phosphate dehydrogenase deficiency].
[Efficiency of a package of therapeutic and preventive measures in the Republic of Tajikistan in the malaria postepidemic period (2000-2007)]
[Enzymatic activity of the oxydative shunt in human leukocytes of normal and pathological subjects and patients with G6PD deficiency during the process of slow phagocytosis in vitro]
[Enzyme-deficient hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a child of German descent]
[Epidemiological survey on malaria situation in Motuo County of Tibet, China]
[Epidemiology of glucose-6-phosphate dehydrogenase deficiency]
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
[Erythrocyte G-6-PD deficiency in blood donors of Oristano]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in a 3-year-old child]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in African newborn infants in Dakar]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Rumania: anthropogenetic significance]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency. Review and report of a case]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency: histochemical study of the duodenal mucosa]
[Erythrocyte polymorphism in Mali: epidemiology and resistance mechanisms against severe Plasmodium falciparum malaria]
[Erythrocyte survival in patients with G6PD deficiency during administration of suprofen]
[Erythrocytic enzymopathy in Uzbekistan].
[Erythrocytic glucose-6-phosphate dehydrogenase deficiency, hemolysis and diabetic ketoacidosis]
[Erythrocytic mosaicism and pseudomosaicism in glucose-6-phosphate dehydrogenase deficiency]
[Etiology of hemolytic anemia]
[Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo)]
[Evaluations of newborn screening program performance and enzymatic diagnosis of glucose-6-phosphate dehydrogenase deficiency in Guangzhou].
[Expression of G-6-PD mRNA in children with G-6-PD deficiency]
[Expression of g6pd gene in wild type zebrafish embryos of early development].
[Expression of human G6PD gene in K562 cells mediated by retroviral vector]
[Familial glucose-6-phosphate dehydrogenase deficiency]
[Familial study in a case of congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Favism (study of 8 families)]
[Favism after ingestion of fava beans in a three-year-old child with glucose-6-phosphate dehydrogenase deficiency].
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. FURTHER OBSERVATIONS IN ANOTHER SPANISH FAMILY.]
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. STUDY OF THIS ENZYMATIC DISTURBANCE IN A SPANISH FAMILY.]
[Favism, hemolytic attacks caused by drugs and grave neonatal jaundice in populations with high incidence of G-6-PD deficiency]
[Favism, hemolytic crises and severe jaundice of the newborn infant in the population with increased G-6-PD deficiency]
[Favism. A clinical syndrome caused by glucose-6-phosphate dehydrogenase deficiency in the erthrocytes.]
[Favism. Glucose-6-phosphate dehydrogenase deficiency]
[Favism: hemolytic crisis due to glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[Favism]
[Favourable erythrocyte rheology in patients with glucose-6-phosphate dehydrogenase deficiency (author's transl)]
[FIRST RESULTS ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCIES IN THE DAKAR REGION. PRELIMINARY NOTES.]
[Frequency and complications of erythrocyte glucose-6-phosphate dehydrogenase deficiency in the African newborn in Dakar. Preliminary study]
[Frequency of color blindness and glucose-6-phosphate dehydrogenase enzyme deficiency in non-industrialized populations in the state of Nuevo León, México]
[Frequency of G6PD deficiency in a group of preschool-aged children in a centrally located area of Cambodia]
[Frequency of glucose-6-phosphate dehydrogenase deficiency (A-376/202) in three Malian ethnic groups].
[Furosemide (Lasilix) can be used in patients with G6PD deficiency. Apropos of a case]
[G-6-PD deficiency hemolytic anemia with abnormal BSP retention]
[G-6-PD deficiency with hemoglobinopathy and alpha-thalassemia]
[G-6PD deficiency in newborns in Algiers (author's transl)]
[G6PD deficiency and acute poisoning by anti-mite mothballs]
[G6PD deficiency in a western area of Genoa. Genetic study of 4 new variants]
[G6PD deficiency in females with neonatal revelation. Report of four cases].
[G6PD deficiency in populations of the Bolivian Andes]
[G6PD deficiency revealed by eating of beans and the ingestion of sulfamethoxazole]
[G6PD deficiency]
[G6PD gene mutations in Guangxi, China]
[G6PD Gene Mutations in Shui people in Sandu of Guizhou]
[G6PD phenotype and red blood cell sensitivity to the oxidising action of chlorites in drinking water]
[Gd- allele distribution patterns in Azerbaijan. III. The identification of mutant forms of glucose-6-phosphate dehydrogenase]
[Gene analysis and genetic diagnosis of hereditary erythrocyte abnormalities. Glucose-6-phosphate dehydrogenase deficiency]
[Gene diagnosis of hemolytic anemia]
[Gene geography of hereditary glucose-6-phosphate dehydrogenase deficiency and pulmonary tuberculosis in Azerbaijan]
[Gene Mutants and Their Clinical Characteristics of G6PD Deficiency Among Children in Luzhou Area].
[Gene promoter methylation in glucose-6-phosphate dehydrogenase de?ciency].
[Generalized saturnine paralysis. Discovery of a double congenital disease: glucose-6-phosphate dehydrogenase deficiency (new variant) and distal tubular acidosis]
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[Genetic diagnosis for female carriers of glucose-6-phosphate dehydrogenase deficiency by RT-PCR-DGGE]
[Genetic heterogeneity of G6PD deficiency: mutant alleles of G6PD in the Shekii district of Azerbaijan]
[Genetic mutation screening of glucose-6-phosphate dehydrogenase deficiency in Dongguan district].
[Genetic questionnaire. Genetic counseling for a patient with the complex association of G-6-PD deficiency, Gronblad-Strandberg syndrome (pseudo-xanthoma elasticum) and epilepsy]
[Genetic resistance to malaria]
[Genetic traits in the area of Bodrogköz]
[Genetico-epidemiological and molecular investigation of G-6-PD deficiency in a Brazilian community]
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
[Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents]
[Glucose-6-phosphate dehydrogenase (G6PD) deficiency--a cause of anaemia in pregnant women]
[Glucose-6-phosphate dehydrogenase deficiencies]
[Glucose-6-phosphate dehydrogenase deficiency among the student population of Milan]
[Glucose-6-phosphate dehydrogenase deficiency and hemoglobinuric biliary fever after taking mefloquine]
[Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia in a Danish boy]
[Glucose-6-phosphate dehydrogenase deficiency and hereditary hemolytic anemia]
[Glucose-6-phosphate dehydrogenase deficiency and leprosy]
[Glucose-6-phosphate dehydrogenase deficiency and other erythrocyte enzyme abnormalities]
[Glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency]
[Glucose-6-phosphate dehydrogenase deficiency as the cause of hemolytic icterus in a German family]
[Glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia (author's transl)]
[Glucose-6-phosphate dehydrogenase deficiency in 2 girls]
[Glucose-6-phosphate dehydrogenase deficiency in 2 siblings. (Quantitative determination)]
[Glucose-6-phosphate dehydrogenase deficiency in a general hospital of Salvador, Bahia, Brazil (author's transl)]
[Glucose-6-phosphate dehydrogenase deficiency in Algeria.]
[Glucose-6-phosphate dehydrogenase deficiency in Algeria]
[Glucose-6-phosphate dehydrogenase deficiency in an 81-year-old]
[Glucose-6-phosphate dehydrogenase deficiency in an Austrian family]
[Glucose-6-phosphate dehydrogenase deficiency in blood donors in a general hospital of Salvador, Bahia, Brazil]
[Glucose-6-phosphate dehydrogenase deficiency in children: a case report].
[Glucose-6-phosphate dehydrogenase deficiency in erythrocytes observed in two cases]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN ERYTHROCYTES OF A POLISH FAMILY.]
[Glucose-6-phosphate dehydrogenase deficiency in erythrocytes of foreign students studying in Poland]
[Glucose-6-phosphate dehydrogenase deficiency in Japan].
[Glucose-6-phosphate dehydrogenase deficiency in Mali. Epidemiology and pathological aspects]
[Glucose-6-phosphate dehydrogenase deficiency in Mecklenburg]
[Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia]
[Glucose-6-phosphate dehydrogenase deficiency in newborn Brazilian infants]
[Glucose-6-phosphate dehydrogenase deficiency in the Congo. Clinical, genetic and public-health aspects]
[Glucose-6-phosphate dehydrogenase deficiency in the erythrocytes of foreign students]
[Glucose-6-phosphate dehydrogenase deficiency in three generations of an Aachen family]
[Glucose-6-phosphate dehydrogenase deficiency in Viet-nam]
[Glucose-6-phosphate dehydrogenase deficiency of erythrocytes in 3 German children. Determination of a new mutation]
[Glucose-6-phosphate dehydrogenase deficiency of erythrocytes in the GDR]
[Glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type B minus. 1. Favism in childhood]
[Glucose-6-phosphate dehydrogenase deficiency of the mediterranean type B minus. 2. Etiological basis for severe hyperbilirubinemia in the newborn]
[Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report]
[Glucose-6-phosphate dehydrogenase deficiency, 1 of the forms of hemolytic anemia (review of the literature)]
[Glucose-6-phosphate dehydrogenase deficiency, neonatal hyperbilirubinemia and Gilbert syndrome]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. APROPOS OF A CASE OF FAVISM.]
[Glucose-6-phosphate dehydrogenase deficiency. Diagnosis during treatment of a mandibular fracture]
[Glucose-6-phosphate dehydrogenase deficiency.]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Glucose-6-phosphate dehydrogenase deficiency: anesthetic implications]
[Glucose-6-phosphate dehydrogenase deficiency: clinical presentation and eliciting factors]
[Glucose-6-phosphate dehydrogenase deficiency: its frequency in Hb AS and Hb AA individuals among the black population of Limón]
[Glucose-6-phosphate dehydrogenase deficiency: report of 2 cases]
[Glucose-6-phosphate dehydrogenase deficiency]
[Glucose-6-phosphate dehydrogenase et neonatal jaundice]
[Glucose-6-phosphate dehydrogenase gene mutations in She nationality, Fujian province]
[Glucose-6-phosphate-dehydrogenase deficiency management in western countries. A literature review].
[Haemolytic anemia associated with G-6-PD deficiency]
[Haemolytic crisis of blackwater fever following artemether-lumefantrine intake.]
[Haptoglobin and hemopexin in glucose-6-phosphate dehydrogenase deficiency]
[Haptoglobin, groups Gm andG Gc, hemoglobin S and glucose-6-phosphate dehydrogenase deficiency: their incidence in South Tanzania]
[Heinz body formation and GSH content in erythrocytes with glucose-6-phosphate dehydrogenase deficiency and disruption of glutathione synthesis after x-irradiation in vitro]
[Hematologic characteristics in Black Africa]
[Hemocoagulation disturbances in drug-provoked hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]
[HEMOGLOBIN, METHEMALBUMIN AND HAPTOGLOBINEMIA IN PLASMA OF NEWBORNS WITH HEMOLYTIC JAUNDICE DUE TO ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. ELECTROPHORETIC RESEARCH.]
[Hemoglobinopathies and erythrocyte enzyme deficiencies in Switzerland: laboratory diagnoses of the last 10 years]
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
[Hemoglobinoses and G6PD deficiency in Africans in the Dakar area]
[Hemoglobinosis S and glucose-6-phosphate dehydrogenase deficiency]
[Hemoglobinuria in children hospitalized in Ouagadougou: short term inpatient care and prognosis].
[Hemolysis in congenital G-6-PD deficiency. Description of 2 cases with different clinical and laboratory findings]
[Hemolytic anemia after treatment with sulfamethoxypyridazine in a child with temporary G-6-PD deficiency and grave hypothyroidism]
[Hemolytic anemia associated with minor salmonellosis in an HIV positive, G6PD deficient Congolese woman]
[Hemolytic anemia based on congenital glucose-6-phosphate dehydrogenase deficiency in erythrocytes in the Taszhik SSR]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency during typhoid fever]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Condition with diagnostic pitfalls].
[HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic anemia due to congenital glucose-6-phosphate dehydrogenase deficiency.]
[Hemolytic anemia due to G6PD deficiency. Apropos of 3 cases]
[Hemolytic anemia due to the dysfunction of the protection against oxidative attack]
[HEMOLYTIC ANEMIAS DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic complications of para-amino-salicylic acid (2 cases of glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic congenital nonspherocytic anemia secondary to an erythrocyte glucose-6-phosphate dehydrogenase deficiency. Description of 2 new variants: Gd (-) Saint-Louis (Paris) and Gd (-) Hayem]
[Hemolytic crisis due to a G-6-PD deficiency during the course of viral hepatitis A]
[Hemolytic crisis in glucose-6-phosphate dehydrogenase deficiency and lead poisoning]
[Hemolytic effect of niridazole in G6PD deficiency]
[Hemolytic syndrome caused by primaquine and glucose-6-phosphate dehydrogenase deficiency]
[Hereditary and epidemiological aspects of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Mexico]
[Hereditary coproporphyria with grand mal epilepsy, glucose-6-phosphate dehydrogenase deficiency and phenobarbital tolerance]
[Hereditary glucose-6-phosphate dehydrogenase deficiency in human erythrocytes]
[Hereditary glucose-6-phosphate dehydrogenase deficiency in newborn infants]
[Hereditary hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency discovered in a 6-year-old child]
[Hereditary non-spherocytic hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Formation of an enzyme protein with modified characteristics in the blood cells of a German family]
[Hereditary transmission of glucose-6-phosphate dehydrogenase deficiency (G-6-PD) in the granulocytes and erythrocytes of 3 Sardinian families with a history of favism]
[Heterogeneity of erythrocytic glucose-6-phosphate dehydrogenase deficiency in negroes. Kinetic study and description of 2 new variants "Gd(-)Dakar and Gd(-)Mali"]
[Hydrops fetalis and G-6-PD deficiency]
[Identification of molecular variants of the enzyme glucose-6-phosphate dehydrogenase by the polymerase chain reaction technique]
[Impaired glutathione metabolism in hemolytic anemia]
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Imported malaria: 6 cases, 2 of them with an erythrocyte glucose-6-phosphate dehydrogenase deficiency]
[Incidence in the glucose-6-phosphate dehydrogenase deficiency of erythrocytes in the population of North Oriente province (Republic of Cuba)]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in blood donors of Sofia]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in erythrocytes of the population in Armenia]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in Negroes of Minas Gerais]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in the blood of persons living in the Arkhangelsk region]
[Incidence of hemolytic disease of the newborn due to glucose-6-phosphate dehydrogenase deficiency in the case reports of our hospital]
[Increase in genetically determined anemia as a result of migration in Germany].
[Increasing prevalence of G6PD deficiency in the Netherlands].
[Infantile transitory distal renal tubular acidosis with bicarbonate loss]
[Infectious hepatitis, acute hemolysis and glucose-6-phosphate dehydrogenase deficiency]
[Influence of huanglian and berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats]
[Influence of huanglian used in combination with huangqin and gancao on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats]
[Influence of human genetic variants on resistance and immunity against malaria]
[Interrelation between beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency and characteristics of the clinico-hemato-logic indices when the 2 are combined]
[Intraoperative intravascular hemolysis in a female patient with glucose-6-phosphate dehydrogenase deficiency]
[Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics]
[Jaundice in a family with glucose 6-phosphate dehydrogenase deficiency]
[Jaundice in the newborn infant of a "poly-drug-dependent" mother. Heroin and methadone, G6PDH deficiency and antagonism in the enzymatic modulation]
[Kawasaki disease in a subject with G6PD deficiency]
[Kernicterus in a newborn due to glucose-6-phosphate dehydrogenase deficiency.]
[KERNICTERUS IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY OF ERYTHROCYTES.]
[Kernicterus is preventable but still occurs].
[Lethal acute hemolytic anemia in viral hepatitis, caused by glucose-6-phosphate dehydrogenase deficiency]
[Letter: Glucose 6-phosphate dehydrogenase deficiency (G.6-PD) in Cameroon]
[Letter: Hemolysis induced by niridazole in 2 patients with G6PD deficiency]
[Letter: Hemolytic anemia after antibilharzia treatment with niridazole in an Antillean with G6PD deficiency]
[Linkage analysis of the G6PD gene mutations and its Nla III polymorphic site]
[Lipid aspects in subjects with glucose-6-phosphate dehydrogenase deficiency]
[Malaria hypothesis--the significance of the hereditary red cell traits Hb S and glucose-6-phosphate dehydrogenase deficiency in malaria (author's transl)]
[Malaria in childhood and G6PD deficiency. Report of three cases]
[Malaria, hemoglobinosis and glucose-6-phosphate dehydrogenase deficiency. (Preliminary note)]
[Malignant mediterranean boutonneuse fever in a patient with partial glucose-6-phosphate dehydrogenase deficiency]
[Manifestation of glucose-6-phosphate dehydrogenase deficiency caused by primaquine in malaria therapy]
[Mechanisms of hemolysis in glucose-6-phosphate dehydrogenase deficiency]
[Methemoglobinemia caused by dapsone. Report of one case].
[Methylene blue disclosing G6PD deficiency in a newborn infant]
[Molecular analysis of glucose-6-dehydrogenase deficiency in Spain]
[Molecular characterization of 71 cases of glucose-6-phosphate dehydrogenase deficiency in Hainan province]
[Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Han and Li nationalities in Hainan, China and identification of a new mutation in human G6PD gene]
[Molecular characterization of glucose-6-phosphate dehydrogenase variants in four ethnic groups in Yunnan province of China]
[Molecular epidemiology of G6PD deficiency in Chaozhou area of eastern Guangdong Province].
[Molecular-genetic studies of carrier stage of glucose-6-phosphate dehydrogenase deficiency]
[Morbidity patterns in a non-German population (migrant workers) (author's transl)]
[Neo-natal hyperbilirubinemia and G-6-PD Ankara deficiency, a new enzymatic variant discovered in a Turkish family (author's transl)]
[Neonatal erythrocytic pathology caused by glucose-6-phosphate dehydrogenase deficiency.]
[Neonatal hemolytic anemia due to G-6-PD deficiency in a family of the South-West. Detection of a double set of erythrocytes in heterozygotes]
[Neonatal hemolytic icterus due to congenital glucose-6-phosphate dehydrogenase deficiency. Apropos of 17 cases]
[Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency]
[Neonatal icterus and erythrocyte glucose-6-phosphate dehydrogenase deficiency in Congolese newborn infants in Brazzaville]
[Neonatal icterus and erythrocyte glucose-6-phosphate dehydrogenase deficiency. Experience in Costa Rica]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Havana]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency]
[Neonatal jaundice with intra-erythrocyte G-6-PD deficiency]
[Neonatal screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Mauritania].
[Neonatal screening of G6PD deficiency in Tunisia].
[Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in umbilical cord blood]
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population.]
[Neutrophil glucose-6-phosphate dehydrogenase deficiency]
[Non-spherocytic congenital hemolytic anemias due to G6PD deficiency. Clinical and hematologic aspects and mechanism of hyperhemolysis]
[OBSERVATION OF A CASE OF ACUTE HEMOLYTIC ANEMIA RELATED TO A GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Ofloxacin is contraindicated in case of G6PD deficiency: Is it evidenced based?]
[On 50 cases of glucose-6-phosphate dehydrogenase deficiency observed in an hospital environment in Tananarive]
[ON A CASE OF HEMOLYTIC ANEMIA DUE TO SULFAMETHOXYPYRIDAZINE IN A SUBJECT WITH ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[On a rare form of glucose-6-phosphate dehydrogenase deficiency with congenital nonspherocytic hemolytic anemia]
[On case histories of acute hemolytic anemia in persons with glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN AUTOCHTHONOUS POPULATIONS OF LEBANON.]
[One hundred and twenty-three cases of sickle-cell trait (author's transl)]
[Ophthalmologic anomalies in 2 brothers presenting with glucose-6-phosphate dehydrogenase deficiency]
[Patterns in the distribution of GPD- alleles in Azerbaijan. I. Incidence and polymorphism of glucose-6-phosphate dehydrogenase deficiency in the Shekii region of the Azerbaijan SSR]
[Patterns of Gd- allele distribution in Azerbaijan. IV. The incidence and polymorphism of erythrocytic glucose-6-phosphate dehydrogenase deficiency in the settlement of Kobi, Apsheron District]
[Perinatal transmission of Plasmodium falciparum malaria]
[Perineogluteal actinomycosis and G6PD deficiency]
[Phagocytic activity of neutrophils in children with hereditary glucose-6-phosphate dehydrogenase deficiency during acute pneumonia]
[Phenotypic and genotypic spectra of patients with glucose-6-phosphate dehydrogenase deficiency gene known pathogenic variants: a single-center study].
[Plant Traditional Treatment with Acalypha indica Inducing Haemolysis in Patients with G6PD Deficiency: A Frequent Circumstance in Mayotte?]
[Plasmodium vivax, a parasite coming out of the shadows].
[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University Hospital Center in Lome]
[Post-transfusion hemolytic reactions in regions endemic for the hereditary glucose-6-phosphate dehydrogenase deficiency]
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
[Preliminary note on the incidence of abnormal hemoglobulins and glucose-6-phosphate dehydrogenase deficiency in the Mexican population.]
[Prenatal prevention of hyperbilirubinemia due to G6PD deficiency]
[Prevalence and incidence of glucose-6-phosphate dehydrogenase deficiency in the central region of Cuba]
[Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote]
[Prevalence of glucose-6-phosphate dehydrogenase deficiency in a student population on the island of Menorca]
[Primaquine and travelers from the Arab world. A report and recommendations]
[Proceedings: Behavior of the ratio between normal and deficient red blood cells in Sardinian subjects heterozygous for G-6-PD deficiency during hemolytic crises]
[Procetofen: hemolytic effect in subjects with G6PD deficiency. Description of a case]
[Pulmonary tuberculosis in patients with hereditary glucose-6-phosphate dehydrogenase deficiency]
[Pulse oximetry and methemoglobinemia]
[Quantitative determination of erythrocytic catalase in normal Sardianians and those with glucose-6-phosphate dehydrogenase deficiency]
[Rapid screening test for determining the glucose-6-phosphate dehydrogenase deficiency of erythrocytes]
[Recurrent acute renal failure during the course of hemolytic crisis in a patient with glucose-6-phosphate dehydrogenase deficiency]
[Relation between G6PD deficiency and drepanocytosis]
[RELATION BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE.]
[Relationship between G6PD deficiency and hand-foot-mouth disease induced by enterovirus 71].
[Relationship between glucose-6-phosphate dehydrogenase gene mutations and neonatal jaundice in Naning, Guangxi]
[Relative frequency of glucose-6-phosphate dehydrogenase deficiency in jaundiced newborn infants in the metropolitan area of Monterrey, Nuevo León.]
[Research of coptis effect on incidence of neonatal jaundice based on Cox model]
[RESEARCH ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN FRANCE. APROPOS OF 200 DETERMINATIONS.]
[Research Progress in Acute Hemolysis and Safe Blood Transfusion of Glucose-6-Phosphate Dehydrogenase Deficiency-Review].
[Retinal findings in the hereditary persistence of fetal hemoglobin and glucose-6-phosphate dehydrogenase deficiency (G-6-PD deficiency)]
[Review of abnormal genes. II. Hereditary enzyme defects in the erythrocytes: drug-induced hemolytic anemia indirectly caused by glucose-6-phosphate dehydrogenase deficiency]
[Risk medications in case of glucose-6-phosphate dehydrogenase deficiency]
[Role of genetic factors in occurrence of neonatal jaundice in Guangxi region]
[Role of primaquine in malaria control and elimination in French-speaking Africa].
[Rosette-forming capability and proliferative activity of peripheral blood lymphocytes in subjects with glucose-6-phosphate dehydrogenase deficiency]
[Safety of lornoxicam in G-6-PDH deficiency]
[Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism]
[Screening for glucose-6-phosphate (G-6-PD) deficiency in the Chinese newborns and the correlation between infants with G-6-PD deficiency and their parents' nativities]
[Screening for hemoglobinopathies and G-6-PD deficiency anemia in school children of a city in the Turin region]
[Screening for hemoglobinopathies and G6PD deficiencies in Morocco]
[Screening of G6PD deficiency using the blood collected on filter paper]
[Screening of the G-6-PD deficiency in a sample of the Abruzzi population (author's transl)]
[Screening results and genetic features of glucose-6-phosphate dehydrogenase deficiency in 54 025 preterm infants in Chengdu, China].
[Separation of red blood cells from G6PD-deficient patients in dextran density gradients]
[Severe hemolytic anemia for the first time in a 42-year-old patient. Homozygote G-6-PD deficiency in a woman]
[Sickle-cell anemia and glucose-6-phosphate dehydrogenase deficiency]
[Studies on a G6PD polymorphic site, cDNA C1311T]
[Studies on autohemolysis. II. The autohemolysis phenomenon and its relation to reduced erythrocyte glutathione in subjects with erythrocytic deficiency of glucose-6-phosphate dehydrogenase deficiency without acute hemolytic attacks.]
[Studies on some hereditary hematologic characteristics in the Mexican population. III. Erythrocytic glucose-6-phosphate dehydrogenase deficiency in 7 indigenous and mestizo groups.]
[Study of serum C3 and C4 fractions in patients with glucose-6-phosphate dehydrogenase deficiency (author's transl)]
[Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes]
[Survey on the transmission of glucose-6-phosphate dehydrogenase deficiency. Study apropos of 34 families including 86 enzymopenic patients]
[Survival of Gd- allele carriers in the absence of malaria]
[The African variant of glucose-6-phosphate dehydrogenase deficiency as a factor favoring anemia: comparative study of 157 deficient adults and 300 non-deficient adults]
[The C1155G mutation of the red blood cell glucose-6-phosphate dehydrogenase gene in a subject with severe hereditary chronic nonspherocytic anaemia]
[The client's viewpoint on genetic counseling. Acceptability of the service in an Oristanese community (Cabras)]
[The diagnosis of glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]
[The erythrocyte catalase in normal subjects and patients with glucose-6-phosphate dehydrogenase deficiency: quantitative determination of the enzyme and its chromatographic characterization]
[THE EXISTENCE OF 2 POPULATIONS OF ERYTHROCYTES IN WOMEN HETEROZYGOTIC FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. DEMONSTRATION BY SPECTROPHOTOMETRY ON INDIVIDUALLY EXAMINED ERYTHROCYTES.]
[The genotype analysis of glucose-6-phosphate dehydrogenase deficiency in Yunnan province]
[The glucose-6-phosphate dehydrogenase/6-phosphogluconate dehydrogenase ratio in the identification of glucose-6-phosphate dehydrogenase heterozygosity]
[The importance of determination of ferritin levels in erythrocytes]
[The incidence of congenital glucose-6-phosphate dehydrogenase deficiency in the newborn infants of the city of Bologna.]
[The preliminary study on the gene mutations of sixty patients with G6PD deficiency in Yunnan province]
[The role of NADPH in the development of neonatal jaundice with G6PD deficiency]
[The significance of an analysis of abnormal hemoglobin and glucose-6-phosphate dehydrogenase deficiency in military examination of persons coming from the tropics.]
[The significance of Tönz's test in detecting patients with glucose-6-phosphate dehydrogenase deficiency]
[Tolerability of imidazole-2-hydroxybenzoate treatment in children with total erythrocytic glucose-6-phosphate dehydrogenase deficiency (Mediterranean Gd variant)]
[Tonsillectomy in a 6-year-old child with hemolytic anemia caused by erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Topical corticosteroids as a therapeutic alternative in linear immunoglobulin A bullous dermatosis in childhood: case report].
[Triple erythrocyte disorders: thalassemia, hemoglobinopathy L Glucose-6-phosphate dehydrogenase deficiency in a girl from Polesine. First study]
[Unexplained hyperbilirubinemic icterus in the newborn infant and glucose-6-phosphate dehydrogenase deficiency]
[Unexplained hyperbilirubinemic jaundice in the newborn and glucose-6-phosphate dehydrogenase deficiency]
[Use of nuclear magnetic resonance in the study of hemolytic anemia. Preliminary report]
[Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children]
[Variations in enzymatic patterns in G6PD deficiency and favism]
[What do we know today about diaminodiphenylsulfone?]
[Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency].
glucose-6-phosphate isomerase deficiency
A combined system for the study of glutathione metabolism in erythrocytes.
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
Glucosephosphate Dehydrogenase Deficiency
"COMPLETE" ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
"Hemolysis, or not Hemolysis, that is the Question". Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency.
1376G-->T mutation of G6PD gene in Han and Li nationalities in Hainan, China.
16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity.
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
3'-UTR variations and G6PD deficiency.
50 Years Ago in The Journal of Pediatrics: The Hemolytic Crisis of Sickle Cell Disease: The Role of Glucose-6-Phosphate Dehydrogenase Deficiency.
50 Years Ago in The Journal of Pediatrics: The Relationship of Erythrocyte Glucose-6-Phosphate Dehydrogenase Deficiency to Hyperbilirubinemia in Negro Premature Infants.
59Fe study of red blood cells life span in glucose-6-phosphate dehydrogenase deficiency heterozygote.
6-Phosphogluconate dehydrogenase deficiency in an Italian family.
6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency.
?-Lipoic acid supplementation up-regulates antioxidant capacity in adults with G6PD deficiency.
A belated diagnosis of G6PD deficiency in an 81-year-old woman.
A benign sickle-cell disease in a Saudi subject with beta zero-thalassemia and glucose-6-phosphate dehydrogenase deficiency.
A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency.
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.
A case of kernicterus in New Zealand: a predictable tragedy?
A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?
A case report of a 4-year-old child with glucose-6-phosphate dehydrogenase deficiency: An evidence based approach to nutritional management.
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
A challenge to the concept of selection by malaria in glucose-6-phosphate dehydrogenase deficiency.
A child with xeroderma pigmentosum and G6PD deficiency.
A clinician's view of the mass screening of the newborn for inherited diseases: current practice and future considerations.
A community-based study of common hereditary blood disorders in Oman.
A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct.
A comparison of the two-generation and three-generation methods of estimating linkage values on the X chromosome in man with special reference to the loci determining the Xg blood group and glucose-6-phosphate dehydrogenase deficiency.
A comprehensive analysis of membrane and morphology of erythrocytes from patients with glucose-6-phosphate dehydrogenase deficiency.
A comprehensive study on the major mutations in glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in the coastal provinces of Caspian Sea in the north of Iran.
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A-c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations.
A controlled study of polymorphisms in serum globulin and glucose-6-phosphate dehydrogenase deficiency in leprosy.
A correlative study of A B O blood groups, sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency as genetic marker in Mahar community of rural population of Wardha District in Maharashtra.
A deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes from patients with favism.
A difficult diagnosis of lysinuric protein intolerance: association with glucose-6-phosphate dehydrogenase deficiency.
A DUAL HEREDITARY RED BLOOD CELL DEFECT IN ONE FAMILY: HYPOCATALASEMIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
A genetic profile of the South African Ashkenazi Jewish population.
A genetic study among the Lepchas of the Darjeeling area of eastern India.
A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.
A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency.
A glucose-6-phosphate dehydrogenase stain for frozen human skeletal muscle biopsy specimens. A sensitive indicator of fiber degeneration.
A greater awareness of children with glucose-6-phosphate dehydrogenase deficiency is imperative in western countries.
A hematological survey of preschool children of the United Arab Emirates.
A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency. Vicia sativa (Vetch).
A Japanese neonatal case of glucose-6-phosphate dehydrogenase deficiency presenting as severe jaundice and hemolytic anemia without apparent trigger.
A large, systematic molecular-genetic study of G6PD in Indian populations identifies a new non-synonymous variant and supports recent positive selection.
A model of glucose-6-phosphate dehydrogenase deficiency in the zebrafish.
A new glucose-6-phosphate dehydrogenase deficiency variant, G6PD Mizushima, showing increases in serum ferritin and cytosol leucine aminopeptidase levels.
A new glucose-6-phosphate dehydrogenase variant (G6PD Nagano) associated with congenital hemolytic anemia.
A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-->Gly), is the major polymorphic variant in tribal populations in India.
A new lease of life for an old enzyme.
A new mutation responsible for severe G6PD deficiency in two ethnic Chinese with different clinical presentations: determination by a direct PCR sequencing technique.
A new paper-based analytical device for detection of Glucose-6-phosphate dehydrogenase deficiency.
A new variant of glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia, G6PD Cornell: erythrocyte, leukocyte, and platelet studies.
A note on oseltamivir treatment in a boy with G6PD deficiency.
A Novel A1088T Mutation in the Glucose-6-Phosphate Dehydrogenase Gene Detected by RT-PCR Combined with DNA Sequencing.
A novel C to T substitution at nucleotide 1360 of cDNA which abolishes a natural Hha I site accounts for a new G6PD deficiency gene in Chinese.
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.
A Novel de novo Mutation in the G6PD Gene in a Korean Boy with Glucose-6-phosphate Dehydrogenase Deficiency: Case Report.
A novel G473A mutation in the glucose-6-phosphate dehydrogenase gene.
A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency.
A novel G6PD mutation leading to chronic hemolytic anemia.
A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices.
A novel mutation of the ITGB2 gene in a Chinese Zhuang minority patient with leukocyte adhesion deficiency type 1 and glucose-6-phosphate dehydrogenase deficiency.
A novel R198H mutation in the glucose-6-phosphate dehydrogenase gene in the tribal groups of the Nilgiris in Southern India.
A Novel Variant in G6PD (c.1375C>G) Identified from a Hispanic Neonate with Extreme Hyperbilirubinemia and Low G6PD Enzymatic Activity.
A Pale Baby With Blue Blood.
A paper-based biosensor for visual detection of glucose-6-phosphate dehydrogenase from whole blood.
A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
A positive correlation between sickle cell anemia and g6pd deficiency from population of Chhattisgarh, India.
A preliminary survey for glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in Ethiopia.
A prolonged neonatal jaundice associated with a rare G6PD mutation.
A prospective study of the role of bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria.
A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan.
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
A rapid screening dye test for the detection of glucose-6-phosphate dehydrogenase deficiency in red cells.
A rare disorder or not? How a child with jaundice changed a nationwide regimen in the Netherlands.
A RE-EVALUATION OF THE RELATIONSHIP BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE BEHAVIORAL MANIFESTATIONS OF SCHIZOPHRENIA.
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
A review of G6PD deficiency in Pakistani perspective.
A review of Orang Asli newborns admitted to a neonatal unit in a Malaysian general hospital.
A Review of Pharmacogenetics of Antimalarials and Associated Clinical Implications.
A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency.
A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency.
A Severe Episode of Hemolytic Anemia After Amoxicillin Exposure in A G6PD Deficient Patient.
A simple and rapid dye test for glucose-6-phosphate dehydrogenase deficiency for routine use.
A SIMPLE MICROMETHOD FOR THE DETECTION OF ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
A simple screening procedure for adenylate kinase, hexokinase and glucose-6-phosphate dehydrogenase deficiencies.
A simple visual screening test for glucose-6-phosphate dehydrogenase deficiency employing ascorbate and cyanide.
A single mutation is responsible for the high prevalence of G6PD deficiency in the Vataliya Prajapatis--an endogamous caste group from Western India.
A study of some genetic characteristics of the Fur and Baggara tribes of the Sudan.
A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency. II. Investigation of leukocyte enzymes.
A study of subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency: investigation of platelet enzymes.
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
A survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Rumania.
A survey of glucose-6-phosphate dehydrogenase deficiency & sickle-cell trait on a local population of Tirupati.
A survey of glucose-6-phosphate dehydrogenase deficiency and some of its correlates in a Maharashtra village.
A Survey of Practice and Knowledge of Refugee and Migrant Pregnant Mothers Surrounding Neonatal Jaundice on the Thailand-Myanmar Border.
A survey of the incidence of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Zambia.
A tetrazolium-linked cytochemical method for estimation of glucose-6-phosphate dehydrogenase activity in individual erythrocytes: applications in the study of heterozygotes for glucose-6-phosphate dehydrogenase deficiency.
A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.
A typical presentation of dengue fever in a G6PD deficient patient: A case report.
A vegetable-induced hemolytic crisis in a G6PD deficient person: a case report.
ABNORMAL HAEMOGLOBIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN MALAYAN ABORIGINES.
Abnormal haemoglobin, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in North Sumatra, Indonesia.
Abnormal hemoglobins, glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Dayaks of Sarawak.
Abnormal hemoglobins, thalasemia trait & G6PD deficiency in young Pakistani males.
ABNORMAL ORAL GLUCOSE TOLERANCE RESPONSE IN ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency presenting as Hydrops Foetalis.
Abrogation of red blood cell G6PD enzyme activity through Heat treatment: development of survey material for the UK NEQAS G6PD scheme.
Absence of parvovirus and cytomegalovirus in red-cell aplastic crises in glucose-6-phosphate dehydrogenase deficiency.
Acalypha indica induced haemolysis in G6PD deficiency.
Acalypha indica-Induced Hemolysis and Methemoglobinemia in a Child With G6PD Deficiency.
Access to orphan drugs in the Middle East: Challenge and perspective.
Active transport of nitrofurantoin into human milk.
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency.
Acute episodic hemolysis in the African black rhinoceros as an analogue of human glucose-6-phosphate dehydrogenase deficiency.
Acute haemolysis induced by high dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency.
Acute haemolysis with Ambilhar treatment in glucose-6-phosphate dehydrogenase deficiency.
Acute haemolytic anaemia and myolysis due to G6PD deficiency.
Acute haemolytic crisis in a Thai patient with homozygous haemoglobin Constant Spring (Hb CS/CS): a case report.
Acute hemolysis in a patient with a newly diagnosed glioblastoma.
Acute hemolytic anemia and acute kidney injury induced by non-high-dose ascorbic acid in a Child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Acute Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase Deficiency Complicated by Ginkgo biloba.
Acute hemolytic anemia induced by a pyrazolonic drug in a child with glucose-6-phosphate dehydrogenase deficiency.
Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency.
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency.
Acute Kidney Injury following Ingestion of Henna Leaf Extract: A Case Report from Myanmar.
Acute lung injury after exchange transfusion in two newborns with Glucose-6-phosphate dehydrogenase deficiency.
Acute massive haemolysis in children with glucose-6-phosphate dehydrogenase deficiency.
Acute renal failure and typhoid fever.
Acute renal failure following analgesic overdose in G6PD deficiency.
Acute renal failure in favism revealing familial glucose-6-phosphate dehydrogenase deficiency.
Acute renal failure in tropical Africa.
Acute Retroviral Syndrome Presenting with Hemolytic Anemia Induced by G6PD Deficiency.
Acute reversible renal failure and Stevens-Johnson syndrome in a patient having glucose-6-phosphate dehydrogenase deficiency.
Acute rhabdomyolysis induced by tonic-clonic epileptic seizures in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis with severe hyperbilirubinemia and massive hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Acyanotic Hypoxia in a Febrile Child.
Aczone, a topical gel formulation of the antibacterial, anti-inflammatory dapsone for the treatment of acne.
Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency.
Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.
Adequacy and pitfalls of G6PD deficiency counseling in Hong Kong.
Adult T-cell leukemia/lymphoma and Glucose-6-phosphate dehydrogenase deficiency rapidly diagnosed through blood smear examination.
Adult-onset Still's disease associated with G6PD deficiency: a case report and literature review.
Advanced glycation end products inhibit glucose-6-phosphate dehydrogenase activity and expression in human umbilical vein endothelial cells.
Adverse effects of herbal or dietary supplements in G6PD deficiency: A systematic review.
African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.
Age, Ethnicity, Glucose-6-Phosphate Dehydrogenase Deficiency, Micronutrient Powder Intake, and Biomarkers of Micronutrient Status, Infection, and Inflammation Are Associated with Anemia Among Children 6-59 Months in Nepal.
Agriculture-related anaemias.
Alcoholic liver disease in black men with G6PD deficiency.
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.
Alpha-1-antitrypsin deficiency in babies with prolonged jaundice.
Alpha-thalassemia in Papua New Guinea.
Alpha-thalassemia minor and neonatal hyperbilirubinemia.
Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency.
Alternatives to currently used antimalarial drugs: in search of a magic bullet.
Amino acid conservation and clinical severity of human glucose-6-phosphate dehydrogenase mutations.
Amoxycillin in treatment of typhoid fever in patients with haematological contraindications to chloramphenicol.
Amyl Nitrite-Induced Hemolytic Anemia: Acute Therapy and Prevention.
An anthropological perspective on the epidemiology of hemoglobin defects and glucose-6-phosphate dehydrogenase deficiencies in the northern half of the African continent.
An Ashkenazi Jewish woman presenting with favism.
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire.
An evaluation of screening procedures for red cell glucose-6-phosphate dehydrogenase deficiency in the newborn infant.
An examination of the role of vitamin E in glucose-6-phosphate dehydrogenase deficiency.
An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency.
An In vivo Drug Screening Model Using Glucose-6-Phosphate Dehydrogenase Deficient Mice to Predict the Hemolytic Toxicity of 8-Aminoquinolines.
An intriguing case of Prurigo pigmentosa in a Sicilian young patient.
An investigation into the riboflavin status of young Egyptians from the oasis with glucose-6-phosphate dehydrogenase deficiency.
An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.
An optimised system for refolding of human glucose 6-phosphate dehydrogenase.
An unusual distribution of glucose-6-phosphate dehydrogenase deficiency of south Indian newborn population.
An unusual syncope cause in the ED: Favism.
An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates.
Anaemia, a common but often unrecognized risk in diabetic patients: A review.
Anaemic crisis in sickle cell disease.
Anaesthesia and glucose-6-phosphate dehydrogenase deficiency. A case report and review of the literature.
Anaesthesia Management of a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Total Thyroidectomy.
Anaesthetic management in a child with an atypical triad for reconstructive scoliosis surgery.
Anaesthetic management in patients with glucose-6-phosphate dehydrogenase deficiency undergoing neurosurgical procedures.
Analysis of common mutations and associated haplotypes in Chinese patients with glucose-6-phosphate dehydrogenase deficiency.
Analysis of G6PD enzyme deficiency in Saudi population.
Analysis of genotype distribution of thalassemia and G6PD deficiency among Hakka population in Meizhou city of Guangdong Province.
Analysis of Glucose-6-Phosphate Dehydrogenase Genetic Polymorphism in the Hakka Population in Southern China.
Analysis of malaria associated genetic traits in Cabo Verde, a melting pot of European and sub Saharan settlers.
Anemia and the liver. Hepatobiliary manifestations of anemia.
Anemia associated with new-onset diabetes: improvement with blood glucose control.
Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias.
Anemia during actue infections. Role of glucose-6-phosphate dehydrogenase deficiency in Negroes.
Anemia in adolescence. 2. Hemoglobinopathies and other causes.
Anemia in newborn.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Anemia in pregnancy.
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Anemia-induced liver injury: A rare case revealing glucose-6-phosphate dehydrogenase deficiency.
Anesthesia and glucose-6-phosphate dehydrogenase deficiency in a child with congenital heart disease.
Anesthetic Management in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency Undergoing Coblation Adenoidectomy With Septoplasty and Turbinectomy.
Anesthetic Management of a Child With Severe Dystonia and G6PD Deficiency for Deep Brain Stimulation.
Angiographic preoperative bowel segment localization using methylene blue, isosulfan blue, and fluorescein.
Aniline-induced methaemoglobinaemia in a glucose-6-phosphate dehydrogenase enzyme deficient patient.
Antimalarial NADPH-Consuming Redox-Cyclers as Superior G6PD Deficiency Copycats.
Antioxidant enzymatic systems and oxidative stress in erythrocytes with G6PD deficiency: effect of deferoxamine.
Antioxidant vitamins and glucose-6-phosphate dehydrogenase deficiency in full-term neonates.
Antiplatelet and invasive treatment in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and acute coronary syndrome. The safety of aspirin.
Antiplatelet therapy in patients with glucose-6-phosphate dehydrogenases deficiency after percutaneous coronary intervention: A reappraisal for clinical and interventional cardiologists.
Aortic valve replacement for a patient with glucose-6-phosphate dehydrogenase deficiency and autoimmune hemolytic anemia.
Apert syndrome with glucose-6-phosphate dehydrogenase deficiency: a case report.
Apparent hemolysis in an AIDS patient receiving trimethoprim/sulfamethoxazole: case report and literature review.
Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program.
Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis.
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.
Aspects of sickle cell gene in Saudi Arabia--interaction with glucose-6-phosphate dehydrogenase deficiency.
ASPECTS OF THE POPULATION DYNAMICS OF THE ABNORMAL HEMOGLOBIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY GENES.
Aspects of tropical paediatrics.
Aspirin and glucose-6-phosphate dehydrogenase deficiency.
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Assessment of G6PD screening program in premature infants in a NICU.
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Assessment of potential donors for living related liver transplantation.
Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency: a preliminary study.
Assessment of the humoral and cell-mediated immunity against the Plasmodium falciparum vaccine candidates circumsporozoite protein and SPf66 in adults living in highly endemic malarious areas of Papua New Guinea.
Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.
Association between ACP(1) genetic polymorphism and favism.
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.
Association Between G6PD Deficiency and Hyperbilirubinemia in Neonates: A Meta-Analysis.
Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors.
Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.
Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis.
Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus in ethnic groups of Singapore.
Association of glucose-6-phosphate dehydrogenase deficiency with diabetes mellitus.
Association of homozygous sickle cell anemia and glucose-6-phosphate dehydrogenase deficiency.
Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
Association of red cell glucose-6-phosphate dehydrogenase with haemoglobinopathies.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study.
Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study.
At least five polymorphic mutants account for the prevalence of glucose-6-phosphate dehydrogenase deficiency in Algeria.
Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Audit of birth defects in 34,109 deliveries in a tertiary referral center.
Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
Autistic feature as a presentation of Inborn Errors of Metabolism.
Autoimmune hemolytic anemia.
Automated determination of glucose-6-phosphate dehydrogenase (G6PD) on a SPOTCHECK Microflow analyzer.
Automated fluorometric method for screening for erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Automated-red cell exchange for methaemoglobinaemia in a G6PD-deficient patient.
B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.
Bacterial infections in children with glucose-6-phosphate dehydrogenase deficiency.
Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.
Barriers to routine G6PD testing prior to treatment with primaquine.
Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.
Berberine-induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases.
Bilateral cataracts associated with glucose-6-phosphate dehydrogenase deficiency.
Bilateral pulmonary edema after endoscopic sympathectomy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Bilirubin crystals were detected in peripheral blood neutrophils in newborn with sepsis and G6PD deficiency.
Bilirubin levels in the acute hemolytic crisis of G6PD deficiency are related to Gilbert's syndrome.
Bimodal distribution of erythrocytes in heterozygotes for strong Mediterranean glucose-6-phosphate dehydrogenase deficiency.
Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency.
Biochemical changes caused by glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency.
Biogenetical studies of Nagas: glucose-6-phosphate dehydrogenase deficiency in Angami Nagas.
Biological activities of broad bean (Vicia faba L.) extracts cultivated in South Anatolia in favism sensitive subjects.
Blackwater fever at the Kenyatta National Hospital in Kenya: a case report.
Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases.
Blackwater fever: the rise and fall of an exotic disease.
Blister and bite cells in G6PD deficiency.
Blood cell parameters for screening and diagnosis of hereditary spherocytosis.
Blood genetic markers in the Chinese of two eastern provinces.
Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency.
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency.
Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype.
Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
Brilliant cresyl blue screening test for demonstrating glucose-6-phosphate dehydrogenase deficiency in red cells.
Brown recluse spider bites.
Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Calcium activated neutral protease & calcium ATPase in glucose-6-phosphate dehydrogenase deficiency hemizygotes.
Campaign to control genetic blood diseases in Bahrain.
Can African-variant G6PD deficiency trigger hemolysis in DKA?
Can glucose-6-phosphate dehydrogenase deficiency be correlated with ABO blood type?
Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.
Cardiac failure associated with G6PD deficiency.
Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
Cataracts in glucose-6-phosphate dehydrogenase deficiency.
Cataracts in Glucose-6-phosphate Dehydrogenase Deficiency.
Catatonia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Report of Two Cases and a Review.
Cation channels, cell volume and the death of an erythrocyte.
Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.
Cell-Derived Microparticles in Blood Products from Blood Donors Deficient in Glucose-6-Phosphate Dehydrogenase.
Central Nervous System Symptoms Due to Transient Methemoglobinemia in a Child With G6PD Deficiency.
Central retinal vein occlusion in an Army Ranger with glucose-6-phosphate dehydrogenase deficiency.
Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency.
Centrality of G6PD in COVID-19: The Biochemical Rationale and Clinical Implications.
Cerebellar Toxoplasmosis in an Immunocompetent Patient with G6PD Deficiency.
Certain red cell genetic factors and prevalence of chloroquine-induced pruritus.
Changes in globus pallidus with (pre)term kernicterus.
Changes in incidence and sex ratio of glucose-6-phosphate dehydrogenase deficiency by population drift in Taiwan.
Changes in red blood cell membrane structure in G6PD deficiency: An atomic force microscopy study.
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
Characterization of abnormal glucose-6-phosphate dehydrogenase variants.
Characterization of G6PD deficiency and thalassaemia in Papua New Guinea.
Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.
Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.
Characterization of G6PD Rohini--a new class III Indian variant.
Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress.
Characterization of glucose-6-phosphate dehydrogenase deficiency and identification of a novel haplotype 487G>A/IVS5-612(G>C) in the Achang population of Southwestern China.
Chemical toxicity of red cells.
Chemotherapeutic malaria control as a selective primary health care activity in the Solomon Islands.
Chemotherapy in a Patient With G6PD Deficiency and Advanced Testicular Cancer.
Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017.
Chloramine-induced haemolysis presenting as erythropoietin resistance.
Chloramphenicol-induced hemolysis in Caucasian glucose-6-phosphate dehydrogenase deficiency.
Cholinsalicylate gel induced oral lesion: report of case.
Chronic granulomatous disease with leukocytic glucose-6-phosphate dehydrogenase deficiency in a 28-month-old girl.
Chronic haemolytic anaemia and glucose-6 phosphate dehydrogenase deficiency. Case report and review of the literature.
Chronic haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
CHRONIC HEMOLYSIS ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role of vitamin E in its treatment.
Chronic hemolytic anemia is associated with a new glucose-6-phosphate dehydrogenase in-frame deletion in an older woman.
Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants.
Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP). Molecular study of a new variant (G6PD Clinic) with markedly acidic pH optimum.
Chronic nonspherocytic hemolytic anemia and G6PD deficiency.
Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi.
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Clinical and biochemical interactions of glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Clinical and genetic risk factors for moderate hyperbilirubinemia in Brazilian newborn infants.
Clinical and haematological consequences of recurrent G6PD mutations and a single new mutation causing chronic nonspherocytic haemolytic anaemia.
Clinical and hematological phenotype of homozygous hemoglobin E: revisit of a benign condition with hidden reproductive risk.
Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.
Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia.
Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.
Clinical consequences of enzyme deficiencies in the erythrocyte.
Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre.
Clinical disorders of the red cell membrane skeleton.
Clinical examination and hematological data in asymptomatic & apparently healthy school children in a boarding school in a tribal area.
Clinical experience with multigene carrier panels in the reproductive setting.
Clinical experience with phototherapy.
Clinical implications of glucose-6-phosphate dehydrogenase deficiency.
Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients.
Clinical Manifestations and Therapeutic Findings of the Children with Glucose-6-Phosphate Dehydrogenase Deficiency Presenting Favism.
Clinical mutants of human glucose 6-phosphate dehydrogenase: impairment of NADP(+) binding affects both folding and stability.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Clinical rounds in the well-baby nursery: treating jaundiced newborns.
Clinical significance of glucose-6-phosphate dehydrogenase deficiency in Nigerian patients with sickle cell disease.
Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Clinical spectrum of hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Clinical Spectrum of Primaquine-induced Hemolysis in G6PD Deficiency: A Nine-Year Hospitalization-Based Study from the Brazilian Amazon.
Clinico-Haematological Profile of Hereditary Haemolytic Anaemias in a Tertiary Health Care Hospital in South India.
Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield.
Clonorchiasis: treatment with praziquantel in 50 cases.
Clostridium difficile infection precipitating hemolysis in glucose-6-phosphate dehydrogenase-deficient preterm twins causing severe neonatal jaundice.
Co-evolution of glucose-6-phosphate dehydrogenase deficiency and quinine taste sensitivity.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Co-inheritance of Southeast Asian Ovalocytosis (SAO) and G6PD deficiency associated with acute hemolysis in a Thai patient.
Co-trimoxazole in the treatment of typhoid fever in children with glucose-6-phosphate dehydrogenase deficiency.
Co-trimoxazole-induced severe haemolysis: the experience of a large general hospital in Hong Kong.
Coexistence of five G6PD variants indicates ethnic complexity of Phuket islanders, Southern Thailand.
Coinheritance of variant UDP-glucuronosyl transferase 1A1 gene and glucose-6-phosphate dehydrogenase deficiency in adults with hyperbilirubinemia.
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.
Colorectal Cancer Mortality in Relation to Glucose - 6 - Phosphate Dehydrogenase Deficiency and Consanguinity in Sardinia: A Spatial Correlation Analysis
Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.
Combined erythrocyte glucosephosphate isomerase (GPI) and glucose-6-phosphate dehydrogenase (G6PD) deficiency in an Italian family.
Combined erythrocyte phosphohexose isomerase and glucose-6-phosphate dehydrogenase deficiency.
Combined glucose phosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of erythrocytes.
Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome.
Combined glucosephosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of the erythrocytes: a new haemolytic syndrome.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.
Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices.
Comparative analysis of glucose-6-phosphate dehydrogenase levels in pre-term and term babies delivered at University of Ilorin Teaching Hospital.
Comparison between G6PD-Deficient and Normal Individuals after Eccentric Exercise.
Comparison between the chromate inhibition test and a cytochemical method for the determination of glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
Comparison of molecular mutations of G6PD deficiency gene between icteric and nonicteric neonates.
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.
Comparison of serum copper, magnesium, zinc and calcium levels between G6PD deficient and normal Chinese adults.
Comparison of Spectrophotometry, Chromate Inhibition, and Cytofluorometry Versus Gene Sequencing for Detection of Heterozygously Glucose-6-Phosphate Dehydrogenase-Deficient Females.
Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
Complete molecular characterisation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a group of Malaysian Chinese neonates.
Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment.
Component therapy.
Computer simulation of evolutionary trends in an X linked trait. Application to glucose-6-phosphate dehydrogenase deficiency in man.
Computer simulation of the metabolic consequences of the combined deficiency of 6-phosphogluconolactonase and glucose-6-phosphate dehydrogenase in human erythrocytes.
Congenital disorders of the function of polymorphonuclear neutrophils.
Congenital dyserythropoietic anaemia type II associated with a new type of G6PD deficiency (G6PD Gabrovizza).
Congenital dyserythropoietic anemia type II associated with G6PD Seattle in a Sicilian child.
Congenital erythrocyte enzyme deficiencies.
Congenital haemolytic anaemia associated with adenylate kinase deficiency.
Congenital nonspherocytic hemolytic anemia associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Japanese child. Clinical and metabolic studies.
Congenital nonspherocytic hemolytic disease secondary to glucose-6-phosphate dehydrogenase deficiency: report of three cases.
Congenital nonspherocytic hemolytic disease. With erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency.
Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study.
Consideration of ethics in primaquine therapy against malaria transmission.
Control and elimination of Plasmodium vivax.
Control of glucose-6-phosphate dehydrogenase deficiency on the formation of mutagenic and carcinogenic metabolites derived from benzo(a)pyrene.
Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
Controlled reversible assembly of gold nanoparticles as a new colorimetric and sensitive detection of glucose-6-phosphate dehydrogenase deficiency.
Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator.
Correction: Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
CORRELATION OF S HEMOGLOBIN WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND ITS SIGNIFICANCE.
Corrigendum to 'Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients' [Clin. Biochem. 49 (2016) 808-810].
Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Corrigendum: Genetic Epidemiology of Glucose-6-Phosphate Dehydrogenase Deficiency in the Arab World.
Cortisol levels in glucose-6-phosphate dehydrogenase deficiency.
Cortisol metabolism in glucose-6-phosphate dehydrogenase deficiency.
Cost-benefit analysis of G6PD screening in Lebanese newborn males.
Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients.
Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests.
Current and future perspective of newborn screening: an Indian scenario.
Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency.
Cyanosis Due to Methemoglobinemia as the Presenting Sign of Glucose-6-Phosphate Dehydrogenase Deficiency in a Child: Diagnostic and Clinical Implications.
Cytochemical determination of heterozygous glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
Cytokine responses of TNF-?, IL-6, and IL-10 in G6PD-deficient infants.
Cytomegalovirus infection and aplastic crisis in glucose-6-phosphate dehydrogenase deficiency.
Cytomegalovirus infection and hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency.
D-Glucaric acid excretion in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.
Dapsone for immune thrombocytopenic purpura in children and adults.
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Dapsone intoxication: two case reports.
Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.
Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
Dapsone: An Old but Effective Therapy in Pediatric Refractory Immune Thrombocytopenia.
Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.
Death from drug-induced hemolytic anemia.
Decreased Glucose-6-PhosphateDehydrogenase (G6PD) Activity and Risk of Senile Cataract in Taiwan.
Decreased Glutathione S-transferase Level and Neonatal Hyperbilirubinemia Associated with Glucose-6-phosphate Dehydrogenase Deficiency: A Perspective Review.
Deep Hypothermic Circulatory Arrest in a Patient With Severe G6PD Deficiency.
Deep vein thrombosis in association with acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency: a unique case.
Defects in the oxidative killing of microorganisms by phagocytic leukocytes.
Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G-6-PD) IN NIGERIA.
Deficiency of glucose-6-phosphate dehydrogenase found in a case of hepatic fructose-1,6-diphosphatase deficiency.
Deficiency of glucose-6-phosphate dehydrogenase.
Deficiency of glucose-6-phosphate dehydrogenase: some aspects of the trait in people of Papua-New Guinea.
Definition of the mutations of G6PD Wayne, G6PD Viangchan, G6PD Jammu, and G6PD 'LeJeune'.
Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Demographics and co-occurring conditions in a clinic-based cohort with Down syndrome in the United Arab Emirates.
Denaturing high-performance liquid chromatography technique platform applied to screen G6PD deficient variants.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Dental Considerations in Children with Glucose-6-phosphate Dehydrogenase Deficiency (Favism): A Review of the Literature and Case Report.
Depression of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in enteric fever.
Description of a novel missense mutation of glucose-6-phosphate dehydrogenase gene associated with asymptomatic high enzyme deficiency.
Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PDViangchan and G6PDViangchan+Mahidol: Decreased stability and catalytic efficiency contribute to the clinical phenotype.
Detection of glucose-6-phosphate dehydrogenase deficiency in erythrocytes: a spectrophotometric assay and a fluorescent spot test compared with a cytochemical method.
Detection of glucose-6-phosphate dehydrogenase deficiency in the newborn using blood specimens dried on filter paper.
Detection of inborn errors of metabolism in 1,117 patients studied because of suspected inherited disease.
Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants.
Detection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency Anemia.
Detection of three common G6PD gene mutations in Chinese individuals by probe melting curves.
Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.
Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor.
Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism.
Development of a novel mouse model of severe glucose-6-phosphate dehydrogenase (G6PD)-deficiency for in vitro and in vivo assessment of hemolytic toxicity to red blood cells.
Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
Development of allelic discrimination assay to detect Mediterranean G6PD mutation and its linked inheritance with normal vision and/colorblindness loci for 4 generations among Egyptian and Emirati families.
Development of suitable external quality control material for G6PD deficiency screening with the fluorescent spot test.
Dexmedetomidine-based intravenous anesthesia of a pediatric patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency: A case report.
Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another.
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Diabetic ketoacidosis revealing glucose-6-phosphate dehydrogenase deficiency: description of an adult case.
Diabetic Ketoacidosis Revealing Severe Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D) Deficiency with Methemoglobinemia: A Case Report.
Diagnosis and management of G6PD deficiency.
Diagnosis and treatment of Plasmodium vivax malaria.
Diagnosis of erythrocyte glucose-6-phosphate dehydrogenase deficiency in the negro male despite hemolytic crisis.
Diagnosis of glucose-6-phosphate dehydrogenase (G6PD) mutations by DNA amplification and allele-specific oligonucleotide probes.
Diagnosis of red cell G-6-PD deficiency in a Chinese neonate.
Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping.
Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.
Diagnostic Practices and Treatment for P. vivax in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods Study.
Diagnostic problems in severe neonatal jaundice and G6PD deficiency in Greece.
Diet in dermatology: revisited.
Dietary alterations modulate susceptibility to Plasmodium infection.
Dietary restrictions for people with glucose-6-phosphate dehydrogenase deficiency.
Differential fertility as a mechanism maintaining balanced polymorphisms in Sardinia.
Differentiation of hair growth cycle from scalp hair roots for the diagnosis of glucose-6-phosphate dehydrogenase deficiency in neonates.
Diminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells.
Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Discovery of Small-Molecule Activators for Glucose-6-Phosphate Dehydrogenase (G6PD) Using Machine Learning Approaches.
Discussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs.
Disease-modifying influences of coexistent G6PD-deficiency, Gilbert syndrome and deletional alpha thalassemia in hereditary spherocytosis: A report of three cases.
Disorders in the metabolism of erythrocytes in a case of congenital nonspherocytic hemolytic anemia with glucose-6-phosphate dehydrogenase deficiency.
Distance and sequence of the loci for protan and deutan defects and for glucose-6-phosphate dehydrogenase deficiency.
Distinct phenotypic expression of two de novo missense mutations affecting the dimer interface of glucose-6-phosphate dehydrogenase.
Distribution of ABO and Rhesus blood groups in G6PD deficient Chinese and Malay newborns.
Distribution of ABO blood groups, G6PD deficiency, and abnormal haemoglobins in leprosy.
Distribution of beta-thalassemia trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency in the Markham River Valley of New Guinea.
Distribution of Gd- alleles in some ethnic groups of the USSR.
Distribution of red cell G6PD and 6PGD phenotypes in Saudi Arabia.
Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.
Diverse point mutations result in glucose-6-phosphate dehydrogenase (G6PD) polymorphism in Taiwan.
Diversity in expression of glucose-6-phosphate dehydrogenase deficiency in females.
DNA damage and apoptosis in mononuclear cells from glucose-6-phosphate dehydrogenase-deficient patients (G6PD Aachen variant) after UV irradiation.
DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.
DNA haplotypes in the G6PD gene cluster studied in the Chinese Li population and their relationship to G6PDCanton.
DNA sequence abnormalities of human glucose-6-phosphate dehydrogenase variants.
Do all patients with acquired methemoglobinemia need treatment? A lesson learnt.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs.
Does G6PD deficiency protect against cancer? A critical review.
DOES GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY MODIFY THE COURSE OF LEPROSY OR ITS TREATMENT.
Does Ibuprofen increase neonatal hyperbilirubinemia?
Dominance of high-producing interleukin 6 and low-producing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenase-deficient trauma patients.
Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.
Double heterozygosity for glucose-6-phosphate dehydrogenase deficiency.
Double phototherapy in jaundiced term infants with hemolysis.
Drug induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency subjects.
Drug-eluting stents in a patient with favism: is the aspirin administration safe?
Drug-induced anemia associated with glucose-6-phosphate dehydrogenase deficiency.
Drug-induced glucose-6-phosphate dehydrogenase deficiency-related hemolysis risk assessment.
Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
DRUG-INDUCED HEMOYTIC ANEMIAS ASSOCIATED WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY: AGENETICALLY HETEROGENOUS TRAIT.
Drug-induced red cell dyscrasias.
Drugs in Development for Malaria.
Dual anti-platelet therapy in patients with G6PD deficiency after percutaneous coronary intervention.
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents.
Dubin-Johnson syndrome coexisting with glucose-6-phosphate dehydrogenase deficiency presenting after acute viral hepatitis.
Dynamic simulation of red blood cell metabolism and its application to the analysis of a pathological condition.
Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
Economic evaluation of point of care universal newborn screening for glucose-6-Phosphate dehydrogenase deficiency in United States.
Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults.
Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.
Effect of desferrioxamine B on hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Effect of desferrioxamine in acute haemolytic anaemia of glucose-6-phosphate dehydrogenase deficiency.
Effect of exercise on oxidative stress in individuals with glucose-6-phosphate dehydrogenase deficiency.
Effect of G-6 PD deficiency on sickle cell disease in Saudi Arabia.
Effect of gamma irradiation on blood from glucose 6 phosphate dehydrogenase deficient blood donors.
Effect of glucose-6-phosphate dehydrogenase deficiency on neutrophil function.
Effect of glucose-6-phosphate dehydrogenase deficiency on reduced and oxidized glutathione and lipid peroxide levels in the blood of African-Americans.
Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes.
Effect of glucose-6-phosphate dehydrogenase deficiency on the benz(a)pyrene toxicity for in vitro cultured human skin fibroblasts.
Effect of inherited red cell defects on growth of Plasmodium falciparum: An in vitro study.
Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever.
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.
Effectiveness of doxycycline combined with primaquine for malaria prophylaxis.
Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Effects of Glucose 6-Phosphate Dehydrogenase Deficiency on the Metabolic and Cardiac Responses to Obesogenic or High Fructose Diets.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anaemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia.
Effects of glucose-6-phosphate dehydrogenase deficiency upon the host and upon host-drug-malaria parasite interactions.
Effects of Single and Double Mutants in Human Glucose-6-Phosphate Dehydrogenase Variants Present in the Mexican Population: Biochemical and Structural Analysis.
Effects of variant UDP-glucuronosyltransferase 1A1 gene, glucose-6-phosphate dehydrogenase deficiency and thalassemia on cholelithiasis.
Efficacy and Safety of a Naphthoquine-Azithromycin Co-Formulation for Malaria Prophylaxis in Southeast Asia: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial.
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
Efficacy of phototherapy in neonatal hyperbilirubinaemia associated with glucose-6-phosphate dehydrogenase deficient status.
Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Endotoxemia down-regulates bone marrow lymphopoiesis but stimulates myelopoiesis: the effect of G6PD deficiency.
Enhanced binding of FAD to glutathione reductase in G6PD deficiency.
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts.
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Enzyme activity of glucose-6-phosphate dehydrogenase-deficient Malaysian neonates during the first 10 days of life.
Enzyme cytochemistry of blood and marrow cells.
Enzyme deficiencies in neonates with jaundice.
Enzyme kinetics and molecular modeling studies of G6PD(Mahidol) associated with acute hemolytic anemia.
EP21.21: Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Epidemiological, clinical and laboratory profile of glucose-6-phosphate dehydrogenase deficiency in the middle and north of Iraq: a comparative study.
Epidemiology and Associated Morbidity of Pterygium: A Large, Community-Based Case-Control Study.
Epidemiology and clinical features of Mediterranean spotted fever in Italy.
Epidemiology and Control of Plasmodium vivax in Afghanistan.
Epidemiology of clinical hyperbilirubinaemia in Al Ain, United Arab Emirates.
Epidemiology of Plasmodium vivax in Indonesia.
Epidemiology of Plasmodium vivax Malaria in Peru.
Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations.
Epistasis and the sensitivity of phenotypic screens for beta thalassaemia.
Equine glucose-6-phosphate dehydrogenase deficiency.
Ernest Beutler: his life and contribution to medical science.
Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Erthrocyte glucose-6-phosphate dehydrogenase deficiency: precautions for dental treatment.
Erythrocyte (Ca+2 + Mg+2)-ATPase activity: increased sensitivity to oxidative stress in glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte acid phosphomonesterase and glucose-6-phosphate dehydrogenase deficiency in Caucasians.
Erythrocyte enzyme abnormalities in leukemias.
Erythrocyte enzyme disorders in children.
Erythrocyte enzymes in neonatal juandice.
Erythrocyte glucose-6-phosphate dehydrogenase and pyruvate kinase activities in hemoglobin H disease.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency & thalassaemic genes in the scheduled castes of Rajasthan.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency does not pose an increased risk for black Americans exposed to oxidant gases in the workplace or general environment.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Aleppo.
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN CHINESE.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in diabetes (maturity onset).
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in New Guinea and New Britain.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Poland--a study on the 563 and 1311 mutations of the G6PD gene.
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN TURKEY.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Uganda.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency in West Africa.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait.
Erythrocyte glutathione concentrations in diabetics with cataracts, with and without glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte glutathione determination in the diagnosis of glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte glutathione reductase in gout and in glucose-6-phosphate dehydrogenase deficiency.
Erythrocyte hemighosts in a patient with tumor lysis syndrome: One train may hide another.
Erythrocyte ion channels in regulation of apoptosis.
Erythrocyte membrane abnormalities in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean and A-types.
Erythrocyte membrane ATPase activity of G6PD-deficient individuals and the effect of primaquine metabolite(s) on membrane ATPase enzymes.
Erythrocyte pyridoxamine phosphate oxidase activity: a potential biomarker of riboflavin status?
Erythrocyte pyruvate kinase deficiency: 11 new cases.
Erythrocyte superoxide dismutase, catalase and glutathione peroxidase in glucose-6-phosphate dehydrogenase deficiency.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency amongst non tribal population of Orissa.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency and its significance with special emphasis on malaria.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency as a problem in the selection of blood donors.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency at Varanasi.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency in the Bania community of Punjab.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency.
Estimated disease burden and lost economic productivity due to glucose-6-phosphate dehydrogenase deficiency in Nigerian newborns.
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
Estimation of risk of glucose 6-phosphate dehydrogenase-deficient red cells to ozone and nitrogen dioxide.
Etiology and Outcomes of Thrombotic Microangiopathies.
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.
Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia.
Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia.
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency.
Evaluation of a flow cytometric test for G6PD-deficient erythrocytes.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency.
Evaluation of DNA damage in leukocytes of G6PD-deficient Iranian newborns (Mediterranean variant) using comet assay.
Evaluation of glucose-6-phosphate dehydrogenase deficiency without hemolysis in icteric newborns at Mazandaran province, Iran.
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Evaluation of liver and kidney function in favism patients.
Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency.
Evaluation of neonatal jaundice in the Makkah region.
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Evaluation of the blue formazan spot test for screening glucose 6 phosphate dehydrogenase deficiency.
Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Evaluation of the Diagnostic Accuracy of the CareStart™ Glucose-6-Phosphate Dehydrogenase Deficiency Rapid Diagnostic Test among Chinese Newborns.
Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency.
Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency.
Evidence for balancing selection from nucleotide sequence analyses of human G6PD.
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree.
Ex Vivo Study of Laban's Role in Decreasing Hemolysis Crisis in G6PD-Deficient Patients.
Exaggeration of hypoxic lung injury in a patient with glucose-6-phosphate dehydrogenase deficiency.
Excess release of ferriheme in G6PD-deficient erythrocytes: possible cause of hemolysis and resistance to malaria.
Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital.
Exchange transfusion in neonatal hyperbilirubinaemia: experience in Isfahan, Iran.
Exercise and Redox Status Responses Following Alpha-Lipoic Acid Supplementation in G6PD Deficient Individuals.
Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review.
Exercise-induced oxidative stress in G6PD-deficient individuals.
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
Expression and biochemical characterization of human glucose-6-phosphate dehydrogenase in Escherichia coli: a system to analyze normal and mutant enzymes.
External quality assessment program for detection of glucose-6-phosphate dehydrogenase deficiency in the Guangxi region.
External quality assurance programme for newborn screening of glucose-6-phosphate dehydrogenase deficiency.
Extramedullary blast crisis and hemolytic anemia in a patient with t(3p+;4q-) and rapidly evolving myelogenous leukemia.
Extreme Hyperbilirubinemia and G6PD Deficiency With No Laboratory Evidence of Hemolysis.
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.
Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.
Falciparum malaria and beta-thalassaemia trait in northern Liberia.
Falciparum malaria--present day problems. An experience with 425 cases.
False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency.
Familial Hirschsprung's disease: report of autosomal dominant and probable recessive X-linked kindreds.
Familial hypohaptoglobinemia. A genetically determined trait segragating from glucose-6-phosphate dehydrogenase deficiency.
Fast hemoglobin and glucose-6-phosphate dehydrogenase deficiency as artefacts imputable to an anticoagulant added to the blood sample.
Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.
Fatal familial haemolytic anaemia.
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
Fatal hemolysis from mafenide treatment of burns in a patient with glucose-6-phosphate dehydrogenase deficiency. Case report.
Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality.
Favism and Glucose-6-Phosphate Dehydrogenase Deficiency.
Favism in a female newborn infant whose mother ingested fava beans before delivery.
Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-).
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Favism: looking for an autosomal gene associated with glucose-6-phosphate dehydrogenase deficiency.
Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
Fetal anemia caused by the Guadalajara variant of G6PD deficiency.
Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia.
Fetal Hemoglobin Modulators May Be Associated With Symptomology of Football Players with Sickle Cell Trait.
Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.
Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria.
Fine Mapping of Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency in a Rural Malaria Area of South West Odisha Using the Clinical, Hematological and Molecular Approach.
First episode of acute hemolysis due to G6PD deficiency in a middle-aged woman and transmission of the enzymatic defect through bone marrow transplant.
First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in-silico.
Five novel glucose-6-phosphate dehydrogenase deficiency haplotypes correlating with disease severity.
Flow cytofluorometric analysis of enzyme reactions based on quenching of fluorescence by the final reaction product: detection of glucose-6-phosphate dehydrogenase deficiency in human erythrocytes.
Fluorescent spot test for screening erythrocyte glucose-6-phosphate dehydrogenase deficiency in newborn babies.
Food-borne nitrates and nitrites as a cause of methemoglobinemia.
Fractionation of serum bilirubin conjugates in the exploration of the pathogenesis of significant neonatal bilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency.
Fragmentation and myelin formation in hereditary xerocytosis and other hemolytic anemias.
Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya.
Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.
Frequency of glucose 6 phosphate dehydrogenase deficiency and related hemolytic anemia in Riyadh, Saudi Arabia.
Frequency of glucose-6-phosphate dehydrogenase (G6PD) mutations in Chinese, Filipinos, and Laotians from Hawaii.
Frequency of Glucose-6-Phosphate dehydrogenase deficiency in Egyptian infants.
Frequency of glucose-6-phosphate dehydrogenase deficiency in individuals with normal and sickle cell haemoglobin--a preliminary study.
Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude: a malaria hypothesis.
Frequency of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease. A study in Saudi Arabia.
Frequency of glucose-6-phosphate dehydrogenase deficiency in some ethnic groups of Pakistan.
Frequency of glucose-6-phosphate dehydrogenase phenotypes and deficiency in Al-Baha.
Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service.
Frequency of glutathione reductase, pyruvate kinase and glucose-6-phosphate dehydrogenase deficiency in a Spanish population.
FREQUENCY OF HAEMOGLOBIN S AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN SOUTHERN TANZANIA.
Frequency of Haemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency in Southern Tanzania.
Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra.
Frequency of Inborn Errors of Metabolism in a Northeastern Iranian Sample with High Consanguinity Rates.
Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan.
Frequency of Mediterranean mutation among a group of Saudi G6PD patients in Western region-Jeddah.
Frequency of thalassemia and G6PD deficiency in five provinces of Spain.
From prejudice to evidence: the case of rhizoma coptidis in singapore.
Frostbite: A Novel Presentation of Glucose-6-Phosphate Dehydrogenase Deficiency?
Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency.
Functional analysis of polymorphonuclear leukocytes in siblings of glucose-6-phosphate dehydrogenase deficiency.
Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.
Functional and structural analysis of double and triple mutants reveals the contribution of protein instability to clinical manifestations of G6PD variants.
Further data from Greece on recombination between the Xg blood group and glucose-6-phosphate dehydrogenase deficiency.
Further evidence for heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea.
Further Molecular Analysis of G6PD Deficiency Variants in Southern Vietnam and a Novel Variant Designated as G6PD Ho Chi Minh (173 A>G; 58 Asp>Gly): Frequency Distributions of Variants Compared with Those in Other Southeast Asian Countries.
Further studies of haemoglobin glycosylation: influence of diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency in Nigerians.
Further studies on glucose-6-phosphate dehydrogenase deficiency in Chinese subjects.
G-6PD deficiency in malaria endemic areas of Udaipur District in Rajasthan.
G6PD (Dublin): chronic non-spherocytic haemolytic anaemia resulting from glucose-6-phosphate dehydrogenase deficiency in an Irish kindred.
G6PD A- Deficiency and Severe Malaria in The Gambia: Heterozygote Advantage and Possible Homozygote Disadvantage.
G6PD A- is the major cause of G6PD deficiency among the Siddis of Karnataka, India.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
G6PD Aures: a new mutation (48 Ile-->Thr) causing mild G6PD deficiency is associated with favism.
G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
G6PD deficiency and absence of ?-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.
G6PD deficiency and aluminum phosphide poisoning.
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
G6PD deficiency and breast cancer.
G6PD deficiency and chronic hemolysis: four new mutants--relationships between clinical syndrome and enzyme kinetics.
G6PD deficiency and diabetes mellitus in northern Sardinian subjects.
G6PD deficiency and fava bean consumption do not produce hemolysis in Thailand.
G6PD deficiency and favism in the island of Rhodes (Greece).
G6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus.
G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.
G6PD deficiency and malaria in India.
G6PD deficiency and malaria selection.
G6PD Deficiency and Priapism: Is There a Link Between the Two Entities?
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
G6PD deficiency and stroke in the CSSCD.
G6PD Deficiency as a predisposing factor for attention deficit/hyperactivity disorder: a hypothesis.
G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A-.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6pd Deficiency Does Not Affect the Cytosolic Glutathione or Thioredoxin Antioxidant Defense in Mouse Cochlea.
G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients.
G6PD deficiency from lyonization after hematopoietic stem cell transplantation from female heterozygous donors.
G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic.
G6PD deficiency in an unselected Brazilian population.
G6pd deficiency in Asian children.
G6PD deficiency in autism : A case-series from Saudi Arabia.
G6PD deficiency in blood donors of Manaus, Amazon Region, northern Brazil.
G6PD Deficiency in Children: From Clinical Auditing to Optimizing Care.
G6PD deficiency in females screened at tertiary care hospital.
G6PD deficiency in Latin America: systematic review on prevalence and variants.
G6PD deficiency in malaria endemic areas of Nepal.
G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study.
G6PD deficiency in neonates: a prospective study.
G6PD deficiency in newborn infants.
G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients.
G6PD deficiency in senile cataracts.
G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost.
G6PD deficiency in two autochthonous Croatian families.
G6PD deficiency in Vataliya Prajapati community settled in Surat.
G6PD deficiency is not an uncommon cause of pigment nephropathy.
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
G6PD Deficiency Prevalence as a Cause of Neonatal Jaundice in a Neonatal Ward in Dohuk, Iraq.
G6PD deficiency shifts polarization of monocytes/macrophages towards a proinflammatory and profibrotic phenotype.
G6PD Deficiency with Arnold-Chiari Malformation.
G6PD deficiency with Gd(-)A like variant in a Chinese family from Cambodia.
G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia.
G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.
G6PD deficiency, distribution and variants in Saudi Arabia: an overview.
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
G6PD deficiency-induced hemolysis in a Chinese diabetic patient: a case report with clinical and molecular analysis.
G6PD deficiency.
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria.
G6PD Deficiency: A Possible Cardiovascular Risk Factor in Older People.
G6PD deficiency: An update.
G6PD deficiency: global distribution, genetic variants and primaquine therapy.
G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus.
G6PD deficiency: the genotype-phenotype association.
G6PD diaxBox: Digital image-based quantification of G6PD deficiency.
G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.
G6PD Enzyme Deficiency in Neonatal Pathologic Hyperbilirubinemia in Yazd.
G6PD genetic variations in neonatal Hyperbilirubinemia in Indonesian Deutromalay population.
G6PD Genotype and Its Associated Enzymatic Activity in a Chinese Population.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews.
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
G6PD Ube, a glucose-6-phosphate dehydrogenase variant found in four unrelated Japanese families.
G6PD variant distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19.
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
G6PD Viangchan and G6PD Mediterranean are the main variants in G6PD deficiency in the Malay population of Malaysia.
G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
G6PD-deficient donor blood as a cause of hemolysis in two preterm infants.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
G6PD-MutDB: a mutation and phenotype database of glucose-6-phosphate (G6PD) deficiency.
G6PD/PK ratio: a reliable parameter to identify glucose-6-phosphate dehydrogenase deficiency associated with microcytic anemia in heterozygous subjects.
G6PD: population genetics and clinical manifestations.
G6PDdb, an integrated database of glucose-6-phosphate dehydrogenase (G6PD) mutations.
Galactitol accumulation by glucose-6-phosphate deficient fibroblasts: a cellular model for resistance to the complications of diabetes mellitus.
Gallstones due to hereditary spherocytosis with glucose-6-phosphate dehydrogenase deficiency.
Gene action in erythrocyte deficiency of glucose-6-phosphate dehydrogenase: tissue enzyme-levels.
Gene symbol: G6PD. Disease: Glucose-6-phosphate dehydrogenase deficiency.
Gene-nutrient interactions in G6PD-deficient subjects--implications for cardiovascular disease susceptibility.
General Anesthesia in a Glucose-6-Phosphate Dehydrogenase Deficiency Child: A Case Report.
Genes and people in the Caspian Littoral: a population genetic study in Northern Iran.
Genetic analysis of the glucose-6-phosphate dehydrogenase deficiency in a southern Croatia.
Genetic association in infertility: ABO, Rh (subtypes), Lea blood groups, G6PD deficiency and haemoglobin types.
Genetic association in myocardial infarction. Ethnicity; ABO, Rh, Le, Xg blood groups; G6PD deficiency; and abnormal haemoglobins.
Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift ?-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].
Genetic benefits of consanguinity through selection of genotypes protective against malaria.
Genetic Blood Disorders Survey in the Sultanate of Oman.
Genetic components in susceptibility to nasopharyngeal carcinoma.
Genetic compounds--Hb S, thalassaemias and enzymopathies: spectrum of interactions.
Genetic control of resistance to human malaria.
Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya.
Genetic disorders and malaria in Indo-China region.
Genetic disorders in Southern Africa.
Genetic disorders of glutathione and sulfur amino-acid metabolism. New biochemical insights and therapeutic approaches.
Genetic disorders of human red blood cells.
Genetic distances among the five tribal populations of Andhra, Pradesh, South India.
Genetic diversity among the Arabs.
Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.
Genetic diversity of the "Mediterranean" glucose-6-phosphate dehydrogenase deficiency phenotype.
Genetic factors and malaria in the Temuan.
Genetic factors related to unconjugated hyperbilirubinemia amongst adults.
Genetic heterogeneity and pathophysiology of G6PD deficiency.
Genetic heterogeneity at the glucose-6-phosphate dehydrogenase locus in southern Italy: a study on a population from the Matera district.
Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency in south-east Sicily.
Genetic heterogeneity of glucose-6-phosphate dehydrogenase deficiency revealed by single-strand conformation and sequence analysis.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Genetic linkage between X-chromosome markers and bipolar affective illness.
Genetic modifiers of severity in sickle cell disease.
Genetic polymorphism of G6PD in a Bulgarian population.
Genetic polymorphisms among Bukharan and Georgian Jews in Israel.
Genetic polymorphisms among Iranian Jews in Israel.
Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.
Genetic Profiles of Korean Patients With Glucose-6-Phosphate Dehydrogenase Deficiency.
Genetic red cell disorders and severity of falciparum malaria in Myanmar.
Genetic screening for low-penetrance variants in protein-coding genes.
Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.
Genetic structure of Rajaka caste and affinities with other caste populations of Andhra Pradesh, India.
Genetic studies among the Nagas and Hmars of eastern India.
Genetic study of retinitis pigmentosa in China.
Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection.
Genetical linkage between the loci for glucose-6-phosphate dehydrogenase deficiency and colour-blindness in American Negroes.
Genetically determined deficiency of glucose 6-phosphate dehydrogenase (type-A-) is expressed in the liver.
Genetics of glucose-6-phosphate dehydrogenase deficiency in Saudi patients.
Genotype and phenotype correlation in glucose-6-phosphate dehydrogenase deficiency.
Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency.
Genotype-Phenotype Correlations of Glucose-6-Phosphate-Deficient Variants Throughout an Activity Distribution.
Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria.
Genotyping of Malaysian G6PD-deficient neonates by reverse dot blot flow-through hybridisation.
Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana.
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.
Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates.
Gilbert's syndrome associated with glucose-6-phosphate dehydrogenase deficiency.
Global burden of genetic disease and the role of genetic screening.
Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia.
Glucose 6 phosphate dehydrogenase deficiency and hemoglobinopathy in South Western Region Nepal: a boon or burden.
Glucose 6 phosphate dehydrogenase deficiency in adults.
Glucose 6 phosphate dehydrogenase deficiency unmasked by diabetic ketoacidosis: an underrated phenomenon.
Glucose 6-phosphate dehydrogenase activity in membranes of erythrocytes from normal individuals and subjects with Mediterranean G6PD deficiency.
Glucose 6-phosphate dehydrogenase and the kidney.
Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.
Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia.
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part I.
Glucose 6-phosphate dehydrogenase deficiency both in red blood cells and lenses of the normal and cataractous native population of Cukurova, the southern part of Turkey. Part II.
Glucose 6-phosphate dehydrogenase deficiency enhances germ cell apoptosis and causes defective embryogenesis in Caenorhabditis elegans.
Glucose 6-Phosphate dehydrogenase deficiency genetic, pathophysiological and therapeutic aspects.
Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure.
Glucose 6-phosphate dehydrogenase knockdown enhances IL-8 expression in HepG2 cells via oxidative stress and NF-?B signaling pathway.
Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.
Glucose-6 phosphate dehydrogenase deficiency and psychotic illness.
Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
Glucose-6-phosphatase and glucose-6-phosphate dehydrogenase deficiency: how are they different?
Glucose-6-phosphate dehydrogenase (G6PD) activity and deficiency in a population of Nigerian males resident in Jos.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency and senile cataract in a Sardinian male population, Italy.
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in Greek newborns: The Mediterranean C563T mutation screening.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a study on the population of the Cosenza province.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Yogyakarta and its surrounding areas.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina Faso.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and UDP-glucuronosyltransferase promoter polymorphism among G6PD deficient Kuwaitis.
Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population.
Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population.
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese.
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient infants: Enzyme activity and gene variants as risk factors for phototherapy in the first week of life.
Glucose-6-Phosphate Dehydrogenase - Beyond the Realm of Red Cell Biology.
Glucose-6-phosphate dehydrogenase activity in bipolar disorder and schizophrenia: Relationship to mitochondrial impairment.
Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
Glucose-6-phosphate dehydrogenase activity in male premature and term neonates.
Glucose-6-phosphate dehydrogenase activity measured by spectrophotometry and associated genetic variants from the Oromiya zone, Ethiopia.
Glucose-6-phosphate dehydrogenase activity, structure, molecular characteristics and role in neonatal hyperbilirubinemia in cord blood in Cukurova region.
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
Glucose-6-phosphate dehydrogenase deficiency & neonatal hyperbilirubinaemia.
Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis.
Glucose-6-phosphate dehydrogenase deficiency A- variant in febrile patients in Haiti.
Glucose-6-Phosphate Dehydrogenase Deficiency Activates Endothelial Cell and Leukocyte Adhesion Mediated via the TGF?/NADPH Oxidases/ROS Signaling Pathway.
Glucose-6-phosphate dehydrogenase deficiency allelic variants and their prevalence in malaria patients in Eritrea.
Glucose-6-phosphate dehydrogenase deficiency among children attending the Emergency Paediatric Unit of Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
Glucose-6-phosphate dehydrogenase deficiency among ethnic groups in Iraq.
Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.
Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
Glucose-6-Phosphate Dehydrogenase Deficiency among Male Blood Donors in Sana'a City, Yemen.
Glucose-6-phosphate dehydrogenase deficiency among three national minorities in Hainan Island, China.
Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Glucose-6-phosphate dehydrogenase deficiency and abnormal hemoglobins in mexican newborns with jaundice.
Glucose-6-phosphate dehydrogenase deficiency and acute renal failure.
Glucose-6-phosphate dehydrogenase deficiency and adrenal hemorrhage in a filipino neonate with hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
Glucose-6-phosphate dehydrogenase deficiency and bacterial infections in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and blood groups in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and blood transfusion.
Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study.
Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants.
Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery.
Glucose-6-phosphate dehydrogenase deficiency and cataracts.
Glucose-6-phosphate dehydrogenase deficiency and chronic haemolysis in an English family.
Glucose-6-phosphate dehydrogenase deficiency and colour-vision studies in Indian Muslims.
Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
Glucose-6-phosphate dehydrogenase deficiency and COVID-19 mortality.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus.
Glucose-6-phosphate dehydrogenase deficiency and duodenal ulcer.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND FALCIPARUM MALARIA.
Glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome: a gene interaction underlies severe jaundice without severe hemolysis.
Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
Glucose-6-phosphate dehydrogenase deficiency and haemoglobin level in Jamaican children.
Glucose-6-phosphate dehydrogenase deficiency and haemolytic disease of the newborn in Israel.
Glucose-6-phosphate dehydrogenase deficiency and haptoglobin polymorphism among Rajput and Brahmin children in Himachal Pradesh.
Glucose-6-phosphate dehydrogenase deficiency and hematopoietic stem cell transplantation.
Glucose-6-phosphate dehydrogenase deficiency and hereditary ovalocytosis in the Ok Tedi impact region of Papua New Guinea.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo.
Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Jamaica.
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Glucose-6-phosphate dehydrogenase deficiency and hyperbilirubinemia in the newborn.
Glucose-6-phosphate dehydrogenase deficiency and idiopathic presenile cataract in Dalmatia, Croatia.
Glucose-6-phosphate dehydrogenase deficiency and incidence of cataract in Sicily.
Glucose-6-phosphate dehydrogenase deficiency and infection: a study of hospitalized patients in Iran.
Glucose-6-phosphate dehydrogenase deficiency and intravascular haemolysis.
Glucose-6-phosphate dehydrogenase deficiency and its variants in India.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND JAUNDICE IN NEWBORN INFANTS IN NORTHERN THAILAND.
Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia.
Glucose-6-phosphate dehydrogenase deficiency and lobar pneumonia. Fine structure of the liver.
Glucose-6-phosphate dehydrogenase deficiency and lung cancer: a hospital based case-control study.
Glucose-6-phosphate dehydrogenase deficiency and malaria--a study on north Madras population.
Glucose-6-phosphate dehydrogenase deficiency and malaria.
Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women.
Glucose-6-phosphate dehydrogenase deficiency and malignant hepatoma in a Bantu population.
Glucose-6-phosphate dehydrogenase deficiency and Mediterranean fever in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and mental retardation.
Glucose-6-phosphate dehydrogenase deficiency and metabolic profiling in adolescence from the Chinese birth cohort: "Children of 1997".
Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia.
Glucose-6-phosphate dehydrogenase deficiency and myelofibrosis.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice among population groups of Cape Town.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Al-Hofuf area.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN NIGERIA: THEIR RELATION TO THE USE OF PROPHYLACTIC VITAMIN K.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN SOUTH AFRICAN BANTU INFANTS.
Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NONSPHEROCYTIC CONGENITAL HEMOLYTIC ANEMIA.
Glucose-6-phosphate dehydrogenase deficiency and osteoarthritis in men of Northern Sardinia.
Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence.
Glucose-6-phosphate Dehydrogenase Deficiency and Pre-eclampsia: Possibility of Treatment.
Glucose-6-phosphate dehydrogenase deficiency and red cell glutathione peroxidase.
Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Glucose-6-phosphate dehydrogenase deficiency and related disorders of the pentose phosphate pathway.
Glucose-6-phosphate dehydrogenase deficiency and Rh factor.
Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study.
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study.
Glucose-6-phosphate dehydrogenase deficiency and risk of diabetes: a systematic review and meta-analysis.
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.
Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior.
Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell genes in Bisha.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell genes in two regions of western Saudi Arabia.
Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana.
Glucose-6-phosphate dehydrogenase deficiency and sickle-cell anemia.
Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia.
Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes.
Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE INCIDENCE OF CANCER.
Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.
Glucose-6-phosphate dehydrogenase deficiency and the sickle cell gene in Makkah, Saudi Arabia.
Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs.
Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes.
Glucose-6-phosphate dehydrogenase deficiency as a cause of drug-induced hemolysis with renal shut down and kernicterus.
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
Glucose-6-phosphate dehydrogenase deficiency associated with hemogobin H disease.
Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Glucose-6-Phosphate Dehydrogenase Deficiency Diagnosed in an Adolescent with Type 1 Diabetes Mellitus and Hemoglobin A1c Discordant with Blood Glucose Measurements.
Glucose-6-phosphate dehydrogenase deficiency does not increase the susceptibility of sperm to oxidative stress induced by H2O2.
Glucose-6-phosphate dehydrogenase deficiency does not result from mutations in the promoter region of the G6PD gene.
Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection.
Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.
Glucose-6-Phosphate Dehydrogenase Deficiency Genetic Variants in Malaria Patients in Southwestern Ethiopia.
Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia.
Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN BRUNEI, SABAH AND SARAWAK.
Glucose-6-phosphate dehydrogenase deficiency in a community with a high incidence of the mutant gene.
Glucose-6-phosphate dehydrogenase deficiency in a dog.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN A DUTCH FAMILY.
Glucose-6-phosphate dehydrogenase deficiency in a native Danish family. A new variant.
Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study.
Glucose-6-phosphate dehydrogenase deficiency in a rural Saudi population.
Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in manaus: a cross-sectional survey in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase deficiency in an XO individual.
Glucose-6-phosphate dehydrogenase deficiency in blood donors.
Glucose-6-phosphate dehydrogenase deficiency in blood donors: screening by micromethaemoglobin reduction test.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Glucose-6-phosphate dehydrogenase deficiency in Canadian Negroes.
Glucose-6-phosphate dehydrogenase deficiency in children in Zulfi (Riyadh) area - needs immediate attention.
Glucose-6-phosphate dehydrogenase deficiency in Chinese.
Glucose-6-phosphate dehydrogenase deficiency in congenital hemolytic disease. A review.
Glucose-6-phosphate dehydrogenase deficiency in Cukurova Province, Turkey.
Glucose-6-phosphate dehydrogenase deficiency in dermatology.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN DIFFERENT ETHNIC GROUPS IN THAILAND.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN EAST AFRICANS.
Glucose-6-Phosphate dehydrogenase deficiency in Egypt: with a note on the methemoglobin reduction test.
Glucose-6-phosphate dehydrogenase deficiency in erythrocytes in sheep and goats.
Glucose-6-phosphate dehydrogenase deficiency in ethnic minorities in Britain.
Glucose-6-phosphate dehydrogenase deficiency in ethnic minorities in The Netherlands.
Glucose-6-phosphate dehydrogenase deficiency in female heterozygotes and the X-inactivation hypothesis.
Glucose-6-phosphate dehydrogenase deficiency in female octogenarians, nanogenarians, and centenarians.
Glucose-6-phosphate dehydrogenase deficiency in females, diagnosed by partial inhibition of glutathione reductase activity in the erythrocytes after incubation with chromate.
Glucose-6-phosphate dehydrogenase deficiency in Greece.
Glucose-6-phosphate dehydrogenase deficiency in health and disease.
Glucose-6-phosphate dehydrogenase deficiency in healthy Nepalese patients.
Glucose-6-phosphate dehydrogenase deficiency in hemolytic anemia.
Glucose-6-phosphate dehydrogenase deficiency in human platelets and its effect on platelet aggregation.
Glucose-6-phosphate dehydrogenase deficiency in immigrant greek infants.
Glucose-6-phosphate dehydrogenase deficiency in India and its clinical significance.
Glucose-6-phosphate dehydrogenase deficiency in India.
Glucose-6-phosphate dehydrogenase deficiency in internationally adopted children.
Glucose-6-phosphate dehydrogenase deficiency in Iraq.
Glucose-6-phosphate dehydrogenase deficiency in Italian blood donors: prevalence and molecular defect characterization.
Glucose-6-phosphate dehydrogenase deficiency in Italy. A study of the distribution and severity of the enzymatic defect.
Glucose-6-phosphate dehydrogenase deficiency in Kuwait, Syria, Egypt, Iran, Jordan and Lebanon.
Glucose-6-phosphate dehydrogenase deficiency in Kuwait.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN MALAYANS.
Glucose-6-phosphate dehydrogenase deficiency in male patients with Mediterranean spotted fever in Sardinia.
Glucose-6-phosphate dehydrogenase deficiency in Maltese newborn infants.
Glucose-6-phosphate Dehydrogenase Deficiency in Marfan's Syndrome.
Glucose-6-phosphate dehydrogenase deficiency in military recruits.
Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinaemia: Hacettepe exper?ence.
Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia in a south Indian referral hospital.
Glucose-6-phosphate Dehydrogenase Deficiency in Neonatal Indirect Hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency in neonates.
Glucose-6-phosphate dehydrogenase deficiency in newborn infants.
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency in northern Mexico and description of a novel mutation.
Glucose-6-phosphate dehydrogenase deficiency in northern Vietnam.
Glucose-6-phosphate dehydrogenase deficiency in Orissa.
Glucose-6-phosphate dehydrogenase deficiency in Pakistani males.
Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea using a simple methylene blue reduction test.
Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea. The description of 13 new variants.
Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.
Glucose-6-phosphate dehydrogenase deficiency in pleiotropic carbohydrate-negative mutant strains of Rhizobium meliloti.
Glucose-6-phosphate dehydrogenase deficiency in Portugal: biochemical and mutational profiles, heterogeneity, and haplotype association.
Glucose-6-phosphate dehydrogenase deficiency in pregnancy.
Glucose-6-phosphate dehydrogenase deficiency in Project Head Start children.
Glucose-6-phosphate dehydrogenase deficiency in red blood cells of East Africans.
Glucose-6-phosphate dehydrogenase deficiency in red cells.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN RED CELLS. INCIDENCE IN THE CURA CAO POPULATION, ITS CLINICAL AND GENETIC ASPECTS.
Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia.
Glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. A study in Al-Ula.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN SAUDI ARABIA: A SURVEY.
Glucose-6-phosphate dehydrogenase deficiency in Sicily. Incidence, biochemical characteristics and clinical implications.
Glucose-6-phosphate dehydrogenase deficiency in sickle cell disease by DNA analysis.
Glucose-6-phosphate dehydrogenase deficiency in Sickle-cell anemia. A study in adults.
Glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease.
Glucose-6-phosphate dehydrogenase deficiency in Singapore.
Glucose-6-phosphate dehydrogenase deficiency in South Vietnamese.
Glucose-6-phosphate dehydrogenase deficiency in Southeast Asian refugees entering the United States.
Glucose-6-phosphate dehydrogenase deficiency in Taiwan.
Glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Glucose-6-phosphate dehydrogenase deficiency in Thailand: the influence on the clinical presentation of malaria in male adult patients.
Glucose-6-phosphate dehydrogenase deficiency in Thailand; its significance in the newborn.
Glucose-6-phosphate dehydrogenase deficiency in the Bhanushali community--a survey.
Glucose-6-phosphate dehydrogenase deficiency in the Dr. Cipto Mangunkusumo General Hospital.
Glucose-6-phosphate dehydrogenase deficiency in the Greek population of Cape Town.
Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution.
Glucose-6-phosphate dehydrogenase deficiency in the newborn and its relation to serum bilirubin.
Glucose-6-phosphate dehydrogenase deficiency in the newborn: its prevalence and relation to neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency in the Parsee community, Bombay.
Glucose-6-phosphate dehydrogenase deficiency in the peoples of the Niger Delta.
Glucose-6-phosphate dehydrogenase deficiency in the Philippines: report of a new variant--G6PD Panay.
Glucose-6-phosphate dehydrogenase deficiency in the Sudan.
Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks.
Glucose-6-phosphate dehydrogenase deficiency in triplets of African-American descent.
Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association.
Glucose-6-phosphate dehydrogenase deficiency in Tunisian jaundiced neonates.
Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
Glucose-6-phosphate dehydrogenase deficiency in two siblings of a Chinese family.
Glucose-6-Phosphate dehydrogenase deficiency incidence in a Hispanic population.
Glucose-6-phosphate dehydrogenase deficiency increases cell adhesion molecules and activates human monocyte-endothelial cell adhesion: Protective role of l-cysteine.
Glucose-6-phosphate dehydrogenase deficiency induced haemolysis in a woman with newly diagnosed diabetes after normalisation of hyperglycaemia.
Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum.
Glucose-6-Phosphate Dehydrogenase Deficiency is Associated with Cardiovascular Disease in U.S. Military Centers.
Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Glucose-6-phosphate dehydrogenase deficiency is associated with lower fibrosis score in non-progressive HBsAg-positive subjects.
Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
Glucose-6-phosphate dehydrogenase deficiency mutations in Papua New Guinea.
Glucose-6-phosphate dehydrogenase deficiency neonatal screening: preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening.
Glucose-6-phosphate dehydrogenase deficiency presented with convulsion: a rare case.
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability.
Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-phosphate dehydrogenase deficiency screening in Madeira.
Glucose-6-phosphate dehydrogenase deficiency severely restricts the biotransformation of daunorubicin in human erythrocytes.
Glucose-6-phosphate dehydrogenase deficiency trait in Nigeria.
Glucose-6-Phosphate Dehydrogenase Deficiency Unveiled by Diabetic Ketoacidosis: A Dual Dilemma.
Glucose-6-phosphate dehydrogenase deficiency with bilateral cataract.
Glucose-6-phosphate dehydrogenase deficiency with psychosis.
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Glucose-6-phosphate dehydrogenase deficiency, haemoglobin variants, and blood groups distribution in a Liberian sample.
Glucose-6-phosphate dehydrogenase deficiency, hemoglobin and haptoglobin types in Mexicans and American Negroes.
Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis.
Glucose-6-phosphate dehydrogenase deficiency, thalassaemia & abnormal haemoglobins in Bohra Muslims.
Glucose-6-phosphate dehydrogenase deficiency, the sickling trait, and malaria in Saudi Arab children.
Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency, vitamin K, and ambiguity in medical textbooks.
Glucose-6-phosphate dehydrogenase deficiency--report of 4 cases.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Glucose-6-phosphate dehydrogenase deficiency.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-Phosphate Dehydrogenase Deficiency.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency. A new aetiological factor of severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency. Diagnosis, clinical and genetic implications.
Glucose-6-phosphate dehydrogenase deficiency. Part 1: Tropical Africa.
Glucose-6-phosphate dehydrogenase deficiency. Part 2. Tropical Asia.
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Glucose-6-phosphate dehydrogenase deficiency: a brief review.
Glucose-6-phosphate dehydrogenase deficiency: a contraindication for living donor liver transplantation?
Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a historical perspective.
Glucose-6-phosphate dehydrogenase deficiency: a new hypothesis for an old disease.
Glucose-6-phosphate dehydrogenase deficiency: a novel role for thyroxine in peroxide-induced hemolysis.
Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation.
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
Glucose-6-phosphate dehydrogenase deficiency: an unusual cause of acute jaundice after paracetamol overdose.
Glucose-6-phosphate dehydrogenase deficiency: another risk factor for necrotizing enterocolitis?
Glucose-6-phosphate dehydrogenase deficiency: biochemical and histochemical studies on hair roots for carrier detection.
Glucose-6-phosphate dehydrogenase deficiency: correlation between the genotype, biochemistry and phenotype.
Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits.
Glucose-6-phosphate dehydrogenase deficiency: genetic heterogeneity in Sardinia.
Glucose-6-phosphate dehydrogenase deficiency: mechanisms of drug-induced hemolysis.
Glucose-6-phosphate dehydrogenase deficiency: molecular heterogeneity in southeast Asian countries.
Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males.
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever.
Glucose-6-phosphate dehydrogenase deficiency: pre-natal and post-natal implications.
Glucose-6-phosphate dehydrogenase deficiency: screening of 200 Zambian newborn.
Glucose-6-phosphate dehydrogenase deficiency: some biological implications.
Glucose-6-phosphate dehydrogenase deficiency: the added value of cytology.
Glucose-6-phosphate dehydrogenase deficiency: why girls are affected?
Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase is indispensable in embryonic development by modulation of epithelial-mesenchymal transition via the NOX/Smad3/miR-200b axis.
Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes.
Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis.
Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.
Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar.
Glucose-6-phosphate dehydrogenase of malaria parasite Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.
Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.
Glucose-6-phosphate dehydrogenase red blood cell phenotype in GdMediterranean heterozygous females and hemizygous males at birth.
Glucose-6-phosphate dehydrogenase screening of babies born in a tertiary care hospital in West Bengal.
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong, China.
Glucose-6-phosphate dehydrogenase variants from Italian subjects associated with severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.
Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria.
Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.
Glucose-6-phosphate metabolism in Plasmodium falciparum.
Glucose-6-phosphate-dehydrogenase deficiency and haematopoietic stem cell transplantation in Chinese patients.
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium.
Glutathione and glucose-6-phosphate dehydrogenase deficiency can increase protein glycosylation.
Glutathione reductase activity and its relationship to pyridoxine phosphate activity in G6PD deficiency.
Glutathione reductase in the south-western province of Saudi Arabia--genetic variation vs. acquired deficiency.
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
Glyburide-induced acute haemolysis in a G6PD-deficient patient with NIDDM.
Glycosylated haemoglobin in glucose-6-phosphate dehydrogenase deficiency.
Glycosylated hemoglobin in Saudi sickle cell patients with glucose-6-phosphate dehydrogenase deficiency.
Grand rounds, University Hospital. G6PD deficiency.
Green Tea Polyphenol Epigallocatechin-3-gallate Protects Cells against Peroxynitrite-Induced Cytotoxicity: Modulatory Effect of Cellular G6PD Status.
Groups at potentially high risk from chlorine dioxide treated water.
GSSG-reducing activity in lenses deficient in glucose-6-phosphate dehydrogenase.
Haematological study in Cabo Delgado province, Mozambique; sickle cell trait and G6PD deficiency.
Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population.
Haemoglobin disorders: a pattern for thalassaemia and haemoglobinopathies in Arabia.
Haemoglobin O Arab, beta-thalassaemia and glucose-6-phosphate dehydrogenase deficiency in a Hungarian family.
Haemoglobin, serum iron, transferrin, ferritin concentrations and total iron-binding capacity in erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in a Scandinavian perspective.
Haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Eastern Libya.
Haemoglobinopathies, glucose-6-phosphate dehydrogenase deficiency and allied problems in the Indian subcontinent.
Haemoglobinopathies, thalassaemias and enzymopathies in Saudi Arabia: the present status.
Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.
Haemoglobinuria among adult Nigerians due to glucose-6-phosphate dehydrogenase deficiency with drug sensitivity.
Haemoglobinuria and haptoglobin in G6PD deficiency.
Haemolysis complicating acute viral hepatitis in patients with normal or deficient glucose-6-phosphate dehydrogenase activity.
Haemolysis complicating fulminant hepatitis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Haemolysis complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Haemolysis due to glucose-6-phosphate dehydrogenase deficiency in Malaya.
Haemolysis during diabetic ketoacidosis treatment in two girls with incomplete glucose-6-phosphate dehydrogenase deficiency.
Haemolysis during sodium dimercaptosulphonate therapy for Wilson's disease in G6PD-deficient patients: First report of two cases.
Haemolysis in a G6PD-deficient child induced by eating unripe peaches.
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency.
Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency.
Haemolytic anaemia after ingestion of Neem (Azadirachta indica) tea.
Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency.
Haemolytic anaemia after oral self-giving of naphthalene-containing oil.
Haemolytic anaemia associated with Nigerian barbecued meat (red suya).
Haemolytic anaemia with massive haemoglobinuria due to glucose-6-phosphate dehydrogenase deficiency in Ceylon.
Haemolytic crises caused by Hoya carnosa in a patient with G6PD deficiency.
Haemolytic crises due to glucose-6-phosphate dehydrogenase deficiency in the mid-southern region of Turkey.
Haemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait.
Haemolytic jaundice following aspirin administration to a patient with a deficiency of glucose-6-phosphate dehydrogenase in erythrocytes.
Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Hair root versus red cell individual phenotype in Sardinian heterozygotes for G6PD deficiency (Mediterranean type).
Hairy-cell leukemia and glucose-6-phosphate dehydrogenase deficiency in two brothers.
Haptoglobin therapy for acute favism: a Japanese boy with glucose-6-phosphate dehydrogenase Guadalajara.
Haptoglobin, hemopexin, hemoglobin and hematocrit in newborns with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review.
Hb Belfast (beta 15 (A 12) Trp leads to Arg) in combination with G6PD deficiency in an Italian carrier.
Hb Buffalo [alpha89(FG1)His-->Gln (alpha1)], observed solely and in the presence of an Hb S [beta6(A3)Glu-->Val] heterozygosity.
HB H disease with homozygosity for red cell G6PD deficiency in a Turkish female.
HbA1c levels in diabetic Sardinian patients with or without G6PD deficiency.
HbE-beta-thalassemia associated with G6PD deficiency.
Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice.
Hematologic disorders and nonimmune hydrops fetalis.
Hematologic findings in Southeast Asian immigrants with particular reference to hemoglobin E.
Hematologic genetic disorders among Southeast Asian refugees.
Hematologic problems in pregnancy. 3. Glucose-6-phosphate dehydrogenase deficiency.
Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
Hematological findings and severity of G6PD deficiency in Vataliya Prajapati subjects.
Hematological findings in neonatal hyperbilirubinemia due to G6PD deficiency.
Hematological parameters and red blood cell morphological abnormality of Glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.
Hematological profile in neonatal jaundice.
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).
Hemoglobin A2, E and F levels and the incidence of hemoglobin E, beta-thalassemia, and glucose-6-phosphate dehydrogenase deficiency in lymphoma.
Hemoglobin C trait and glucose-6-phosphate dehydrogenase deficiency.
Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh.
Hemoglobin H disease in the Al-Qatif Region of Saudi Arabia.
Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria.
Hemoglobin variants in India.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in one of the regions of Azerbaijan: mass screening and laboratory investigations.
Hemoglobinopathies in relation to the erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemoglobinopathies, G6PD deficiency, and hereditary elliptocytosis in Bahrain.
Hemolysis after acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia.
Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Hemolysis and Mediterranean G6PD mutation (c.563 C>T) and c.1311 C>T polymorphism among Palestinians at Gaza Strip.
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Hemolysis as a potential complication of acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolysis following transfusion of erythrocytes from a donor with G6PD deficiency and beta-thalassemia minor.
Hemolysis in G6PD deficiency in Qatif, Saudi Arabia.
Hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia after acetaminophen overdose in patient with glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.
Hemolytic anemia and erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia and G6PD deficiency.
Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia due to G6PD deficiency and urate oxidase in a kidney-transplant patient.
Hemolytic anemia following succimer administration in a glucose-6-phosphate dehydrogenase deficient patient.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Hemolytic Anemia Induced by Pegloticase Infusion in a Patient With G6PD Deficiency.
Hemolytic anemia.
Hemolytic anemias and erythrocyte enzymopathies.
Hemolytic anemias due to erythrocyte enzyme deficiencies.
Hemolytic anemias. Diagnosis and management.
Hemolytic crisis after excessive ingestion of fava beans in a male infant with G6PD Canton.
Hemolytic crisis following acetaminophen overdose in a patient with G6PD deficiency.
Hemolytic Crisis following Naphthalene Mothball Ingestion in a 21-Month-Old Patient with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency.
Hemolytic crisis in a G6PD-deficient infant after ingestion of pumpkin.
Hemolytic crisis in a non-ketotic and euglycemic child with glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus.
Hemolytic crisis in G6PD-deficient individuals in the occupational setting.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn.
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report.
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report: Retraction.
Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice.
Henna (Lawsonia inermis Linn.) induced haemolytic anaemia in siblings.
Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Henna causes life-threatening hyperbilirubinaemia in glucose-6-phosphate dehydrogenase deficiency.
Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia.
Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hepatitis E with Intravascular Hemolysis in Beta Thalassemia Trait: A Rare Association or Coincidence.
Hereditary anaemias and iron deficiency in a tribal population (the Baiga) of central India.
Hereditary anaemias in Portugal: epidemiology, public health significance, and control.
HEREDITARY AND ACQUIRED BLOOD FACTORS IN THE NEGROID POPULATION OF SURINAM. II. THE INCIDENCE OF HAEMOGLOBIN ANOMALIES AND THE DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.
Hereditary characteristics of enzyme deficiency and dermatoglyphics in congenital color blindness.
Hereditary disorders in the Eastern Mediterranean Region.
Hereditary elliptocytosis (the first report in Thailand) in association with erythrocyte glucose-6-phosphate dehydrogenase deficiency and hemoglobin E.
Hereditary hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency (Mediterranean type).
HEREDITARY HEMOLYTIC ANEMIA DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY; IMPROVEMENT FOLLOWING SPLENECTOMY AND FOLIC ACID THERAPY.
HEREDITARY HEMOLYTIC DISEASE SECONDARY TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY: REPORT OF THREE CASES WITH SPECIAL EMPHASIS ON ATP METABOLISM.
Hereditary red blood cell disorders in middle eastern patients.
Hereditary red cell disorders in Southeast Asian refugees and the effect on the prevalence of thalassemia disorders in the United States.
Hereditary sideroblastic anemia and glucose-6-phosphate dehydrogenase deficiency in a Negro family.
Hereditary spherocytosis and glucose-6-phosphate dehydrogenase deficiency.
Hereditary spherocytosis in association with severe G6PD deficiency: report of an unusual case.
Heterogeneity and variation of clinical and haematological expression of haemoglobin S in Saudi Arabs.
Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions.
Heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Algeria. Study in Northern Algeria with description of five new variants.
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.
Heterozygote detection in glucose-6-phosphate dehydrogenase deficiency: limitation of hair follicle analysis.
Heterozygous pyruvate kinase deficiency and severe hemolytic anemia in a pregnant woman with concomitant, glucose-6-phosphate dehydrogenase deficiency.
High cut-off membrane for in-vivo dialysis of free plasma hemoglobin in a patient with massive hemolysis.
High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
High Frequency of Blackwater Fever Among Children Presenting to Hospital With Severe Febrile Illnesses in Eastern Uganda.
High frequency of diabetes and impaired fasting glucose in patients with glucose-6-phosphate dehydrogenase deficiency in the Western brazilian Amazon.
High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria.
High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and beta-cell apoptosis.
High incidence of 3-thalassemia, hemoglobin E, and glucose-6-phosphate dehydrogenase deficiency in populations of malaria-endemic southern Shan State, Myanmar.
High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island, Croatia.
High Incidence of Malaria Along the Sino-Burmese Border Is Associated With Polymorphisms of CR1, IL-1A, IL-4R, IL-4, NOS, and TNF, But Not With G6PD Deficiency.
High prevalence of anaemia among African migrants in Germany persists after exclusion of iron deficiency and erythrocyte polymorphisms.
High prevalence of G6PD deficiency in Vataliya Prajapati community in western India.
High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
High prevalence of microcytic anaemia in Omani children: a prospective study.
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency.
Histochemistry and cytochemistry of glucose-6-phosphate dehydrogenase.
HLA antigens and erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Sardinia.
HLA-DRB1 and DQB1 allele distribution in the Muong population exposed to malaria in Vietnam.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Homozygous G6PD deficiency and propacetamol induced hemolysis.
Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case.
Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea.
Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission.
Host factors against Salmonella typhi in children with glucose-6-phosphate dehydrogenase deficiency.
Host-targeted Interventions as an Exciting Opportunity to Combat Malaria.
How malaria has affected the human genome and what human genetics can teach us about malaria.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Human embryonic stem cells derived from abnormal blastocyst donated by glucose-6-phosphate dehydrogenase deficiency patient.
Human erythrocyte G6PD deficiency: pathophysiology, prevalence, diagnosis, and management.
Human genetic factors related to susceptibility to mild malaria in Gabon.
Human genetics and malaria resistance.
Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency.
Human hair follicles may be used for population screening of heterozygotes of glucose-6-phosphate dehydrogenase deficiency.
Human mutations in glucose 6-phosphate dehydrogenase reflect evolutionary history.
Human red blood cell polymorphisms prevalent in Colombian population and its protective role against malaria.
Hydroxychloroquine in a G6PD-Deficient Patient with COVID-19 Complicated by Haemolytic Anaemia: Culprit or Innocent Bystander?
Hydroxychloroquine is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients.
Hyperbilirubinaemia and erythrocytic glucose 6 phosphate dehydrogenase deficiency in Malaysian children.
Hyperbilirubinaemia, glucose-6-phosphate dehydrogenase deficiency and Gilbert syndrome.
Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
Hyperbilirubinemia following hepatitis A in a patient with G6pD deficiency.
Hyperbilirubinemia in black infants. Role of glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome.
Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.
Hyperlactatemia and hemolysis in G6PD deficiency after nitrofurantoin ingestion.
Hyperlipidemia in acute hemolysis.
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Hypoxic Activation of G6PD Controls the Expression of Genes Involved in the Pathogenesis of Pulmonary Hypertension Through the Regulation of DNA Methylation.
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
Ichthyosis accompanied by neurological symptoms with special reference to epilepsy.
Identification of a case of glucose-6-phosphate dehydrogenase deficiency with G6PD mediterranean-middle east subtype in China.
Identification of Genetic Risk Factors for Neonatal Hyperbilirubinemia in Fujian Province, Southeastern China: A Case-Control Study.
Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia.
Identification of Inflammatory Biomarkers for Pediatric Malarial Anemia Severity using Novel Statistical Methods.
Identification of Mutation of Glucose-6-Phosphate Dehy-drogenase (G6PD) in Iran: Meta- analysis Study.
Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights.
Identifying risk of neonatal hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns in Singapore.
If Vitamins Could Kill: Massive Hemolysis Following Naturopathic Vitamin Infusion.
Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.
Impact of G6PD status on red cell storage and transfusion outcomes.
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.
Impact of glucose-6-phosphate dehydrogenase deficiency on the severity of coronary atherosclerosis in patients with acute coronary syndromes.
Impact of Hemoglobin S Trait on Cell Surface Antibody Recognition of Plasmodium falciparum-Infected Erythrocytes in Pregnancy-Associated Malaria.
Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H(2)O(2)-induced apoptosis.
Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolism.
Impaired inflammasome activation and bacterial clearance in G6PD deficiency due to defective NOX/p38 MAPK/AP-1 redox signaling.
Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency.
Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes.
Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States.
Implementation of G6PD testing and primaquine for P. vivax radical cure: Operational perspectives from Thailand and Cambodia.
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh.
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency.
Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis.
Improved quantitative method for G6PD deficiency detection.
In the Light of Evolution IV: The Human Condition Sackler Colloquium: Gene-culture coevolution in the age of genomics.
In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector.
Inborn defects in the antioxidant systems of human red blood cells.
Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants.
Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
Incidence and characteristics of glucose-6-phosphate dehydrogenase variants in Japan.
Incidence and complete molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Guangxi Zhuang autonomous region of southern China: description of four novel mutations.
Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency.
Incidence and molecular analysis of glucose-6-phosphate dehydrogenase deficiency in the province of Denizli, Turkey.
Incidence and molecular characterization of Glucose-6-Phosphate Dehydrogenase deficiency among neonates for newborn screening in Chaozhou, China.
Incidence and mutation analysis of glucose-6-phosphate dehydrogenase deficiency in eastern Indonesian populations.
Incidence of Chronic Bilirubin Encephalopathy in Canada, 2007-2008.
Incidence of erythrocyte glucose-6-phosphate dehydrogenase deficiency among different ethnic groups of India.
Incidence of G6PD deficiency in patients of three different ethnic groups suffering from pulmonary tuberculosis.
Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants.
Incidence of glucose-6-phosphate dehydrogenase deficiency and haemoglobinopathies in Bhil tribe of Udaipur District.
Incidence of glucose-6-phosphate dehydrogenase deficiency in a hospital population of Delhi.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Egypt.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Jabalpur area.
Incidence of glucose-6-phosphate dehydrogenase deficiency in jaundiced punjabi neonates.
Incidence of glucose-6-phosphate dehydrogenase deficiency in three Gujarati populations.
Incidence of glucose-6-phosphate dehydrogenase deficiency in Zimbabwe.
Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984.
Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns.
Increase of F cells during acute hemolysis in glucose-6-phosphate dehydrogenase-deficient males.
Increased basal oxidation of peroxiredoxin 2 and limited peroxiredoxin recycling in glucose-6-phosphate dehydrogenase-deficient erythrocytes from newborn infants.
Increased bilirubin production, ceruloplasmin concentrations and hyperbilirubinaemia in full-term newborn infants.
Increased incidence of cataracts in male subjects deficient in glucose-6-phosphate dehydrogenase.
Increased incidence of hyperbilirubinaemia in 'unchallenged' glucose-6-phosphate dehydrogenase deficiency in term Saudi newborns.
Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients.
Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient.
Increased morbidity following acute viral hepatitis in children with glucose-6-phosphate dehydrogenase deficiency.
Increased morbidity in acute viral hepatitis with glucose-6-phosphate dehydrogenase deficiency.
Increased prevalence of glucose-6-phosphate dehydrogenase deficiency in patients with cholelithiasis.
Increased prevalence of proliferative retinopathy in patients with type 1 diabetes who are deficient in glucose-6-phosphate dehydrogenase.
Index of suspicion. Case 3. Diagnosis: glucose-6-phosphate dehydrogenase deficiency.
Index of suspicion. Case 3. Kernicterus in a baby girl homozygous for glucose-6-phosphate dehydrogenase deficiency.
Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014.
Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study.
Infantile pyknocytosis and glucose-6-phosphate dehydrogenase deficiency.
Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization.
Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency.
Infectious hepatitis with excessive hyperbilirubinemia and a hemolytic crisis in an 8-year-old boy. His G6PD deficiency was an aggravating factor.
Influence of blood group, Glucose-6-phosphate dehydrogenase and Haemoglobin genotype on Falciparum malaria in children in Vihiga highland of Western Kenya.
Influence of Changes in the Evaluation of Neonatal Jaundice.
Influence of glucose-6-phosphate dehydrogenase deficiency on the glutathione reductase test for ariboflavinosis.
Influence of hemoglobin E trait on the antimalarial effect of artemisinin derivatives.
Influence of hemoglobin E trait on the severity of Falciparum malaria.
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia.
Influence of pharmacogenetics on drug disposition and response.
Influence of the Inherited Glucose-6-phosphate Dehydrogenase Deficiency on the Appearance of Neonatal Hyperbilirubinemia in Southern Croatia.
Influenza-induced hemolytic crisis in glucose-6-phosphate dehydrogenase deficiency.
Inherited anaemias in the Greek community of Cape Town.
Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.
Inherited haemolytic states: glucose-6-phosphate dehydrogenase deficiency.
Inherited, non-spherocytic haemolysis due to deficiency of glucose-6-phosphate dehydrogenase.
Inhibition of Glucose-6-Phosphate Dehydrogenase Could Enhance 1,4-Benzoquinone-Induced Oxidative Damage in K562 Cells.
Inhibition of glucose-6-phosphate dehydrogenase protects hepatocytes from aluminum phosphide-induced toxicity.
Insertion/Deletion polymorphisms do play any role in G6PD deficiency individuals in the Kingdom of the Saudi Arabia.
Instability of reduced glutathione and deficiency of glucose-6-phosphate dehydrogenase activity of red cells in normal Indians.
Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C.
Interaction between glucose-6-phosphate dehydrogenase deficiency and sickle cell gene in Saudi Arabia.
Interaction between the glucose-6-phosphate dehydrogenase deficiency and thalassaemia genes at phenotype level.
Interaction of malarial infection and glucose-6-phosphate dehydrogenase deficiency in Muria gonds of district Bastar, central India.
Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon.
Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Interesting case of G6PD deficiency anemia with severe hemolysis.
Internal carotid artery aneurysm: a singular anomaly.
Interplay between glutathione-S-transferase and glucose-6-phosphate dehydrogenase in neonatal cord blood.
Interrelationships of erythrocyte glutathione peroxidase system enzymes in the fasted Beagle.
Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Intraoperative hemolysis. The initial manifestation of glucose-6-phosphate dehydrogenase deficiency.
Intravascular haemolysis and renal insufficiency in children with glucose-6-phosphate dehydrogenase deficiency, following antimalarial therapy.
Intravascular haemolysis due to glucose-6-phosphate dehydrogenase deficiency in a patient with aluminium phosphide poisoning.
Intravascular Hemolysis in Aluminum Phosphide Poisoning.
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
Intravenous Thrombolysis for Stroke Patients with G6PD Deficiency.
Introduction to discussion of glucose-6-phosphate dehydrogenase deficiency.
Inverse Association between Glucose?6?Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma
Investigation of glucose 6-phosphate dehydrogenase (G6PD) kinetics for normal and G6PD-deficient persons and the effects of some drugs.
Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
Investigation of prolonged neonatal jaundice.
Investigation of the mutation points and effects of some drugs on glucose-6-phosphate dehydrogenase-deficient people in the Erzurum region.
Investigations of the fluorescent spot test for erythrocyte glucose-6-phosphate dehydrogenase deficiency in southeast Thailand.
Investigations regarding glucose-6-phosphate dehydrogenase deficiency in Hungary.
Iron overload, G6PD deficiency, and lead levels on blood smears.
Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells.
Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.
Is glucose-6-phosphate dehydrogenase deficiency a risk factor for hyperbaric oxygen exposure?
Is glucose-6-phosphate dehydrogenase deficiency more prevalent in Carrion's disease endemic areas in Latin America?
Is testing for glucose-6-phosphate dehydrogenase deficiency before starting sulfa useful in HIV-infected male patients originating from sub-Saharan Africa?
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?
Is there a need for neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Canada?
Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?
Isoflurane Induced Malignant Hyperthermia in a Patient with Glucose 6-Phosphate Dehydrogenase Deficiency and Growth Hormone Abuse.
Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates.
Jaundice associated with lobar pneumonia. A clinical, laboratory and histological study.
Jaundice: a 10 year review of 41,000 live born infants.
Jaundice: clinical practice in 88,000 liveborn infants.
Jordan: communities and community genetics.
Kawasaki disease with G6PD deficiency - Report of one case and literature review.
Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report.
Kelley-Seegmiller syndrome in a patient with complete hypoxanthine-guanine phosphoribosyltransferase deficiency.
Kernicterus and G6PD deficiency--a case series from Oman.
Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature.
Kinetic analysis in single, intact cells by microspectrophotometry: evidence for two populations of erythrocytes in an individual heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
Lack of association between falciparum malaria parasitemia and acute diarrhea in Nigerian children.
Lack of association between glucose-6-phosphate dehydrogenase deficiency and dextromethorphan O-demethylation polymorphism.
Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism.
Laparoscopic cholecystectomy and postoperative pain control in a patient with chronic non-spherocytic hemolytic anemia from glucose-6-phosphate dehydrogenase deficiency.
Large cohort screening of G6PD deficiency and the mutational spectrum in the Dongguan District in Southern China.
Late onset jaundice and urinary tract infection in neonates.
Late-Life Presentation of Unsuspected G6PD Deficiency.
Leg ulcers in a family with both beta thalassaemia and glucose-6-phosphate dehydrogenase deficiency.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Letter to the editor: G6PD deficiency in the Tafenoquine era.
Letter: complete deficiency of glucose-6-phosphate dehydrogenase and neutrophil dysfunction.
Letter: Glucose-6-phosphate dehydrogenase deficiency and co-trimoxazole.
Leucocyte glucose-6-phosphate dehydrogenase deficiency and necrotizing pneumonia.
Leukocytoclastic vasculitis resolution with topical dapsone.
Life and Death of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Erythrocytes - Role of Redox Stress and Band 3 Modifications.
Life-threatening haemolysis induced by henna in a Sudanese child with glucose-6-phosphate dehydrogenase deficiency.
Linkage between deficiency of glucose-6-phosphate dehydrogenase and colour-blindness.
Linkage between glucose-6-phosphate dehydrogenase deficiency and colour-blindness.
Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis.
Linkage disequilibrium between glucose-6-phosphate dehydrogenase deficiency and congenital color blindness in Turkish population.
Lipid peroxidation and antioxidant capacity of G6PD-deficient patients with A-(202G>A) mutation.
Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency.
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.
Loss of flaps due to glucose-6-phosphate dehydrogenase deficiency. Case report.
Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern Tanzania.
Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency.
Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria.
Low to Normal Plasma Levels of Marinobufagenin 24 Hours or More after an Ischemic Stroke: A Pilot Study.
Low-grade haemolysis and assessment of iron status during the steady state in G6PD-deficient subjects.
Malaria and diabetes.
Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa.
Malaria and glucose 6-phosphate dehydrogenase deficiency in populations with high and low spleen rates in Madang, Papua New Guinea.
Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia.
MALARIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THAILAND.
Malaria and glucose-6-phosphate dehydrogenase deficiency.
Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border.
Malaria chemoprophylaxis.
Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago.
Malaria in Brent: successful treatment in the community.
Malaria in the Greater Mekong Subregion: Heterogeneity and complexity.
Malaria in the Guangxi Zhuang Autonomous Region in China: A Twelve-Year Surveillance Data Study.
Malaria, favism and glucose-6-phosphate dehydrogenase deficiency.
Malaria, glucose-6-phosphate dehydrogenase deficiency, and Hb S.
Malaysian mothers' knowledge & practices on care of neonatal jaundice.
Malignant hyperthermia and glucose-6-phosphate dehydrogenase deficiency.
Management of Athletes With G6PD Deficiency: Does Missing an Enzyme Mean Missing More Games?
Management of children with glucose-6-phosphate dehydrogenase deficiency presenting with acute haemolytic crisis during the SARs-COV-2 pandemic.
Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
Management of relapsing Plasmodium vivax malaria.
Mandibular nerve neuropathy in sickle cell disease. Local factors.
Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X.
Marked decline of favism after neonatal glucose-6-phosphate dehydrogenase screening and health education: the northern Sardinian experience.
Marked variation in prevalence of malaria-protective human genetic polymorphisms across Uganda.
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Mary Lyon and the hypothesis of random X chromosome inactivation.
Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore.
Mass newborn screening in Singapore.
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Mass screening for glucose-6-phosphate dehydrogenase deficiency: improved fluorescent spot test.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Massive acute haemolysis in neonates with glucose-6-phosphate dehydrogenase deficiency.
Massive hemolysis following inhalation of volatile nitrites.
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children.
Maternal Empowerment - an underutilized strategy to prevent kernicterus?
Maternal inheritance of manic depression in hemizygotes for the G6PD-Mediterranean mutation. Indirect evidence for Xq28 transmission in Sardinia.
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal.
Mathematical modelling of energy and redox metabolism of G6PD-deficient erythrocytes.
Mathematical modelling of metabolic pathways affected by an enzyme deficiency. Energy and redox metabolism of glucose-6-phosphate-dehydrogenase-deficient erythrocytes.
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Mechanisms of perturbation of erythrocyte calcium homeostasis in favism.
Mechanisms underlying glucose-6-phosphate dehydrogenase deficiency: heterogeneity of response to stromal activation in erythrocytes.
Medical genetics in Singapore.
Medical genetics in Thailand.
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Mediterranean glucose 6-phosphate dehydrogenase (G6PD) deficiency--near normal decay of the mutant enzyme protein in circulating erythrocytes.
Membrane protein carbonylation of Plasmodium falciparum infected erythrocytes under conditions of sickle cell trait and G6PD deficiency.
Metabolic Insight of Neutrophils in Health and Disease.
Metabolic profiling reveals alterations in the erythrocyte response to fava bean ingestion in G6PD-deficient mice.
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
Metabolism of human erythrocytes. Studies in health and disease.
Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
Metformin-Induced Hemolytic Anemia in a Patient With Glucose-6-Phosphate Dehydrogenase Deficiency.
Methaemoglobinaemia after cardiac catheterisation: a rare cause of cyanosis.
Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result.
Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
Methaemoglobinaemia with G6PD deficiency; rare cause of persistently low saturations in neonates.
Methemoglobinemia - The Cryptic Cause of Dyspnoea.
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
Methemoglobinemia and intravascular hemolysis in a patient with G6PD deficiency.
Methemoglobinemia associated with massive acetaminophen ingestion: a case series.
Methemoglobinemia in an elderly patient with glucose-6-phosphate dehydrogenase deficiency: a case report.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Methemoglobinemia induced by methylene blue pertubation during laparoscopy.
Methemoglobinemia induced by rasburicase in a pediatric patient: A case report and literature review.
Methemoglobinemia: etiology, pharmacology, and clinical management.
Methylene Blue Induced Methemoglobinemia with Acute Kidney Injury in a Glucose-6-Phosphate Dehydrogenase-deficient Patient.
Methylene blue-induced hyperbilirubinemia in neonatal glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment.
Microsomal incubation test of potentially hemolytic drugs for glucose-6-phosphate dehydrogenase deficiency.
MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN GREEK MALES.
Military ethics and G6PD deficiency.
Modeling human glucose-6-phosphate dehydrogenase mutations using C. elegans GSPD-1.
Modeling Plasmodium vivax: Relapses, treatment, seasonality, and G6PD deficiency.
Modelling primaquine-induced haemolysis in G6PD deficiency.
Moderate G6PD deficiency increases mutation rates in the brain of mice.
Moderate to severe hemolytic disease of the newborn in a referral centre in Saudi Arabia.
Modification of neonatal screening test for erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts.
Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.
Molecular basis of G6PD deficiency in India.
Molecular basis of glucose-6-phosphate dehydrogenase (G6PD) deficiency in three Taiwan aboriginal tribes.
Molecular basis of glucose-6-phosphate dehydrogenase deficiency among Filipinos.
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population.
Molecular characterisation of red cell glucose-6-phosphate dehydrogenase deficiency in north-west Pakistan.
Molecular characterisation of red cell glucose-6-phosphate dehydrogenase deficiency in Singapore Chinese.
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
Molecular characterization of a German variant of glucose-6-phosphate dehydrogenase deficiency (G6PD Aachen).
Molecular characterization of Chinese G6PD deficiency by using polymerase chain reaction/single strand conformation polymorphism.
Molecular Characterization of Cosenza Mutation among Patients with Glucose-6-Phosphate Dehydrogenase Deficiency in huzestan Province, Southwest Iran.
Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District, United Arab Emirates.
Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Tunisia.
Molecular Characterization of G6PD Deficiency at a North Indian Centre: Implications for Diagnostic Testing Laboratories in Different Regions of India.
Molecular characterization of G6PD deficiency in Cyprus.
Molecular characterization of G6PD deficiency in Oman.
Molecular characterization of G6PD deficiency in Southern Italy: heterogeneity, correlation genotype-phenotype and description of a new variant (G6PD Neapolis).
Molecular Characterization of G6PD Deficiency: Report of Three Novel G6PD Variants.
Molecular characterization of G6PD Insuli--a novel 989 CGC --> CAC (330 Arg --> His) mutation in the Indian population.
Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population.
Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites: five mutations account for most G6PD deficiency cases in Taiwan.
Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency among Jordanians.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Brazil.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Chinese infants with or without severe neonatal hyperbilirubinaemia.
Molecular Characterization of Glucose-6-phosphate Dehydrogenase Deficiency in Families from the Republic of Macedonia and Genotype-phenotype Correlation.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Jeddah, Kingdom of Saudi Arabia.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Pakistani population.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Eastern Province of Saudi Arabia.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Shenzhen Population.
Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Turkey.
Molecular Characterization of Glucose-6-Phosphate Dehydrogenase: Do Single Nucleotide Polymorphisms Affect Hematological Parameters in HIV-Positive Patients?
Molecular deficiency of glucose-6-phosphate dehydrogenase in primaquine sensitivity.
Molecular epidemiological investigation of G6PD deficiency by a gene chip among Chinese Hakka of southern Jiangxi province.
Molecular Epidemiological Survey of Glucose-6-Phosphate Dehydrogenase Deficiency and Thalassemia in Uygur and Kazak Ethnic Groups in Xinjiang, Northwest China.
Molecular epidemiology and activity of erythrocyte G6PD variants in a homogeneous Nigerian population.
Molecular Epidemiology of G6PD Genotypes in Different Ethnic Groups Residing in Saharan and Sahelian Zones of Mauritania.
Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in a population of newborns from Ivory Coast.
Molecular genetics of glucose-6-phosphate dehydrogenase deficiency in Mexico.
Molecular genetics of the glucose-6-phosphate dehydrogenase (G6PD) Mediterranean variant and description of a new G6PD mutant, G6PD Andalus1361A.
Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese.
Molecular genotyping of G6PD mutations and Duffy blood group in Afro-descendant communities from Brazilian Amazon.
Molecular heterogeneity of G6PD deficiency in an Amazonian population and description of four new variants.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase A-.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency among the tribals in Western India.
Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Gaza Strip Palestinians.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Malays in Malaysia.
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Mexico: overall results of a 7-year project.
Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population.
Molecular identification of mutations in G6PD gene in patients with favism in Iran.
Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Molecular study of eight Japanese cases of glucose-6-phosphate dehydrogenase deficiency by nonradioisotopic single-strand conformation polymorphism analysis.
Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India.
Molecular variants of red cell glucose-6-phosphate dehydrogenase deficiency in Central Java, Indonesia.
More on the association of glucose-6-phosphate dehydrogenase deficiency with hairy-cell leukemia.
MORPHOLOGICAL DEMONSTRATION OF 2 RED CELL POPULATIONS IN HUMAN FEMALES HETEROZYGOUS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency.
Multimodality imaging of a neonatal wandering spleen.
Multiple G6PD mutations are associated with a clinical and biochemical phenotype similar to that of G6PD Mediterranean.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).
Multiplex primer extension reaction screening and oxidative challenge of glucose-6-phosphate dehydrogenase mutants in hemizygous and heterozygous subjects.
Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.
Muscle expression of glucose-6-phosphate dehydrogenase deficiency in different variants.
Muscle G6PD deficiency.
Muscle glucose-6-phosphate dehydrogenase deficiency.
Muscle glucose-6-phosphate dehydrogenase deficiency: restoration of enzymatic activity in hybrid myotubes.
Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: mechanism and implication.
Mutation in the glucose-6-phosphate dehydrogenase gene leads to inactivation of Ku DNA end binding during oxidative stress.
Mutation of glucose-6-phosphate dehydrogenase deficiency in Chinese Han children in eastern Fujian.
Mutations and haplotype diversity in 70 Portuguese G6PD-deficient individuals: an overview on the origin and evolution of mutated alleles.
N-acetyl cysteine, L-cysteine, and beta-mercaptoethanol augment selenium-glutathione peroxidase activity in glucose-6-phosphate dehydrogenase-deficient human erythrocytes.
N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency.
NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites.
NADP+ and NADPH in glucose-6-phosphate dehydrogenase-deficient erythrocytes under oxidative stimulation.
NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Naphthalene Toxicity in a Three-Year-Old Child Complicated by Severe Hemolytic Anemia and Mild Methemoglobinemia: A Case Report.
Naphthalene Toxicity in Clinical Practice.
Naphthalene-induced hemolytic anemia in a child with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
National G6PD neonatal screening program in Gaza Strip of Palestine: rationale, challenges and recommendations.
Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn.
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Negro variant of glucose-6-phosphate dehydrogenase deficiency (A-) in man.
Neonatal anti-Kell isoimmune hemolytic disease with spherocytes.
Neonatal bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in preterm and low-birth-weight infants in Israel.
Neonatal bilirubin production-conjugation imbalance: effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity.
Neonatal biochemical screening for disease.
Neonatal cholestasis and glucose-6-P-dehydrogenase deficiency.
Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency.
Neonatal exchange transfusion: a Jordanian experience.
Neonatal hyperbilirubinaemia in heterozygous glucose-6-phosphate dehydrogenase deficient females.
Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.
Neonatal Hyperbilirubinemia in infants with G6PD c.563C > T Variant.
Neonatal hyperbilirubinemia: don't let glucose-6-phosphate dehydrogenase deficiency off the hook.
Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants.
Neonatal jaundice and severity of glucose-6-phosphate dehydrogenase deficiency in Sardinian babies.
Neonatal jaundice associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a non-Mediterranean Caucasian infant with trisomic Down's Syndrome.
Neonatal Jaundice Associated with Familial G6PD Deficiency in Israel.
Neonatal jaundice in Asia.
Neonatal jaundice in Qatif: The role of glucose-6-phosphate dehydrogenase deficiency in the etiology among outpatient cases.
Neonatal jaundice in Zaria, Nigeria--a second prospective study.
Neonatal jaundice, aflatoxins and naphthols: report of a study in Ibadan, Nigeria.
Neonatal jaundice--traditional Chinese medicine approach.
Neonatal jaundice. A second 4-year experience in Toa Payoh Hospital (1986-1989).
Neonatal jaundice: two cases associated with glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Neonatal nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a Danish infant.
Neonatal nucleated red blood cells in G6PD deficiency.
Neonatal screening and monitoring system in Taiwan.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency fails to detect heterozygote females.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: sex distribution.
Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa.
Neonatal screening in Hong Kong and Macau.
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Khorfakkan, United Arab Emirates.
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia.
Neonatal screening program for G6PD deficiency in India: need and feasibility.
Neonatal screening program in Rajavithi Hospital, Thailand.
Neonatal transfusion malaria requiring exchange transfusion.
Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia.
Neurological complications of kernicterus.
Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency.
Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.
New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension.
New considerations on the distribution of malaria, thalassemia, and glucose-6-phosphate dehydrogenase deficiency in Sardinia.
New data on glucose-6-phosphate dehydrogenase deficiency in Saudi Arabia. G6PD variants, and the association between enzyme deficiency and hemoglobins S.
New developments in glucose-6-phosphate dehydrogenase deficiency.
New Diagnosis of G6PD Deficiency Presenting as Severe Rhabdomyolysis.
New genetic variants of glucose 6-phosphate dehydrogenase (G6PD) in Italy.
New insights into G6PD deficiency.
New onset diabetes complicated by haemolysis and rhabdomyolysis: a case report and review of the literature.
New stable mutant (Gd(-) variants: G6PD Tashkent and G6PD Nucus. Molecular basis of hereditary enzyme deficiency.
Newborn Screening for Congenital Hypothyroidism, Congenital Adrenal Hyperplasia, and Glucose-6-Phosphate Dehydrogenase Deficiency for Improving Health Care in India.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
Newborn screening for G6PD deficiency: A 2-year data from North India.
Newborn screening for glucose-6-phosphate dehydrogenase deficiency in Isfahan, Iran: a quantitative assay.
Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
Newborn screening in Singapore.
Newborn screening in the Asia Pacific region.
Newborn screening in the Philippines.
Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin.
Non-inactivation of an x-chromosome locus in man.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Novel human pathological mutations. Gene symbol: G6PD. Disease: glucose-6-phosphate dehydrogenase deficiency.
Novel point mutation in exon 12 of the glucose-6- phosphate dehydrogenase gene: G6PD FLORES.
Nucleotide 1376 G-->T mutation in G6PD-deficient Chinese in Malaysia.
Nucleotide variability at G6pd and the signature of malarial selection in humans.
Nutritional Status of Young Children with Inherited Blood Disorders in Western Kenya.
Ob-Gyn Section: G6PD deficiency.
Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
Observations on the inheritance of glucose-6-phosphate dehydrogenase deficiency in erythrocytes and in leucocytes.
Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.
Occurrence and clinical implications of red-cell glucose-6-phosphate dehydrogenase deficiency in South African racial groups.
OCT Angiographic Findings in Glucose-6-Phosphate Dehydrogenase Deficiency.
Ocular cicatricial pemphigoid (Review).
Old and new genetics help ordering loci at the telomere of the human X-chromosome long arm.
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.
Optimizing Measurement and Interpretation of the G6PD/Hb Ratio.
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East.
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Oseltamivir and G6PD deficiency.
Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life.
Overt hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a survey in general practice.
Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation.
Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells.
Oxidative damage in chemical teratogenesis.
Oxidative haemolysis secondary to high-dose vitamins in a woman with glucose-6-phosphate dehydrogenase deficiency.
Oxidative hemoglobin breakdown induced by a rubber additive.
Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency.
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
Ozone: a possible cause of hemolytic anemia in glucose-6-phosphate dehydrogenase deficient individuals.
Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom.
Parental discussion of G6PD deficiency and child health: implications for clinical practice.
Paroxysmal Nocturnal Hemoglobinuria with Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Review of the Literature.
Partial exchange transfusion prior to treating cerebral malaria in an African child with glucose-6-phosphate dehydrogenase deficiency.
Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
Parvovirus-associated aplastic crisis in a patient with red blood cell glucose-6-phosphate dehydrogenase deficiency.
Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review.
Pathogenesis of anemia in malaria: a concise review.
Pathogenesis, laboratory diagnosis, and clinical implications of erythrocyte enzyme deficiencies in dogs, cats, and horses.
Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Pathophysiology of spontaneous neonatal bilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency.
Pathways for the reduction of oxidized glutathione in the Plasmodium falciparum-infected erythrocyte: can parasite enzymes replace host red cell glucose-6-phosphate dehydrogenase?
Patient with toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report.
Patients with genetic defects in the gamma-glutamyl cycle.
Pattern of Hemolytic Anemia Among Egyptian Pediatric Emergency Department Patients.
Patterns of sickle cell, thalassaemia and glucose-6-phosphate dehydrogenase deficiency genes in north-western Saudi Arabia.
PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.
Peas, beans, and the Pythagorean theorem - the relevance of glucose-6-phosphate dehydrogenase deficiency in dermatology.
Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency.
Pegloticase Induced Hemolytic Anemia in a Patient With G6PD Deficiency.
Pelvic pain, low blood pressure, and hemolysis after outpatient hysteroscopy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Percentage glycosylated haemoglobin in normal, G6PD deficient and HbSS Saudi Arabs.
Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects.
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Periodontal considerations in a patient with glucose-6-phosphate dehydrogenase deficiency with associated pancytopenia: A rare case report.
Periodontal disease and hemolysis in glucose-6-phosphate dehydrogenase deficiency: Is there a nexus?
Perioperative challenges in a patient of severe G6PD deficiency undergoing open heart surgery.
Perioperative management in a case of glucose-6-phosphate dehydrogenase deficiency undergoing orthopaedic surgery.
Perioperative management of glucose 6 phosphate dehydrogenase deficiency. A review of the literature.
Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiency.
Peripheral red blood cell survival invariance during piroxicam treatment in subjects with glucose-6-phosphate dehydrogenase deficiency.
Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
PGI*3(Israel), a new, unstable allele in the phosphoglucose isomerase system.
Pharmacoanthropology: outline, problems, and the nature of case histories.
Pharmacogenetic considerations in the treatment of gout.
Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
Pharmacogenetics. Glucose-6-phosphate dehydrogenase deficiency.
Pharmacokinetic Interactions and Safety Evaluations of Coadministered Tafenoquine and Chloroquine in Healthy Subjects.
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria.
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Phenazopyridine-induced hemolytic anemia in a patient with G6PD deficiency.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Phenotype heterogeneity of hyperbilirubinemia condition: the lesson by coinheritance of glucose-6-phosphate dehydrogenase deficiency and Crigler-Najjar syndrome type II in an Italian patient.
Phenotypic and genotypic characterization of glucose-6-phosphate dehydrogenase deficiency in Argentina. Retrospective and descriptive study.
Phosphoglycerate kinase deficiency: biochemical studies on hair follicles.
Phospholipid content and phospholipid fatty acid composition of red blood cells in enzyme defect hemolytic anemias.
Phototherapy for neonatal jaundice in erythrocyte glucose-6-phosphate dehydrogenase-deficient infants.
Phototherapy in newborn infants with glucose-6-phosphate dehydrogenase deficiency.
Pityriasis rotunda and G6PD deficiency.
Plan and process for hematology laboratory standard in Thailand.
Plasma cell leukemia revealing a G6PD deficiency.
Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.
Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes.
Platelet-function studies in patients with glucose-6-phosphate dehydrogenase deficiency.
Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study.
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies.
Poor iron store recovery in voluntary blood donors in the northern zone of Ghana; a five-month three-centre cohort study.
Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity.
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria.
Population genetic studies in the Congo. II. Effect of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency on mortality and fertility.
Population genetic study among the Orange Asli (Semai Senoi) of Malaysia: Malayan aborigines.
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.
Population genetics of malaria resistance in humans.
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Population screening for glucose-6-phosphate dehydrogenase deficiency on the Baleares.
Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria.
Population study of 1311 C/T polymorphism of Glucose 6 Phosphate Dehydrogenase gene in Pakistan - an analysis of 715 X-chromosomes.
Populations and genetic polymorphisms.
Positive Impact of Clinical Audit on Appropriateness of Laboratory Investigations for Glucose-6-Phosphate Dehydrogenase-Deficient Patients in the Emergency Department.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency.
Possible fenugreek induced haemolysis in a patient with previously unknown G6PD deficiency.
Possible incompatibility of glucose-6-phosphate dehydrogenase deficiency and championship athletic performance.
Possible potentiation of hemolytic anemia by tolbutamide. Report of a patient with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Post-anaesthetic jaundice due to glucose-6-phosphate dehydrogenase deficiency.
Posttransfusional hemolysis in recipients of glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Potential Risks of Hemolysis after Short-Term Administration of Analgesics in Children with Glucose-6-Phosphate Dehydrogenase Deficiency.
Predicting significant hyperbilirubinaemia and early discharge for glucose-6-phosphate dehydrogenase deficient newborns.
Prediction of functional consequences of the five newly discovered G6PD variations in Taiwan.
Predictive models for human glucose-6-phosphate dehydrogenase deficiency.
Predictors of Acute Bilirubin Encephalopathy Among Nigerian Term Babies with Moderate-to-severe Hyperbilirubinaemia.
Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Preliminary experience with the differential pH technique for glucose-6-phosphate dehydrogenase (G6PD) measurement in whole blood: application to an area with high prevalence of thalassaemia and G6PD deficiency.
Preliminary report on neonatal screening for congenital hypothyroidism, congenital adrenal hyperplasia and glucose-6-phosphate dehydrogenase deficiency: a Chandigarh experience.
Preliminary results of a geographic correlation study on G6PD deficiency and cancer.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency.
Prenatal selection and fetal development disturbances occurring in carriers of G6PD deficiency.
Prenatal Training Improves New Mothers' Understanding of Jaundice.
Present status of understanding on the G6PD deficiency and natural selection.
Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes.
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Prevalence and Genetic Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in Anemic Subjects from Uttar Pradesh, India.
Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Females from Previously Malaria Endemic Regions in Northeastern Thailand and Identification of a Novel G6PD Variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand.
Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Lue ethnic group of northern Thailand.
Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq.
Prevalence and molecular defect characterization of glucose-6-phosphate dehydrogenase deficiency in Brazilian blood donors.
Prevalence and molecular identification of the mediterranean variant among G6PD-deficient Sistani and Balouch males in Southeastern Iran.
Prevalence and molecular study of G6PD deficiency in Malaysian Orang Asli.
Prevalence and Molecular Study of G6PD Deficiency in the Dai and Jingpo Ethnic Groups in the Dehong Prefecture of the Yunnan Province.
Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
Prevalence and Significance of G6PD Deficiency in Patients of an Urban HIV Clinic.
Prevalence and spectrum of mutations causing G6PD deficiency in Indian populations.
Prevalence of abnormal hemoglobins, thalassaemia and erythrocyte glucose-6-phosphate dehydrogenase deficiency in Kashmiris: a preliminary study.
Prevalence of and mothers' knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study.
Prevalence of anemia, iron deficiency, thalassemia and glucose-6-phosphate dehydrogenase deficiency among hill-tribe school children in Omkoi District, Chiang Mai Province, Thailand.
Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews.
Prevalence of classic erythrocyte polymorphisms among 749 children in southern highland Rwanda.
Prevalence of erythrocyte G6PD deficiency in Sabah.
Prevalence of Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Population of Western Turkey.
Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population.
Prevalence of G6PD deficiency among recruits in the Singapore Armed Forces.
Prevalence of G6PD deficiency and associated haematological parameters in children from Botswana.
Prevalence of G6PD deficiency and knowledge of diagnosis in a sample of previously unscreened Lebanese males: clinical implications.
Prevalence of G6PD deficiency and molecular characterization of G202A, A376G and C563T polymorphisms in newborns in Southeastern Brazil.
Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Prevalence of G6PD deficiency in Children with Hepatitis A.
Prevalence of G6PD deficiency in Iran, a mata-analysis.
Prevalence of G6PD Deficiency in Iran.
Prevalence of G6PD deficiency in Iranian neonates with jaundice: a systematic review and meta-analysis.
Prevalence of G6PD Deficiency in Neonatal Sepsis in Iran.
Prevalence of G6PD deficiency in newborns in the south of Brazil.
Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.
Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency Among Children in Eastern Saudi Arabia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency among neonates at a tertiary care centre in Lebanon.
Prevalence of glucose-6-phosphate dehydrogenase deficiency among schoolboys in Kermanshah, Islamic Republic of Iran.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency and Gametocytemia in a Pre-Elimination, Low Malaria Transmission Setting in Southern Zambia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and the role of the A- variant in a Saudi population.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Northern Greece.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Sichuan, China.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in sickle-cell disease.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Prevalence of glucose-6-phosphate dehydrogenase deficiency.
Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok.
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.
Prevalence of malaria in Ao Nagas and its association with G6PD and HbE.
Prevalence of neonatal hyperbilirubinaemia and its association with glucose-6-phosphate dehydrogenase deficiency and blood-type incompatibility in sub-Saharan Africa: a systematic review and meta-analysis.
Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.
Prevalence of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency.
Prevalence of thalassaemia, iron-deficiency anaemia and glucose-6-phosphate dehydrogenase deficiency among Arab migrating nomad children, southern Islamic Republic of Iran.
Prevalence of thalassemia and G6PD deficiency in North Cyprus.
Prevalence of Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency in Newborns and Adults at the Ramathibodi Hospital, Bangkok, Thailand.
Prevalence of UGT1A1 (TA)n promoter polymorphism in Panamanians neonates with G6PD deficiency.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Prevention of intellectual and other disabilities: the Singapore experience.
Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.
Priapism and glucose-6-phosphate dehydrogenase deficiency: An underestimated correlation?
Priapism in hematological and coagulative disorders: an update.
Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate.
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Primaquine overdose in a toddler.
Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk.
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
Primaquine therapy for malaria.
Primaquine toxicity forestalls effective therapeutic management of the endemic malarias.
Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Primaquine: the risks and the benefits.
Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Proceedings: Red cell cytochemistry in glucose-6-phosphate dehydrogenase deficiency.
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects.
Prognosis of hemolytic anemia in G6PD- subjects. Multifactorial cluster analysis of biochemical characteristics of red cell age groups.
Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion.
Prolonged indirect hyperbilirubinemia in a moderately preterm boy with Mediterranean glucose-6-phosphate dehydrogenase and glutathione S-transferase Mu 1 null mutations.
Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.
Propofol infusion in an infant with glucose-6-phosphate dehydrogenase deficiency.
Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi.
Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria.
Protective Role of G6PD Deficiency in Aluminium Phosphide Poisoning.
Protective role of G6PD deficiency in poisoning by aluminum phosphide; are there possible new treatments?
Protein methylation as a marker of aspartate damage in glucose-6-phosphate dehydrogenase-deficient erythrocytes: role of oxidative stress.
Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B?-mediated cytotoxicity.
Proteomic signature of muscle fibre hyperplasia in response to faba bean intake in grass carp.
Protoporphyrin (proto)-determined hepatopathy in a South African Jewish family.
PSEUDO-MOSAICISM IN MALES WITH MILD GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects.
Pulmonary hypertension in children and young adults with sickle cell disease: Evidence for familial clustering.
Pulmonary toxicity with mefloquine.
Pycnogenol prevents haemolytic injury in G6PD deficient human erythrocytes.
Pyruvate kinase deficiency. Association with G6PD deficiency.
Quality assurance program for neonatal screening of glucose-6-phosphate dehydrogenase deficiency.
Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis.
Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader.
Rapid and label-free single-nucleotide discrimination via an integrative nanoparticle-nanopore approach.
Rapid and reliable detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations in Han Chinese using high-resolution melting analysis.
Rapid detection of common Chinese glucose-6-phosphate dehydrogenase (G6PD) mutations by microarray-based assay.
Rapid detection of G6PD mutations by multicolor melting curve analysis.
Rapid detection of glucose-6-phosphate dehydrogenase gene mutations by denaturing high-performance liquid chromatography.
Rapid detection of twenty-nine common Chinese glucose-6-phosphate dehydrogenase variants using a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay on dried blood spots.
Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.
Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
Rapid genotyping of two common G6PD variants, African (A-) and Mediterranean, by high-resolution melting analysis.
Rapid quantitative assays for glucose-6-phosphate dehydrogenase (G6PD) and hemoglobin combined on a capillary-driven microfluidic chip.
Rapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA method.
Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem.
Rasburicase : a review of its use in the management of anticancer therapy-induced hyperuricaemia.
Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency.
Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect.
Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
Rasburicase-Induced Methemoglobinemia.
Rasburicase-induced Methemoglobinemia: A Case Report and Literature Review.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Rasburicase: a potent uricolytic agent.
Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome.
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies.
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
Rationale for short course primaquine in Africa to interrupt malaria transmission.
Re-evaluation of methaemoglobin reduction as a screening procedure for glucose-6-phosphate dehydrogenase (G6PD).
Re-inventing the wheel; the use of autologous and fresh donor blood in cardiac surgery.
Reactivity of Blood Samples Spotted onto Filter Papers in the WST-8 Method for Screening of G6PD Deficiency.
Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: A hospital-based retrospective study.
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Real-time monitoring of glucose-6-phosphate dehydrogenase activity using liquid droplet arrays and its application to human plasma samples.
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.
Reappraisal of known malaria resistance loci in a large multicenter study.
Reassessing an old claim: Natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.
Recombinant human G6PD for quality control and quality assurance of novel point-of-care diagnostics for G6PD deficiency.
Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
Red Blood Cell Enzyme Disorders.
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias.
Red blood cell-derived microparticles: An overview.
Red cell acid phosphatase activity in carriers of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Red cell and platelet derived microparticles are increased in g6pd deficient subjects.
Red cell enzyme deficiencies in the tribal population groups of the Bastar District, Madhya Pradesh, India.
Red cell enzymes glucose-6-phosphate dehydrogenase deficiency.
Red cell enzymopathies as a model of inborn errors of metabolism.
Red cell genetic abnormalities in Peninsular Arabs: sickle haemoglobin, G6PD deficiency, and alpha and beta thalassaemia.
Red cell genetic abnormalities, beta-globin gene haplotypes, and APOB polymorphism in the Great Andamanese, a primitive Negrito tribe of Andaman and Nicobar Islands, India.
Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Red cell glucose-6-phosphate dehydrogenase deficiency among Andhras.
Red cell glucose-6-phosphate dehydrogenase deficiency and haemoglobin variants among ten endogamous groups of Maharshtra and West Bengal.
Red cell glucose-6-phosphate dehydrogenase deficiency in ethnic groups in Israel.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland. Characterization of a new variant with severe enzyme deficiency.
Red cell glucose-6-phosphate dehydrogenase deficiency in Finland. Further biochemical characterization of G-6-PD Helsinki.
Red cell glucose-6-phosphate dehydrogenase deficiency in Pakistan.
Red cell glucose-6-phosphate dehydrogenase deficiency in the Jammu region of J&K State.
Red cell glucose-6-phosphate dehydrogenase deficiency in Turkey.
Red cell membrane protein in thalassemia and glucose-6-phosphate dehydrogenase deficiency anemia.
Red cell metabolism and severe neonatal jaundice in West Malaysia.
Red cell NADP+ and NADPH in glucose-6-phosphate dehydrogenase deficiency.
Red cell phosphoglucomutase (PGM)-deficiency: hereditary defect of the PGM1-locus.
Red cell proteasome modulation by storage, redox metabolism and transfusion.
Red cell pyruvate kinase deficiency in Southern Sardinia.
Red-cell GSH regeneration and glutathione reductase activity in G6PD variants in the Ferrara area.
Red-cell-membrane polypeptide aggregates in glucose-6-phosphate dehydrogenase mutants with chronic hemolytic disease. A clue to the mechanism of hemolysis.
Redox and energetic state of red blood cells in G6PD deficiency, heterozygous beta-thalassemia and the combination of both.
Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.
Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy.
Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns.
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency.
Reduction and transport of lipoic acid by human erythrocytes.
Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Reference levels for glucose-6-phosphate dehydrogenase enzyme activity in infants 7-90 days old in Taiwan.
Refractory Causes of Kernicterus in Developed Countries: Can We Eradicate G6PD Deficiency Triggered and Low-Bilirubin Kernicterus?
Regional enteritis and glucose-6-phosphate dehydrogenase deficiency.
Regional enteritis and granulomatous colitis associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.
Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria.
Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality.
Reliability of quantitative and qualitative tests to identify heterozygotes carrying severe or mild G6PD deficiency.
Reliability of three screening tests in detection of glucose-6-phosphate dehydrogenase deficiency in adults and neonates.
Report of an Italian family carrying a typical Indian variant of the Nilgiris tribal groups resulting from a
Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells.
Resistance to falciparum malaria among adults in central Sudan.
Response to the letter of Morán et al. regarding our use of an inaccurate reference for the maximal dose of vitamin C in G6PD deficiency.
Reticulocyte analysis in iron deficiency anemia and hemolytic anemia.
Retinitis Pigmentosa Associated with Glucose-6-Phosphate Dehydrogenase Deficiency.
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
Rhabdomyolysis and hemolysis associated with sickle cell trait and glucose-6-phosphate dehydrogenase deficiency.
Ribose metabolism and nucleic acid synthesis in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes infected with Plasmodium falciparum.
Right Middle Lobe Collapse and Pleural Effusion in an 18-Year-Old Man.
Risk Assessment for Adverse Outcome in Term and Late Preterm Neonates with Bilirubin Values of 20 mg/dL or More.
Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.
Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.
Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals.
Risk Factors for Sensorineural Hearing Loss in Neonatal Hyperbilirubinemia.
Risk of Hyperbilirubinemia in Breast-Fed Infants.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.
Role of G6PD, ABO incompatibility, low birth weight and infection in neonatal hyperbilirubinaemia.
Role of genetic factors and ethnicity on the multiplicity of Plasmodium falciparum infection in children with asymptomatic malaria in Yaoundé, Cameroon.
Role of glucose 6-phosphate dehydrogenase (G6PD) deficiency and its association to Autism Spectrum Disorders.
ROLE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN ACUTE HEMOLYTIC CRISIS AND NEONATAL JAUNDICE.
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
Role of vitamin E supplementation on serum levels of copper and zinc in hemolytic anemic patients with G6PD deficiency.
Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use.
Safe chemotherapy and hormone therapy for treating early breast cancer in a glucose 6-phosphate dehydrogenase-deficient patient: case report.
Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Safe neoadjuvant trastuzumab-based treatment in HER2?+?inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.
Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial.
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.
Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.
Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review.
Safety of Live Liver Donation by Individuals With G6PD Deficiency: Initial Results and Comparative Study.
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies.
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.
Safety of vitamin C in sepsis: a neglected topic.
Salicylamide glucuronide formation in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Sanfilippo syndrome, glucose-6-phosphate dehydrogenase deficiency and sickle cell/?(+) thalassemia in a child: The burden of consanguinity.
Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China.
Screening for G6PD Deficiency Among Neonates with Neonatal Jaundice Admitted to Tertiary Care Center: A Need in Disguise.
Screening for G6PD Deficiency in Blood Donor Population.
Screening for galactosemia and glucose-6-phosphate dehydrogenase deficiency in newborn infants.
Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Screening for glucose-6-phosphate dehydrogenase deficiency in a hospital laboratory.
Screening for glucose-6-phosphate dehydrogenase deficiency in blood donors.
Screening for glucose-6-phosphate dehydrogenase deficiency in haemolytic disorders: the methylene blue reduction test.
Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples.
Screening for glucose-6-phosphate dehydrogenase deficiency in newborns-practical considerations.
Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy.
Screening for glucose-6-phosphate dehydrogenase deficiency using a modified formazan method: a pilot study on Filipino male newborns.
Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Screening for glucose-6-phosphate dehydrogenase deficiency.
Screening for haemoglobinopathies and G6PD deficiency among the Mizos of Mizoram: a preliminary study.
Screening of jaundiced neonates for glucose-6-phosphate dehydrogenase deficiency.
Screening of pyruvate kinase deficiency and G6PD deficiency in Chinese newborn in Hong Kong.
Screening of the newborns for glucose-6-phosphate dehydrogenase deficiency.
Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype.
Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.
Senile cataract and glucose-6-phosphate dehydrogenase deficiency in Indians.
Seroprevalence of Malaria and Hepatitis B Coinfection among Pregnant Women in Tamale Metropolis of Ghana: A Cross-Sectional Study.
Serratia marcescens osteomyelitis in an infant.
Serum and red blood cell magnesium, copper, and zinc content in G6PD deficiency.
Serum bilirubin levels in 1-month-old, healthy, term infants from southern Turkey.
Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Serum lipoproteins in schoolboys in relation to glucose-6-phosphate dehydrogenase deficiency and thalassaemia trait.
Several mutations including two novel mutations of the glucose-6-phosphate dehydrogenase gene in Polish G6PD deficient subjects with chronic nonspherocytic hemolytic anemia, acute hemolytic anemia, and favism.
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency.
Severe atazanavir-associated hyperbilirubinemia revealing Canton G6PD deficiency in an Asian HIV-infected patient.
Severe G6PD Deficiency Due to a New Missense Mutation in an Infant of Northern European Descent.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Severe hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency and Epstein-Barr virus infection.
Severe hemolytic anemia due to transient acquired G6PD deficiency after ingestion of sodium chlorite.
Severe hemolytic anemia in black children with glucose-6-phosphate dehydrogenase deficiency.
Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency.
Severe hyperbilirubinemia in a glucose-6-phosphate dehydrogenase-deficient preterm neonate: could prematurity be the main responsible factor?
Severe hyperbilirubinemia in Thai newborns in association with erythrocyte G6PD deficiency.
Severe infections in thalassaemic patients: prevalence and predisposing factors.
Severe inflammatory reaction following corneal collagen cross-linking in a patient with glucose-6-phosphate dehydrogenase deficiency.
Severe jaundice in a gunshot casualty due to the coexistence of Dubin-Johnson and glucose-6-phosphate dehydrogenase deficiency.
Severe jaundice in a patient with a previously undescribed glucose-6-phosphate dehydrogenase (G6PD) mutation and Gilbert syndrome.
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.
Severe methemoglobinemia and syncope in a patient with glucose-6-phosphate dehydrogenase deficiency.
Severe methemoglobinemia in an infant with glucose-6-phosphate dehydrogenase deficiency.
Severe Methemoglobinemia Secondary to Ferula asafoetida Ingestion in an Infant: A Case Report.
Severe Neonatal Hyperbilirubinemia Decreased after the 2007 Canadian Guidelines.
Severe neonatal hyperbilirubinemia in the southeast region of Turkey
Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.
Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.
Severe Plasmodium vivax malaria, HIV, tuberculosis co-infection in a Sri Lankan traveller: case management and challenges during the prevention of malaria reintroduction phase.
Severe Rhabdomyolysis in Glucose-6-Phosphate Dehydrogenase Deficiency.
Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).
Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells.
Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?
Sickle cell anaemia in Jordan and its clinical patterns.
Sickle cell disease in Bahrain: coexistence and interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Sickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.
Sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency among Dhobis of Visakhapatnam, Andhra Pradesh, India.
Sickle cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency among Rellis of Visakhapatnam, Andhra Pradesh, South India.
Sickle cell hemoglobin, beta-thalassemia and G6PD deficiency in tribes of Maharashtra, India.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Sickle cell trait and G6PD deficiency in blood donors in eastern Saudi Arabia.
Sickle cell trait and glucose-6-phosphate dehydrogenase deficiency. Effects on health and military performance in black Navy enlistees.
Sickle cell trait, thalassaemia and glucose-6-phosphate dehydrogenase deficiency in the Bhil tribe of southern Rajasthan.
Sickle cell-thalassemia associated with G6PD deficiency in an African girl in Tanzania.
Sickle-cell haemoglobin and glucose-6-phosphate dehydrogenase deficiency in tribal populations of Andhra Pradesh.
Side-effects of henna and semi-permanent 'black henna' tattoos: a full review.
Sideroblastic anemia segregating with glucose-6-phosphate dehydrogenase deficiency.
Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
Single dose primaquine in a preclinical model of G6PD deficiency: implications for use in malaria transmission blocking programs.
Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
Small-Molecule Activators of Glucose-6-phosphate Dehydrogenase (G6PD) Bridging the Dimer Interface.
Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.
Some hereditary red-cell traits in Kalahari Bushmen and Bantu: hemoglobins, glucose-6-phosphate dehydrogenase deficiency, and blood groups.
Some Mexican glucose-6-phosphate dehydrogenase variants revisited.
Some observations on glutathione instability and glucose-6-phosphate dehydrogenase deficiency in infants and children having anaemia and jaundice.
Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency.
Spectrophotometric evaluation of results of the ascorbate and the ascorbate-cyanide screening tests for glucose-6-phosphate dehydrogenase deficiency.
Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
Spectrum of acute cortical necrosis in Indian patients.
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
Spleen size determined by ultrasound in patients with sickle cell trait, HbAC trait and glucose-6-phosphate-dehydrogenase deficiency in a malaria hyperendemic area (Ashanti Region, Ghana).
Splenic visualization in a patient with glucose-6-phosphate dehydrogenase deficiency.
Sporadic G6PD deficiency with haemolytic anaemia in two children of West European ancestry.
Spotlight on rasburicase in anticancer therapy-induced hyperuricemia.
Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer.
Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency.
Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A(-) deficiency.
Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity.
Structural defects underlying protein dysfunction in human glucose-6-phosphate dehydrogenase A(-) deficiency.
Structure and function of glucose-6-phosphate dehydrogenase-deficient variants in Chinese population.
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia.
Student screening for inherited blood disorders in Bahrain.
Studies of Glucose-6-Phosphate Dehydrogenase Activity of Individual Erythrocytes: The Methemoglobin-Elution Test for Identification of Females Heterozygous for G6PD Deficiency.
Studies of the distribution of haemoglobin E, thalassaemias and glucose-6-phosphate dehydrogenase deficiency in north-eastern Thailand.
Studies on several genetic hematologic traits of Mexicans IX. Abnormal hemoglobins and erythrocytic glucose-6-phosphate dehydrogenase deficiency in several Indian tribes.
STUDIES ON SEVERAL GENETIC HEMATOLOGICAL TRAITS OF THE MEXICAN POPULATION. 8. HEMOGLOBIN S, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, AND OTHER CHARACTERISTICS IN A MALARIAL REGION.
Studies on several genetic hematological traits of the Mexican population. XVI. Hemoglobin, S and glucose-6-phosphate dehydrogenase deficiency in the east coast.
Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain).
STUDIES ON THE CORRELATION OF THE GENETICALLY DETERMINED TRAIT, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, WITH BEHAVIORAL MANIFESTATIONS IN SCHIZOPHRENIA.
STUDIES ON THE DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, THALASSEMIA, AND OTHER GENETIC TRAITS IN THE COASTAL AND MOUNTAIN VILLAGES OF CYPRUS.
Study of a family in the province of Matera presenting with glucose-6-phosphate dehydrogenase deficiency and Gilbert's syndrome.
Study of erythrocyte G6PD deficiency in leprosy.
Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India.
Study of glucose-6-phosphate dehydrogenase (G6PD) in the Kissan tribals of Orissa and the Kannikar tribals of Kerala, India.
Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
Study of glucose-6-phosphate dehydrogenase: history and molecular biology.
Study of red cell membrane lipids in glucose-6-phosphate dehydrogenase deficiency anemia.
Study on glucose-6-phosphate dehydrogenase deficiency in Laos.
STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis.
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana.
Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test.
Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.
Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests.
Superoxide dismutase activity and reduced glutathione content in cataractous lens of patients with glucose-6-phosphate dehydrogenase deficiency.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Fiji.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Hawaii.
Survey for erythrocyte glucose-6-phosphate dehydrogenase deficiency in Polynesians.
Survey on haemoglobin variants, beta thalassaemia, glucose-6-phosphate dehydrogenase deficiency, and haptoglobin types in Turks from western Thrace.
Survey on haemoglobin variants, beta-thalassaemia, glucose-6-phosphate dehydrogenase deficiency and haptoglobin types in Turkish people living in Manavgat, Serik and Boztepe (Antalya).
SURVIVAL OF 51 CR-LABELLED RED CELLS IN SUBJECTS WITH THALASSAEMIA-TRAIT OR G6PD DEFICIENCY OR BOTH ABNORMALITIES.
Sweat test in patients with glucose-6-phosphate-1-dehydrogenase deficiency.
Sweetened blood cools hot tempers: physiological self-control and aggression.
Synchrony of G6PD activity and RBC fragility under oxidative stress exerted at normal and G6PD deficiency.
Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.
Tafenoquine and G6PD: a primer for clinicians.
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Tafenoquine for primary and terminal prophylaxis of malaria in apparently healthy people: a systematic review.
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
Tafenoquine Is a Promising Drug Candidate for the Treatment of Babesiosis.
Tafenoquine: a toxicity overview.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
tert-Butyl Hydroperoxide (tBHP)-Induced Lipid Peroxidation and Embryonic Defects Resemble Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in C. elegans.
Thalassaemia and glucose-6-phosphate dehydrogenase deficiency in sickle-cell disorder patients in Taiz, Yemen.
Thalassaemia and glucose-6-phosphate dehydrogenase screening in 13- to 14-year-old students of the Sardinian population: preliminary findings.
THALASSAEMIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, SICKLING, AND MALARIAL ENDEMICITY IN GREECE: A STUDY OF FIVE AREAS.
Thalassemia and G6PD deficiency in Spanish blood donors.
Thalassemia trait and G6PD deficiency in Thai blood donors.
THALASSEMIAS, ABNORMAL HEMOGLOBINS AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THE ARTA AREA OF GREECE: DIAGNOSTIC AND GENETIC ASPECTS OF COMPLETE VILLAGE STUDIES.
The ascorbate cyanide test and the detection of females heterozygous for glucose-6-phosphate dehydrogenase deficiency.
The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females.
The association between glucose-6-phosphate dehydrogenase deficiency and cancer in American Negroes.
The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia.
The blood groups, serum groups, red-cell isoenzymes and haemoglobins of the Sandawe and Nyaturu of Tanzania.
The burden and consequences of inherited blood disorders among young children in western Kenya.
The burden of genetic disorders in India and a framework for community control.
The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.
The clonal organization of the squamous epithelium of the tongue.
The co-evolution of people, plants, and parasites: biological and cultural adaptations to malaria.
The coincidence of glucose-6-phosphate dehydrogenase deficiency and hemoglobin S gene in Cukurova Province, Turkey.
The Controversial Role of Glucose-6-Phosphate Dehydrogenase Deficiency on Cardiovascular Disease: A Narrative Review.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The detection of glucose-6-phosphate dehydrogenase deficiency in mediterraneans by comparative quantitative enzyme electrophoresis.
The detection of heterozygous G6PD deficiency; similarity between glutathione deficiency and G6PD deficiency.
The detection of heterozygous glucose-6-phosphate dehydrogenase deficiency in Mediterraneans by comparative enzyme assay.
The distribution of glucose-6-phosphate dehydrogenase deficiency in Greece.
The distribution of hereditary erythrocytic disorders associated with malaria, in a lowland area of Nepal: a micro-epidemiological study.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum.
The effect of glucose-6-phosphate dehydrogenase deficiency on the severity of neonatal jaundice in Cape Town.
The effect of the coinheritance of Glucose-6-phosphate dehydrogenase deficiency on the severity of sickle cell disease.
The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells.
The Effectiveness of Oral Tin Mesoporphyrin Prophylaxis in Reducing Bilirubin Production after an Oral Heme Load in a Transgenic Mouse Model.
The effects of di- and trichloroacetic acid on sheep erythrocytes: an animal model with a glucose-6-phosphate dehydrogenase deficiency.
The effects of glucose-6-phosphate dehydrogenase deficiency on the haematological parameters and clinical manifestations in patients with sickle cell anaemia.
The effects of some antibiotics on sheep lens glucose 6-phosphate dehydrogenase in vitro.
The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern Iran.
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.
The epidemiology of recurrent pregnancy loss.
The erythroenzymopathies. With particular reference to glucose-6-phosphate dehydrogenase deficiency and favism.
The existence of the glucose-6-phosphate dehydrogenase deficiency trait in Nigeria and its clinical implications.
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency.
The fatty acid composition of red cells deficient in glucose-6-phosphate dehydrogenase and their susceptibility to lipid peroxidation.
The First Case of a Class I Glucose-6-phosphate Dehydrogenase Deficiency, G6PD Santiago de Cuba (1339 GA), in a Chinese Population as Found in a Survey for G6PD Deficiency in Northeastern and Central China.
The first reported case of G6PD deficiency due to Seoul mutation in Poland.
The frequency of glucose-6-phosphate dehydrogenase deficiency in Colombia.
The frequency of glucose-6-phosphate dehydrogenase deficiency in the newborns and adults in Kuwait.
The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell genes in Al-Qatif oasis.
The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.
The gene spectrum of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Guangdong province, China.
The genetics of glucose-6-phosphate dehydrogenase deficiency.
The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
The haematological effects of glucose-6-phosphate dehydrogenase deficiency and thalassaemia trait: interaction between the two genes at the phenotype level.
The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.
The hemolytic crisis of sickle cell disease: the role of glucose-6-phosphate dehydrogenase deficiency.
The hemolytic effect of various sulfonamides on subjects with a deficiency of glucose-6-phosphate dehydrogenase of erythrocytes.
The HLA system and G6PD deficiency in the Bulgarian population.
The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase.
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study.
The incidence of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Singapore.
The incidence of glucose-6-phosphate dehydrogenase deficiency and thalassaemia in Malta.
The incidence of glucose-6-phosphate dehydrogenase deficiency in a population of Greek, Italian and Yugoslav origin in Australia.
The incorporation of isotopically labelled glycine into glutathione of erythrocytes with glucose-6-phosphate dehydrogenase deficiency.
The influence of haemoglobin-S and G6PD deficiency on the activity of the 17 beta-hydroxysteroid dehydrogenase of intact human erythrocytes.
The integrity and stability of specimens under different storage conditions for glucose-6-phosphate dehydrogenase deficiency screening using WST-8.
The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels.
The Interaction between Hb A1C and Selected Genetic Factors in the African American Population in the USA.
The laboratory use of butylnitrite for the production of methemoglobin.
The Le(a) antigen and neonatal hyperbilirubinemia in Taiwan.
The methylene blue reduction test: evaluation of a screening method for glucose-6-phosphate dehydrogenase deficiency.
The micro-methemoglobin reduction screening test for G6PD deficiency in childhood.
The molecular basis of glucose-6-phosphate dehydrogenase deficiency.
The molecular biology of G6PD variants and other red cell enzyme defects.
The mortality of exchange transfusions.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
The ocular findings in glucose-6-phosphate dehydrogenase deficiency.
The possible role of glucose-6-phosphate dehydrogenase deficiency in COVID-19 global prevalence and distribution.
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
The potential use of xylitol in glucose-6-phosphate dehydrogenase deficiency anemia.
The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.
The prevalence of factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T among G6PD deficient individuals from Western Iran.
The prevalence of G6PD deficiency in blood transfusion recipients.
The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.
The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.
The prevalence of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in Jordanian newborn.
The prevalence of the erythrocyte glucose-6-phosphate dehydrogenase deficiency among Africans in Uganda.
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos.
The Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran.
The reality of using primaquine.
The reduction of methemoglobin in erythrocytes of a patient with congenital methemoglobinemia, subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency, and normal individuals.
The relationship between glucose-6-phosphate dehydrogenase deficiency and cataracts in Sardinia. An epidemiological and biochemical study.
The relationship of erythrocyte glucose-6-phosphate dehydrogenase deficiency to byperbilirubinemia in Negro premature infants.
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
The role of anti-malarial drugs in eliminating malaria.
The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis.
The role of glucose-6-phosphate dehydrogenase deficiency in blackwater fever.
The role of haemolysis in neonatal hyperbilirubinaemia as reflected in carboxyhaemoglobin levels.
The role of oxidative stress in hemolytic anemia.
The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal.
The roles of glucose-6-phosphate dehydrogenase deficiency and ventilation support in outcome of carbon monoxide poisoning.
The separation of glucose-6-phosphate dehydrogenase deficient erythrocytes from blood of heterozygotes for glucose-6-phosphate dehydrogenase deficiency.
The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability.
The significance of glucose-6-phosphate dehydrogenase deficiency in pregnancy.
The Spectrum of Hemolytic Disease of the Newborn: Evaluating the Etiology of Unconjugated Hyperbilirubinemia Among Neonates Pertinent to Immunohematological Workup.
The status of neonatal screening in China, 2013.
The study of G6PD in erythrocyte and lens in senile and presenile cataract.
The suitability of saliva for detection of glucose-6-phosphate dehydrogenase deficiency.
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians.
The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
The value of a routine screening test for glucose-6-phosphate dehydrogenase deficiency.
The value of screening tests for glucose-6-phosphate dehydrogenase deficiency.
Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.
Therapeutic potential of manipulating suicidal erythrocyte death.
Three major G6PD-deficient polymorphic variants identified among the Mauritian population.
Three mutations analysis of glucose-6-phosphate dehydrogenase deficiency in neonates in South-west China.
Three new mutations account for the prevalence of glucose 6 phosphate deshydrogenase (G6PD) deficiency in Tunisia.
Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.
Topical benzocaine (Hurricaine) induced methemoglobinemia during endoscopic procedures in gastric bypass patients.
Topical herbal medicine causing haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Towards one standard treatment for uncomplicated Plasmodium falciparum and Plasmodium vivax malaria: Perspectives from and for the Peruvian Amazon.
Toxic effects of drugs on erythrocytes.
Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review.
Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients.
Traditional African remedies induce hemolysis in a glucose-6-phopshate dehydrogenase deficient zebrafish model.
Traditional Chinese medicine and treatment of neonatal jaundice.
Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells.
Transcutaneous bilirubin nomogram for Taiwanese newborns - A single center study.
Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units.
Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.
Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.
Transient, acquired glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Treatment and prevention of malaria in children.
Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful?
Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange.
Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin.
Treatment of MRSA Infections in an African-American male with G6PD Deficiency.
Treatment of schistosomiasis mansoni with hycanthone in glucose-6-phosphate dehydrogenase deficiency in St. Lucia.
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.
Trends of Transcutaneous Bilirubin in Neonates Who Develop Significant Hyperbilirubinemia.
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
TRIPLE ERYTHROPOIETIC ANOMALY: PORPHYRIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND HETEROZYGOUS STATE OF HAEMOGLOBIN E.
Triplo-X constitution of mother explains apparent occurrence of two recombinants in sibship segregating at two closely X-linked loci (G6PD and deutan).
Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia.
Two cases of glucose-6-phosphate dehydrogenase-deficient Nepalese belonging to the G6PD Mediterranean-type, not India-Pakistan sub-type but Mediterranean-Middle East sub-type.
Two commonly occurring nucleotide base substitutions in Chinese G6PD variants.
Two new class III G6PD variants [G6PD Tunis (c.920A>C: p.307Gln>Pro) and G6PD Nefza (c.968T>C: p.323 Leu>Pro)] and overview of the spectrum of mutations in Tunisia.
Two new variants of G6PD deficiencies in Singapore.
Two new variants of glucose-6-phosphate dehydrogenase associated with hereditary non-spherocytic hemolytic anemia: G6PD Wayne and G6PD Huron.
Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients.
Two novel glucose-6-phosphate dehydrogenase variants found in newborn mass-screening for galactosaemia.
Two novel mutations (2976INSA, 4311insA) of ATP7B in a patient with Wilson's disease coexisting with glucose-6-phosphate dehydrogenase deficiency.
Two point mutations are responsible for G6PD polymorphism in Sardinia.
Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.
Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
UGT1A1 Gene Polymorphisms in North Indian Neonates Presenting with Unconjugated Hyperbilirubinemia.
UGT1A1 Genetic Analysis as a Diagnostic Aid for Individuals with Unconjugated Hyperbilirubinemia.
UK malaria treatment guidelines 2016.
UK malaria treatment guidelines.
Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
Ultrasound-Guided Regional Anesthesia in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Geriatric Trauma Patient.
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
Unexpected glucose-6-phosphate dehydrogenase deficiency.
Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system.
Universal Implementation of Newborn Screening in India.
Unnecessary deprivation of common food items in glucose-6-phosphate dehydrogenase deficiency.
Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy.
Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates.
Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.
Urinary acidification in a patient with glucose-6-phosphate dehydrogenase deficiency. A reevaluation of the role of the hexose monophosphate shunt in renal acid secretion.
Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
Use and safety of elevated dosages of vitamin E in adults.
Use of fosamprenavir, a sulfa-containing protease inhibitor, in HIV-infected patients with glucose-6-phosphate dehydrogenase deficiency.
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Use of tolfenamic acid in febrile children with and without glucose-6-phosphate dehydrogenase deficiency.
Use of trimethoprim-sulfamethoxazole in a patient with G6PD deficiency for treating Pneumocystis jirovecii pneumonia without haemolysis: Case report and literature review.
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Using the fluorescence spot test for neonatal screening of G6PD deficiency.
USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania.
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Variability of red cell phenotypes between and within individuals in an unbiased sample of 77 heterozygotes for G6PD deficiency in Sardinia.
Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
Variants of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) in Bulgarian populations.
Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.
Viral hepatitis with haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
Vitamin C and kidney transplantation: Nutritional status, potential efficacy, safety, and interactions.
Vitamin C Inhibits Aggravated Eryptosis by Hydrogen Peroxide in Glucose-6-Phosphated Dehydrogenase Deficiency.
What has passed is prolog: new cellular and physiological roles of G6PD.
What is the role of the second "structural" NADP+-binding site in human glucose 6-phosphate dehydrogenase?
When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin concentration.
Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria.
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
X-linkage and genetic heterogeneity in bipolar-related major affective illness: reanalysis of linkage data.
X-linked dyskeratosis congenita with pancytopenia.
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.
X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus.
X-mapping in man: evidence against measurable linkage between anhidrotic ectodermal dysplasia and G6PD deficiency.
Xq28: epidemiology and sex-linkage between red-green colour blindness and G6PD deficiency.
Yield of reticulocyte counts and blood smears in term infants.
[A boy with jaundice.]
[A case of acute hemolytic anemia caused by deficiency of glucose-6-phosphate dehydrogenase (G-6-PD) in erythrocytes]
[A case of acute recurrent benign pericarditis in a patient with glucose-6-phosphate dehydrogenase deficiency, treated with sodium salicylate]
[A case of nt 1004C --> A G6PD gene mutation in Yunnan Han people]
[A case of typhoid fever in a visitor from India with glucose-6-phosphate dehydrogenase deficiency. Remarkable conjugated hyperbilirubinemia probably induced by an analgesic drug (author's transl)]
[A frequently occurring imported illness, glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[A new reagent for methemoglobin reduction test]
[A search for glucose-6-phosphate dehydrogenase deficiency, among Toros Seljouck Turks, in both normal and pathological conditions. The explanation of hemolytic anemias seen, in snake bite and poisonous insect bites cases. Three cases of favism and hemolytic syndrome]
[A severe G6PD deficiency revealed during a chemotherapy protocol including rasburicase]
[A young man with acute generalised jaundice and intermittent epigastric pain]
[Abnormal hemoglobins and glucose-6-phosphate dehydrogenase deficiency in El Salvador]
[Abnormal hemoglobins, alpha thalassemia and erythrocyte G6PD deficiency in newborn infants of the negroid race]
[Acute drug-induced hemolytic anemia in persons with congenital glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[Acute hemolysis after ingestion of glyceryl aminophenaquine in a subject presenting with G6PD deficiency]
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolysis caused by glucose-6-phosphate dehydrogenase deficiency at the outset of myeloma therapy. Role of melphalan?]
[Acute hemolysis due to trinitrotoluene in G6PD deficiency]
[Acute hemolytic anemia after the consumption of fava beans. Familial case study on glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Acute hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency (apropos of a case)]
[Acute hemolytic anemia in the course of spesis caused by Proteus morganii in a subject with erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Acute myocarditis complicating Mediterranean spotted fever. A case report.]
[Acute post-operative hemolysis related to a G6DP deficiency. Report of one case (author's transl)]
[Acute renal failure manifest of glucose-6-phosphate dehydrogenase deficiency: severity of iatrogenic hemolysis. Originality of genetic distribution in a family from Sardinia]
[AN ASHKENAZI FAMILY WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Anaesthetic management of a child with hemoglobinopathy].
[Anesthesia in glucose 6-phosphate dehydrogenase-deficient patient: case report.]
[Anesthesia in patients with glucose-6-phosphate dehydrogenase deficiency: case report and perioperative anesthesiologic management]
[Antihemolytic action of an extract of Carica papaya bark. Possibilities of use in glucose-6-phosphate dehydrogenase deficiencies]
[Aplastic crisis due to human parvovirus B19 infection in glucose-6-phosphate dehydrogenase deficiency]
[Aregenerative anemia and erythrocytes hemighosts: a case report].
[Association between disturbances in intestinal absorption or glucose and G6PD deficiency in immigrants from Kurdistan]
[Association of a triple genetic erythrocyte defect: thalassemia, sickle cell disease and glucose-6-phosphate dehydrogenase deficiency in a child of Calabro-Sardinian origin]
[Association of hemoglobinosis and glucose-6-phosphate dehydrogenase deficiency]
[Association of heterozygote drepanocytosis and G6PD deficiency: apropos of a case]
[Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine]
[Attempt at characterization of 2 erythrocyte variants of glucose-6-phosphate dehydrogenase in a patient with a partial enzymatic deficit]
[Autointoxication with 'suicide powder'].
[Beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency]
[Bilirubinemia in newborn infants with deficiency of glucose-6-phosphate dehydrogenase.]
[Biology of glucose-6-phosphate dehydrogenase deficiency]
[Blackwater fever in adults with sickle cell anemia. Two fatal cases]
[Can glucose-6-phosphate dehydrogenase deficiency alone explain neonatal jaundice]
[Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency]
[Case of nonspherocytic anemia complicated by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]
[Catalase activity in red blood cells with glucose-6-phosphate dehydrogenase deficiency]
[Cataract and glucose-6-phosphate dehydrogenase deficiency in Sardinians]
[Changes in the contents of membrane phospholipid and membrane phospholipid asymmetry in glucose-6-phosphate dehydrogenase deficient erythrocyte]
[Changes of erythrocyte membrane lipid in hereditary G6PD deficiency]
[Changes of protein tyrosine phosphorylation in erythrocyte band 3 glucose-6-phosphate dehydrogenase deficiency]
[Characteristics of two new mutant forms of erythrocyte glucose-6-phosphate dehydrogenase: "Kirovograd" G6PD and "Zhitomir" G6PD]
[CHRONIC HEMOLYTIC ANEMIA WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Chronic non-conjugated hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day]
[Clinical evaluation of a melting curve analysis-based PCR assay for glucose phosphate dehydrogenase gene mutation detection].
[Clinical experience of primaquine use for treatment of vivax and ovale malaria in Japanese travelers].
[Clinical Features and Laboratory Data Analysis of Glucose-6- Phosphate Dehydrogenase Deficiency].
[Clinical polymorphism of glucose-6-phosphate dehydrogenase deficiency: the Seattle variant]
[Clinical Significance of Gene Mutation Detection for Female Heterozygotes with Glucose-6-Phosphate Dehydrogenase Deficiency].
[Clinical study on the prevention of kernicterus caused by hereditary glucose-6-phosphate dehydrogenase deficiency]
[Clinical, erythrokinetic and metabolic aspects of congenital hemolytic non-spherocytic anemia due to erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Clinico-biochemical characteristics of patients with congenital glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[Clinico-genetic polymorphism of erythrocytes glucose-6-phosphate dehydrogenase deficiency in Bulgaria]
[Clinico-genetic significance of glucose-6-phosphate dehydrogenase deficiency of erythrocytes]
[Clinico-immunologic characteristics of patients with pulmonary tuberculosis, psychic diseases and a congenital glucose-6-phosphate dehydrogenase deficiency]
[Clinicogenetic studies of a patient with the Corinth type of glucose-6-phosphate dehydrogenase deficiency]
[Common mutation analysis for patients found in Tianjin area with glucose-6-phosphate dehydrogenase deficiency]
[Comparative study of three common G6PD gene mutations in Yao and Han People in Guangxi]
[Complete glucose-6-phosphate dehydrogenase deficiency associated with Gilbert's familial cholemia in a metropolitan French subject]
[Complex mutations of 1311 C-->T in exon 11 and 93 T-->C in intron 11 in G6PD gene]
[Complicated viral to cholestatic hepatitis in a child with glucose-6-phosphate dehydrogenase deficiency from a high andean region].
[Complications of exchange transfusion in term and preterm newborns]
[CONGENITAL AND RECESSIVE METHEMOGLOBINEMIA. ITS ASSOCIATION WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THALASSEMIA MINOR.]
[Congenital colour-blindness and deficiency of glucose-6-phosphate dehydrogenase]
[CONGENITAL HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Congenital hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Congenital hemolytic non-spherocytic anemia caused by glucose-6-phosphate dehydrogenase deficiency (case contribution)]
[Congenital non-spherocytic hemolytic jaundice with glucose-6-phosphate dehydrogenase deficiency. 2 cases.]
[Congenital nonspherocytic hemolytic anemia with deficiency of glucose-6-phosphate dehydrogenase]
[Congenital nonspherocytic hemolytic anemia, cataract and glucose-6-phosphate dehydrogenase deficiency]
[Congenital nonspherocytic hemolytic anemias caused by glucose-6-phosphate dehydrogenase deficiency of the erythrocytes in a Japanese family]
[Correlation analysis of genotypes and the enzymatic activities of glucose-6-phosphate dehydrogenase in neonates in Guangzhou].
[Course of epidemic viral hepatitis in subjects with glucose-6-phosphate dehydrogenase deficiency. Apropos of 6 cases]
[Critical observations on the morphological methods used to demonstrate 2 cell populations in heterozygotic women with erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Critical study of various technics of detection and determination of glucose-6-phosphate dehydrogenase deficiency]
[Current clinical approaches and gene mutation study of beta-thalassemia major]
[CURRENT PROBLEMS IN ERYTHROCYTE DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.]
[Deficiency of glucose-6-phosphate dehydrogenase in a family]
[Demonstration of enzymatic anomaly of the liver in subjects with erythrocytic deficiency of glucose-6-phosphate dehydrogenase.]
[Density-specific distribution of erythrocytes in different types of anemia]
[Dermatoglyphics and creases in a large family with glucose-6-phosphate dehydrogenase deficiency]
[Description of new mutant forms of erythrocyte glucose-6-phosphate dehydrogenase in man]
[Detection of a new anomalous variant of glucose-6-phosphate dehydrogenase in human erythrocytes]
[Detection of female heterozygous glucose-6-phosphate dehydrogenase deficiency]
[Detection of G6PD deficiency by tests of methemoglobin reduction]
[Detection of gene mutation in glucose-6-phosphate dehydrogenase deficiency by RT-PCR sequencing].
[Determination of glucose-6-phosphate dehydrogenase deficiency to prevent possible drug-induced hemolysis]
[Determination of superoxide dismutase (sod) in erythrocytes in glucose-6-phosphate dehydrogenase deficiency (G6PD-deficiency)]
[Diagnosis of glucose-6-phosphate dehydrogenase deficiency by activation of the erythrocytic redox systems]
[Digitalis intoxication during the neonatal period: role of dehydration]
[Double erythrocyte enzymopathy. Acquired pyruvate kinase and inherited glucose-6-phosphate dehydrogenase deficiencies]
[DREPANOCYTEMIA, ERYTHROCYTIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (G-6-PD) AND MALARIA IN THE CUANGO POST (LUNDA-ANGOLA).]
[Drug-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency: an update].
[Drug-induced hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency]
[Drugs and other agents leading to increased hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]
[Early detection of color blindness from the viewpoint of occupational medicine with various references to internistic and human genetic symptom complexes]
[Effect of ethanol on the detoxification of hydrogen peroxide induced by ascorbic acid in normal erythrocytes and those with glucose-6-phosphate dehydrogenase deficiency]
[Effects of Yinzhihuang oral liquid and Lonicera japonica extract on hemolysis and hyperbilirubinemia in rats with glucose-6-phosphate dehydrogenase deficiency].
[Efficiency of a package of therapeutic and preventive measures in the Republic of Tajikistan in the malaria postepidemic period (2000-2007)]
[Enzymatic activity of the oxydative shunt in human leukocytes of normal and pathological subjects and patients with G6PD deficiency during the process of slow phagocytosis in vitro]
[Enzyme-deficient hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency in a child of German descent]
[Epidemiological survey on malaria situation in Motuo County of Tibet, China]
[Epidemiology of glucose-6-phosphate dehydrogenase deficiency]
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in a 3-year-old child]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in African newborn infants in Dakar]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency in Rumania: anthropogenetic significance]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency. Review and report of a case]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency: histochemical study of the duodenal mucosa]
[Erythrocyte polymorphism in Mali: epidemiology and resistance mechanisms against severe Plasmodium falciparum malaria]
[Erythrocyte survival in patients with G6PD deficiency during administration of suprofen]
[Erythrocytic enzymopathy in Uzbekistan].
[Erythrocytic glucose-6-phosphate dehydrogenase deficiency, hemolysis and diabetic ketoacidosis]
[Erythrocytic mosaicism and pseudomosaicism in glucose-6-phosphate dehydrogenase deficiency]
[Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo)]
[Evaluations of newborn screening program performance and enzymatic diagnosis of glucose-6-phosphate dehydrogenase deficiency in Guangzhou].
[Expression of g6pd gene in wild type zebrafish embryos of early development].
[Expression of human G6PD gene in K562 cells mediated by retroviral vector]
[Familial glucose-6-phosphate dehydrogenase deficiency]
[Familial study in a case of congenital nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency]
[Favism after ingestion of fava beans in a three-year-old child with glucose-6-phosphate dehydrogenase deficiency].
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. FURTHER OBSERVATIONS IN ANOTHER SPANISH FAMILY.]
[FAVISM AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. STUDY OF THIS ENZYMATIC DISTURBANCE IN A SPANISH FAMILY.]
[Favism. A clinical syndrome caused by glucose-6-phosphate dehydrogenase deficiency in the erthrocytes.]
[Favism. Glucose-6-phosphate dehydrogenase deficiency]
[Favism: hemolytic crisis due to glucose-6-phosphate dehydrogenase deficiency in erythrocytes]
[Favism]
[Favourable erythrocyte rheology in patients with glucose-6-phosphate dehydrogenase deficiency (author's transl)]
[FIRST RESULTS ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCIES IN THE DAKAR REGION. PRELIMINARY NOTES.]
[Frequency and complications of erythrocyte glucose-6-phosphate dehydrogenase deficiency in the African newborn in Dakar. Preliminary study]
[Frequency of color blindness and glucose-6-phosphate dehydrogenase enzyme deficiency in non-industrialized populations in the state of Nuevo León, México]
[Frequency of G6PD deficiency in a group of preschool-aged children in a centrally located area of Cambodia]
[Frequency of glucose-6-phosphate dehydrogenase deficiency (A-376/202) in three Malian ethnic groups].
[Furosemide (Lasilix) can be used in patients with G6PD deficiency. Apropos of a case]
[G6PD deficiency and acute poisoning by anti-mite mothballs]
[G6PD deficiency in a western area of Genoa. Genetic study of 4 new variants]
[G6PD deficiency in females with neonatal revelation. Report of four cases].
[G6PD deficiency in populations of the Bolivian Andes]
[G6PD deficiency revealed by eating of beans and the ingestion of sulfamethoxazole]
[G6PD deficiency]
[G6PD gene mutations in Guangxi, China]
[G6PD Gene Mutations in Shui people in Sandu of Guizhou]
[G6PD phenotype and red blood cell sensitivity to the oxidising action of chlorites in drinking water]
[Gd- allele distribution patterns in Azerbaijan. III. The identification of mutant forms of glucose-6-phosphate dehydrogenase]
[Gene analysis and genetic diagnosis of hereditary erythrocyte abnormalities. Glucose-6-phosphate dehydrogenase deficiency]
[Gene geography of hereditary glucose-6-phosphate dehydrogenase deficiency and pulmonary tuberculosis in Azerbaijan]
[Gene Mutants and Their Clinical Characteristics of G6PD Deficiency Among Children in Luzhou Area].
[Gene promoter methylation in glucose-6-phosphate dehydrogenase de?ciency].
[Generalized saturnine paralysis. Discovery of a double congenital disease: glucose-6-phosphate dehydrogenase deficiency (new variant) and distal tubular acidosis]
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[Genetic diagnosis for female carriers of glucose-6-phosphate dehydrogenase deficiency by RT-PCR-DGGE]
[Genetic heterogeneity of G6PD deficiency: mutant alleles of G6PD in the Shekii district of Azerbaijan]
[Genetic mutation screening of glucose-6-phosphate dehydrogenase deficiency in Dongguan district].
[Genetic resistance to malaria]
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
[Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents]
[Glucose-6-phosphate dehydrogenase (G6PD) deficiency--a cause of anaemia in pregnant women]
[Glucose-6-phosphate dehydrogenase deficiencies]
[Glucose-6-phosphate dehydrogenase deficiency among the student population of Milan]
[Glucose-6-phosphate dehydrogenase deficiency and hemoglobinuric biliary fever after taking mefloquine]
[Glucose-6-phosphate dehydrogenase deficiency and hemolytic anemia in a Danish boy]
[Glucose-6-phosphate dehydrogenase deficiency and hereditary hemolytic anemia]
[Glucose-6-phosphate dehydrogenase deficiency and leprosy]
[Glucose-6-phosphate dehydrogenase deficiency and other erythrocyte enzyme abnormalities]
[Glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency]
[Glucose-6-phosphate dehydrogenase deficiency as the cause of hemolytic icterus in a German family]
[Glucose-6-phosphate dehydrogenase deficiency hereditary hemolytic anemia (author's transl)]
[Glucose-6-phosphate dehydrogenase deficiency in 2 girls]
[Glucose-6-phosphate dehydrogenase deficiency in 2 siblings. (Quantitative determination)]
[Glucose-6-phosphate dehydrogenase deficiency in a general hospital of Salvador, Bahia, Brazil (author's transl)]
[Glucose-6-phosphate dehydrogenase deficiency in Algeria.]
[Glucose-6-phosphate dehydrogenase deficiency in Algeria]
[Glucose-6-phosphate dehydrogenase deficiency in an 81-year-old]
[Glucose-6-phosphate dehydrogenase deficiency in an Austrian family]
[Glucose-6-phosphate dehydrogenase deficiency in blood donors in a general hospital of Salvador, Bahia, Brazil]
[Glucose-6-phosphate dehydrogenase deficiency in children: a case report].
[Glucose-6-phosphate dehydrogenase deficiency in erythrocytes observed in two cases]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN ERYTHROCYTES OF A POLISH FAMILY.]
[Glucose-6-phosphate dehydrogenase deficiency in erythrocytes of foreign students studying in Poland]
[Glucose-6-phosphate dehydrogenase deficiency in Japan].
[Glucose-6-phosphate dehydrogenase deficiency in Mali. Epidemiology and pathological aspects]
[Glucose-6-phosphate dehydrogenase deficiency in Mecklenburg]
[Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia]
[Glucose-6-phosphate dehydrogenase deficiency in newborn Brazilian infants]
[Glucose-6-phosphate dehydrogenase deficiency in the Congo. Clinical, genetic and public-health aspects]
[Glucose-6-phosphate dehydrogenase deficiency in the erythrocytes of foreign students]
[Glucose-6-phosphate dehydrogenase deficiency in three generations of an Aachen family]
[Glucose-6-phosphate dehydrogenase deficiency in Viet-nam]
[Glucose-6-phosphate dehydrogenase deficiency of erythrocytes in 3 German children. Determination of a new mutation]
[Glucose-6-phosphate dehydrogenase deficiency of erythrocytes in the GDR]
[Glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type B minus. 1. Favism in childhood]
[Glucose-6-phosphate dehydrogenase deficiency of the mediterranean type B minus. 2. Etiological basis for severe hyperbilirubinemia in the newborn]
[Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report]
[Glucose-6-phosphate dehydrogenase deficiency, 1 of the forms of hemolytic anemia (review of the literature)]
[Glucose-6-phosphate dehydrogenase deficiency, neonatal hyperbilirubinemia and Gilbert syndrome]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. APROPOS OF A CASE OF FAVISM.]
[Glucose-6-phosphate dehydrogenase deficiency. Diagnosis during treatment of a mandibular fracture]
[Glucose-6-phosphate dehydrogenase deficiency.]
[GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Glucose-6-phosphate dehydrogenase deficiency: anesthetic implications]
[Glucose-6-phosphate dehydrogenase deficiency: clinical presentation and eliciting factors]
[Glucose-6-phosphate dehydrogenase deficiency: its frequency in Hb AS and Hb AA individuals among the black population of Limón]
[Glucose-6-phosphate dehydrogenase deficiency: report of 2 cases]
[Glucose-6-phosphate dehydrogenase deficiency]
[Glucose-6-phosphate dehydrogenase et neonatal jaundice]
[Glucose-6-phosphate dehydrogenase gene mutations in She nationality, Fujian province]
[Glucose-6-phosphate-dehydrogenase deficiency management in western countries. A literature review].
[Haemolytic crisis of blackwater fever following artemether-lumefantrine intake.]
[Haptoglobin and hemopexin in glucose-6-phosphate dehydrogenase deficiency]
[Haptoglobin, groups Gm andG Gc, hemoglobin S and glucose-6-phosphate dehydrogenase deficiency: their incidence in South Tanzania]
[Heinz body formation and GSH content in erythrocytes with glucose-6-phosphate dehydrogenase deficiency and disruption of glutathione synthesis after x-irradiation in vitro]
[Hematologic characteristics in Black Africa]
[Hemocoagulation disturbances in drug-provoked hemolysis in persons with glucose-6-phosphate dehydrogenase deficiency]
[HEMOGLOBIN, METHEMALBUMIN AND HAPTOGLOBINEMIA IN PLASMA OF NEWBORNS WITH HEMOLYTIC JAUNDICE DUE TO ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. ELECTROPHORETIC RESEARCH.]
[Hemoglobinopathies and erythrocyte enzyme deficiencies in Switzerland: laboratory diagnoses of the last 10 years]
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
[Hemoglobinoses and G6PD deficiency in Africans in the Dakar area]
[Hemoglobinosis S and glucose-6-phosphate dehydrogenase deficiency]
[Hemoglobinuria in children hospitalized in Ouagadougou: short term inpatient care and prognosis].
[Hemolysis and primaquine treatment. Preliminary report]
[Hemolytic anemia associated with minor salmonellosis in an HIV positive, G6PD deficient Congolese woman]
[Hemolytic anemia based on congenital glucose-6-phosphate dehydrogenase deficiency in erythrocytes in the Taszhik SSR]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency during typhoid fever]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Condition with diagnostic pitfalls].
[HEMOLYTIC ANEMIA CAUSED BY GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic anemia due to congenital glucose-6-phosphate dehydrogenase deficiency.]
[Hemolytic anemia due to G6PD deficiency. Apropos of 3 cases]
[Hemolytic anemia due to the dysfunction of the protection against oxidative attack]
[HEMOLYTIC ANEMIAS DUE TO GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Hemolytic complications of para-amino-salicylic acid (2 cases of glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic congenital nonspherocytic anemia secondary to an erythrocyte glucose-6-phosphate dehydrogenase deficiency. Description of 2 new variants: Gd (-) Saint-Louis (Paris) and Gd (-) Hayem]
[Hemolytic crisis in glucose-6-phosphate dehydrogenase deficiency and lead poisoning]
[Hemolytic effect of niridazole in G6PD deficiency]
[Hemolytic syndrome caused by primaquine and glucose-6-phosphate dehydrogenase deficiency]
[Hereditary and epidemiological aspects of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Mexico]
[Hereditary coproporphyria with grand mal epilepsy, glucose-6-phosphate dehydrogenase deficiency and phenobarbital tolerance]
[Hereditary glucose-6-phosphate dehydrogenase deficiency in human erythrocytes]
[Hereditary glucose-6-phosphate dehydrogenase deficiency in newborn infants]
[Hereditary hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency discovered in a 6-year-old child]
[Hereditary non-spherocytic hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Formation of an enzyme protein with modified characteristics in the blood cells of a German family]
[Hereditary transmission of glucose-6-phosphate dehydrogenase deficiency (G-6-PD) in the granulocytes and erythrocytes of 3 Sardinian families with a history of favism]
[Heterogeneity of erythrocytic glucose-6-phosphate dehydrogenase deficiency in negroes. Kinetic study and description of 2 new variants "Gd(-)Dakar and Gd(-)Mali"]
[Hydrops fetalis and G-6-PD deficiency]
[Identification of molecular variants of the enzyme glucose-6-phosphate dehydrogenase by the polymerase chain reaction technique]
[II. Chronic hemolytic anemia caused by erythrocytic deficiency of glucose-6-phosphate dehydrogenase (G6PD)]
[Impaired glutathione metabolism in hemolytic anemia]
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Imported malaria: 6 cases, 2 of them with an erythrocyte glucose-6-phosphate dehydrogenase deficiency]
[Incidence in the glucose-6-phosphate dehydrogenase deficiency of erythrocytes in the population of North Oriente province (Republic of Cuba)]
[Incidence of deficiency of glucose-6-phosphate dehydrogenase in icterus gravis of the newborn.]
[Incidence of erythrocyte deficiency of glucose-6-phosphate dehydrogenase and its relations to jaundice]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in blood donors of Sofia]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in erythrocytes of the population in Armenia]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in Negroes of Minas Gerais]
[Incidence of glucose-6-phosphate dehydrogenase deficiency in the blood of persons living in the Arkhangelsk region]
[Incidence of hemolytic disease of the newborn due to glucose-6-phosphate dehydrogenase deficiency in the case reports of our hospital]
[Incidence of hereditary deficiency of glucose-6-phosphate dehydrogenase activity of erythrocytes in Azerbaijan SSR]
[Increase in genetically determined anemia as a result of migration in Germany].
[Increasing prevalence of G6PD deficiency in the Netherlands].
[Infectious hepatitis, acute hemolysis and glucose-6-phosphate dehydrogenase deficiency]
[Influence of huanglian and berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats]
[Influence of huanglian used in combination with huangqin and gancao on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats]
[Influence of human genetic variants on resistance and immunity against malaria]
[Interrelation between beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency and characteristics of the clinico-hemato-logic indices when the 2 are combined]
[Intraoperative intravascular hemolysis in a female patient with glucose-6-phosphate dehydrogenase deficiency]
[Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics]
[Kawasaki disease in a subject with G6PD deficiency]
[Kernicterus in a newborn due to glucose-6-phosphate dehydrogenase deficiency.]
[KERNICTERUS IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY OF ERYTHROCYTES.]
[Kernicterus is preventable but still occurs].
[Lethal acute hemolytic anemia in viral hepatitis, caused by glucose-6-phosphate dehydrogenase deficiency]
[Letter: Hemolysis induced by niridazole in 2 patients with G6PD deficiency]
[Letter: Hemolytic anemia after antibilharzia treatment with niridazole in an Antillean with G6PD deficiency]
[Linkage analysis of the G6PD gene mutations and its Nla III polymorphic site]
[Lipid aspects in subjects with glucose-6-phosphate dehydrogenase deficiency]
[Malaria hypothesis--the significance of the hereditary red cell traits Hb S and glucose-6-phosphate dehydrogenase deficiency in malaria (author's transl)]
[Malaria in childhood and G6PD deficiency. Report of three cases]
[Malaria, hemoglobinosis and glucose-6-phosphate dehydrogenase deficiency. (Preliminary note)]
[Malignant mediterranean boutonneuse fever in a patient with partial glucose-6-phosphate dehydrogenase deficiency]
[Manifestation of glucose-6-phosphate dehydrogenase deficiency caused by primaquine in malaria therapy]
[Mechanisms of hemolysis in glucose-6-phosphate dehydrogenase deficiency]
[Methemoglobinemia caused by dapsone. Report of one case].
[Methylene blue disclosing G6PD deficiency in a newborn infant]
[Molecular analysis of glucose-6-dehydrogenase deficiency in Spain]
[Molecular characterization of 71 cases of glucose-6-phosphate dehydrogenase deficiency in Hainan province]
[Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Han and Li nationalities in Hainan, China and identification of a new mutation in human G6PD gene]
[Molecular characterization of glucose-6-phosphate dehydrogenase variants in four ethnic groups in Yunnan province of China]
[Molecular epidemiology of G6PD deficiency in Chaozhou area of eastern Guangdong Province].
[Molecular-genetic studies of carrier stage of glucose-6-phosphate dehydrogenase deficiency]
[Neonatal erythrocytic pathology caused by glucose-6-phosphate dehydrogenase deficiency.]
[Neonatal hemolytic icterus due to congenital glucose-6-phosphate dehydrogenase deficiency. Apropos of 17 cases]
[Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency]
[Neonatal icterus and erythrocyte glucose-6-phosphate dehydrogenase deficiency in Congolese newborn infants in Brazzaville]
[Neonatal icterus and erythrocyte glucose-6-phosphate dehydrogenase deficiency. Experience in Costa Rica]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Havana]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency]
[Neonatal screening for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Mauritania].
[Neonatal screening of G6PD deficiency in Tunisia].
[Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in umbilical cord blood]
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population.]
[Neutrophil glucose-6-phosphate dehydrogenase deficiency]
[Non-spherocytic congenital hemolytic anemias due to G6PD deficiency. Clinical and hematologic aspects and mechanism of hyperhemolysis]
[OBSERVATION OF A CASE OF ACUTE HEMOLYTIC ANEMIA RELATED TO A GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[Ofloxacin is contraindicated in case of G6PD deficiency: Is it evidenced based?]
[On 50 cases of glucose-6-phosphate dehydrogenase deficiency observed in an hospital environment in Tananarive]
[ON A CASE OF HEMOLYTIC ANEMIA DUE TO SULFAMETHOXYPYRIDAZINE IN A SUBJECT WITH ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY.]
[On a rare form of glucose-6-phosphate dehydrogenase deficiency with congenital nonspherocytic hemolytic anemia]
[On case histories of acute hemolytic anemia in persons with glucose-6-phosphate dehydrogenase deficiency in the erythrocytes]
[On congenital hemolytic, nonspherocytic anemias with a deficiency of glucose-6-phosphate dehydrogenase in red blood cells.]
[ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN AUTOCHTHONOUS POPULATIONS OF LEBANON.]
[One hundred and twenty-three cases of sickle-cell trait (author's transl)]
[OPEN PROBLEMS IN THE FIELD OF ANEMIAS DUE TO DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.]
[Ophthalmologic anomalies in 2 brothers presenting with glucose-6-phosphate dehydrogenase deficiency]
[Patterns in the distribution of GPD- alleles in Azerbaijan. I. Incidence and polymorphism of glucose-6-phosphate dehydrogenase deficiency in the Shekii region of the Azerbaijan SSR]
[Patterns of Gd- allele distribution in Azerbaijan. IV. The incidence and polymorphism of erythrocytic glucose-6-phosphate dehydrogenase deficiency in the settlement of Kobi, Apsheron District]
[Perinatal transmission of Plasmodium falciparum malaria]
[Perineogluteal actinomycosis and G6PD deficiency]
[Phagocytic activity of neutrophils in children with hereditary glucose-6-phosphate dehydrogenase deficiency during acute pneumonia]
[Phenotypic and genotypic spectra of patients with glucose-6-phosphate dehydrogenase deficiency gene known pathogenic variants: a single-center study].
[Plant Traditional Treatment with Acalypha indica Inducing Haemolysis in Patients with G6PD Deficiency: A Frequent Circumstance in Mayotte?]
[Plasmodium vivax, a parasite coming out of the shadows].
[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University Hospital Center in Lome]
[Post-transfusion hemolytic reactions in regions endemic for the hereditary glucose-6-phosphate dehydrogenase deficiency]
[Posthepatic obstructive jaundice caused by primary extragonadal germ-cell tumor in a patient with glucose-6-phosphatase dehydrogenase deficiency].
[Preliminary note on the incidence of abnormal hemoglobulins and glucose-6-phosphate dehydrogenase deficiency in the Mexican population.]
[Prenatal prevention of hyperbilirubinemia due to G6PD deficiency]
[Prevalence and incidence of glucose-6-phosphate dehydrogenase deficiency in the central region of Cuba]
[Prevalence and morbidity of G6PD deficiency in sickle cell disease in the homozygote]
[Prevalence of glucose-6-phosphate dehydrogenase deficiency in a student population on the island of Menorca]
[Primaquine and travelers from the Arab world. A report and recommendations]
[Procetofen: hemolytic effect in subjects with G6PD deficiency. Description of a case]
[Pulmonary tuberculosis in patients with hereditary glucose-6-phosphate dehydrogenase deficiency]
[Pulse oximetry and methemoglobinemia]
[Quantitative determination of erythrocytic catalase in normal Sardianians and those with glucose-6-phosphate dehydrogenase deficiency]
[Rapid screening test for determining the glucose-6-phosphate dehydrogenase deficiency of erythrocytes]
[Recurrent acute renal failure during the course of hemolytic crisis in a patient with glucose-6-phosphate dehydrogenase deficiency]
[Relation between G6PD deficiency and drepanocytosis]
[RELATION BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE.]
[Relations between chronic non-spherocytic hemolytic anemia and neonatal jaundice due to deficiency of glucose-6-phosphate dehydrogenase]
[Relationship between G6PD deficiency and hand-foot-mouth disease induced by enterovirus 71].
[Relative frequency of glucose-6-phosphate dehydrogenase deficiency in jaundiced newborn infants in the metropolitan area of Monterrey, Nuevo León.]
[Research of coptis effect on incidence of neonatal jaundice based on Cox model]
[RESEARCH ON GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN FRANCE. APROPOS OF 200 DETERMINATIONS.]
[Research Progress in Acute Hemolysis and Safe Blood Transfusion of Glucose-6-Phosphate Dehydrogenase Deficiency-Review].
[Retinal findings in the hereditary persistence of fetal hemoglobin and glucose-6-phosphate dehydrogenase deficiency (G-6-PD deficiency)]
[Review of abnormal genes. II. Hereditary enzyme defects in the erythrocytes: drug-induced hemolytic anemia indirectly caused by glucose-6-phosphate dehydrogenase deficiency]
[Risk medications in case of glucose-6-phosphate dehydrogenase deficiency]
[Role of primaquine in malaria control and elimination in French-speaking Africa].
[Rosette-forming capability and proliferative activity of peripheral blood lymphocytes in subjects with glucose-6-phosphate dehydrogenase deficiency]
[Scanning electron microscopic study of the morphological changes induced by acetylsalicylic acid in therapeutic doses in the red blood cells of a patient with a very severe G6PD deficiency and clinical manifestations of favism]
[Screening for hemoglobinopathies and G6PD deficiencies in Morocco]
[Screening of G6PD deficiency using the blood collected on filter paper]
[Screening results and genetic features of glucose-6-phosphate dehydrogenase deficiency in 54 025 preterm infants in Chengdu, China].
[Separation of red blood cells from G6PD-deficient patients in dextran density gradients]
[Sickle-cell anemia and glucose-6-phosphate dehydrogenase deficiency]
[Studies on a G6PD polymorphic site, cDNA C1311T]
[Studies on autohemolysis. II. The autohemolysis phenomenon and its relation to reduced erythrocyte glutathione in subjects with erythrocytic deficiency of glucose-6-phosphate dehydrogenase deficiency without acute hemolytic attacks.]
[Studies on some hereditary hematologic characteristics in the Mexican population. III. Erythrocytic glucose-6-phosphate dehydrogenase deficiency in 7 indigenous and mestizo groups.]
[Study of serum C3 and C4 fractions in patients with glucose-6-phosphate dehydrogenase deficiency (author's transl)]
[Study of the relationships between hereditary transmission of the erythrocytic thrombocytic deficiency of glucose-6-phosphate dehydrogenase in Sardinian subjects with favism]
[Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes]
[Survey on the transmission of glucose-6-phosphate dehydrogenase deficiency. Study apropos of 34 families including 86 enzymopenic patients]
[Survival of Gd- allele carriers in the absence of malaria]
[Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase]
[The African variant of glucose-6-phosphate dehydrogenase deficiency as a factor favoring anemia: comparative study of 157 deficient adults and 300 non-deficient adults]
[The C1155G mutation of the red blood cell glucose-6-phosphate dehydrogenase gene in a subject with severe hereditary chronic nonspherocytic anaemia]
[The client's viewpoint on genetic counseling. Acceptability of the service in an Oristanese community (Cabras)]
[The diagnosis of glucose-6-phosphate dehydrogenase deficiency of the erythrocytes]
[The erythrocyte catalase in normal subjects and patients with glucose-6-phosphate dehydrogenase deficiency: quantitative determination of the enzyme and its chromatographic characterization]
[THE EXISTENCE OF 2 POPULATIONS OF ERYTHROCYTES IN WOMEN HETEROZYGOTIC FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY. DEMONSTRATION BY SPECTROPHOTOMETRY ON INDIVIDUALLY EXAMINED ERYTHROCYTES.]
[THE FAIRBANKS AND BEUTLER TEST FOR THE ROUTINE DETECTION OF ERYTHROCYTE DEFICIENCY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.]
[The genotype analysis of glucose-6-phosphate dehydrogenase deficiency in Yunnan province]
[The importance of determination of ferritin levels in erythrocytes]
[The incidence of congenital glucose-6-phosphate dehydrogenase deficiency in the newborn infants of the city of Bologna.]
[The preliminary study on the gene mutations of sixty patients with G6PD deficiency in Yunnan province]
[The role of NADPH in the development of neonatal jaundice with G6PD deficiency]
[The significance of an analysis of abnormal hemoglobin and glucose-6-phosphate dehydrogenase deficiency in military examination of persons coming from the tropics.]
[The significance of Tönz's test in detecting patients with glucose-6-phosphate dehydrogenase deficiency]
[Tolerability of imidazole-2-hydroxybenzoate treatment in children with total erythrocytic glucose-6-phosphate dehydrogenase deficiency (Mediterranean Gd variant)]
[Tonsillectomy in a 6-year-old child with hemolytic anemia caused by erythrocytic glucose-6-phosphate dehydrogenase deficiency]
[Topical corticosteroids as a therapeutic alternative in linear immunoglobulin A bullous dermatosis in childhood: case report].
[Triple erythrocyte disorders: thalassemia, hemoglobinopathy L Glucose-6-phosphate dehydrogenase deficiency in a girl from Polesine. First study]
[Unexplained hyperbilirubinemic icterus in the newborn infant and glucose-6-phosphate dehydrogenase deficiency]
[Unexplained hyperbilirubinemic jaundice in the newborn and glucose-6-phosphate dehydrogenase deficiency]
[Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children]
[Variations in enzymatic patterns in G6PD deficiency and favism]
[What do we know today about diaminodiphenylsulfone?]
[Widespread use of primaquine for control of Plasmodium vivax epidemics in a population with varying degrees of G6PD deficiency].
glutamate-cysteine ligase deficiency
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias.
glutathione peroxidase deficiency
Erythrocyte enzymes in neonatal juandice.
glutathione synthase deficiency
Chronic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency or glutathione synthetase deficiency: the role of vitamin E in its treatment.
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
Improved erythrocyte survival with high-dose vitamin E in chronic hemolyzing G6PD and glutathione synthetase deficiencies.
glutathione-disulfide reductase deficiency
A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency.
Case studies on haemoglobin S heterozygotes with severe clinical manifestations.
Visual test for erythrocytic glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, and glutathione reductase deficiencies.
Glycogen Storage Disease
Metabolic Insight of Neutrophils in Health and Disease.
Goiter
Congenital defects of the central nervous system associated with hyperendemic goiter in a neolithic highland society of Netherlands New Guinea II. Glucose-6-phosphate dehydrogenase in the mulia population.
Gout
Diet in dermatology: revisited.
Erythrocyte glutathione reductase in gout and in glucose-6-phosphate dehydrogenase deficiency.
Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result.
Granuloma
[Periapical odontogenic processes of inflammatory origin. Enzyme activity]
Granulomatous Disease, Chronic
Accelerated decay of glucose 6-phosphate dehydrogenase activity in chronic granulomatous disease.
Altered levels of glucose-6-phosphate dehydrogenase stabilizing factors in X-linked chronic granulomatous disease.
Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections.
Chronic granulomatous disease with leukocytic glucose-6-phosphate dehydrogenase deficiency in a 28-month-old girl.
Estrogen binding by leukocytes during phagocytosis,.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Studies on the pathogenesis of chronic granulomatous disease. 2. Impaired activation of glucose-6-phosphate dehydrogenase in leukocytes of a patient with chronic granulomatous disease during phagocytosis.
[Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report]
Graves Disease
Cytochemistry--a tool in thyroid pathology.
Cytoenzymologic activities of some oxidreductases in thyreopathies.
Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.
Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
Head and Neck Neoplasms
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Hearing Loss
Clinical experience with multigene carrier panels in the reproductive setting.
G6PD overexpression protects from oxidative stress and age-related hearing loss.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Risk Factors for Sensorineural Hearing Loss in Neonatal Hyperbilirubinemia.
Heart Arrest
Oxidative stress reversibly inactivates myocardial enzymes during cardiac arrest.
Heart Defects, Congenital
Anesthesia and glucose-6-phosphate dehydrogenase deficiency in a child with congenital heart disease.
Heart Diseases
A case-control study of primary hepatocellular carcinoma in Taiwan.
Epidemiology and clinical features of Mediterranean spotted fever in Italy.
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.
Metabolic findings in the erythrocytes of cardiopathic and anaemic dogs.
REDUCTIVE STRESS LINKED TO SMALL HSPs, G6PD AND NRF2 PATHWAYS IN HEART DISEASE.
Heart Failure
Cardiac failure associated with G6PD deficiency.
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure.
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart.
Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases.
Healing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Reversible pulmonary trunk banding. VI: Glucose-6-phosphate dehydrogenase activity in rapid ventricular hypertrophy in young goats.
Reversible pulmonary trunk banding: IX. G6PD activity of adult goat myocardium submitted to ventricular retraining.
Therapeutic potential of manipulating suicidal erythrocyte death.
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart.
[Correlation of some parameters of carbohydrate metabolism and central hemodynamics in the early stages of circulatory insufficiency in patients with ischemic heart disease]
[Histochemical study of the enzyme activity of the myocardium of sudden death victims with postinfarct cardiosclerosis]
Heart Septal Defects, Ventricular
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
HELLP Syndrome
Anemia and the liver. Hepatobiliary manifestations of anemia.
Hematologic Diseases
Development of allelic discrimination assay to detect Mediterranean G6PD mutation and its linked inheritance with normal vision and/colorblindness loci for 4 generations among Egyptian and Emirati families.
Plan and process for hematology laboratory standard in Thailand.
Hematologic Neoplasms
Clonal analysis of hematologic malignancies using Mediterranean G6PD mosaicism.
Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.
Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.
Hemochromatosis
Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?
Genetic screening for low-penetrance variants in protein-coding genes.
Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.
Safety of vitamin C in sepsis: a neglected topic.
[A new glucose 6-phosphate dehydrogenase (G6PD) variant (G6PD Niigata) with chronic hemolysis and liver hemochromatosis]
Hemoglobinopathies
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Access to orphan drugs in the Middle East: Challenge and perspective.
Anemia in adolescence. 2. Hemoglobinopathies and other causes.
Anemia in newborn.
Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE).
Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Campaign to control genetic blood diseases in Bahrain.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.
G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.
Genetic diversity of hemoglobinopathies, G6PD deficiency, and ABO and Rhesus blood groups in two isolates of a primitive Kharia Tribe in Sundargarh District of Northwestern Orissa, India.
Genetic studies of the Seneca Indians: haptoglobins, transferrins, G-6-PD deficiency, hemoglobinopathy, color blindness, morphological traits and dermatoglyphics.
Global burden of genetic disease and the role of genetic screening.
Glucose 6 phosphate dehydrogenase deficiency and hemoglobinopathy in South Western Region Nepal: a boon or burden.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Brazil.
Heinz-body anemia: "bite cell" variant--a light and electron microscopic study.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain.
Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in one of the regions of Azerbaijan: mass screening and laboratory investigations.
Hemoglobinopathies in relation to the erythrocyte glucose-6-phosphate dehydrogenase deficiency.
Hemoglobinopathies, G6PD deficiency, and hereditary elliptocytosis in Bahrain.
Hereditary hemolytic disorders among the Ashram school children in Mayurbhanj district of Orissa.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Iron metabolism and malaria.
Medical genetics in Thailand.
Neonatal biochemical screening for disease.
Neonatal screening for sickle cell disease, glucose-6-phosphate dehydrogenase deficiency and a-thalassemia in Qatif and Al Hasa.
Newborn Screening for Hemoglobinopathies and Red Cell Enzymopathies in Tripura State: A Malaria-Endemic State in Northeast India.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
Sickle cell trait and glucose-6-phosphate dehydrogenase deficiency. Effects on health and military performance in black Navy enlistees.
The Interaction between Hb A1C and Selected Genetic Factors in the African American Population in the USA.
Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.
[Favism, hemoglobin H, alpha-thalassemia and hemoglobinopathy in various Sardinian families. Studies on glucose-6-phosphate dehydrogenase]
[G-6-PD deficiency with hemoglobinopathy and alpha-thalassemia]
[Genetic resistance to malaria]
[Glucose-6-phosphate dehydrogenase deficiency in Mali. Epidemiology and pathological aspects]
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Increase in genetically determined anemia as a result of migration in Germany].
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population.]
[One hundred and twenty-three cases of sickle-cell trait (author's transl)]
[Screening for hemoglobinopathies and G-6-PD deficiency anemia in school children of a city in the Turin region]
[Screening for hemoglobinopathies and G6PD deficiencies in Morocco]
[Triple erythrocyte disorders: thalassemia, hemoglobinopathy L Glucose-6-phosphate dehydrogenase deficiency in a girl from Polesine. First study]
Hemoglobinuria
Acute Kidney Injury following Ingestion of Henna Leaf Extract: A Case Report from Myanmar.
Anemia and the liver. Hepatobiliary manifestations of anemia.
Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases.
Case Report: A Case of Primaquine-Induced Hemoglobinuria in Glucose-6-Phosphate Dehydrogenase Deficient Malaria Patient in Southeastern Bangladesh.
Case Report: Paroxysmal nocturnal hemoglobinuria in a woman heterozygous for G6PD A-.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Paroxysmal Nocturnal Hemoglobinuria with Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Review of the Literature.
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
The prevalence of G6PD deficiency in blood transfusion recipients.
The role of oxidative stress in hemolytic anemia.
[A case of falciparum malaria successfully treated with intravenous artesunate]
[Density-specific distribution of erythrocytes in different types of anemia]
[Hemoglobinuria in children hospitalized in Ouagadougou: short term inpatient care and prognosis].
[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University Hospital Center in Lome]
[Typhoid fever, hemoglobinuria and glucose-6-phosphate dehydrogenase deficiency. (Apropos of 2 cases)]
Hemoglobinuria, Paroxysmal
Anemia and the liver. Hepatobiliary manifestations of anemia.
Case Report: Paroxysmal nocturnal hemoglobinuria in a woman heterozygous for G6PD A-.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Paroxysmal Nocturnal Hemoglobinuria with Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Review of the Literature.
The role of oxidative stress in hemolytic anemia.
[Density-specific distribution of erythrocytes in different types of anemia]
[Glucose-6-phosphate dehydrogenase content of the erythrocytes and their ultrastructure in Marchiafava-Micheli syndrome]
Hemolytic-Uremic Syndrome
Erythrocyte programmed cell death.
Impaired antioxidant defense mechanisms in two children with hemolytic-uremic syndrome.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Oxidative Stress and Suicidal Erythrocyte Death.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Hemophilia A
A rapid multifluorescent polymerase chain reaction for genetic counselling in Chinese haemophilia A families.
An IKBKG, and not a G6PD, short tandem repeat marker is used in indirect diagnosis of haemophilia A.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Linkage Between the X Chromosome Loci for Glucose-6-Phosphate Dehydrogenase Electrophoretic Variation and Hemophilia A.
Preimplantation gender diagnosis by fluorescence in situ hybridization.
Prenatal diagnosis by linkage: hemophilia A and polymorphic glucose-6-phosphate deydrogenase.
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
[Early detection of color blindness from the viewpoint of occupational medicine with various references to internistic and human genetic symptom complexes]
Hemophilia B
Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site.
Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree.
The human genes for hemophilia A and hemophilia B flank the X chromosome fragile site at Xq27.3.
Hepatic Encephalopathy
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Pancreatitis in acute hemolysis.
Hepatitis
A comparative study of acute haemolytic anaemia in patients of viral hepatitis in relation to erythrocyte glucose 6-phosphate dehydrogenase deficiency.
Acquired enzymopathy of erythrocyte glucose-6-phosphate dehydrogenase in acute viral hepatitis.
Acute hemolytic anemia complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis with severe hyperbilirubinemia and massive hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Acute viral hepatitis, intravascular haemolysis, severe hyperbilirubinaemia and renal failure in glucose-6-phosphate dehydrogenase deficient patients.
Alcoholic liver disease in black men with G6PD deficiency.
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Coombs-negative severe hemolysis associated with hepatitis A.
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Dubin-Johnson syndrome coexisting with glucose-6-phosphate dehydrogenase deficiency presenting after acute viral hepatitis.
Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Haemolysis complicating acute viral hepatitis in patients with normal or deficient glucose-6-phosphate dehydrogenase activity.
Haemolysis complicating viral hepatitis in patients with glucose-6-phosphate dehydrogenase deficiency.
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hyperbilirubinemia following hepatitis A in a patient with G6pD deficiency.
Increased morbidity following acute viral hepatitis in children with glucose-6-phosphate dehydrogenase deficiency.
Increased morbidity in acute viral hepatitis with glucose-6-phosphate dehydrogenase deficiency.
Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency.
Inverse Association between Glucose?6?Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma
Investigation of prolonged neonatal jaundice.
Letters to the editor: Acute hemolytic anemia, G-6PD deficiency and viral hepatitis.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient patients during viral hepatitis.
The hemolytic process of viral hepatitis in children with normal or deficient glucose-6-phosphate dehydrogenase activity.
Typhoid fever and viral hepatitis in a G6PD deficient individual.
Viral hepatitis with extreme hyperbilirubinemia, massive hemolysis and encephalopathy in a patient with a new G6PD variant.
Viral hepatitis with haemolytic anaemia due to glucose-6-phosphate dehydrogenase deficiency.
[Complicated viral to cholestatic hepatitis in a child with glucose-6-phosphate dehydrogenase deficiency from a high andean region].
[Course of epidemic viral hepatitis in subjects with glucose-6-phosphate dehydrogenase deficiency. Apropos of 6 cases]
[Glucose-6-phosphate dehydrogenase deficiency: report of 2 cases]
[Hemolytic crisis due to a G-6-PD deficiency during the course of viral hepatitis A]
[Lactate dehydrogenase, glucosephosphate dehydrogenase, glutathione reductase and adenosine triphosphatase activities in the erythrocytes of patients with acute viral hepatitis]
[Lethal acute hemolytic anemia in viral hepatitis, caused by glucose-6-phosphate dehydrogenase deficiency]
[The behavior of G6PD in erythrocytes in the course of contagious hepatitis in childhood]
Hepatitis A
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Crigler-Najjar syndrome type 2.
Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Hepatitis A and cytomegalovirus infection precipitating acute hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hepatitis A Virus-induced Severe Hemolysis Complicated by Severe Glucose-6-Phosphate Dehydrogenase Deficiency.
Hyperbilirubinemia following hepatitis A in a patient with G6pD deficiency.
Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency.
Infectious hepatitis with excessive hyperbilirubinemia and a hemolytic crisis in an 8-year-old boy. His G6PD deficiency was an aggravating factor.
Prevalence of G6PD deficiency in Children with Hepatitis A.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status.
Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency.
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Hemolytic crisis due to a G-6-PD deficiency during the course of viral hepatitis A]
[Infectious hepatitis, acute hemolysis and glucose-6-phosphate dehydrogenase deficiency]
Hepatitis B
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Assessment of potential donors for living related liver transplantation.
Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors.
Essential in-vitro laboratory diagnostic services provision in accordance with the WHO standards in Guragae zone primary health care unit level, South Ethiopia.
Frequency of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and its relationship to hepatitis B surface antigen (HBS-Ag) in normal Tanzanian males.
Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors.
The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females.
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
[Role of glucose-6-phosphate dehydrogenase in hepatitis B virus replication and its possible mechanism of action].
Hepatitis B, Chronic
Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Severe hyperbilirubinemia due to acute hepatitis A superimposed on a chronic hepatitis B carrier with glucose-6-phosphate dehydrogenase deficiency.
Hepatitis C
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.
Hepatitis C, Chronic
Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful?
Hepatitis E
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Dubin-Johnson syndrome coexisting with glucose-6-phosphate dehydrogenase deficiency presenting after acute viral hepatitis.
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.
Hepatitis E virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase deficiency.
Hepatitis E with Intravascular Hemolysis in Beta Thalassemia Trait: A Rare Association or Coincidence.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Severe hyperbilirubinemia and acute renal failure associated with hepatitis E in a patient whose glucose-6-phosphate dehydrogenase levels were normal.
Hepatitis, Chronic
Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers.
Hepatoblastoma
Investigation of prolonged neonatal jaundice.
Hepatolenticular Degeneration
Ceramide in suicidal death of erythrocytes.
Erythrocyte programmed cell death.
G6PD-deficiency: a potential high-risk group to copper and chlorite ingestion.
Gall stones, G-6PD deficiency and Wilson's disease.
Hemolysis in Wilson's disease. The role of glucose-6-phosphate dehydrogenase inhibition.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Oxidative Stress and Suicidal Erythrocyte Death.
Pancreatitis in acute hemolysis.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Two novel mutations (2976INSA, 4311insA) of ATP7B in a patient with Wilson's disease coexisting with glucose-6-phosphate dehydrogenase deficiency.
Hepatomegaly
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Herpes Zoster
160 zona pellucida birefringence correlates with cumulus morphology and glucose-6-phosphate dehydrogenase activity of equine oocytes.
Adrenocortical changes in rats during acute and chronic administration of delta-9-tetrahydrocannabinol.
Follicular Size is Associated with the Levels of Transcripts and Proteins of Selected Molecules Responsible for the Fertilization Ability of Oocytes of Puberal Gilts.
Histochemical observations on the adrenal gland of bat Vesperugo pipistrellus (Dobson).
Intraovarian influence of bovine corpus luteum on oocyte morphometry and developmental competence, embryo production and cryotolerance.
Zona pellucida birefringence correlates with developmental capacity of bovine oocytes classified by maturational environment, COC morphology and G6PDH activity.
Zona pellucida glycoprotein 3 (pZP3) and integrin ?2 (ITGB2) mRNA and protein expression in porcine oocytes after single and double exposure to brilliant cresyl blue test.
hexokinase deficiency
Frequency of glucose-6-phosphate dehydrogenase, pyruvate kinase and hexokinase deficiency in the Saudi population.
Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress.
Hirschsprung Disease
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Histiocytosis
Estrogen binding by leukocytes during phagocytosis,.
HIV Infections
Acute Retroviral Syndrome Presenting with Hemolytic Anemia Induced by G6PD Deficiency.
Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency.
[Hemolytic anemia associated with minor salmonellosis in an HIV positive, G6PD deficient Congolese woman]
Hodgkin Disease
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease.
[Considerations on a case of autoimmune hemolytic anemia in the course of malignant granuloma with complete defect of erythrocyte glucose-6-phosphate dehydrogenase]
Homocystinuria
Diet in dermatology: revisited.
Neonatal screening and monitoring system in Taiwan.
Newborn screening in the Philippines.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
[Congenital hypothyroidism missed on newborn screening: report of two cases]
Huntington Disease
Genetic disorders in Southern Africa.
Hydrops Fetalis
Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid.
Nonimmune hydrops fetalis caused by G6PD deficiency hemolytic crisis and congenital dyserythropoietic anemia.
[Hydrops fetalis and G-6-PD deficiency]
Hyperaldosteronism
Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid "adenomas".
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Hyperbilirubinemia, Hereditary
Coinheritance of Rotor syndrome, G-6-PD deficiency, and heterozygous beta thalassemia: a possible genetic interaction.
Hyperbilirubinemia, Neonatal
(TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates.
Antioxidant vitamins and glucose-6-phosphate dehydrogenase deficiency in full-term neonates.
Applying a multiplexed primer extension method on dried blood spots increased the detection of carriers at risk of glucose-6-phosphate dehydrogenase deficiency in newborn screening program.
beta-Thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants.
Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia.
Cooperating G6PD mutations associated with severe neonatal hyperbilirubinemia and cholestasis.
Decreased Glutathione S-transferase Level and Neonatal Hyperbilirubinemia Associated with Glucose-6-phosphate Dehydrogenase Deficiency: A Perspective Review.
Delayed development of sensorineural hearing loss after neonatal hyperbilirubinemia: a case report with brain magnetic resonance imaging.
Diagnosis and management of G6PD deficiency.
Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia.
Enzyme deficiencies in neonates with jaundice.
Erratum to: Neonatal Hyperbilirubinemia in infants with G6PD c.563C?>?T Variant.
Exchange transfusion with G-6-PD deficient donor blood causes exaggeration of neonatal hyperbilirubinemia.
G-6PD "ankara". a new G-6PD variant with deficiency found in a Turkish family.
G6PD Deficiency Prevalence as a Cause of Neonatal Jaundice in a Neonatal Ward in Dohuk, Iraq.
G6PD genetic variations in neonatal Hyperbilirubinemia in Indonesian Deutromalay population.
Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Genetic polymorphisms in Thai neonates with hyperbilirubinemia.
Genotype-Phenotype Correlation of G6PD Mutations among Central Thai Children with G6PD Deficiency.
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase activity, structure, molecular characteristics and role in neonatal hyperbilirubinemia in cord blood in Cukurova region.
Glucose-6-phosphate dehydrogenase deficiency and borderline deficiency: association with neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.
Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia in a south Indian referral hospital.
Glucose-6-phosphate Dehydrogenase Deficiency in Neonatal Indirect Hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency in neonates.
Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
Glucose-6-phosphate dehydrogenase isoenzyme pattern and evaluation of screening methods for G-6-PD deficiency in neonatal hyperbilirubinemia.
Hematological findings in neonatal hyperbilirubinemia due to G6PD deficiency.
Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia.
High resolution melting curve analysis enables rapid and reliable detection of G6PD variants in heterozygous females.
Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.
Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency.
Hyperbilirubinemia, glucose-6-phosphate-dehydrogenase deficiency and Gilbert's syndrome.
Identification of Genetic Risk Factors for Neonatal Hyperbilirubinemia in Fujian Province, Southeastern China: A Case-Control Study.
Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
Influence of the Inherited Glucose-6-phosphate Dehydrogenase Deficiency on the Appearance of Neonatal Hyperbilirubinemia in Southern Croatia.
Is it Accurate to Separate Glucose-6-Phosphate Dehydrogenase Activity in Neonatal Hyperbilirubinemia as Deficient and Normal?
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese.
Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency.
Neonatal Hyperbilirubinemia in infants with G6PD c.563C > T Variant.
Neonatal hyperbilirubinemia: don't let glucose-6-phosphate dehydrogenase deficiency off the hook.
Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants.
Neonatal jaundice--traditional Chinese medicine approach.
Newborn screening for G6PD deficiency: A 2-year data from North India.
Pediatric Provider Insight Into Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency.
Phototherapy for neonatal hyperbilirubinemia in mature newborn infants with erythrocyte G-6-PD deficiency.
Phototherapy for neonatal jaundice in erythrocyte glucose-6-phosphate dehydrogenase-deficient infants.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates.
Readmission for neonatal hyperbilirubinemia in an area with a high prevalence of glucose-6-phosphate dehydrogenase deficiency: A hospital-based retrospective study.
Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.
Risk Factors Associated with Neonatal Jaundice: A Cross-Sectional Study from Iran.
Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.
Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.
The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.
The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency.
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
[Can glucose-6-phosphate dehydrogenase deficiency alone explain neonatal jaundice]
[Clinical studies on glucose-6-phosphate dehydrogenase activity in neonatal hyperbilirubinemia]
[G6PD deficiency in females with neonatal revelation. Report of four cases].
[Glucose-6-phosphate dehydrogenase deficiency in neonatal hyperbilirubinemia]
[Glucose-6-phosphate dehydrogenase deficiency, neonatal hyperbilirubinemia and Gilbert syndrome]
[Neonatal hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency]
[Role of genetic factors in occurrence of neonatal jaundice in Guangxi region]
Hypercalcemia
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.
Hypercholesterolemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Hyperglycemia
Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice.
Antioxidative enzyme and glutathione S-transferase activities in diabetic rats exposed to long-term ASA treatment.
Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia.
Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex.
Diet, diabetes, hypertension and blacks.
Effects of high sucrose diet on insulin-like effects of vanadate in diabetic rats.
Epigenetic modification of the pentose phosphate pathway and the IGF-axis in women with gestational diabetes mellitus.
G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus.
Glucose-6-phosphate dehydrogenase activity and NADPH/NADP+ ratio in liver and pancreas are dependent on the severity of hyperglycemia in rat.
Glucose-6-phosphate dehydrogenase deficiency induced haemolysis in a woman with newly diagnosed diabetes after normalisation of hyperglycaemia.
Growth factors in the fetus and pre-adolescent offspring of hyperglycemic rats.
Hyperglycemia potentiates carbonyl stress-induced apoptosis in naïve PC-12 cells: relationship to cellular redox and activator protease factor-1 expression.
Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats.
Spironolactone improves nephropathy by enhancing glucose-6-phosphate dehydrogenase activity and reducing oxidative stress in diabetic hypertensive rat.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
[The clinical and diagnostic value of biochemical parameters for the evaluation of type 2 diabetes compensation].
Hyperhidrosis
Bilateral pulmonary edema after endoscopic sympathectomy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hyperinsulinism
Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal substrates, hormones, and hepatic enzymes.
Effects of Glucose 6-Phosphate Dehydrogenase Deficiency on the Metabolic and Cardiac Responses to Obesogenic or High Fructose Diets.
Possible metabolic implications of pyruvate and lactate accumulation in the liver of pregnant rats.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
Hyperlactatemia
Hyperlactatemia and hemolysis in G6PD deficiency after nitrofurantoin ingestion.
Hyperlipidemias
Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics.
Hyperlipidemia in acute hemolysis.
Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy.
Laparoscopic cholecystectomy in children and adolescents.
The impact of hydroxycitric acid on the lipid metabolism profile under experimental insulin resistance syndrome of Syrian hamsters.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
Hyperlipoproteinemia Type II
Genetic diversity among the Arabs.
Hypernatremia
Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review.
Hyperoxaluria
Safety of vitamin C in sepsis: a neglected topic.
Hyperparathyroidism
The two-hit theory of neoplasia: implications for the pathogenesis of hyperparathyroidism.
[Infantile transitory distal renal tubular acidosis with bicarbonate loss]
Hypersensitivity
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats.
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Identification of Ald6p as the target of a class of small-molecule suppressors of FK506 and their use in network dissection.
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
Investigation of Heterologously Expressed Glucose-6-Phosphate Dehydrogenase Genes in a Yeast zwf1 Deletion.
Leukocytoclastic vasculitis resolution with topical dapsone.
Pharmacogenetic considerations in the treatment of gout.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rasburicase : a review of its use in the management of anticancer therapy-induced hyperuricaemia.
Rasburicase: an innovative new treatment for hyperuricemia associated with tumor lysis syndrome.
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies.
Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy.
Spotlight on rasburicase in anticancer therapy-induced hyperuricemia.
Structural characterization and tissue-specific expression of the mouse glucose-6-phosphate dehydrogenase gene.
Hypersplenism
Splenic artery pseudoaneurysm due to seatbelt injury in a glucose-6-phosphate dehydrogenase-deficient adult.
Hypertension
A case-control study of primary hepatocellular carcinoma in Taiwan.
An increase in a circulating inhibitor of Na+,K+-dependent ATPase: a possible link between salt intake and the development of essential hypertension.
Cardiac hypertrophy in spontaneously hypertensive rats.
Clinical characteristics of asymptomatic and symptomatic COVID-19 patients in the Eastern Province of Saudi Arabia.
Cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating/Na-K-ATPase-inhibiting activity of plasma and hypothalamus in reduced renal mass hypertension.
Does the Mediterranean G6PD S188F Polymorphism Confer Vascular Protection?: A Novel Rat Model Offering CRISPR Insight Into High Fat-Induced Vascular Dysfunction and Hypertension.
G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus.
Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.
Levels of erythrocyte malonyldialdehyde, vitamin E, reduced glutathione, G6PD activity & plasma urate in patients of pregnancy induced hypertension.
New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension.
Spectrum of genetic disorders and the impact on health care delivery: an introduction.
The association between glucose-6-phosphate dehydrogenase deficiency and abnormal blood pressure among prepregnant reproductive-age Chinese females.
The possible role of hypertension in aggravating hemolytic episodes in G-6PD deficient persons.
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.
The significance of renal glucose-6-phosphate dehydrogenase in experimental hypertension in the rat (a histochemical study).
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
[Intraerythrocyte levels of glucose-6-phosphate dehydrogenase in patients with essential arterial hypertension and persons with normal blood pressure. Modifications after nifedipine therapy]
Hypertension, Pregnancy-Induced
Levels of erythrocyte malonyldialdehyde, vitamin E, reduced glutathione, G6PD activity & plasma urate in patients of pregnancy induced hypertension.
Hypertension, Pulmonary
Activation of glucose-6-phosphate dehydrogenase promotes acute hypoxic pulmonary artery contraction.
Glucose-6-phosphate dehydrogenase deficiency contributes to metabolic abnormality and pulmonary hypertension.
Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats.
Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases.
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice.
Human platelets modulate edema formation in isolated rabbit lungs.
Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension.
Hypoxic Activation of G6PD Controls the Expression of Genes Involved in the Pathogenesis of Pulmonary Hypertension Through the Regulation of DNA Methylation.
Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure.
Inhibition of Glucose-6-Phosphate Dehydrogenase Activity Attenuates Right Ventricle Pressure and Hypertrophy Elicited by VEGFR Inhibitor + Hypoxia.
Pentose Shunt, Glucose-6-Phosphate Dehydrogenase, NADPH Redox, and Stem Cells in Pulmonary Hypertension.
Hyperthyroidism
A Histochemical study of the coronary vasculature in euthyroid and hyperthyroid rats.
Adaptation of red cell enzymes and intermediates in metabolic disorders.
Changes in hexokinase and glucose-6-phosphate dehydrogenase in red cells during hypo and hyperthyroidism.
Changes in the rates of synthesis and messenger RNA levels of hepatic glucose-6-phosphate and 6-phosphogluconate dehydrogenases following induction by diet or thyroid hormone.
Increased acylphosphatase levels in erythrocytes from hyperthyroid patients.
Investigation of red blood cell carbonic anhydrase, glucose 6-phosphate dehydrogenase, hexokinase enzyme activities, and zinc concentration in patients with hyperthyroid diseases.
Metabolism of coronary vasculature in euthyroid, hyperthyroid and recovering hyperthyroid rats: a histochemical study.
The Effect of Experimental Thyroid Dysfunction on Markers of Oxidative Stress in Rat Pancreas.
The glucose-6-phosphate dehydrogenase activity (G-6-PD) of the red blood cells in hyperthyroidism and hypothyroidism.
[Glucose-6-phosphate dehydrogenase activity (G-6-PD) of the erythrocytes in hyperthyroidism]
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
Hyperthyroxinemia
[Glucose-6-phosphate dehydrogenase activity in the liver of rats with experimental hyperthyroxinemia and hypothyroidism]
Hypertrophy, Right Ventricular
Increased reactive oxygen species, metabolic maladaptation, and autophagy contribute to pulmonary arterial hypertension-induced ventricular hypertrophy and diastolic heart failure.
Hypoalbuminemia
Does Ibuprofen increase neonatal hyperbilirubinemia?
Hypoglycemia
Adaptation of red cell enzymes and intermediates in metabolic disorders.
Effect of diabetes and insulin-induced hypoglycemia on hexokinase and glucose-6-phosphate dehydrogenase in red blood cells.
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Hypokinesia
[Glycogen level and activity of carbohydrate metabolism enzymes in the liver of rats during the readaptation period after a 20-day hypokinesia]
Hypophosphatemia
Genetic localization and phenotypic expression of X-linked cataract (Xcat) in Mus musculus.
Pancreatitis in acute hemolysis.
Hypopituitarism
Erythrocyte glucose-6-phosphate dehydrogenase activity in children with hypothyroidism and hypopituitarism.
Hypospadias
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
Hypotension
Does amyl nitrite have a role in the management of pre-hospital mass casualty cyanide poisoning?
Pelvic pain, low blood pressure, and hemolysis after outpatient hysteroscopy in a patient with glucose-6-phosphate dehydrogenase deficiency.
Hypotension, Orthostatic
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Hypothyroidism
Burden of genetic disorders in India.
Changes of activity and kinetics of certain liver and heart enzymes of hypothyroid and T(3)-treated rats.
Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones.
Erythrocyte glucose-6-phosphate dehydrogenase activity in children with hypothyroidism and hypopituitarism.
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.
Extreme hyperbilirubinemia in newborn infants.
Newborn screening in Singapore.
Newborn screening in the Philippines.
Newborn screening: need of the hour in India.
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.
The glucose-6-phosphate dehydrogenase activity (G-6-PD) of the red blood cells in hyperthyroidism and hypothyroidism.
Underlying etiologies of prolonged icterus in neonates.
[Behavior of the erythrocyte glucose-6-phosphate dehydrogenase in patients with functional thyroid disorders and in hyperthyroxinemic rats]
[Glucose-6-phosphate dehydrogenase activity in the liver of rats with experimental hyperthyroxinemia and hypothyroidism]
[Hemolytic anemia after treatment with sulfamethoxypyridazine in a child with temporary G-6-PD deficiency and grave hypothyroidism]
hypoxanthine phosphoribosyltransferase deficiency
Stability of X chromosomal inactivation in human somatic cells transformed by SV-40.
Ileus
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Infant, Newborn, Diseases
Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns.
Infarction, Middle Cerebral Artery
Inhibition of Calcium/Calmodulin-Dependent Protein Kinase II? Suppresses Oxidative Stress in Cerebral Ischemic Rats Through Targeting Glucose 6-Phosphate Dehydrogenase.
Infections
"Hemolysis, or not Hemolysis, that is the Question". Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency.
A carbohydrate-rich diet stimulates glucose-6-phosphate dehydrogenase expression in rat hepatic sinusoidal endothelial cells.
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A-c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations.
A hemolysis trigger in glucose-6-phosphate dehydrogenase enzyme deficiency. Vicia sativa (Vetch).
A new glucose-6-phosphate dehydrogenase variant (G6PD Tsukui) associated with congenital hemolytic anemia.
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute viral hepatitis E presenting with haemolytic anaemia and acute renal failure in a patient with glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, glucose-6-phosphate dehydrogenase deficiency and prolonged acute renal failure: a case report.
Acyanotic Hypoxia in a Febrile Child.
Age, Ethnicity, Glucose-6-Phosphate Dehydrogenase Deficiency, Micronutrient Powder Intake, and Biomarkers of Micronutrient Status, Infection, and Inflammation Are Associated with Anemia Among Children 6-59 Months in Nepal.
Alterations in enzymatic activities of the intestinal mucosa during the course of Giardia lamblia infection in mice.
Alterations of the glutathione cycle enzymes during and after SV40-transformation of human fibroblasts.
Anemia associated with new-onset diabetes: improvement with blood glucose control.
Anemia during actue infections. Role of glucose-6-phosphate dehydrogenase deficiency in Negroes.
Apigenin-induced ABCC1-mediated efflux of glutathione from mature erythrocytes inhibits the proliferation of plasmodium falciparum.
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Association between glucose 6-phosphate dehydrogenase (G6PD) deficiency and fatal outcome of hepatitis E infection in middle-aged men.
Association of glucose-6-phosphate dehydrogenase deficiency and X-linked chronic granulomatous disease in a child with anemia and recurrent infections.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases.
Brucellosis triggering hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Cellular mucosal defense is attenuated with chronicity of Helicobacter pylori infection.
Cerebellar Toxoplasmosis in an Immunocompetent Patient with G6PD Deficiency.
Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.
Contrasting histories of G6PD molecular evolution and malarial resistance in humans and chimpanzees.
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
Correlation of viral RNA biosynthesis with glucose-6-phosphate dehydrogenase activity and host resistance.
COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Diagnostic Practices and Treatment for P. vivax in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods Study.
Dialytic support in acute renal failure.
Diurnal fluctuation of leukocyte G6PD activity. A possible explanation for the normal neutrophil bactericidal activity and the low incidence of pyogenic infections in patients with severe G6PD deficiency in Israel.
Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice.
Effect of praziquantel on some aspects of carbohydrate metabolism in mice infected with Schistosoma mansoni.
Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers.
Effect of sodium acetate on serum activity of glucose-6-phosphate dehydrogenase in Plasmodium berghei-infected mice.
Effects of 5,8-dimethylthieno[2,3-b]quinoline-2-carboxylic acid on the antioxidative defense and lipid membranes in Plasmodium berghei-infected erythrocytes.
Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Endotoxin stimulates the expression of glucose-6-phosphate dehydrogenase in Kupffer and hepatic endothelial cells.
Energetics of cyanophage N-1 multiplication in the diazotrophic cyanobacterium Nostoc muscorum.
Enhancement of neuronal protection from oxidative stress by glutamic acid decarboxylase delivery with a defective herpes simplex virus vector.
Erythrocyte hemighosts: a hallmark of severe oxidative injury in vivo.
Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.
Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Evaluation of glucose-6-phosphate dehydrogenase (G6PD) status in US military and VA patients with COVID-19 infection.
Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Evidence of positively selected G6PD A- allele reduces risk of Plasmodium falciparum infection in African population on Bioko Island.
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
Exploring putative molecular mechanisms of human pyruvate kinase enzyme deficiency and its role in resistance against Plasmodium falciparum malaria.
Factors influencing resistance to reinfection with Plasmodium falciparum.
Falciparum malaria and beta-thalassaemia trait in northern Liberia.
Favism, the commonest form of severe hemolytic anemia in Palestinian children, varies in severity with three different variants of G6PD deficiency within the same community.
Features and outcomes of malaria infection in glucose-6-phosphatedehydrogenase normal and deficient Nigerian children.
Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.
Fine Mapping of Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency in a Rural Malaria Area of South West Odisha Using the Clinical, Hematological and Molecular Approach.
First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in-silico.
Free radical scavengers in susceptible/resistant Biomphalaria alexandrina snails before and after infection.
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
G6PD A-variant influences the antibody responses to Plasmodium falciparum MSP2.
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients.
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
G6PD deficiency: An update.
G6PD deficiency: the genotype-phenotype association.
G6PD gene variants and its association with malaria in a Sri Lankan population.
G6PD: population genetics and clinical manifestations.
Glucose 6-phosphate dehydrogenase variants: a unique variant (G6PD Kobe) showed an extremely increased affinity for galactose 6-phosphate and a new variant (G6PD Sapporo) resembling G6PD Pea Ridge.
Glucose-6-phosphate dehydrogenase (G6PD) activity can modulate macrophage response to Leishmania major infection.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-Phosphate Dehydrogenase - Beyond the Realm of Red Cell Biology.
Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
Glucose-6-phosphate dehydrogenase deficiency and infection: a study of hospitalized patients in Iran.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica.
Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia.
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.
Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection.
Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.
Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in manaus: a cross-sectional survey in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Glucose-6-Phosphate Dehydrogenase Deficiency Unveiled by Diabetic Ketoacidosis: A Dual Dilemma.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites.
Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase screening of babies born in a tertiary care hospital in West Bengal.
Glucose-6-phosphate metabolism in Plasmodium falciparum.
Glutathione stability and oxidative stress in P. falciparum infection in vitro: responses of normal and G6PD deficient cells.
Hematological findings and severity of G6PD deficiency in Vataliya Prajapati subjects.
Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Hemolytic anemias. Diagnosis and management.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
High resolution melting curve analysis enables rapid and reliable detection of G6PD variants in heterozygous females.
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency.
Human genetic factors related to susceptibility to mild malaria in Gabon.
Hybrids between Schistosoma haematobium and S. mattheei and their identification by isoelectric focusing of enzymes.
Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand.
Hypoxia inducible factor -1 regulates WSSV-induced glycolytic genes in the white shrimp Litopenaeus vannamei.
Identification of appropriate reference genes for local immune-related studies in Morada Nova sheep infected with Haemonchus contortus.
Immunological and metabolic effects of acute sublethal exposure to glyphosate or glyphosate-based herbicides on juvenile rainbow trout, Oncorhynchus mykiss.
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.
Inborn defects in the antioxidant systems of human red blood cells.
Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants.
Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose.
Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review.
Interaction of malarial infection and glucose-6-phosphate dehydrogenase deficiency in Muria gonds of district Bastar, central India.
Intravascular hemolysis in aluminium phosphide poisoning.
Inverse Association between Glucose?6?Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma
Investigation of prolonged neonatal jaundice.
Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
Isoenzyme replacement of glucose-6-phosphate dehydrogenase in the cytosol improves stress tolerance in plants.
Isotopologue profiling of Legionella pneumophila: The role of serine and glucose as carbon substrates.
iTRAQ-based proteomic profile analysis of ISKNV-infected CPB cells with emphasizing on glucose metabolism, apoptosis and autophagy pathways.
Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
Loss of cytosolic glucose-6-phosphate dehydrogenase increases the susceptibility of Arabidopsis thaliana to root-knot nematode infection.
Lymphocytes and antibody in retrovirus-induced feline pure red cell aplasia.
Maintaining Specimen Integrity for G6PD Screening by Cytofluorometric Assays.
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Metabolic Linkage and Correlations to Storage Capacity in Erythrocytes from Glucose 6-Phosphate Dehydrogenase-Deficient Donors.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
Modeling Plasmodium vivax: Relapses, treatment, seasonality, and G6PD deficiency.
Molecular Analysis of Glucose-6-Phosphate Dehydrogenase Gene Mutations in Bangladeshi Individuals.
Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.
Molecular basis and haematological characterization of beta-thalassaemia major in Taiwan, with a mutation of IVS-1 3' end TAG-->GAG in a Chinese patient.
Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands.
Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.
Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.
Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells.
Newborn screening for G6PD deficiency: A 2-year data from North India.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Pathogenesis of anemia in malaria: a concise review.
Periodontal disease and hemolysis in glucose-6-phosphate dehydrogenase deficiency: Is there a nexus?
Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Plasmodium falciparum malaria and human red cells. II. Red cell genetic traits and resistance against malaria.
Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda.
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Prenatal Training Improves New Mothers' Understanding of Jaundice.
Prevalence and molecular identification of the mediterranean variant among G6PD-deficient Sistani and Balouch males in Southeastern Iran.
Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.
Rat liver glucose-6-phosphate dehydrogenase isozymes: influence of infection with Trypanosoma.
Reappraisal of known malaria resistance loci in a large multicenter study.
Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice.
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency.
Relationship between erythrocyte glucose-6-phosphate dehydrogenase and the hemolytic anemia of infection.
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals.
Risk factors for severe hyperbilirubinemia in neonates.
Role of G6PD, ABO incompatibility, low birth weight and infection in neonatal hyperbilirubinaemia.
Role of intracellular second messengers and reactive oxygen species in the pathophysiology of V. cholera O139 treated rabbit ileum.
SCIENTIFIC AND PRACTICAL STUDIES OF MALARIA IN THE CIS COUNTRIES AND GEORGIA.
Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Severe glucose-6-phosphate dehydrogenase deficiency leads to susceptibility to infection and absent NETosis.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Severe infections in thalassaemic patients: prevalence and predisposing factors.
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.
Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona).
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
Stenotrophomonas infection in a patient with glucose-6-phosphate dehydrogenase deficiency.
Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A(-) deficiency.
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana.
Subversion of Schwann Cell Glucose Metabolism by Mycobacterium leprae.
Successful treatment of acute renal failure secondary to complicated infective endocarditis by peritoneal dialysis: a case report.
Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females.
The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia.
The blood groups, serum groups, red-cell isoenzymes and haemoglobins of the Sandawe and Nyaturu of Tanzania.
The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum.
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease.
The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar.
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
The molecular basis of glucose-6-phosphate dehydrogenase deficiency.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
The pentose phosphate pathway and parasitic protozoa.
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos.
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.
The Redox Systems of Plasmodium falciparum and Plasmodium vivax: Comparison, In silico Analyses and Inhibitor Studies.
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients.
Treatment and prevention of malaria in children.
Treatment of MRSA Infections in an African-American male with G6PD Deficiency.
Two new glucose-6 phosphate dehydrogenase (G6PD) variants associated with hemolytic anemia: G6PD Amman-1 and G6PD Amman-2.
UK malaria treatment guidelines 2016.
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
Underlying etiologies of prolonged icterus in neonates.
Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Alterations in natural immunity and risk of infection in patients with diabetes mellitus]
[Aplastic crisis due to human parvovirus B19 infection in glucose-6-phosphate dehydrogenase deficiency]
[Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine]
[Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency]
[Change of G6PD Activity in Children with Acute Leukemia and Its Clinical Significance].
[Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day]
[Clinical significance of the changes in glucose-6-phosphate dehydrogenase activity in blood cells of children with acute intestinal infections]
[Epidemiological survey on malaria situation in Motuo County of Tibet, China]
[Glucose-6-phosphate dehydrogenase deficiency with recurrent infections: case report]
[Glucose-6-phosphate dehydrogenase deficiency: clinical presentation and eliciting factors]
[Glycolysis and pentose-phosphate pathway ratio in staphylococcus from the female genitalia in norm and dysbiosis]
[Hemoglobin Woodville associated with double point mutation in the gene of glucose-6-phosphate dehydrogenase].
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Increasing prevalence of G6PD deficiency in the Netherlands].
[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University Hospital Center in Lome]
Infectious Mononucleosis
Acute renal failure in a glucose-6-phosphate dehydrogenase deficient individual with infectious mononucleosis.
Anemia in adolescence. 2. Hemoglobinopathies and other causes.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Infertility
An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis.
Genetic association in infertility: ABO, Rh (subtypes), Lea blood groups, G6PD deficiency and haemoglobin types.
Glucose-6-phosphate dehydrogenase deficiency does not increase the susceptibility of sperm to oxidative stress induced by H2O2.
[Glucose-6-phosphate dehydrogenase (G6PD) deficiency--a cause of anaemia in pregnant women]
Infertility, Male
Glucose-6-phosphate dehydrogenase deficiency does not increase the susceptibility of sperm to oxidative stress induced by H2O2.
The pathogenesis of transaldolase deficiency.
Influenza, Human
An influenza hemagglutinin A peptide assay based on the enzyme-multiplied immunoassay technique.
Insulin Resistance
Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats.
Blunted Reducing Power Generation in Erythrocytes Contributes to Oxidative Stress in Prepubertal Obese Children with Insulin Resistance.
Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics.
Evaluation of 90-day Repeated Dose Oral Toxicity, Glycometabolism, Learning and Memory Ability, and Related Enzyme of Chromium Malate Supplementation in Sprague-Dawley Rats.
Evaluation of the hypoglycaemic and antioxidant effects of submerged Ganoderma lucidum cultures in type 2 diabetic rats.
Evaluation of the Reproductive Toxicity, Glycometabolism, Glycometabolism-Related Enzyme Levels and Lipid Metabolism of Chromium Malate Supplementation in Sprague-Dawley Rats.
Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle.
Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy.
Macrophage glucose-6-phosphate dehydrogenase stimulates proinflammatory responses with oxidative stress.
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
New evaluations of redox regulating system in adipose tissue of obesity.
Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
The 1975 type Japanese diet improves the gut microbial flora and inhibits visceral fat accumulation in mice.
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.
The role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in obesity.
Intellectual Disability
Biochemical genetics and mental retardation: a study of hemoglobins, Australia antigen and the enzymes pseudocholinesterase and glucose-6-phosphate dehydrogenase.
Glucose-6-phosphate dehydrogenase and its relationship to mental retardation.
Glucose-6-phosphate dehydrogenase deficiency and mental retardation.
Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation.
Linkage studies of X-linked mental retardation: high frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome).
Mental retardation in heterozygotes for the fragile-X mutation: evidence in favor of an X inactivation-dependent effect.
Synthesis and concentration of 5-phosphoribosyl-1-pyrophosphate in erythrocytes from patients with Down's syndrome.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
X-linked syndrome: mental retardation, hip luxation, and G6PD variant [Gd(+) Butantan]
[Clinical study on the prevention of kernicterus caused by hereditary glucose-6-phosphate dehydrogenase deficiency]
Intestinal Volvulus
Studies on glucose-6-phosphate dehydrogenase from the human parasite, Onchocerca volvulus.
Intracranial Hemorrhages
Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China.
Hematological profile in neonatal jaundice.
Intravenous Thrombolysis for Stroke Patients with G6PD Deficiency.
Invasive Fungal Infections
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Iron Deficiencies
Bio-inorganic regulation of pathways of carbohydrate and lipid metabolism. II. The effect of iron-deficiency on the profile of enzymes in the developing rat adrenal gland.
Ceramide in suicidal death of erythrocytes.
Current prevalence of intestinal parasitic infections and their impact on hematological and nutritional status among Karen hill tribe children in Omkoi District, Chiang Mai Province, Thailand.
Eryptosis: Ally or Enemy.
Erythrocyte programmed cell death.
Excessive fluoride consumption increases haematological alteration in subjects with iron deficiency, thalassaemia, and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Hereditary anaemias and iron deficiency in a tribal population (the Baiga) of central India.
Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Nutritional Status of Young Children with Inherited Blood Disorders in Western Kenya.
Oxidative Stress and Suicidal Erythrocyte Death.
Prevalence of anemia, iron deficiency, thalassemia and glucose-6-phosphate dehydrogenase deficiency among hill-tribe school children in Omkoi District, Chiang Mai Province, Thailand.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
[Erythrocyte structure and function in iron-deficiency states in painters]
[Genetic, biochemical, pathogenetic and laboratory aspects of thalassemia. Heterozygote thalassemia in Alghero]
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
[The importance of determination of ferritin levels in erythrocytes]
Iron Overload
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
In vitro and in vivo effects of iron on the expression and activity of glucose 6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and glutathione reductase in rat spleen.
Iron overload, G6PD deficiency, and lead levels on blood smears.
Stimulation of gene expression and activity of antioxidant related enzyme in Sprague Dawley rat kidney induced by long-term iron toxicity.
Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.
Ischemic Attack, Transient
Knockdown of glucose-6-phosphate dehydrogenase (G6PD) following cerebral ischemic reperfusion: The pros and cons.
Ischemic Stroke
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.
G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway.
Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.
Jaundice, Chronic Idiopathic
Dubin-Johnson syndrome coexisting with glucose-6-phosphate dehydrogenase deficiency presenting after acute viral hepatitis.
Jaundice, Neonatal
A longitudinal study of red cell enzymes in infants of low birth weight.
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency.
A prolonged neonatal jaundice associated with a rare G6PD mutation.
A prospective study of the role of bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria.
A research on the erupted fetal diseases caused by traditional Chinese drugs--discussion from the issue that Chinese goldthread rhizome is prohibited in Singapore.
A review of Orang Asli newborns admitted to a neonatal unit in a Malaysian general hospital.
A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates.
Aspects of tropical paediatrics.
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency: a preliminary study.
Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors.
Can severe neonatal jaundice be prevented by neonatal screening for glucose-6-phosphate dehydrogenase deficiency?--a review of evidence.
Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi.
Correlation between oxidative stress and G6PD activity in neonatal jaundice.
D-Glucaric acid excretion in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.
Deficiency of erythrocyte G-6-PD as a cause of neonatal jaundice in India.
Diagnostic problems in severe neonatal jaundice and G6PD deficiency in Greece.
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia.
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
Erythrocyte enzymes in neonatal juandice.
Erythrocyte glucose 6-phosphate dehydrogenase deficiency (G6PD type A-) and neonatal jaundice.
Erythrocyte glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice.
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency.
Evaluation of Glucose-6-Phosphate Dehydrogenase stability in stored blood samples.
Evaluation of neonatal jaundice in the Makkah region.
Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection.
Foetal loss & family size in neonatal jaundice due to ABO-HDN, G-6-PD deficiency & low birth weight.
From prejudice to evidence: the case of rhizoma coptidis in singapore.
Functional and Biochemical Characterization of Three Recombinant Human Glucose-6-Phosphate Dehydrogenase Mutants: Zacatecas, Vanua-Lava and Viangchan.
G6PD Deficiency Prevalence as a Cause of Neonatal Jaundice in a Neonatal Ward in Dohuk, Iraq.
G6PD deficiency: An update.
G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.
G6PD NanKang (517 T-->C; 173 Phe-->Leu): a new Chinese G6PD variant associated with neonatal jaundice.
G6PD: population genetics and clinical manifestations.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Genotype-Phenotype Correlations of Glucose-6-Phosphate-Deficient Variants Throughout an Activity Distribution.
Glucose 6-phosphate dehydrogenase variants: Gd (+) Alexandra associated with neonatal jaundice and Gd (-) Camperdown in a young man with lamellar cataracts.
Glucose-6-phosphate dehydrogenase (G-6-PD) levels in jaundiced neonates in Calabar.
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency in Greek newborns: The Mediterranean C563T mutation screening.
Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice among population groups of Cape Town.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Al-Hofuf area.
Glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Jamaica.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN NIGERIA: THEIR RELATION TO THE USE OF PROPHYLACTIC VITAMIN K.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE IN SOUTH AFRICAN BANTU INFANTS.
Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Glucose-6-phosphate dehydrogenase deficiency in ethnic minorities in The Netherlands.
Glucose-6-phosphate dehydrogenase deficiency in neonates.
Glucose-6-phosphate dehydrogenase deficiency in Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency in Sicily. Incidence, biochemical characteristics and clinical implications.
Glucose-6-phosphate dehydrogenase deficiency in Thailand; its significance in the newborn.
Glucose-6-phosphate dehydrogenase deficiency in the newborn: its prevalence and relation to neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency in Tunisian jaundiced neonates.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency. A new aetiological factor of severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Glucose-6-phosphate dehydrogenase Ferrara. A new variant of g-6-PD identified in Northern Italy.
Glucose-6-phosphate dehydrogenase screening of babies born in a tertiary care hospital in West Bengal.
Glucose-6-phosphate dehydrogenase status and neonatal jaundice.
Glucose-6-phosphate dehydrogenase variants from Italian subjects associated with severe neonatal jaundice.
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases.
Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World.
Gold nanostructures for the multiplex detection of glucose-6-phosphate dehydrogenase gene mutations.
Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency.
Hypohidrotic ectodermal dysplasia associated with glucose-6-phosphate dehydrogenase deficiency.
Incidence and mechanism of neonatal jaundice related to glucose-6-phosphate dehydrogenase deficiency.
Increased incidence of hyperbilirubinaemia in 'unchallenged' glucose-6-phosphate dehydrogenase deficiency in term Saudi newborns.
Lack of effect of phototherapy on red cell riboflavin status and on glucose-6-phosphate dehydrogenase activity in normal and G-6-PD-deficient subjects with neonatal jaundice.
Low glucose-6-phosphate dehydrogenase enzyme activity level at the time of hemolysis in a male neonate with the African type of deficiency.
Massive acute haemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient preterm triplets.
Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children.
Molecular characterization of a German variant of glucose-6-phosphate dehydrogenase deficiency (G6PD Aachen).
Molecular Characterization of Glucose-6-phosphate Dehydrogenase Deficiency in Families from the Republic of Macedonia and Genotype-phenotype Correlation.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants.
Neonatal jaundice and severity of glucose-6-phosphate dehydrogenase deficiency in Sardinian babies.
Neonatal jaundice associated with erythrocyte glucose-6-phosphate dehydrogenase deficiency in a non-Mediterranean Caucasian infant with trisomic Down's Syndrome.
Neonatal Jaundice Associated with Familial G6PD Deficiency in Israel.
NEONATAL JAUNDICE DUE TO GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY.
Neonatal jaundice in Asia.
Neonatal jaundice in Qatif: The role of glucose-6-phosphate dehydrogenase deficiency in the etiology among outpatient cases.
Neonatal jaundice in Saudi newborns with G6PD Aures.
Neonatal jaundice, aflatoxins and naphthols: report of a study in Ibadan, Nigeria.
Neonatal jaundice. A second 4-year experience in Toa Payoh Hospital (1986-1989).
Neonatal jaundice: two cases associated with glucose-6-phosphate dehydrogenase deficiency in erythrocytes.
Neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Yanbu, Saudi Arabia.
Neonatology in Singapore: the way we were, the way forward.
Newborn screening for G6PD deficiency: A 2-year data from North India.
Onset of jaundice in glucose-6-phosphate dehydrogenase-deficient neonates.
Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey.
Poor correlation between hemolysis and jaundice in glucose 6-phosphate dehydrogenase-deficient babies.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Prevalence of and mothers' knowledge, attitude and practice towards glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice: a cross-sectional study.
Prevalence of G6PD deficiency in newborns in the south of Brazil.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in jaundiced Egyptian neonates.
Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt.
Prevalence of UGT1A1 (TA)n promoter polymorphism in Panamanians neonates with G6PD deficiency.
RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY--A NEWLY RECOGNIZED CAUSE OF NEONATAL JAUNDICE AND KERNICTERUS IN CANADA.
Red cell metabolism and severe neonatal jaundice in West Malaysia.
Relationship between exposure to icterogenic agents, glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Nigeria.
ROLE OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN ACUTE HEMOLYTIC CRISIS AND NEONATAL JAUNDICE.
Screening for G6PD Deficiency Among Neonates with Neonatal Jaundice Admitted to Tertiary Care Center: A Need in Disguise.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.
Severe neonatal jaundice due to a de novo glucose-6-phosphate dehydrogenase deficient mutation.
Study of erythrocyte glucose-6-phosphate dehydrogenase in neonatal jaundice of full-term babies among Saudi Arabian population.
The effect of glucose-6-phosphate dehydrogenase deficiency on the severity of neonatal jaundice in Cape Town.
The Le(a) antigen and neonatal hyperbilirubinemia in Taiwan.
The risk of jaundice in glucose-6-phosphate dehydrogenase deficient babies exposed to menthol.
The value of methemoglobin reduction test as a screening test for neonatal glucose 6-phosphate dehydrogenase deficiency.
Two new mutations of the glucose-6-phosphate dehydrogenase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and molecular relationships.
[Can glucose-6-phosphate dehydrogenase deficiency alone explain neonatal jaundice]
[Clinical Features and Laboratory Data Analysis of Glucose-6- Phosphate Dehydrogenase Deficiency].
[Clinical study on the prevention of kernicterus caused by hereditary glucose-6-phosphate dehydrogenase deficiency]
[Correlation analysis of genotypes and the enzymatic activities of glucose-6-phosphate dehydrogenase in neonates in Guangzhou].
[Favism, hemolytic attacks caused by drugs and grave neonatal jaundice in populations with high incidence of G-6-PD deficiency]
[Glucose-6-phosphate dehydrogenase deficiency in Japan].
[Glucose-6-phosphate dehydrogenase deficiency: clinical presentation and eliciting factors]
[Glucose-6-phosphate dehydrogenase et neonatal jaundice]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency. Aprpos of 20 cases from 1969 to 1974]
[Icterus gravis neonatorum associated with a deficiency in glucose-6-phosphate dehydrogenase.]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Havana]
[Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency]
[Neonatal jaundice with intra-erythrocyte G-6-PD deficiency]
[Neonatal jaundice with transitory deficiency of erythrocytic glucose-6-phosphate dehydrogenase.]
[RELATION BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND NEONATAL JAUNDICE.]
[Relations between chronic non-spherocytic hemolytic anemia and neonatal jaundice due to deficiency of glucose-6-phosphate dehydrogenase]
[Relationship between glucose-6-phosphate dehydrogenase gene mutations and neonatal jaundice in Naning, Guangxi]
[Research of coptis effect on incidence of neonatal jaundice based on Cox model]
[The role of NADPH in the development of neonatal jaundice with G6PD deficiency]
Jaw Neoplasms
[Changes in the activity of glucose-6-phosphate dehydrogenase and the content of reduced glutathione in erythrocytes of patients with jaw neoplasms]
Keloid
Differential oxygen sensitivities in G6PDH activities of cultured keloid and normal skin dermis single cells.
Effects of intralesional injection of triamcinolone on glucose-6-phosphate dehydrogenase and alanine aminotransferase activity in keloids.
Gene mapping and serendipity. The locus for torticollis, keloids, cryptorchidism and renal dysplasia (31430, Mckusick) is at Xq28, distal to the G6PD locus.
Multiple cell origin of traumatically induced keloids.
Keratitis, Herpetic
[Oxidoreductase activity of peripheral blood lymphocytes of patients with herpetic keratitis]
Keratosis
A quantitative histochemical study of three oxidative enzymes in solar keratoses and Bowen's disease.
Clinical response and tissue effects of etretinate treatment of patients with solar keratoses and basal cell carcinoma.
Kernicterus
A case of kernicterus in New Zealand: a predictable tragedy?
A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates.
A prolonged neonatal jaundice associated with a rare G6PD mutation.
A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
An Iraqi Jewish family with a new red cell glucose-6-phosphate dehydrogenase variant (GD-Bagdad) and kernicterus.
B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.
Berberine-induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases.
Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
Changes in globus pallidus with (pre)term kernicterus.
Chronic hemolytic anemia associated with glucose 6-phosphate dehydrogenase (Guadalajara)1 159 C --> T (387 Arg --> Cys) deficiency associated with Gilbert syndrome in a Turkish patient.
Clinical characteristics of G6PD deficiency in infants with marked hyperbilirubinemia.
Clostridium difficile infection precipitating hemolysis in glucose-6-phosphate dehydrogenase-deficient preterm twins causing severe neonatal jaundice.
Component therapy.
Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus.
Economic evaluation of point of care universal newborn screening for glucose-6-Phosphate dehydrogenase deficiency in United States.
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
Erythrocyte glucose 6 phosphate dehydrogenase deficiency and neonatal jaundice.
Estimated disease burden and lost economic productivity due to glucose-6-phosphate dehydrogenase deficiency in Nigerian newborns.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity.
From prejudice to evidence: the case of rhizoma coptidis in singapore.
Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's Syndrome and glucose-6-phosphate dehydrogenase deficiency.
Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.
Glucose 6-phosphate dehydrogenase deficiency with kernicterus: progressive late recovery from profound deafness.
Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants.
Glucose-6-phosphate dehydrogenase deficiency and kernicterus of South-East anatolia.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening.
Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.
Glucose-6-phosphate dehydrogenase deficiency as a cause of drug-induced hemolysis with renal shut down and kernicterus.
Glucose-6-phosphate Dehydrogenase Deficiency in Neonatal Indirect Hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase deficiency in Singapore.
Glucose-6-phosphate dehydrogenase deficiency in Thailand; its significance in the newborn.
Glucose-6-phosphate dehydrogenase deficiency in Tunisian jaundiced neonates.
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
Glucose-6-phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus.
Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency.
Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn.
High resolution melting curve analysis enables rapid and reliable detection of G6PD variants in heterozygous females.
Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
Index of suspicion. Case 3. Kernicterus in a baby girl homozygous for glucose-6-phosphate dehydrogenase deficiency.
Kernicterus and G6PD deficiency--a case series from Oman.
Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature.
Kernicterus in a newborn female with G-6-PD deficiency.
Markers of oxidative stress in umbilical cord blood from G6PD deficient African newborns.
Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore.
Mass newborn screening in Singapore--position and projections.
Mass newborn screening in Singapore.
Maternal Empowerment - an underutilized strategy to prevent kernicterus?
Medical genetics in Singapore.
Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency.
Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: incidence, severity, and the effect of phototherapy.
Neonatal Hyperbilirubinemia in infants with G6PD c.563C > T Variant.
Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency.
Neonatal jaundice and glucose-6-phosphate dehydrogenase deficiency in Basrah.
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.
Neonatology in Singapore: the way we were, the way forward.
Newborn Screening for G6PD Deficiency- Why is it Important for India?
Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.
PCR-based allelic discrimination for glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ugandan umbilical cord blood.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Prevention of Kernicterus in South Asia: role of neonatal G6PD deficiency and its identification.
RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY--A NEWLY RECOGNIZED CAUSE OF NEONATAL JAUNDICE AND KERNICTERUS IN CANADA.
Refractory Causes of Kernicterus in Developed Countries: Can We Eradicate G6PD Deficiency Triggered and Low-Bilirubin Kernicterus?
Relationship among glucose-6-phosphate dehydrogenase (G-6-PD) activity, G-6-PD variants and reticulocytosis in neonates of northeast Thailand.
Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice.
Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency.
Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology.
Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?
The effect of glucose-6-phosphate dehydrogenase deficiency on the severity of neonatal jaundice in Cape Town.
The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study.
The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.
The suitability of saliva for detection of glucose-6-phosphate dehydrogenase deficiency.
Update on Predicting Severe Hyperbilirubinemia and Bilirubin Neurotoxicity Risks in Neonates.
[Clinical study on the prevention of kernicterus caused by hereditary glucose-6-phosphate dehydrogenase deficiency]
[Increasing prevalence of G6PD deficiency in the Netherlands].
[Kernicterus in a newborn due to glucose-6-phosphate dehydrogenase deficiency.]
[KERNICTERUS IN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY OF ERYTHROCYTES.]
[Kernicterus is preventable but still occurs].
[Relationship between glucose-6-phosphate dehydrogenase gene mutations and neonatal jaundice in Naning, Guangxi]
Ketosis
Blood glucose normalization-induced haemolysis in three adolescents with type 1 diabetes mellitus at onset and unknown G-6-PD deficiency.
Newborn Screening for Five Conditions in a Tertiary Care Government Hospital in Bengaluru, South India-Three Years Experience.
[Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity in animals with experimental ketosis]
Kidney Calculi
Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review.
Safety of vitamin C in sepsis: a neglected topic.
Vitamin C and kidney transplantation: Nutritional status, potential efficacy, safety, and interactions.
Kidney Diseases
Epidemiology and clinical features of Mediterranean spotted fever in Italy.
Glucose 6-phosphate dehydrogenase and the kidney.
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice.
Kidney Failure, Chronic
Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease.
Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia.
Epidemiology and clinical features of Mediterranean spotted fever in Italy.
Erythrocyte glucose-6-phosphate dehydrogenase in chronic renal failure and after renal transplantation.
G-6-PD activity of the red cells in chronic renal failure.
Oxidative Stress and Suicidal Erythrocyte Death.
The role of the oxidative state of glutathione and glutathione-related enzymes in anemia of hemodialysis patients.
Kidney Neoplasms
Glucose 6-phosphate dehydrogenase and the kidney.
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Klinefelter Syndrome
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY IN KLINEFELTER'S SYNDROME.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Kwashiorkor
Glutathione and association antioxidant systems in protein energy malnutrition: results of a study in Nigeria.
lactase deficiency
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism.
Primary lactase deficiency and past malarial endemicity in Sardinia.
Leg Ulcer
Leg ulcers in a family with both beta thalassaemia and glucose-6-phosphate dehydrogenase deficiency.
Leiomyoma
A history of the discovery of random x chromosome inactivation in the human female and its significance.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Enzyme activities in human endometrium, myometrium and leiomyomas of the uterus.
Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas.
Independent origin of uterine leiomyomas with karyotypically identical alterations.
Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase.
Leiomyosarcoma
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Leishmaniasis
Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identificatio nof the parasite species.
Glucose-6-phosphate dehydrogenase (G6PD) activity can modulate macrophage response to Leishmania major infection.
Leishmaniasis, Cutaneous
[Leishmania infantum Nicolle, 1908, the agent of the autochthonous oriental sore. Apropos of the biochemical identification of 2 strains isolated in the eastern Pyrenees]
Lentivirus Infections
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Leprosy
A controlled study of polymorphisms in serum globulin and glucose-6-phosphate dehydrogenase deficiency in leprosy.
Distribution of ABO blood groups, G6PD deficiency, and abnormal haemoglobins in leprosy.
DOES GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY MODIFY THE COURSE OF LEPROSY OR ITS TREATMENT.
Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
Erythrocyte glucose-6-phosphate dehydrogenase isoenzyme phenotypes in leprosy.
Study of erythrocyte G6PD deficiency in leprosy.
[Glucose-6-phosphate dehydrogenase deficiency and leprosy]
[Glucose-6-phosphate dehydrogenase in patients with Hansen's disease receiving sulfones or sulfamethoxypyridazine]
Leptospirosis
A vegetable-induced hemolytic crisis in a G6PD deficient person: a case report.
An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire.
[The role glucose-6-phosphate dehydrogenase in pathogenesis of anemia in leptospirosis]
Lesch-Nyhan Syndrome
Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome.
Stability of X chromosomal inactivation in human somatic cells transformed by SV-40.
Lethargy
[Clinical Features and Laboratory Data Analysis of Glucose-6- Phosphate Dehydrogenase Deficiency].
Leukemia
A decrease in glucose 6-phosphate dehydrogenase activity and mRNA is an early event in phorbol ester-induced differentiation of thp-1 promonocytic leukemia cells.
Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.
Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.
Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia.
Dietary dehydroepiandrosterone inhibits bone marrow and leukemia cell transplants: role of food restriction.
Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.
Erythrocyte enzyme abnormalities in leukemias.
Erythrocyte phosphofructokinase and glucose-6-phosphate dehydrogenase in leukemia.
Evidence for a multistep pathogenesis of chronic myelogenous leukemia.
Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia.
Frequency of missense mutations in the coding region of a eukaryotic gene transferred by retroviral vectors.
Hairy-cell leukemia and glucose-6-phosphate dehydrogenase deficiency in two brothers.
Hairy-cell leukemia and glucose-6-phosphate dehydrogenase.
Heterogeneity of B cell involvement in acute nonlymphocytic leukemia.
Karyotypes and glucose-6-phosphate dehydrogenase activity in various types of leukemia.
More on the association of glucose-6-phosphate dehydrogenase deficiency with hairy-cell leukemia.
Plasma cell leukemia revealing a G6PD deficiency.
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
Priapism in hematological and coagulative disorders: an update.
Red cell enzymopathies in leukemias.
Stem cell origin of human myeloid blood cell neoplasms.
The effect of long-term marrow culture on the origin of colony-forming cells in acute myeloblastic leukemia: studies of two patients heterozygous for glucose-6-phosphate dehydrogenase.
Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Part 1. Myelodysplasias and the acute leukemias.
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.
[Activity of glucose-6-phosphate dehydrogenase in the bone marrow cells in children with acute leukemia]
[Change of G6PD Activity in Children with Acute Leukemia and Its Clinical Significance].
[Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes]
[The osmotic stability, glucose-6-phosphate dehydrogenase and glutathione reductase activity of the erythrocytes of leukemia and anemia patients]
Leukemia, Erythroblastic, Acute
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
Reexpression of normal stem cells in erythroleukemia during remission.
[Expression of human G6PD gene in K562 cells mediated by retroviral vector]
Leukemia, Lymphocytic, Chronic, B-Cell
Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia.
Chronic lymphocytic leukemia: a monoclonal disease.
Leukemia, Lymphoid
The activity of glucose-6-phosphate dehydroxygenase and glutathione enzymes in red blood cells in patients with haemoblastoses.
Leukemia, Megakaryoblastic, Acute
Evidence for clonal development and stem cell origin of M7 megakaryocytic leukemia.
Leukemia, Monocytic, Acute
Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.
Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy.
Clonal nature of Philadelphia chromosome-positive and -negative chronic myelogenous leukemia by DNA hybridization analyses.
Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemia.
Evidence for a multistep pathogenesis of chronic myelogenous leukemia.
In vitro restoration of polyclonal hematopoiesis in a chronic myelogenous leukemia after in vitro treatment with 4-hydroperoxycyclophosphamide.
Nonclonal hemopoietic progenitors in a G6PD heterozygote with chronic myelogenous leukemia revealed after long-term marrow culture.
Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell.
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
Red cell enzymopathies in leukemias.
Stem cell origin of human myeloid blood cell neoplasms.
Leukemia, Myeloid
Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Stem cell origin of human myeloid blood cell neoplasms.
The Use of Genetic Markers in Studies of Myeloid Neoplasia.
Leukemia, Myeloid, Acute
Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation.
Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.
Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.
Enzyme activities of NADPH-forming metabolic pathways in normal and leukemic leukocytes.
G6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus.
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.
Heterogeneity of B cell involvement in acute nonlymphocytic leukemia.
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Leukocyte glucose 6 phosphate dehydrogenase as prognostic indicator in ANLL and CML.
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
Stem cell origin of human myeloid blood cell neoplasms.
The effect of long-term marrow culture on the origin of colony-forming cells in acute myeloblastic leukemia: studies of two patients heterozygous for glucose-6-phosphate dehydrogenase.
Which progenitor is the target cell in the development of acute promyelocytic leukemia?
Leukemia, Plasma Cell
Plasma cell leukemia revealing a G6PD deficiency.
Leukocytosis
Hematological profile in neonatal jaundice.
Leukoplakia
Bioluminescence assay of enzymes obtained from buccal epithelium by superficial scraping.
Lichen Planus
Enzyme changes in lichen planus.
Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Glucose-6-phosphate dehydrogenase in lichen planus skin.
Letter: Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Lipomatosis
[Status of the antioxidant enzyme system in benign symmetrical lipomatosis and changes in it from the use of antioxidant therapy]
Liver Abscess, Amebic
Glucose 6-phosphate dehydrogenase activity in amoebic liver abscess - a preliminary communication.
Liver Cirrhosis
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers.
Liver Diseases
A case-control study of primary hepatocellular carcinoma in Taiwan.
Anemia and the liver. Hepatobiliary manifestations of anemia.
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Glucose-6-phosphate dehydrogenase and mouse Kupffer cell activation: an ultrastructural dual staining enzyme-cytochemical study.
Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A.
Molecular forms of glucose-6-phosphate dehydrogenase in liver diseases.
Oxidative stress and bovine liver diseases: role of glutathione peroxidase and glucose 6-phosphate dehydrogenase.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Transient liver injury and severe neonatal cholestasis in infant with glucose-6-phosphate dehydrogenase deficiency due to a new mutation.
Liver Diseases, Alcoholic
Alcoholic liver disease in black men with G6PD deficiency.
Liver Failure
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Therapeutic potential of manipulating suicidal erythrocyte death.
Liver Failure, Acute
Fulminant Hepatic Failure in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients Caused by Hepatitis E Infection: A Single Disease With Different Spectrums.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
Liver Neoplasms
Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Glucose-6-phosphate dehydrogenase: the key to sex-related xenobiotic toxicity in hepatocytes of European flounder (Platichthys flesus L.)?
Hepatitis B virus stimulates G6PD expression through HBx-mediated Nrf2 activation.
miR-206-G6PD axis regulates lipogenesis and cell growth in hepatocellular carcinoma cell.
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
Long QT Syndrome
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Lung Diseases
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells.
[Glucose-6-phosphate dehydrogenase activity in patients with chronic inflammatory lung diseases]
Lung Injury
Exaggeration of hypoxic lung injury in a patient with glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin.
Inhibition of rabbit lung glucose-6-phosphate dehydrogenase by dehydroepiandrosterone augments oxidant injury.
Pulmonary toxicity with mefloquine.
Lung Neoplasms
4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.
A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation.
Aspirin inhibits glucose?6?phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites.
Glucose-6-phosphate dehydrogenase deficiency and lung cancer: a hospital based case-control study.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines.
Induction of the Mitochondria Apoptosis Pathway by Phytohemagglutinin Erythroagglutinating in Human Lung Cancer Cells.
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.
Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer.
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.
Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B?-mediated cytotoxicity.
The TGF?1-FOXM1-HMGA1-TGF?1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression.
Two high-rate pentose-phosphate pathways in cancer cells.
[Histocytospectrophotometric characteristics of lung cancer]
Lupus Erythematosus, Systemic
A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Metabolic Insight of Neutrophils in Health and Disease.
Lymphatic Metastasis
Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Prognostic estimation of survival of colorectal cancer patients with the quantitative histochemical assay of G6PDH activity and the multiparameter classification program CLASSIF1.
Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
Lymphohistiocytosis, Hemophagocytic
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis.
Lymphoma
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail.
Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR.
Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma.
Glucose 6-phosphate dehydrogenase overexpression models glucose deprivation and sensitizes lymphoma cells to apoptosis.
Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.
Hemoglobin A2, E and F levels and the incidence of hemoglobin E, beta-thalassemia, and glucose-6-phosphate dehydrogenase deficiency in lymphoma.
Letter to the Editor: Do the Matrix Metalloproteinase-1 and the Glucose-6-phosphate dehydrogenase gene polymorphisms interact in promoting lymphoma development?
Low-level laser therapy for beta amyloid toxicity in rat hippocampus.
Redox cycling by motexafin gadolinium enhances cellular response to ionizing radiation by forming reactive oxygen species.
[Hematologic characteristics in Black Africa]
Lymphoma, B-Cell
Clonality analysis of defined cell populations in paraffin-embedded tissue sections by RT-PCR amplification of X-linked G6PD gene.
Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Lymphoma, Large-Cell, Anaplastic
Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
Lymphoma, Non-Hodgkin
Glucose-6-phosphate dehydrogenase polymorphism and lymphoma risk.
[Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase of blood in patients with lymphosarcoma (non-Hodgkin's disease)].
Macular Degeneration
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Malabsorption Syndromes
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Malaria
A case-control study of primary hepatocellular carcinoma in Taiwan.
A challenge to the concept of selection by malaria in glucose-6-phosphate dehydrogenase deficiency.
A COMPARISON OF RAPID DIAGNOSTIC TESTING (BY PLASMODIUM LACTATE DEHYDROGENASE), AND QUANTITATIVE BUFFY COAT TECHNIQUE IN MALARIA DIAGNOSIS IN CHILDREN.
A large, systematic molecular-genetic study of G6PD in Indian populations identifies a new non-synonymous variant and supports recent positive selection.
A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala-->Gly), is the major polymorphic variant in tribal populations in India.
A new lease of life for an old enzyme.
A novel glucose-6-phosphate dehydrogenase in Plasmodium falciparum: cDNA and primary protein structure.
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
ACP1 and human adaptability: association with past malarial morbidity in the Sardinian population.
Activity of glucose-6-phosphate dehydrogenase among Indians living in a malarial region of Mato Grosso and its implication to the Indian-mixed populations in Brazil.
Acute episodic hemolysis in the African black rhinoceros as an analogue of human glucose-6-phosphate dehydrogenase deficiency.
Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme.
African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania.
Agriculture-related anaemias.
Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility.
Alpha-thalassemia in Papua New Guinea.
An epidemiological study of G-6-PD deficiency, sickle cell haemoglobin, and ABO blood groups in relation to malaria incidence in Muslim and Christian communities of Kheda, Gujarat, (India).
An evaluation of concurrent G6PD (A-) deficiency and sickle cell trait in Malian populations of children with severe or uncomplicated P. falciparum malaria.
An unusual distribution of glucose-6-phosphate dehydrogenase deficiency of south Indian newborn population.
An update on glucose-6-phosphate dehydrogenase deficiency in children from Brazzaville, Republic of Congo.
Analysis of malaria associated genetic traits in Cabo Verde, a melting pot of European and sub Saharan settlers.
Antibody responses to P. falciparum Apical Membrane Antigen 1(AMA-1) in relation to haemoglobin S (HbS), HbC, G6PD and ABO blood groups among Fulani and Masaleit living in Western Sudan.
Antimalarial NADPH-Consuming Redox-Cyclers as Superior G6PD Deficiency Copycats.
Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis.
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.
Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Assessment of protective relationship of G6PD and other lifestyle factors with Malaria: A case-control study of medical professionals from a teaching medical institute, Gujarat.
Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis.
Association of red cell glucose-6-phosphate dehydrogenase with haemoglobinopathies.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Associations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study.
Associations between frequencies of a susceptible TNF-alpha promoter allele and protective alpha-thalassaemias and malaria parasite incidence in Vanuatu.
Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study.
Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages.
Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.
Barriers to routine G6PD testing prior to treatment with primaquine.
Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.
Beta thalassaemia trait in western Nigeria.
Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases.
Can the Therapeutically-rational Exchange (T-REX) of Glucose-6-phosphate Dehydrogenase Deficient Red Blood Cells Reduce Plasmodium falciparum Malaria Morbidity and Mortality?
Candidate human genetic polymorphisms and severe malaria in a Tanzanian population.
Case Report: A Case of Primaquine-Induced Hemoglobinuria in Glucose-6-Phosphate Dehydrogenase Deficient Malaria Patient in Southeastern Bangladesh.
Case Report: Paroxysmal nocturnal hemoglobinuria in a woman heterozygous for G6PD A-.
Ceramide in suicidal death of erythrocytes.
Certain red cell genetic factors and prevalence of chloroquine-induced pruritus.
Changes in glucose-6-phosphate dehydrogenase activity in Indian desert malaria vector Anopheles stephensi during aging.
Changing trends in malaria--a decade's experience at a referral hospital.
Characterization of G6PD deficiency in southern Croatia: description of a new variant, G6PD Split.
Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.
Characterization of glucose-6-phosphate dehydrogenase deficiency and identification of a novel haplotype 487G>A/IVS5-612(G>C) in the Achang population of Southwestern China.
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.
Cloning of the glucose 6-phosphate dehydrogenase gene from Plasmodium falciparum.
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Contrasting histories of G6PD molecular evolution and malarial resistance in humans and chimpanzees.
Detecting recent positive selection in the human genome from haplotype structure.
Diagnostic Practices and Treatment for P. vivax in the InterEthnic Therapeutic Encounter of South-Central Vietnam: A Mixed-Methods Study.
Dietary alterations modulate susceptibility to Plasmodium infection.
Do tribal communities show an inverse relationship between sickle cell disorders and glucose-6-phosphate dehydrogenase deficiency in malaria endemic areas of Central-Eastern India?
Dominance of high-producing interleukin 6 and low-producing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenase-deficient trauma patients.
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
Effect of age, period and birth-cohort on the frequency of glucose-6-phosphate dehydrogenase deficiency in Sardinian adults.
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.
Effectiveness of doxycycline combined with primaquine for malaria prophylaxis.
Endogamy and inbreeding since the 17th century in past malarial communities in the Province of Cosenza (Calabria, Southern, Italy).
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Epidemiology and Control of Plasmodium vivax in Afghanistan.
Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations.
Erratum to: Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Eryptosis: Ally or Enemy.
Erythrocyte G-6-PD and 6-PGD genetic polymorphisms in South African Negroes, with a note on G-6-PD and the malaria hypothesis.
Erythrocyte glucose-6-phosphate dehydrogenase and malaria in Thailand.
Erythrocyte programmed cell death.
Erythrocytic glucose-6-phosphate dehydrogenase deficiency and its significance with special emphasis on malaria.
Evaluating Percentage-Based Reporting of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzymatic Activity.
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6-phosphate dehydrogenase deficiency.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Evaluation of a rapid qualitative enzyme chromatographic test for glucose-6-phosphate dehydrogenase deficiency.
Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Evidence of positively selected G6PD A- allele reduces risk of Plasmodium falciparum infection in African population on Bioko Island.
Excess release of ferriheme in G6PD-deficient erythrocytes: possible cause of hemolysis and resistance to malaria.
Exploring putative molecular mechanisms of human pyruvate kinase enzyme deficiency and its role in resistance against Plasmodium falciparum malaria.
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.
Fc gamma receptor IIa-H131R polymorphism and malaria susceptibility in sympatric ethnic groups, Fulani and Dogon of Mali.
Features and outcomes of malaria infection in glucose-6-phosphatedehydrogenase normal and deficient Nigerian children.
Females of HbAS genotype have reduced concentration of the malaria protective deoxyhemoglobin S than males.
Fertility and malaria in Sardinia.
Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.
Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria.
Fine Mapping of Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency in a Rural Malaria Area of South West Odisha Using the Clinical, Hematological and Molecular Approach.
First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
Frequencies of some human genetic markers and their association with Plasmodium falciparum malaria in the Niger Delta, Nigeria.
Frequency of ABO blood groups, sickle-cell haemoglobin, G-6-PD deficiency and their relation with malaria in scheduled castes and scheduled tribes of Kheda District, Gujarat.
Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.
Frequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trials.
Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude: a malaria hypothesis.
Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan.
Further investigations of glucose-6-phosphate dehydrogenase variants in Flores Island, eastern Indonesia.
G-6-PD and haemoglobin variants among twelve endogamous Dhangar castes of Maharashtra, India.
G-6-PD deficiency and malaria in Black Americans in Vietnam.
G-6PD deficiency in malaria endemic areas of Udaipur District in Rajasthan.
G6PD A- Deficiency and Severe Malaria in The Gambia: Heterozygote Advantage and Possible Homozygote Disadvantage.
G6PD A-variant influences the antibody responses to Plasmodium falciparum MSP2.
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.
G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
G6PD Deficiency and Hemoglobinopathies: Molecular Epidemiological Characteristics and Healthy Effects on Malaria Endemic Bioko Island, Equatorial Guinea.
G6PD deficiency and malaria in India.
G6PD deficiency and malaria selection.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6PD deficiency in Latin America: systematic review on prevalence and variants.
G6PD deficiency in malaria endemic areas of Nepal.
G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria.
G6PD deficiency: global distribution, genetic variants and primaquine therapy.
G6PD deficiency: the genotype-phenotype association.
G6PD gene variants and its association with malaria in a Sri Lankan population.
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.
G6PD Viangchan and G6PD Mediterranean are the main variants in G6PD deficiency in the Malay population of Malaysia.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
Genetic benefits of consanguinity through selection of genotypes protective against malaria.
Genetic control of resistance to human malaria.
Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya.
Genetic disorders and malaria in Indo-China region.
Genetic factors and malaria in the Temuan.
Genetic markers in refractory and susceptible malaria patients in village Bhanera, Distt. Ghaziabad, U.P.
Genetic red cell disorders and severity of falciparum malaria in Myanmar.
Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria.
Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana.
Global burden of genetic disease and the role of genetic screening.
Glucose 6 phosphate dehydrogenase deficiency and hemoglobinopathy in South Western Region Nepal: a boon or burden.
Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Yogyakarta and its surrounding areas.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is associated with asymptomatic malaria in a rural community in Burkina Faso.
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.
Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodian population.
Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
Glucose-6-phosphate dehydrogenase activity of the malaria parasite Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant.
Glucose-6-phosphate dehydrogenase deficiency allelic variants and their prevalence in malaria patients in Eritrea.
Glucose-6-phosphate dehydrogenase deficiency among malaria patients of Honduras: a descriptive study of archival blood samples.
Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.
Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND FALCIPARUM MALARIA.
Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study.
Glucose-6-phosphate dehydrogenase deficiency and malaria--a study on north Madras population.
Glucose-6-phosphate dehydrogenase deficiency and malaria.
Glucose-6-phosphate Dehydrogenase Deficiency and Malaria: Cytochemical Detection of Heterozygous G6PD Deficiency in Women.
Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.
Glucose-6-phosphate dehydrogenase deficiency and Southeast Asian ovalocytosis in asymptomatic Plasmodium carriers in Sumba island, Indonesia.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.
Glucose-6-Phosphate Dehydrogenase Deficiency Genetic Variants in Malaria Patients in Southwestern Ethiopia.
Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in manaus: a cross-sectional survey in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase deficiency in India.
Glucose-6-phosphate dehydrogenase deficiency in internationally adopted children.
Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.
Glucose-6-phosphate dehydrogenase deficiency in Thailand: the influence on the clinical presentation of malaria in male adult patients.
Glucose-6-phosphate dehydrogenase deficiency in two returning Operation Iraqi Freedom soldiers who developed hemolytic anemia while receiving primaquine prophylaxis for malaria.
Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Glucose-6-phosphate dehydrogenase deficiency, the sickling trait, and malaria in Saudi Arab children.
Glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits.
Glucose-6-phosphate dehydrogenase deficiency: molecular heterogeneity in southeast Asian countries.
Glucose-6-phosphate dehydrogenase deficient variants are associated with reduced susceptibility to malaria in the Brazilian Amazon.
Glucose-6-phosphate dehydrogenase defiency and malaria.
Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.
Glucose-6-phosphate dehydrogenase of malaria parasite Plasmodium falciparum.
Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.
Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.
Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children.
Glucose-6-phosphate dehydrogenase variants and sickle cell genes in Al-Qunfuda, Saudi Arabia.
Glucose-6-phosphate metabolism in Plasmodium falciparum.
Glutathione reductase-deficient erythrocytes as host cells of malarial parasites.
Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria.
Haemoglobin and glucose-6-phosphate dehydrogenase variants: distribution in relation to malaria endemicity in a Togolese population.
Haemoglobin disorders: a pattern for thalassaemia and haemoglobinopathies in Arabia.
Haemoglobinuria after a single dose treatment with dapsone and pyrimethamine for falciparum malaria in a patient with glucose-6-phosphate dehydrogenase deficiency.
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.
Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh.
Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria.
Hemoglobin S-mediated membrane oxidant injury: protection from malaria and pathology in sickle cell disease.
Heterogeneous alleles comprising G6PD deficiency trait in West Africa exert contrasting effects on two major clinical presentations of severe malaria.
High Incidence of Malaria Along the Sino-Burmese Border Is Associated With Polymorphisms of CR1, IL-1A, IL-4R, IL-4, NOS, and TNF, But Not With G6PD Deficiency.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
HLA-DRB1 and DQB1 allele distribution in the Muong population exposed to malaria in Vietnam.
Host microsatellite alleles in malaria predisposition?
Host polymorphisms and the incidence of malaria in Ugandan children.
Host-targeted Interventions as an Exciting Opportunity to Combat Malaria.
How malaria has affected the human genome and what human genetics can teach us about malaria.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.
Human genetic factors related to susceptibility to mild malaria in Gabon.
Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren.
Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
Implementation of G6PD testing and primaquine for P. vivax radical cure: Operational perspectives from Thailand and Cambodia.
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh.
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Inborn defects in the antioxidant systems of human red blood cells.
Individual-level factors associated with the risk of acquiring human Plasmodium knowlesi malaria in Malaysia: a case-control study.
Influence of blood group, Glucose-6-phosphate dehydrogenase and Haemoglobin genotype on Falciparum malaria in children in Vihiga highland of Western Kenya.
Inherited anaemias in the Greek community of Cape Town.
Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study.
Inhibition of the intraerythrocytic development of Plasmodium falciparum in glucose-6-phosphate dehydrogenase deficient erythrocytes is enhanced by oxidants and by crisis form factor.
Inhibitory effect of a fava bean component on the in vitro development of Plasmodium falciparum in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes.
Interaction of malarial infection and glucose-6-phosphate dehydrogenase deficiency in Muria gonds of district Bastar, central India.
Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?
Lack of chloroquine inhibition of erythrocytic glucose-6-phosphate dehydrogenase in malaria (Plasmodium berghei).
Lactose absorption in patients with glucose 6-phosphate dehydrogenase deficiency with and without favism.
Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria.
Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa.
Malaria and glucose 6-phosphate dehydrogenase deficiency in populations with high and low spleen rates in Madang, Papua New Guinea.
Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia.
MALARIA AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THAILAND.
Malaria and glucose-6-phosphate dehydrogenase deficiency.
Malaria and Glucose-6-phosphate Dehydrogenase.
Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago.
Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase.
Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.
Malaria in the Guangxi Zhuang Autonomous Region in China: A Twelve-Year Surveillance Data Study.
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015).
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting.
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015).
Malaria prophylaxis and treatment in G-6-PD deficiency. An observation on the toxicity of primaquine and chloroquine.
Malaria radical cure opportunity assessment in India: Discussing opportunities through stakeholder convening workshop and recommendation for improved access to malaria treatment.
Malaria was a weak selective force in ancient Europeans.
Malaria, favism and glucose-6-phosphate dehydrogenase deficiency.
Malaria, glucose-6-phosphate dehydrogenase deficiency, and Hb S.
Management of a case of chloroquine-resistant falciparum malaria in a pregnant woman with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Management of Athletes With G6PD Deficiency: Does Missing an Enzyme Mean Missing More Games?
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Methemoglobinemia Hemotoxicity of Some Antimalarial 8-Aminoquinoline Analogues and Their Hydroxylated Derivatives: Density Functional Theory Computation of Ionization Potentials.
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population.
Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population.
Molecular genotyping of G6PD mutations and Duffy blood group in Afro-descendant communities from Brazilian Amazon.
Molecular Heterogeneity of Glucose-6-Phosphate Dehydrogenase Deficiency in Burkina Faso: G-6-PD Betica Selma and Santamaria in People with Symptomatic Malaria in Ouagadougou.
Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India.
Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific).
Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants.
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Neonatal transfusion malaria requiring exchange transfusion.
New considerations on the distribution of malaria, thalassemia, and glucose-6-phosphate dehydrogenase deficiency in Sardinia.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Observational, hypothesis-driven and genomics research strategies for analyzing inherited differences in responses to infectious diseases.
On the relation between malaria and G-6-PD deficiency.
On the relation between malaria and G-6-PD deficiency: a reply.
Operational research needs toward malaria elimination in China.
Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether-lumefantrine.
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Oxidative Stress and Suicidal Erythrocyte Death.
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.
Pancreatitis in acute hemolysis.
Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti.
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.
Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.
Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target.
Plasmodium falciparum malaria and human red cells. I. A genetic and clinical study in children.
Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes.
Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda.
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Point-of-care tests for malaria: speeding up the diagnostics at the bedside and challenges in malaria cases detection.
Polymorphic sites in the African population detected by sequence analysis of the glucose-6-phosphate dehydrogenase gene outline the evolution of the variants A and A-.
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria.
Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.
Population Genomics Reveals Incipient Speciation, Introgression, and Adaptation in the African Mona Monkey (Cercopithecus mona).
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria.
Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians.
Predictive role of laboratory and clinical treatment response parameters and glucose-6-phosphate dehydrogenase status in the therapy of falciparum malaria.
Present status of understanding on the G6PD deficiency and natural selection.
Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes.
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand.
Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in Females from Previously Malaria Endemic Regions in Northeastern Thailand and Identification of a Novel G6PD Variant.
Prevalence and Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency at the China-Myanmar Border.
Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand.
Prevalence and molecular identification of the mediterranean variant among G6PD-deficient Sistani and Balouch males in Southeastern Iran.
Prevalence and spectrum of mutations causing G6PD deficiency in Indian populations.
Prevalence of Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency in the Population of Western Turkey.
Prevalence of G-6-PD deficiency and sickle-cell haemoglobin carriers in malaria endemic tribal dominated districts--Mandla and Jabalpur, Madhya Pradesh.
Prevalence of G-6-PD deficiency in a malaria endemic tribal area of Orissa (India).
Prevalence of G6PD deficiency and associated haematological parameters in children from Botswana.
Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.
Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.
Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.
Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency and Gametocytemia in a Pre-Elimination, Low Malaria Transmission Setting in Southern Zambia.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and its association with Plasmodium falciparum infection among children in Iganga distric in Uganda.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.
Prevalence of malaria in Ao Nagas and its association with G6PD and HbE.
Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.
Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.
Primaquine for prevention of malaria in travelers.
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial.
Primaquine treatment and relapse in Plasmodium vivax malaria.
Primaquine, malaria chemotherapy and G-6-PD deficiency.
Primaquine: the risks and the benefits.
Primary lactase deficiency and past malarial endemicity in Sardinia.
Pyruvate kinase deficiency in mice protects against malaria.
Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.
Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan.
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.
Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
Rapid quantitative assays for glucose-6-phosphate dehydrogenase (G6PD) and hemoglobin combined on a capillary-driven microfluidic chip.
Reactivity of Blood Samples Spotted onto Filter Papers in the WST-8 Method for Screening of G6PD Deficiency.
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Reassessing an old claim: Natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.
Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population.
Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency.
Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.
Resistance of glucose-6-phosphate dehydrogenase deficiency to malaria: effects of fava bean hydroxypyrimidine glucosides on Plasmodium falciparum growth in culture and on the phagocytosis of infected cells.
Resistance to falciparum malaria among adults in central Sudan.
Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report.
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
SCIENTIFIC AND PRACTICAL STUDIES OF MALARIA IN THE CIS COUNTRIES AND GEORGIA.
Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype.
Selective toxicity of the antimalarial primaquine-evidence for both uncoupling and inhibitory effects of a metabolite on the energetics of mitochondria and its ATP synthase complex.
Serum Soluble Transferrin Receptor Concentrations Are Elevated in Congolese Children with Glucose-6-Phosphate Dehydrogenase Variants, but Not Sickle Cell Variants or ?-Thalassemia.
Severe Malaria Complicated by G6PD Deficiency in a Pediatric Tanzanian Immigrant.
Sickle cell haemoglobin, thalassaemia and G-6-PD enzyme deficiency genes in Garasiya tribe inhabited malaria endemic areas of Sirohi District, Rajasthan (India).
Sickle haemoglobin, G-6PD deficiency and malaria in western Orissa.
Single dose primaquine in a preclinical model of G6PD deficiency: implications for use in malaria transmission blocking programs.
Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Spleen size determined by ultrasound in patients with sickle cell trait, HbAC trait and glucose-6-phosphate-dehydrogenase deficiency in a malaria hyperendemic area (Ashanti Region, Ghana).
Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A(-) deficiency.
Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
Suitability of Capillary Blood for Quantitative Assessment of G6PD Activity and Performances of G6PD Point-of-Care Tests.
Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.
Tafenoquine and G6PD: a primer for clinicians.
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
The action of falciparum malaria on the human and chimpanzee genomes compared: Absence of evidence for a genomic signature of malaria at HBB and G6PD in three subspecies of chimpanzee.
The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia.
The blood groups, serum groups, red-cell isoenzymes and haemoglobins of the Sandawe and Nyaturu of Tanzania.
The burden and consequences of inherited blood disorders among young children in western Kenya.
The challenges of introducing routine G6PD testing into radical cure: a workshop report.
The CYB5R3c.350C>G and G6PD A alleles modify severity of anemia in malaria and sickle cell disease.
The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum.
The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells.
The extent of linkage disequilibrium caused by selection on G6PD in humans.
The First Case of a Class I Glucose-6-phosphate Dehydrogenase Deficiency, G6PD Santiago de Cuba (1339 GA), in a Chinese Population as Found in a Survey for G6PD Deficiency in Northeastern and Central China.
The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial.
The genetic control of immunity to Plasmodium infection.
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
The integrity and stability of specimens under different storage conditions for glucose-6-phosphate dehydrogenase deficiency screening using WST-8.
The molecular basis of glucose-6-phosphate dehydrogenase deficiency.
The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.
The Rate of Plasmodium vivax Infectivity within Gloucose-6-Phosphate Dehydrogenase (G6PD) Deficient Individuals in Hormozgan Province, Iran.
The relations between G-6-PD deficiency, thalassemia and malaria. Further analysis of data from Sardinia and the Po Valley.
The role of anti-malarial drugs in eliminating malaria.
The role of cell-mediated immune responses in resistance to malaria, with special reference to oxidant stress.
The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah.
The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Therapeutic potential of manipulating suicidal erythrocyte death.
Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
Unresolved Splenomegaly in Recently Resettled Congolese Refugees - Multiple States, 2015-2018.
Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania.
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Vivax malaria in pregnancy and lactation: a long way to health equity.
Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.
[Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine]
[Clinical importance of hemolysis in the prophylactic treatment of malaria using primaquine on persons with a glucose-6-phosphate dehydrogenase deficit]
[Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti]
[DREPANOCYTEMIA, ERYTHROCYTIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (G-6-PD) AND MALARIA IN THE CUANGO POST (LUNDA-ANGOLA).]
[Epidemiological survey on malaria situation in Motuo County of Tibet, China]
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency--a study on its distribution in the province of Ferrara and its relation to malaria and thalassemia]
[Erythrocyte polymorphism in Mali: epidemiology and resistance mechanisms against severe Plasmodium falciparum malaria]
[Frequency of glucose-6-phosphate dehydrogenase deficiency (A-376/202) in three Malian ethnic groups].
[Genetic heterogeneity of G6PD deficiency: mutant alleles of G6PD in the Shekii district of Azerbaijan]
[Genetic resistance to malaria]
[Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents]
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
[Hemoglobinuria in children hospitalized in Ouagadougou: short term inpatient care and prognosis].
[Hemolysis and primaquine treatment. Preliminary report]
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Imported malaria: 6 cases, 2 of them with an erythrocyte glucose-6-phosphate dehydrogenase deficiency]
[In vitro cultivation of Plasmodium falciparum. Applications and limits.- Methodology]
[Malaria hypothesis--the significance of the hereditary red cell traits Hb S and glucose-6-phosphate dehydrogenase deficiency in malaria (author's transl)]
[Malaria in childhood and G6PD deficiency. Report of three cases]
[Malaria in the municipality of Humaitá, State of Amazonas. XXI. Prevalence of glucose-6-phosphate dehydrogenase in a population sample and in patients with Plasmodium falciparum malaria]
[Malaria, hemoglobinosis and glucose-6-phosphate dehydrogenase deficiency. (Preliminary note)]
[Manifestation of glucose-6-phosphate dehydrogenase deficiency caused by primaquine in malaria therapy]
[Molecular characterization of glucose-6-phosphate dehydrogenase variants in four ethnic groups in Yunnan province of China]
[Primaquine and travelers from the Arab world. A report and recommendations]
Malaria, Cerebral
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria.
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
Imported cerebral malaria complicated with glucose-6-phosphate dehydrogenase deficiency.
Partial exchange transfusion prior to treating cerebral malaria in an African child with glucose-6-phosphate dehydrogenase deficiency.
Reappraisal of known malaria resistance loci in a large multicenter study.
Malaria, Falciparum
Can the Therapeutically-rational Exchange (T-REX) of Glucose-6-phosphate Dehydrogenase Deficient Red Blood Cells Reduce Plasmodium falciparum Malaria Morbidity and Mortality?
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Fc gamma receptor IIa-H131R polymorphism and malaria susceptibility in sympatric ethnic groups, Fulani and Dogon of Mali.
G6PD A- Deficiency and Severe Malaria in The Gambia: Heterozygote Advantage and Possible Homozygote Disadvantage.
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study.
Hemoglobin E and Glucose-6-Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh.
Molecular variants of G6PD deficiency among certain tribal communities of Orissa, India.
Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania.
The effect of X chromosome inactivation on the inhibition of Plasmodium falciparum malaria growth by glucose-6-phosphate-dehydrogenase-deficient red cells.
[Erythrocyte polymorphism in Mali: epidemiology and resistance mechanisms against severe Plasmodium falciparum malaria]
[Malaria in the municipality of Humaitá, State of Amazonas. XXI. Prevalence of glucose-6-phosphate dehydrogenase in a population sample and in patients with Plasmodium falciparum malaria]
Malaria, Vivax
A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities.
Asian G6PD-Mahidol Reticulocytes Sustain Normal Plasmodium Vivax Development.
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania.
Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Barriers to routine G6PD testing prior to treatment with primaquine.
Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon.
Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Determinants of primaquine and carboxyprimaquine exposures in children and adults with Plasmodium vivax malaria.
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Effect of P. vivax malaria on G-6-PD pH-optima of host red cells.
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Fatal Primaquine-Induced Hemolysis in a Patient With Plasmodium vivax Malaria and G6PD A(-) Variant in the Brazilian Amazon.
First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
First report of glucose-6-phosphate dehydrogenase (G6PD) variants (Mahidol and Acores) from malaria-endemic regions of northeast India and their functional evaluations in-silico.
G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria.
G6PD deficiency in malaria endemic areas of Nepal.
G6PD deficiency in male individuals infected by Plasmodium vivax malaria in the Brazilian Amazon: a cost study.
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
G6PD deficiency: global distribution, genetic variants and primaquine therapy.
Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.
Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Implementation of G6PD testing and primaquine for P. vivax radical cure: Operational perspectives from Thailand and Cambodia.
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
Malaria in the Greater Mekong Subregion: Heterogeneity and complexity.
Malaria radical cure opportunity assessment in India: Discussing opportunities through stakeholder convening workshop and recommendation for improved access to malaria treatment.
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria.
Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant.
Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in southeast Iran: implications for malaria elimination.
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Primaquine treatment and relapse in Plasmodium vivax malaria.
Prophylactic efficacy of primaquine for preventing Plasmodium falciparum and Plasmodium vivax parasitaemia in travelers: A meta-analysis and systematic review.
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria.
Rapid diagnostic test for G6PD deficiency in Plasmodium vivax-infected men: a budget impact analysis based in Brazilian Amazon.
Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia.
Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report.
Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India.
Sub-Saharan red cell antigen phenotypes and glucose-6-phosphate dehydrogenase deficiency variants in French Guiana.
Sudden spleen rupture in a Plasmodium vivax-infected patient undergoing malaria treatment.
The footprints of relapsing malaria in southwest Delhi, India.
The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.
The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar.
The impact of phenotypic and genotypic G6PD deficiency on risk of plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan.
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Usability of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency: a multi-country assessment of test label comprehension and results interpretation.
Vivax malaria in pregnancy and lactation: a long way to health equity.
[Clinical and laboratorial alterations in Plasmodium vivax malaria patients and glucose-6-phosphate dehydrogenase deficiency treated with primaquine at 0.50 mg/kg/day]
Malnutrition
Agriculture-related anaemias.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Diet in dermatology: revisited.
Evidence for liver energy metabolism programming in offspring subjected to intrauterine undernutrition during midgestation.
Mandibular Fractures
[Glucose-6-phosphate dehydrogenase deficiency. Diagnosis during treatment of a mandibular fracture]
Mania
A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?
Maple Syrup Urine Disease
Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants.
Marfan Syndrome
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Glucose-6-phosphate Dehydrogenase Deficiency in Marfan's Syndrome.
Massive Hepatic Necrosis
Haemolysis complicating fulminant hepatitis in a patient with glucose-6-phosphate dehydrogenase deficiency.
Infectious hepatitis and glucose-6-phosphate dehydrogenase deficiency.
Mastitis
Glucose-6-phosphate dehydrogenase, glutathione peroxidase, total glutatione and reduced nicotinamide adenine dinucleotide phosphate in milk cells of subclinical mastitic cows.
Measles
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Melanoma
A new G6PD knockdown tumor-cell line with reduced proliferation and increased susceptibility to oxidative stress.
Glucose 6-phosphate dehydrogenase inhibition sensitizes melanoma cells to metformin treatment.
Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2.
Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case.
Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
MELAS Syndrome
Autistic feature as a presentation of Inborn Errors of Metabolism.
Meningitis
[The dynamics of erythrocyte metabolism in severe forms of meningococcal infection and suppurative meningitis in children]
Meningitis, Aseptic
Aseptic meningitis, hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim-sulfamethoxazole.
Meningococcal Infections
[The dynamics of erythrocyte metabolism in severe forms of meningococcal infection and suppurative meningitis in children]
Meningomyelocele
G6PD Deficiency with Arnold-Chiari Malformation.
Mental Retardation, X-Linked
Brief report: linkage between G6PD and fragile-X syndrome.
Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site.
Normal activity and electrophoretic mobility of erythrocyte glucose-6-phosphate dehydrogenase in males with X-linked mental retardation and the fragile Xq.
Metabolic Diseases
Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice.
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
[Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population.]
Metabolic Syndrome
G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases.
Glucose-6-phosphate dehydrogenase increases Ca2+ currents by interacting with Cav1.2 and reducing intrinsic inactivation of the L-type calcium channel.
Subclinical reduced G6PD activity in rheumatoid arthritis and Sjögren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Metabolism, Inborn Errors
Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency.
Methemoglobinemia
A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
A perfect storm: Tumor lysis syndrome with rasburicase-induced methemoglobinemia in a G6PD deficient adult.
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
Acalypha indica-Induced Hemolysis and Methemoglobinemia in a Child With G6PD Deficiency.
Amyl Nitrite-Induced Hemolytic Anemia: Acute Therapy and Prevention.
Blue cures blue but be cautious.
Central Nervous System Symptoms Due to Transient Methemoglobinemia in a Child With G6PD Deficiency.
Complications related to dapsone use for Pneumocystis jirovecii pneumonia prophylaxis in solid organ transplant recipients.
Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.
Cyanosis Due to Methemoglobinemia as the Presenting Sign of Glucose-6-Phosphate Dehydrogenase Deficiency in a Child: Diagnostic and Clinical Implications.
Dapsone Induced Methemoglobinemia and Hemolysis in a G6PD Deficient Girl, Possibly Aggravated by Aggressive Methylene Blue Therapy.
Dapsone-induced agranulocytosis - possible involvement of low activity N-acetyltransferase 2.
Diabetic Ketoacidosis Revealing Severe Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D) Deficiency with Methemoglobinemia: A Case Report.
Do all patients with acquired methemoglobinemia need treatment? A lesson learnt.
Does amyl nitrite have a role in the management of pre-hospital mass casualty cyanide poisoning?
Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient.
Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency.
Favism-induced methemoglobinemia in a G6PD deficient male with a subsequent hemolytic cascade, a therapeutic challenge: Case report and review of literature.
Food-borne nitrates and nitrites as a cause of methemoglobinemia.
Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia.
High dose vitamin C induced methemoglobinemia and hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency.
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
Late-Life Presentation of Unsuspected G6PD Deficiency.
Massive hemolysis following inhalation of volatile nitrites.
Methemoglobinemia - The Cryptic Cause of Dyspnoea.
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
Methemoglobinemia and intravascular hemolysis in a patient with G6PD deficiency.
Methemoglobinemia associated with massive acetaminophen ingestion: a case series.
Methemoglobinemia in an elderly patient with glucose-6-phosphate dehydrogenase deficiency: a case report.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Methemoglobinemia induced by methylene blue pertubation during laparoscopy.
Methemoglobinemia induced by rasburicase in a pediatric patient: A case report and literature review.
Methylene Blue Induced Methemoglobinemia with Acute Kidney Injury in a Glucose-6-Phosphate Dehydrogenase-deficient Patient.
Methylene blue.
Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment.
Not the Typical Pneumonia: An Unusual Case of Rasburicase-induced Methomoglobinemia.
Primaquine overdose in a toddler.
Prolonged hemolysis and methemoglobinemia following organic copper fungicide ingestion.
Quantitative determination of primaquine-5,6-ortho-quinone and carboxyprimaquine-5,6-ortho-quinone in human erythrocytes by UHPLC-MS/MS.
Rasburicase Causing Severe Oxidative Hemolysis and Methemoglobinemia in a Patient with Previously Unrecognized Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
Rasburicase-Induced Methemoglobinemia.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Rasburicase-induced methemoglobinemia: The eyes do not see what the mind does not know.
Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.
Reexamining the risks of drinking-water nitrates on public health.
Severe methemoglobinemia and syncope in a patient with glucose-6-phosphate dehydrogenase deficiency.
Severe methemoglobinemia in an infant with glucose-6-phosphate dehydrogenase deficiency.
Spotlight on rasburicase in anticancer therapy-induced hyperuricemia.
The reduction of methemoglobin in erythrocytes of a patient with congenital methemoglobinemia, subjects with erythrocyte glucose-6-phosphate dehydrogenase deficiency, and normal individuals.
Therapeutic exchange with reconstituted whole blood using plasma exchange kit on a cell separator in G6PD deficient patient requiring red cell exchange for methemoglobinemia.
Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange.
Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy.
Upward trend of dapsone-induced methemoglobinemia in renal transplant community?.
[Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine]
[CONGENITAL AND RECESSIVE METHEMOGLOBINEMIA. ITS ASSOCIATION WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THALASSEMIA MINOR.]
[Detection of combined forms of hemoglobino- and enzymopathies in newborns]
[Pulse oximetry and methemoglobinemia]
Microphthalmos
Linkage studies in Lenz microphthalmia.
Migraine Disorders
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): relevance to genetic disease and polymorphisms.
Mitochondrial Diseases
Assessment of potential donors for living related liver transplantation.
Plasma thiol status is altered in children with mitochondrial diseases.
Mitochondrial Myopathies
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
Mitral Valve Insufficiency
Anaesthetic management in a child with an atypical triad for reconstructive scoliosis surgery.
Mitral Valve Stenosis
Perioperative challenges in a patient of severe G6PD deficiency undergoing open heart surgery.
[Activity of enzymes of pentosephosphate pathway in the erythrocytes, myocardium and intercostal muscle of patients with mitral valve stenosis]
Motor Neuron Disease
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
Mouth Neoplasms
Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy.
[Trial of using erythrocyte glucose-6-phosphate dehydrogenase and reduced glutathione determinations as indices of maxillary and oral neoplasms]
Movement Disorders
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
Mucocutaneous Lymph Node Syndrome
Kawasaki disease with G6PD deficiency - Report of one case and literature review.
Kawasaki disease with Glucose-6-Phosphate Dehydrogenase deficiency, case report.
[Kawasaki disease in a subject with G6PD deficiency]
Mucopolysaccharidosis I
Detection of inborn errors of metabolism in 1,117 patients studied because of suspected inherited disease.
Mucopolysaccharidosis III
Sanfilippo syndrome, glucose-6-phosphate dehydrogenase deficiency and sickle cell/?(+) thalassemia in a child: The burden of consanguinity.
Multiple Myeloma
Erythrocyte enzymes in myelomatosis.
Multiple Sclerosis
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Glucose-6-phosphate dehydrogenase deficiency and multiple sclerosis in northern Sardinia.
Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis.
Mumps
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Muscle Spasticity
Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.
Muscular Diseases
Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome.
The inhibitory effect of actinomycin D and cycloheximide on the increase in activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in experimentally induced diseased skeletal muscles.
Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
[The activity of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in skeletal muscle tissues of patients with muscular diseases]
Muscular Dystrophies
Avian muscular dystrophy: thyroidal influence on pectoralis muscle growth and glucose-6-phosphate dehydrogenase activity.
Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome.
New linkage data for the X-linked types of muscular dystrophy and G6PD variants, colour blindness, and Xg blood groups.
The localization of G6pd, glucose-6-phosphate dehydrogenase, and mdx, muscular dystrophy in the mouse X chromosome.
The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome.
[On the glucose-6-phosphate dehydrogenase and transketolase activities in the serum of subjects with progressive muscular dystrophy.]
Muscular Dystrophy, Duchenne
Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy.
Comparison of Duchenne and normal myoblasts from a heterozygote.
Dystrophin analysis in clonal myoblasts derived from a Duchenne muscular dystrophy carrier.
Enzymatic analysis of individual posterior root ganglion cells in olivopontocerebellar atrophy, amyotrophic lateral sclerosis and Duchenne muscular dystrophy.
Erythrocyte enzyme allotypes in the X-linked recessive disorders, Duchenne muscular dystrophy and haemophilia-A hemizygotes and heterozygotes.
Neonatal biochemical screening for disease.
The myoblast defect identified in Duchenne muscular dystrophy is not a primary expression of the DMD mutation. Clonal analysis of myoblasts from five double heterozygotes for two X-linked loci: DMD and G6PD.
Muscular Dystrophy, Emery-Dreifuss
Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome.
The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome.
Myalgia
Aging is not a barrier to muscle and redox adaptations: applying the repeated eccentric exercise model.
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
Myasthenia Gravis
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Mycoplasma Infections
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Mycoses
Evaluation of Reference Genes for Reverse Transcription Quantitative PCR Studies of Physiological Responses in the Ghost Moth, Thitarodes armoricanus (Lepidoptera, Hepialidae).
G6PD deficiency and fungal infections in patients with acute myeloid leukemia: less enzyme more fungus.
Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
[Change of G6PD Activity in Children with Acute Leukemia and Its Clinical Significance].
Mydriasis
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Myelodysplastic Syndromes
A new glucose 6-phosphate dehydrogenase variant (G-6-PD Verona) in a patient with myelodysplastic syndrome.
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
myeloperoxidase deficiency
Congenital disorders of the function of polymorphonuclear neutrophils.
Lessons Learned from Phagocytic Function Studies in a Large Cohort of Patients with Recurrent Infections.
Myeloproliferative Disorders
Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.
Stem cell origin of human myeloid blood cell neoplasms.
Use of glucose-6-phosphate dehydrogenase markers to study human myeloproliferative disorders.
Myocardial Infarction
Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency.
Genetic association in myocardial infarction. Ethnicity; ABO, Rh, Le, Xg blood groups; G6PD deficiency; and abnormal haemoglobins.
Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency in a Patient with ST-Segment Elevation Acute Myocardial Infarction Successfully Treated by Simple Thrombectomy.
Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart.
Serum glucose-6-phosphate dehydrogenase in the diagnosis of myocardial infarction. Comparison of its clinical value with that of glutamic-oxalacetic transaminase.
Study of glucose-6-phosphate dehydrogenase in acute myocardial infarction and in controls.
[Glucose-6-phosphate dehydrogenase in normal human thrombocytes and in ischemic heart disease]
[The information content and predictive value of cardiac markers in myocardial infarction in the elderly.]
Myocardial Ischemia
Hypoxic acclimation improves cardiac redox homeostasis and protects heart against ischemia-reperfusion injury through upregulation of O-GlcNAcylation.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
[Activation of glucose-6-phosphate dehydrogenase in mouse peritoneal macrophages by sera from patients with ischemic heart disease]
[Glucose-6-phosphate dehydrogenase and lactate dehydrogenase activities and lactate dehydrogenase isoenzyme spectrum in human myocardium after sudden death caused by acute alcohol intoxication and ischemic heart disease]
[Glucose-6-phosphate dehydrogenase in normal human thrombocytes and in ischemic heart disease]
Myocarditis
[Acute myocarditis complicating Mediterranean spotted fever. A case report.]
[Effects of strophanthin, mefenamic acid and dexamethasone on the inflammatory and reparative processes in the heart in experimental myocarditis]
Myoglobinuria
Exercise in Glucose-6-Phosphate Dehydrogenase Deficiency: Harmful or Harmless? A Narrative Review.
Muscle glucose-6-phosphate dehydrogenase deficiency.
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency.
Severe Rhabdomyolysis in Glucose-6-Phosphate Dehydrogenase Deficiency.
Myositis
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
Myotonic Dystrophy
[Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content]
Myxedema
[Glucose-6-phosphate dehydrogenase activities in erythrocytes in thyrotoxicosis and myxedema]
Nasopharyngeal Carcinoma
MicroRNA-206 inhibits tumor metastasis of nasopharyngeal carcinoma through targeting G6PD.
[Histochemistry observation on the activity of deoxyribonucleases (DNase), glucose-6-phosphate dehydrogenase (G 6P DH) and acidic alpha-naphthol acetate esterase (ANAE) in nasopharyngeal carcinoma]
Nematode Infections
Loss of cytosolic glucose-6-phosphate dehydrogenase increases the susceptibility of Arabidopsis thaliana to root-knot nematode infection.
Neonatal Sepsis
Bilateral cataracts associated with glucose-6-phosphate dehydrogenase deficiency.
Component therapy.
Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis.
Prevalence of G6PD Deficiency in Neonatal Sepsis in Iran.
Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality.
Neoplasm Metastasis
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo.
Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer.
Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance.
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis.
MicroRNA-206 inhibits tumor metastasis of nasopharyngeal carcinoma through targeting G6PD.
Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity.
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Prognostic estimation of survival of colorectal cancer patients with the quantitative histochemical assay of G6PDH activity and the multiparameter classification program CLASSIF1.
Prognostic significance of G6PD expression and localization in lung adenocarcinoma.
Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
The histochemical G6PDH reaction but not the LDH reaction with neotetrazolium is suitable for the oxygen sensitivity test to detect cancer cells.
Neoplasm, Residual
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Neoplasms
1,2,3-Triazole tethered 1,2,4?trioxane trimer induces apoptosis in metastatic cancer cells and inhibits their proliferation, migration and invasion.
2-deoxy-glucose-6-phosphate utilization in the study of glucose-6-phosphate dehydrogenase mosaicism.
20-HETE-Induced Mitochondrial Superoxide and Inflammatory Phenotype in Vascular Smooth Muscle is Prevented by Glucose-6-Phosphate Dehydrogenase Inhibition.
4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.
6-phosphogluconate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphate isomerase, and hexokinase activity ratios in some human tumor cytosols.
A case of ataxia telangiectasia with unbalanced glucose 6-phosphate dehydrogenase mosaicism in the granulocytic/monocytic lineages.
A COMPARISON OF RAPID DIAGNOSTIC TESTING (BY PLASMODIUM LACTATE DEHYDROGENASE), AND QUANTITATIVE BUFFY COAT TECHNIQUE IN MALARIA DIAGNOSIS IN CHILDREN.
A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation.
A history of the discovery of random x chromosome inactivation in the human female and its significance.
A new G6PD knockdown tumor-cell line with reduced proliferation and increased susceptibility to oxidative stress.
A perfect storm: Tumor lysis syndrome with rasburicase-induced methemoglobinemia in a G6PD deficient adult.
A simple histochemical assay to detect cancer cells.
Activities of enzymes of the hexose monophosphate pathway in nervous system tumors induced by ethylnitrosourea.
Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in lipoblastic and neurogenic proliferations.
Activity of glycolytic enzymes and glucose-6-phosphate dehydrogenase in smooth muscle proliferation.
Adaptational changes in kinetic parameters of G6PDH but not of PGDH during contamination-induced carcinogenesis in livers of North Sea flatfish.
Alterations in erythrocyte enzymes in cancer.
Altered enzyme expression in propylnitrosamine-induced Syrian hamster lung lesions.
Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Altered oxidative stress and carbohydrate metabolism in canine mammary tumors.
Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata.
Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines.
Antioxidant enzyme levels in cases with gastrointesinal cancer.
Antitumor activities of vanadium(IV), manganese(IV), iron(III), cobalt(II) and copper(II) complexes of 2-methylaminopyridine.
Aspirin inhibits glucose?6?phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites.
ATM Is a Redox Sensor Linking Genome Stability and Carbon Metabolism.
Autoinflammatory Reaction in Dogs Treated for Cancer via G6PD Inhibition.
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.
BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas.
Biochemical alterations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors from rats subjected to caloric restriction.
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
c-Src facilitates tumorigenesis by phosphorylating and activating G6PD.
Caffeine Targets G6PDH to Disrupt Redox Homeostasis and Inhibit Renal Cell Carcinoma Proliferation.
Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs.
Cell lineages in hematopoietic neoplasia studied with glucose-6-phosphate dehydrogenase cell markers.
Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Changes in the cellular phenotype and extracellular matrix during progression of estrogen-induced mesenchymal kidney tumors in Syrian hamsters.
Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development.
Characterization of a new primary human pancreatic tumor line.
Characterization of drug metabolism enzymes in estrogen-induced kidney tumors in male Syrian hamsters.
Characterization of murine hepatoma BW7756. I. Selected biochemical properties of liver and hepatoma.
Clonal interaction in tumours.
Clonal origin of a T cell lymphoproliferative malignancy.
Clonality analysis of defined cell populations in paraffin-embedded tissue sections by RT-PCR amplification of X-linked G6PD gene.
Clonality studies in acute myeloid leukemia.
Clonogenic assay for Wilms' tumor: improved technique for obtaining single-cell suspensions and evidence for tumor cell specificity.
Computational determination of binding structures and free energies of glucose 6-phosphate dehydrogenase with novel steroid inhibitors.
Control of the NADPH supply for oxidative stress handling in cancer cells.
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver.
Cytochemical assay of glucose-6-phosphate dehydrogenase in koilocytes.
Cytochemical investigation of glucose-6-phosphate dehydrogenase activity in rat mammary tissue.
Cytoenzymology of benign and malignant tumours of the corpus uteri. I. Respiratory enzymes.
Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia.
Cytologic studies of glucose-6-phosphate dehydrogenase in malignancy.
Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.
Design of an interface peptide as new inhibitor of human glucose-6-phosphate dehydrogenase.
Detection of a novel, primate-specific 'kill switch' tumor suppression mechanism that may fundamentally control cancer risk in humans: an unexpected twist in the basic biology of TP53.
Differential oxygen sensitivities in G6PDH activities of cultured keloid and normal skin dermis single cells.
Differential sensitivity of tumor cells to externally generated hydrogen peroxide. Role of glutathione and related enzymes.
Diminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells.
Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening.
Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation.
Does G6PD deficiency protect against cancer? A critical review.
Dominance of high-producing interleukin 6 and low-producing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenase-deficient trauma patients.
Dynamics and Control of the Central Carbon Metabolism in Hepatoma Cells.
Effect of estrogen administration on glucose 6-phosphate dehydrogenase and lactate dehydrogenase isoenzymes in rodent mammary tumors and normal mammary glands.
Effect of estrogen on synthesis of glucose-6-phosphate dehydrogenase in R3230AC mammary tumors and uteri.
Effect of X irradiation on adenosine triphosphate and glucose-6-phosphate dehydrogenase in the CaNT mouse tumor.
Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Effects of various dietary fatty acids on enzyme activities of carbohydrate and glutamine metabolism and the metabolic response of lymphocytes and macrophages during Walker-256 ascites cell tumour growth in rats.
Effects of Viral Interleukin 10 Introduced by in vivo Electroporation on Arthrogen-Induced Arthritis in Mice.
Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients.
Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression.
Enhanced susceptibility to a chemical carcinogen in rats carrying MHC-linked genes influencing development (GRC).
Enzyme activities in prostatic carcinoma related to Gleason grades.
Enzyme activities of six different dehydrogenases in Ehrlich ascites cells measured by flow cytometry.
Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels.
Enzymic pattern of preneoplastic and neoplastic lesions induced in the kidney of CBA mice by 1,2-dimethylhydrazine.
eQTL analysis from co-localization of 2739 GWAS loci detects associated genes across 14 human cancers.
Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
Estradiol receptors and glucose-6-phosphate dehydrogenase activity in human breast tumors.
Estrogen-dependent and independent renal tumors. G-6-PD and LDH isoenzyme analysis of estrogen-dependent and independent renal tumors of the Syrian hamster.
Evidence for clonal development of Wilms' tumor.
Evidence of genetic instability in tumors and normal nearby tissues.
Exploring the role of glucose?6?phosphate dehydrogenase in cancer (Review).
Expression of Glucose Metabolism-Related Proteins in Adrenal Neoplasms.
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.
Fine structural, G-6-PD isoenzyme, and HaLV gs antigen studies of poly I/C and antiestrogen treated DES-induced hamster renal tumors.
Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines.
Food Shortage Causes Differential Effects on Body Composition and Tissue-Specific Gene Expression in Salmon Modified for Increased Growth Hormone Production.
Free radical-scavenging properties of lignin.
Free radicals, antioxidant enzymes, and carcinogenesis.
G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells.
G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
G6PD deficiency and breast cancer.
G6PD downregulation triggered growth inhibition and induced apoptosis by regulating STAT3 signaling pathway in esophageal squamous cell carcinoma.
G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS?MAPK axis pathway.
G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3.
G6PD protects from oxidative damage and improves healthspan in mice.
G6PD: A hub for metabolic reprogramming and redox signaling in cancer.
Genetic susceptibility to toxic substances and its relationship to carcinogenesis.
Glucose 6-phosphate dehydrogenase and the kidney.
Glucose 6-phosphate dehydrogenase deficiency and incidence of hematologic malignancy.
Glucose 6-phosphate dehydrogenase isoenzyme patterns and chromosomes in primary liver tumors of the rat.
Glucose tolerance in relation to skeletal muscle enzyme activities in cancer patients.
Glucose-6-phosphate dehydrogenase (G-6-PD) markers in Burkitt lymphoma and other malignancies.
Glucose-6-phosphate dehydrogenase (G6PD) activity in benign and malignant human mammary tumours.
Glucose-6-phosphate dehydrogenase activity and estrogen receptors in human breast cancer.
Glucose-6-phosphate dehydrogenase activity in CaNT tumours of different volume and response to tumour clamping and X-irradiation.
Glucose-6-phosphate dehydrogenase activity in erythrocytes of patients with malignant neoplasms.
Glucose-6-phosphate dehydrogenase activity in human breast cancer. Lack of association with oestrogen receptor content.
Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors.
Glucose-6-phosphate dehydrogenase and NADPH oxidase 4 control STAT3 activity in melanoma cells through a pathway involving reactive oxygen species, c-SRC and SHP2.
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.
Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study.
Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE INCIDENCE OF CANCER.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits.
Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide.
Glucose-6-phosphate dehydrogenase polymorphism: a valuable tool to study tumor origin.
Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.
Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer.
Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines.
Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.
Growth control of C6 glioma in vivo by nerve growth factor.
Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells.
Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin ?-2 Expression, and Induce Antitumor Effects against Human Glioma.
Histochemical evaluation of energy metabolism in rat glioma.
Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
HISTOCHEMICAL STUDY ON THE LOCALIZATION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN HUMAN TUMORS.
Host polymorphisms and the incidence of malaria in Ugandan children.
Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice.
Human tumors studied with genetic markers.
Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats.
Hyperpolarized [U-(2) H, U-(13) C]Glucose reports on glycolytic and pentose phosphate pathway activity in EL4 tumors and glycolytic activity in yeast cells.
Identification and characterization of novel human glucose-6-phosphate dehydrogenase inhibitors.
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.
Identification of malignant cells in primary monolayer cultures of human breast tumors.
In cancer, all roads lead to NADPH.
In vivo induction of hepatocellular carcinoma by diethylnitrosoamine and pharmacological intervention in Balb C mice using Bergenia ciliata extracts.
Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia.
Independent origin of uterine leiomyomas with karyotypically identical alterations.
Influence of insulin on estrogen-induced responses in the r3230ac mammary carcinoma.
Influence of selenium on glutathione and some associated enzymes in rats with mammary tumor induced by 7,12-dimethylbenz(a)anthracene.
Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells.
Inhibition of human cancer cell growth by periodate-oxidized 3-aminopyridine adenine dinucleotide phosphate.
Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation.
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Integrative Gene Expression Profiling Reveals G6PD-Mediated Resistance to RNA-Directed Nucleoside Analogues in B-Cell Neoplasms.
Interaction between dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and cyclic adenosine-3',5'-monophosphate in neoplastic and normal human mammary tissue.
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
Isoenzymes of lactate, malate, and glucose-6-phosphate dehydrogenase in experimental submaxillary gland tumors.
iTRAQ-based quantitative proteomic analysis of cervical cancer.
KRT6A Promotes Lung Cancer Cell Growth and Invasion Through MYC-Regulated Pentose Phosphate Pathway.
Loss of peroxisomes causes oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity to detect cancer cells.
Low tissue enzyme activity seen in breast cancers of patients who fail adjuvant chemotherapy.
Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice.
Mass spectrometry based proteomics profiling of human monocytes.
Mechanism of cancer preventive action of DHEA. Role of glucose-6-phosphate dehydrogenase.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin.
Metabolic control analysis aimed at the ribose synthesis pathways of tumor cells: a new strategy for antitumor drug development.
Metabolic Insight of Neutrophils in Health and Disease.
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase.
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer.
MicroRNA-206 inhibits tumor metastasis of nasopharyngeal carcinoma through targeting G6PD.
MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD.
miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.
Mitochondrial glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase abrogate p53 induced apoptosis in a yeast model: Possible implications for apoptosis resistance in cancer cells.
Mitotic recombination can explain the apparent polyclonal origin of some tumors.
Modification of the hexokinase activity in the red blood cells of subjects with differentiated adenocarcinoma.
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency.
Mortality of lead smelter workers with the glucose-6-phosphate dehydrogenase-deficient phenotype.
NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex.
NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism.
Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
NF-?B and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC.
Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP
Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells.
Nuclear 8-hydroxy-2'-deoxyguanosine as survival biomarker in patients with cutaneous melanoma.
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.
Occupational lead exposure and screening of glucose-6-phosphate dehydrogenase polymorphism: useful prevention or nonvoluntary discrimination?
Oncogenic viruses and tumor glucose metabolism: like kids in a candy store.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer.
Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity.
Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease.
Oxygen insensitivity of the histochemical assay of glucose-6-phosphate dehydrogenase activity for the discrimination between nonmalignant and malignant cells.
Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation.
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.
Phytol induces ROS mediated apoptosis by induction of caspase 9 and 3 through activation of TRAIL, FAS and TNF receptors and inhibits tumor progression factor Glucose 6 phosphate dehydrogenase in lung carcinoma cell line (A549).
PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3.
Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway.
Poor prognosis in nasopharyngeal cancer patients with low glucose-6-phosphate-dehydrogenase activity.
Potential antitumour and pro-oxidative effects of (E)-methyl 2-(7-chloroquinolin-4-ylthio)-3-(4-hydroxyphenyl) acrylate (QNACR).
Preliminary results of a geographic correlation study on G6PD deficiency and cancer.
Premorphological metabolic changes in human breast carcinogenesis.
Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid "adenomas".
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers.
Prognostic role of glycolysis for cancer outcome: evidence from 86 studies.
Properties of cell lines established from transitional cell cancers of the human urinary tract.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Protein-bound NAD(P)H Lifetime is Sensitive to Multiple Fates of Glucose Carbon.
Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours.
Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Reactive oxygen species in cancer, too much or too little?
Real-time monitoring of glucose-6-phosphate dehydrogenase activity using liquid droplet arrays and its application to human plasma samples.
Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision.
Relative value of oestrogen receptor assay, lactoferrin content, and glucose-6-phosphate dehydrogenase activity as prognostic indicators in primary breast cancer.
Renal cell carcinoma and oxidative stress: The lack of peroxisomes.
Roles of the hexosamine biosynthetic pathway and pentose phosphate pathway in bile acid-induced cancer development.
RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells.
Safe neoadjuvant trastuzumab-based treatment in HER2?+?inflammatory early breast cancer in a glucose 6-phosphate dehydrogenase-deficient postmenopausal woman: A case report and review of the literature.
Safety of vitamin C in sepsis: a neglected topic.
Simultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells.
Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
Smyd1 And G6Pd Modulation Are Critical Events For Mir-206-Mediated Differentiation Of Rhabdomyosarcoma.
Studies of methyl 2-nitroimidazole-1-acetohydroxamate (KIN-804) 1: effect on free radical scavenging system in mice bearing Ehrlich ascites carcinoma.
Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors.
Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.
Test for fused-cell origin of tumors with Mus caroli carrying glucose-6-phosphate dehydrogenase cellular mosaicism.
The association between glucose-6-phosphate dehydrogenase deficiency and cancer in American Negroes.
The clonal origin of thyroid nodules and adenomas.
The histochemical G6PDH reaction but not the LDH reaction with neotetrazolium is suitable for the oxygen sensitivity test to detect cancer cells.
The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma.
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer.
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
The specific PKC-? inhibitor chelerythrine blunts costunolide-induced eryptosis.
The two-hit theory of neoplasia: implications for the pathogenesis of hyperparathyroidism.
Therapeutic potential of manipulating suicidal erythrocyte death.
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
This is not a pipe - But how harmful is electronic cigarette smoke.
Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapy.
Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway.
Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
TSP50 promotes hepatocyte proliferation and tumour formation by activating glucose-6-phosphate dehydrogenase (G6PD).
Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Tumor necrosis factor alpha augments the expression of glucose-6-phosphate dehydrogenase in rat hepatic endothelial and Kupffer cells.
Tumour glucose-6-phosphate dehydrogenase inhibition by actinomycin.
Two high-rate pentose-phosphate pathways in cancer cells.
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
Uridine and cytidine nucleotide synthesis in renal hypertrophy: biochemical differences in response to the growth stimulus of diabetes and unilateral nephrectomy.
Use of X-linked clonal analysis in acute promyelocytic leukemia.
Value of genetic variants of glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors.
Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
Viral "tumorigenesis" in man: cell markers in condylomata acuminata.
Walker-256 tumor growth causes oxidative stress in rat brain.
Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Xenografts of five human leiomyosarcomas: radiation response after 60cobalt- and d(14)+Be neutron single doses.
[A study on the relationship among estrogen receptor, progesterone receptor and glucose-6-phosphate dehydrogenase activity in primary breast cancer]
[Activities of dehydrogenases of the pentose phosphate pathway and transketolase in transplanted mouse hepatomas with different growth rates and in organs of tumor carriers]
[Carbohydrate metabolism enzymatic activity and its alteration under the influence of thyroid hormone during tumor growth]
[Changes in the activity of glucose-6-phosphate dehydrogenase and in the content of reduced glutathione in red blood corpuscles in the case of tumorous diseases in the maxillofacial region (author's transl)]
[Characteristics of isoenzymes of glucose-6-phosphate dehydrogenase in estrogen-dependent and estrogen-independent mammary tumors of experimental animals]
[Electrophoretic behavior of LDH, GOT and G6PD isoenzymes in various cancers of the digestive system (esophagus, stomach, cecum, colon and rectum)]
[Enzymic spectrum of preneoplastic and neoplastic changes induced by 1,2-dimethylhydrazine in mouse kidneys]
[Glucose-6-phosphate dehydrogenase as a marker of genetic predisposition to neoplasms]
[Histo- and cytochemical enzymatic characteristics of breast cancer]
[Histochemical investigations on human bladder cancer (author's transl)]
[Histocytospectrophotometric characteristics of lung cancer]
[Oxidoreductase activity in the cells of stomach cancer]
[Preliminary observations on the incidence of neoplasms and on the enzymatic and proliferative behavior of the tumor tissue in individuals deficient in glucose-6-phosphate dehydrogenase (G6-PD)]
[The pentosephosphate pathway or Dickens-Horecker cycle in tumors of the female genital system. I. Glucose-6-phosphate dehydrogenase (G6PDH) activity in vaginal secretion in the course of malignanty neoplasms of the cervix and uterus]
Nephrotic Syndrome
Indirect quantification of lipid peroxidation in steroid responsive nephrotic syndrome.
Neural Tube Defects
Audit of birth defects in 34,109 deliveries in a tertiary referral center.
Neuralgia
Downregulation of glucose-6-phosphate dehydrogenase contributes to diabetic neuropathic pain through upregulation of toll-like receptor 4 in rats.
Neuroblastoma
Altered enzyme expression in "differentiated" murine neuroblastoma cells.
FSHR ablation induces depression-like behaviors.
Neuroprotective effect of liquiritin as an antioxidant via an increase in glucose-6-phosphate dehydrogenase expression on B65 neuroblastoma cells.
Neurodegenerative Diseases
Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.
DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice.
Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: Mapping diagnostic and therapeutic opportunities.
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice.
Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway.
Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
Neurodermatitis
Glyceraldehydephosphate dehydrogenase and glucose-6-phosphate dehydrogenase activities in psoriasis and neurodermatitis and the effect of dithranol.
Neurofibroma
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Neurofibromatoses
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Neurofibromatosis 1
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Neurofibrosarcoma
Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
Neuroinflammatory Diseases
Role of glucose 6-phosphate dehydrogenase (G6PD) deficiency and its association to Autism Spectrum Disorders.
The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration.
Neurologic Manifestations
Glucose-6-Phosphate Dehydrogenase Deficiency and the Benefits of Early Screening.
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.
Neuromuscular Diseases
Elevated activity of several antioxidant enzymes in neuromuscular diseases. A histochemical and biochemical study.
Neuromyelitis Optica
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica.
Neutropenia
A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD "Rehovot") in a Jewish Ethiopian family with variable phenotypes.
Death from drug-induced hemolytic anemia.
Nijmegen Breakage Syndrome
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Non-alcoholic Fatty Liver Disease
Synergistic effect of eicosapentaenoic acid-enriched phospholipids and sea cucumber saponin on orotic acid-induced non-alcoholic fatty liver disease in rats.
Noonan Syndrome
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Obesity
A possible interrelation between glucose-6-phosphate dehydrogenase and dehydroepiandrosterone in obesity.
Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats.
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors.
Effect of hormones on fatty acid release and glucose-6-phosphate dehydrogenase activity in human adipose tissue in relation to obesity.
Effects of dehydroepiandrosterone on obesity and glucose-6-phosphate dehydrogenase activity in the lethal yellow mouse (strain 129/Sv-Ay/Aw).
Effects of Glucose 6-Phosphate Dehydrogenase Deficiency on the Metabolic and Cardiac Responses to Obesogenic or High Fructose Diets.
Evolutionary explanations in medical and health profession courses: are you answering your students' "why" questions?
Glucose-6-Phosphate Dehydrogenase Deficiency Improves Insulin Resistance With Reduced Adipose Tissue Inflammation in Obesity.
Green tea polyphenol extract in vivo attenuates inflammatory features of neutrophils from obese rats.
Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals.
Lipogenic hepatic enzyme activity of raccoon dogs (Nyctereutes procyonoides) fed various diets.
Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity.
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.
Proteomic profile of visceral adipose tissues between low-fat diet-fed obesity-resistant and obesity-prone C57BL/6 mice.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
The role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in obesity.
[Glucose-6-phosphate dehydrogenase activity in the adipose tissue of patients with metabolic-alimentary obesity]
[Influence of reducing diets on the glucose-6-phosphate dehydrogenase activity of the fatty tissue in patients with metabolic-alimentary obesity]
[Roles of glucose-6-phosphate dehydrogenase in obesity induced by high fat diet].
Obstetric Labor, Premature
Hofbauer cell activation and its increased glucose-6-phosphate dehydrogenase activity in second trimester-spontaneous abortion: an ultrastructural dual staining enzyme-cytochemical study.
Oculocerebrorenal Syndrome
Linkage studies in carriers of Lowe oculo-cerebro-renal syndrome.
Odontogenic Cysts
Enzyme histochemical studies on the formation of hyalin bodies in the epithelium of odontogenic cysts.
In situ determination of different dehydrogenase activity profiles in the linings of odontogenic keratocysts and radicular cysts.
Odontogenic keratocysts: a clinical and histological study with special reference to enzyme histochemistry.
Olivopontocerebellar Atrophies
Enzymatic analysis of individual posterior root ganglion cells in olivopontocerebellar atrophy, amyotrophic lateral sclerosis and Duchenne muscular dystrophy.
Optic Atrophy
G-6-PD Worcester. A new variant, associated with X-linked optic atrophy.
Optic Neuropathy, Ischemic
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in nonarteritic anterior ischemic optic neuropathy in a Sardinian population, Italy.
Osteoarthritis
Glucose-6-phosphate dehydrogenase deficiency and osteoarthritis in men of Northern Sardinia.
Peripheral red blood cell survival invariance during pefloxacin treatment in subjects with glucose-6-phosphate dehydrogenase deficiency.
Osteonecrosis
Is GERD a Factor in Osteonecrosis of the Jaw? Evidence of Pathology Linked to G6PD Deficiency and Sulfomucins.
Osteopetrosis
A case of concomitant autosomal recessive osteopetrosis and G6PD deficiency.
Osteosarcoma
Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase.
Ovarian Neoplasms
Corrigendum to "Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1" [Biochem. Pharmacol. 178 (2020), 114092].
Discovery and characterization of a novel glucose-6-phosphate dehydrogenase (G6PD) inhibitor via high-throughput screening.
Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.
Pancreatic Neoplasms
Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines.
Metabolic plasticity imparts erlotinib-resistance in pancreatic cancer by upregulating glucose-6-phosphate dehydrogenase.
Pancreatitis
Anemia associated with new-onset diabetes: improvement with blood glucose control.
Pancreatitis in acute hemolysis.
[Effects of trental and thiotriazoline on neutrophil dehydrogenase activity in acute experimental pancreatitis]
[Erythrocyte membranes and antioxidant provision in experimental acute pancreatitis]
[Histoenzymological characteristics of the adrenal cortical reaction in variants of experimental pancreatitis]
[Use of anti-radical protection enzymes in the treatment of acute experimental pancreatitis]
Pancytopenia
Pancytopenia as a clonal disorder of a multipotent hematopoietic stem cell.
Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
Periodontal considerations in a patient with glucose-6-phosphate dehydrogenase deficiency with associated pancytopenia: A rare case report.
Papillomavirus Infections
Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Paracoccidioidomycosis
Isoniazid acetylating phenotype in patients with paracoccidioidomycosis and its relationship with serum sulfadoxin levels, glucose-6-phosphate dehydrogenase and glutathione reductase activities.
Measurement of glucose-6-phosphate dehydrogenase and glutathione reductase activity in patients with paracoccidioidomycosis treated with ketoconazole.
Paralysis
[Generalized saturnine paralysis. Discovery of a double congenital disease: glucose-6-phosphate dehydrogenase deficiency (new variant) and distal tubular acidosis]
Parasitemia
Artesunate-induced hemolysis in severe complicated malaria - A diagnostic challenge: A case report and literature review of anemia in malaria.
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Changes in rodent-erythrocyte methemoglobin reductase system produced by two malaria parasites, viz. Plasmodium yoelii nigeriensis and Plasmodium berghei.
Effect of beta-arteether treatment on erythrocytic methemoglobin reductase system in Plasmodium yoelii nigeriensis infected mice.
Evaluation of antioxidant status and oxidative stress in cattle naturally infected with Theileria annulata.
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
Genetic factors and malaria in the Temuan.
Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Lack of association between falciparum malaria parasitemia and acute diarrhea in Nigerian children.
Malaria and erythrocyte glucose-6-phosphate dehydrogenase variants in West Africa.
Membrane protein carbonylation of Plasmodium falciparum infected erythrocytes under conditions of sickle cell trait and G6PD deficiency.
Rat liver glucose-6-phosphate dehydrogenase isozymes: influence of infection with Trypanosoma.
Status of oxidative stress, trace elements, sialic acid and cholinesterase activity in cattle naturally infected with Babesia bigemina.
Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice.
[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]
Parasitic Diseases
Associations among Soil-Transmitted Helminths, G6PD Deficiency and Asymptomatic Malaria Parasitemia, and Anemia in Schoolchildren from a Conflict Zone of Northeast Myanmar.
Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes.
G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection.
Hemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency Coinheritance in AS and SS Individuals in Malaria-Endemic Region: A Study in Calabar, Nigeria.
Impact of Hemoglobin S Trait on Cell Surface Antibody Recognition of Plasmodium falciparum-Infected Erythrocytes in Pregnancy-Associated Malaria.
[Dissimilar glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in the Afars and the Somalis of Djibouti]
Parathyroid Neoplasms
Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas.
Multicellular origin of parathyroid "adenomas".
Paratyphoid Fever
Depression of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in enteric fever.
Parkinson Disease
Glucose-6-phosphate dehydrogenase activity in Parkinson's disease.
Parkinsonian Disorders
Mesencephalic and striatal protein profiles in mice over-expressing glucose-6-phosphate dehydrogenase in dopaminergic neurons.
Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.
Parotitis
[The activity of the glutathione antioxidative system in the blood of patients with acute nonepidemic parotitis]
Parvoviridae Infections
Chronic parvovirus infection and G6PD deficiency masquerading as Diamond-Blackfan anemia.
Pellagra
Diet in dermatology: revisited.
Pemphigus
Diet in dermatology: revisited.
Peptic Ulcer
A case-control study of primary hepatocellular carcinoma in Taiwan.
Pericarditis
[A case of acute recurrent benign pericarditis in a patient with glucose-6-phosphate dehydrogenase deficiency, treated with sodium salicylate]
Perinatal Death
Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency.
Periodontal Diseases
Periodontal disease and hemolysis in glucose-6-phosphate dehydrogenase deficiency: Is there a nexus?
Peritonitis
[Disorders of purine metabolism in patients with peritonitis complicated by sepsis]
Persistent Infection
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Phenylketonurias
A neonatal screening in Lebanon: Results of five years' experience.
Comprehensive newborn screening program: ARAMCO experience, the national need and recommendations.
Detection of inherited metabolic disorders via tandem mass spectrometry in Thai infants.
Frequency of Inborn Errors of Metabolism in a Northeastern Iranian Sample with High Consanguinity Rates.
Molecular newborn screening of four genetic diseases in Guizhou Province of South China.
Neonatal screening and monitoring system in Taiwan.
Newborn screening in the Philippines.
The status of neonatal screening in China, 2013.
[Congenital hypothyroidism missed on newborn screening: report of two cases]
Pheochromocytoma
Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma.
phosphogluconate 2-dehydrogenase deficiency
Erythrocytic glutathione reductase, glucose-6-phosphate dehydrogenase, and 6-phosphogluconic dehydrogenase deficiencies in populations of the United States, South Vietnam, Iran, and Ethiopia.
phosphogluconate dehydrogenase (nadp+-dependent, decarboxylating) deficiency
6-Phosphogluconate dehydrogenase deficiency in an Italian family.
Combined G-6PD and 6-PGD deficiency in a Hindu boy.
phosphoglycerate kinase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
phosphoglycerate mutase deficiency
Red cell phosphoglucomutase (PGM)-deficiency: hereditary defect of the PGM1-locus.
Pituitary Neoplasms
Downregulation of glucose?6?phosphate dehydrogenase by microRNA?1 inhibits the growth of pituitary tumor cells.
Pityriasis
Pityriasis rotunda and G6PD deficiency.
Plasmacytoma
Enhancement of Plasmacytoma Cell Growth by Ascorbic Acid is Mediated Via Glucose 6-phosphate Dehydrogenase.
Pneumococcal Infections
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency.
Pneumonia
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.
Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.
Dapsone hypersensitivity syndrome not related to G6PD deficiency.
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Glucose-6-phosphate dehydrogenase deficiency and lobar pneumonia. Fine structure of the liver.
Glucose-6-phosphate dehydrogenase deficiency and susceptibility to childhood diseases in Kilifi, Kenya.
Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Use of trimethoprim-sulfamethoxazole in a patient with G6PD deficiency for treating Pneumocystis jirovecii pneumonia without haemolysis: Case report and literature review.
[Dynamics of neutrophil glucose-6-phosphate dehydrogenase and NADPH2-diaphorase activity in children with acute pneumonia]
[Phagocytic activity of neutrophils in children with hereditary glucose-6-phosphate dehydrogenase deficiency during acute pneumonia]
Pneumonia, Necrotizing
Leucocyte glucose-6-phosphate dehydrogenase deficiency and necrotizing pneumonia.
Pneumonia, Pneumocystis
Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.
Pneumocystis jirovecii pneumonia in a human immunodeficiency virus-infected patient with G6PD deficiency-successful treatment with anidulafungin.
Use of trimethoprim-sulfamethoxazole in a patient with G6PD deficiency for treating Pneumocystis jirovecii pneumonia without haemolysis: Case report and literature review.
Polycythemia
Apoptosis in blood diseases. Review new data.
Elongation index of erythrocytes, study of activity of chosen erythrocyte enzymes, and the levels of glutathione, malonyldialdehyde in polycythemia vera (PV).
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Evaluation of neonatal jaundice in the Makkah region.
Hemolytic erythrocytosis: an amalgamated phenotype from coinherited Chuvash polycythemia and G6PD Kerala-Kalyan with acquired transient stomatocytosis.
Polycythemia vera: stem-cell and probable clonal origin of the disease.
Polycythemia Vera
Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.
Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine.
Polycythemia vera. Physical separation of normal and neoplastic committed granulocyte-macrophage progenitors.
Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.
Polycythemia vera: stem-cell and probable clonal origin of the disease.
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
Stem cell origin of human myeloid blood cell neoplasms.
The activity of glucose-6-phosphate dehydroxygenase and glutathione enzymes in red blood cells in patients with haemoblastoses.
[Erythremia: the activity of erythrocyte antioxidant enzymes and the association with iron deficiency]
Polydactyly
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
Polyneuropathies
Chronic nonspherocytic hemolytic anemia (CNSHA) and glucose 6 phosphate dehydrogenase (G6PD) deficiency in a patient with familial amyloidotic polyneuropathy (FAP). Molecular study of a new variant (G6PD Clinic) with markedly acidic pH optimum.
Porcine Reproductive and Respiratory Syndrome
The GSK3/Shaggy-Like Kinase ASK? Contributes to Pattern-Triggered Immunity.
Porphyria, Acute Intermittent
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Porphyrias
Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. Their impact on heme pathway.
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Genetic disorders in Southern Africa.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
TRIPLE ERYTHROPOIETIC ANOMALY: PORPHYRIA, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND HETEROZYGOUS STATE OF HAEMOGLOBIN E.
Porphyrias, Hepatic
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Pre-Eclampsia
Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia.
Glucose-6-phosphate dehydrogenase activity in pre-eclampsia.
Glucose-6-phosphate Dehydrogenase Deficiency and Pre-eclampsia: Possibility of Treatment.
Glucose-6-phosphate dehydrogenase is present in normal and pre-eclamptic placental trophoblasts: ultrastructural enzyme-histochemical evidence.
Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Clonal development from a progenitor with restricted differentiative expression in acute lymphoblastic leukemia.
Evidence for clonal development of childhood acute lymphoblastic leukemia.
Leukocyte glucose 6 phosphate dehydrogenase (G6PD) as prognostic indicator in children with acute lymphocytic leukemia.
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Prediabetic State
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Pregnancy Complications
Assessment of serum aflatoxin B1 levels in neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency: a preliminary study.
Premature Birth
Risk factors for severe hyperbilirubinemia in neonates.
prenyl-diphosphatase deficiency
Deficiency of glucose-6-phosphate dehydrogenase found in a case of hepatic fructose-1,6-diphosphatase deficiency.
Priapism
Fabry Disease and G6PD in Three Family Members with Priapism: Is the Nitric Oxide Pathway to Blame?
G6PD Deficiency and Priapism: Is There a Link Between the Two Entities?
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?
Priapism and glucose-6-phosphate dehydrogenase deficiency: An underestimated correlation?
Primary Immunodeficiency Diseases
Expanding the clinical and genetic spectrum of G6PD deficiency: The occurrence of BCGitis and novel missense mutation.
Primary Myelofibrosis
A new glucose 6-phosphate dehydrogenase variant (G6PD Thessaloniki) in a patient with idiopathic myelofibrosis.
Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.
Blood leucocyte enzymes. II. Activities at 8-9 a.m. in cells of normal subjects, chronic lymphatic leukaemia and chronic myeloid leukaemia patients.
Gd(--) Abrami: a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis.
Glucose-6-phosphate dehydrogenase deficiency and myelofibrosis.
Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias.
[ON THE ACTIVITY OF ERYTHROCYTIC GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN PRIMARY MYELOFIBROSIS.]
Propionic Acidemia
Frequency of Inborn Errors of Metabolism in a Northeastern Iranian Sample with High Consanguinity Rates.
Prostatic Hyperplasia
Glucose-6-phosphate dehydrogenase: a possible clinical indicator for prostatic carcinoma.
Prostatic Neoplasms
Endogenous control genes in prostate cells: evaluation of gene expression using 'real-time' quantitative polymerase chain reaction.
miR-101 Enhances Cisplatin-Induced DNA Damage Through Decreasing Nicotinamide Adenine Dinucleotide Phosphate Levels by Directly Repressing Tp53-Induced Glycolysis and Apoptosis Regulator Expression in Prostate Cancer Cells.
Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth.
Protein Deficiency
Influence of protein deficiency on hexachlorocyclohexane and malathion toxicity in pregnant rats.
Protein-Energy Malnutrition
Diet in dermatology: revisited.
protein-tyrosine-phosphatase deficiency
PTP1B deficiency enhances liver growth during suckling by increasing the expression of insulin-like growth factor-I.
Proteinuria
Associations between polymorphic variety and disease susceptibility in two New Guinea populations.
Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency.
Glomerular metabolism in protein-load proteinuria.
Pruritus
Certain red cell genetic factors and prevalence of chloroquine-induced pruritus.
Diet in dermatology: revisited.
Pseudoxanthoma Elasticum
[Genetic questionnaire. Genetic counseling for a patient with the complex association of G-6-PD deficiency, Gronblad-Strandberg syndrome (pseudo-xanthoma elasticum) and epilepsy]
Psoriasis
Augmented glucose-6-phosphate dehydrogenase activity and normal penetration and metabolism of dehydroepiandrosterone in mononuclear leukocytes in psoriasis.
Diet in dermatology: revisited.
Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Glyceraldehydephosphate dehydrogenase and glucose-6-phosphate dehydrogenase activities in psoriasis and neurodermatitis and the effect of dithranol.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
[Behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes as demonstrated on patients with psoriasis under silymarine medication]
[On glucose-6-phosphate dehydrogenase activity in healthy skin, in squamae and in erythrocytes of psoriasis patients during treatment with butabenzalbutyramide]
[On the behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes of subjects with psoriasis]
[Study of the glucose-6-phosphate dehydrogenase activity of the blood, erythrocytes, squamae and normal skin in psoriasis patients]
Pterygium
Epidemiology and Associated Morbidity of Pterygium: A Large, Community-Based Case-Control Study.
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium.
Pulmonary Arterial Hypertension
New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension.
Pulmonary Disease, Chronic Obstructive
Urban PM2.5 induces ROS generation and RBC damage in COPD patients.
Pulmonary Edema
Bilateral pulmonary edema after endoscopic sympathectomy in a patient with glucose-6-phosphate dehydrogenase deficiency.
The evolution of biochemical damage in the rat lung after acute cadmium exposure.
Pulmonary Embolism
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
Sickle-cell trait, thalassemia, G-6-PD deficiency and puerperal pulmonary embolism.
Topical benzocaine (Hurricaine) induced methemoglobinemia during endoscopic procedures in gastric bypass patients.
Pulmonary Fibrosis
Pentose pathway in pulmonary fibrosis due to chronic paraquat poisoning.
purine-nucleoside phosphorylase deficiency
[Study on red cell enzymes and isoenzymes in patients with leukemia and myelodysplastic syndromes]
Purpura
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
Purpura, Thrombocytopenic, Idiopathic
Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.
Pyelonephritis
Erythropoiesis and iron metabolism biorhythms in children with chronic pyelonephritis.
pyruvate kinase deficiency
A combined system for the study of glutathione metabolism in erythrocytes.
A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency.
Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE).
Detection of G6PD and pyruvate kinase deficiencies in reticulocytosis by reference to erythrocyte creatine.
Exploring putative molecular mechanisms of human pyruvate kinase enzyme deficiency and its role in resistance against Plasmodium falciparum malaria.
Genetic control of resistance to human malaria.
Glucose-6-phosphate dehydrogenase and red cell pyruvate kinase deficiency in neonatal jaundice cases in egypt.
Heterozygous pyruvate kinase deficiency and severe hemolytic anemia in a pregnant woman with concomitant, glucose-6-phosphate dehydrogenase deficiency.
How I do in front of an hemolytic anemia of unknown etiology?
Molecular aspects of erythroenzymopathies associated with hereditary hemolytic anemia.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
Next-Generation Sequencing-Based Diagnosis of Unexplained Inherited Hemolytic Anemias Reveals Wide Genetic and Phenotypic Heterogeneity.
Pyruvate kinase deficiency. Association with G6PD deficiency.
Red Blood Cell Membrane Conductance in Hereditary Haemolytic Anaemias.
Screening of pyruvate kinase deficiency and G6PD deficiency in Chinese newborn in Hong Kong.
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
[Glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency]
[Pathophysiology and laboratory tests of hemolytic anemia: with special reference to erythroenzymopathies]
[The importance of determination of ferritin levels in erythrocytes]
[Use of nuclear magnetic resonance in the study of hemolytic anemia. Preliminary report]
Pyuria
Hemolysis due to Alpha-Hemolytic Enterococcus Urinary Infection: A Rare Cause of Early and Severe Unconjugated Hyperbilirubinemia in a Neonate.
Hyperlactatemia and hemolysis in G6PD deficiency after nitrofurantoin ingestion.
Radicular Cyst
In situ determination of different dehydrogenase activity profiles in the linings of odontogenic keratocysts and radicular cysts.
Red-Cell Aplasia, Pure
Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia.
Refsum Disease
Diet in dermatology: revisited.
Renal Insufficiency
A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
Acute Hepatitis A Causing Severe Hemolysis and Renal Failure in Undiagnosed Glucose-6-Phosphate Dehydrogenase Deficient Patient: A Case Report and Review of the Literature.
Acute intravascular hemolysis and renal failure in a new glucose-6-phosphate dehydrogenase variant: G-6-PD Siriraj.
Acute reversible renal failure and Stevens-Johnson syndrome in a patient having glucose-6-phosphate dehydrogenase deficiency.
Acute viral hepatitis, intravascular haemolysis, severe hyperbilirubinaemia and renal failure in glucose-6-phosphate dehydrogenase deficient patients.
Anemia associated with new-onset diabetes: improvement with blood glucose control.
Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency.
Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Effect of 4-HNE Modification on ZU5-ANK Domain and the Formation of Their Complex with ?-Spectrin: A Molecular Dynamics Simulation Study.
Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
Falciparum malaria--present day problems. An experience with 425 cases.
Fulminant hemolysis in glucose-6-phosphate dehydrogenase deficiency.
Intravascular haemolysis and renal insufficiency in children with glucose-6-phosphate dehydrogenase deficiency, following antimalarial therapy.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Phenazopyridine: A Preoperative Way to Identify Ureteral Orifices.
Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report.
Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
[Acute hemolysis and renal failure caused by hepatitis A infection with underlying glucose-6-phosphate dehydrogenase deficiency]
[Effect of hemodialysate and its peptide fragments on stromal cells and heme synthesis in bone marrow culture and the activity of selected enzymes and GSH level in human erythrocytes. III. Effect on G-6-PD in erythrocytes of healthy persons and those with terminal renal failure]
[Erythrocyte enzymes in chronic kidney failure]
[Post-hemolytic renal failure in children with glucose-6-phosphate dehydrogenase deficiency at the University Hospital Center in Lome]
Renal Insufficiency, Chronic
Changes in glucose 6-phosphate dehydrogenase and phosphofructokinase activity during maturation and ageing of red blood cells in children with chronic renal insufficiency.
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East.
Reperfusion Injury
Geranylgeranylacetone attenuates cerebral ischemia-reperfusion injury in rats through the augmentation of HSP 27 phosphorylation: a preliminary study.
Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase.
Interleukin-1 treatment increases neutrophils but not antioxidant enzyme activity or resistance to ischemia-reperfusion injury in rat kidneys.
Respiratory Distress Syndrome
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Respiratory Insufficiency
Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.
Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984.
Respiratory Tract Diseases
[Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children]
Respiratory Tract Infections
A new glucose-6-phosphate dehydrogenase variant (G6PD Tsukui) associated with congenital hemolytic anemia.
Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency.
Retinal Diseases
ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
Retinal Vein Occlusion
Central retinal vein occlusion in an Army Ranger with glucose-6-phosphate dehydrogenase deficiency.
Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Retinitis Pigmentosa
Genetic disorders in Southern Africa.
Genetic study of retinitis pigmentosa in China.
Retinitis Pigmentosa Associated with Glucose-6-Phosphate Dehydrogenase Deficiency.
Retinoschisis
Understanding human disease mutations through the use of interspecific genetic variation.
Rh Isoimmunization
Prospective Surveillance of Extreme Neonatal Hyperbilirubinemia in Australia.
Severe neonatal hyperbilirubinemia in the southeast region of Turkey
Spectrum of neonatal hyperbilirubinemia: an analysis of 454 cases.
Rhabdomyolysis
Acute rhabdomyolysis induced by tonic-clonic epileptic seizures in a patient with glucose-6-phosphate dehydrogenase deficiency.
New Diagnosis of G6PD Deficiency Presenting as Severe Rhabdomyolysis.
New onset diabetes complicated by haemolysis and rhabdomyolysis: a case report and review of the literature.
Rhabdomyolysis and hemolysis associated with sickle cell trait and glucose-6-phosphate dehydrogenase deficiency.
Severe acute kidney injury owing to rhabdomyolysis and intravascular haemolysis in an 11-year-old child with G6PD deficiency.
Severe Rhabdomyolysis in Glucose-6-Phosphate Dehydrogenase Deficiency.
Rhabdomyosarcoma
Smyd1 And G6Pd Modulation Are Critical Events For Mir-206-Mediated Differentiation Of Rhabdomyosarcoma.
Rheumatic Diseases
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
[Safety of lornoxicam in G-6-PDH deficiency]
[Use of glucose-6-phosphate dehydrogenase and transketolase for characterization of pathologic processes in the myocardium in rheumatism]
Rhinitis, Allergic
[Activity of glucose-6-phosphate dehydrogenase in erythrocytes in patients with atopic asthma and allergic rhinitis]
Riboflavin Deficiency
Effect of erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency on light-induced riboflavin deficiency in the neonate.
Effects of riboflavin and selenium deficiencies on glutathione and its relating enzyme activities with respect to lipid peroxide content of rat livers.
Enhanced depletion of lens reduced glutathione Adriamycin in riboflavin-deficient rats.
Increased incidence of cataracts in male subjects deficient in glucose-6-phosphate dehydrogenase.
The influence of G-6-PD activity on the response of erythrocyte glutathione reductase to riboflavin deficiency.
Rickettsia Infections
Haemolysis with Mediterranean spotted fever and glucose-6-phosphate dehydrogenase deficiency.
Haemolysis with rickettsiosis and glucose-6-phosphate dehydrogenase deficiency.
Rocky Mountain Spotted Fever
Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency.
Infection of human endothelial cells by Rickettsia rickettsii causes a significant reduction in the levels of key enzymes involved in protection against oxidative injury.
Rocky Mountain spotted fever and deficiency in glucose-6-phosphate dehydrogenase.
Root Resorption
Metabolic activity of deciduous porcine dental pulp in different phases of root development.
Salmonella Infections
[Hemolytic anemia associated with minor salmonellosis in an HIV positive, G6PD deficient Congolese woman]
Sarcoidosis
Decreased redox state in red blood cells from patients with sarcoidosis.
Sarcoma
Carcinogenesis in tissue culture. 29: Neoplastic transformation of a normal human diploid cell strain, WI-38, with Co-60 gamma rays.
Effect of growth of Rhodamina sarcoma in rat on isozymes of liver enzymes, with reference to the seesaw change of two pI-isozymes of glucose-6-phosphate dehydrogenase.
Expression of X-linked genes in deceased neonates and surviving cloned female piglets.
Karyological and isoenzyme characterization of established human sarcoma cell lines.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH).
Sarcopenia
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention.
Schistosomiasis
[Global health of unaccompanied refugee minors in Gironde (France) between 2011 and 2013].
Schistosomiasis mansoni
Treatment of schistosomiasis mansoni with hycanthone in glucose-6-phosphate dehydrogenase deficiency in St. Lucia.
Scoliosis
Anaesthetic management in a child with an atypical triad for reconstructive scoliosis surgery.
Scurvy
Diet in dermatology: revisited.
Seizures
Acute rhabdomyolysis induced by tonic-clonic epileptic seizures in a patient with glucose-6-phosphate dehydrogenase deficiency.
Anemia, cataracts, and seizures in patient with glucose-6-phosphate dehydrogenase deficiency.
Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review.
Cerebral oxidized and reduced nicotinamide-adenine dinucleotide phosphate and glucose 6-phosphate dehydrogenase in mice during exposure to high oxygen pressure.
Features and outcomes of malaria infection in glucose-6-phosphatedehydrogenase normal and deficient Nigerian children.
Glucose-6-phosphate dehydrogenase deficiency presented with convulsion: a rare case.
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
Seminoma
Changes in activities of enzymes related to energy metabolism in testicular tissues of dogs with seminoma.
Sepsis
A prospective study of the role of bacterial infection and G6PD deficiency in severe neonatal jaundice in Nigeria.
Augmented erythrocyte band-3 phosphorylation in septic mice.
B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency.
Bilirubin crystals were detected in peripheral blood neutrophils in newborn with sepsis and G6PD deficiency.
Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
Ceramide in suicidal death of erythrocytes.
Clinical evaluation of severe neonatal Hyperbilirubinaemia in a resource-limited setting: a 4-year longitudinal study in south-East Nigeria.
Closing the Brief Case: Recurrent Chromobacterium violaceum Bloodstream Infection in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patient with a Severe Neutrophil Defect.
Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia.
Erythrocyte programmed cell death.
Evaluation of a new end-tidal carbon monoxide monitor from the bench to the bedside.
Evaluation of neonatal indirect hyperbilirubinaemia at Zanjan Province of Iran in 2001-2003: prevalence of glucose-6-phosphate dehydrogenase deficiency.
Exchange transfusion in neonatal hyperbilirubinemia.
Glucose-6-phosphate dehydrogenase and sepsis: the jury is still out.
Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis.
Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis.
Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria.
Harm or Benefit of High-Dose Vitamin C in Adult Patients With Sepsis and Glucose-6-Phosphate Dehydrogenase Deficiency?
Hematological profile in neonatal jaundice.
Hepatitis A infection related haemophagocytic syndrome: a case report and systematic review.
How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.
Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants.
Incidence of Chronic Bilirubin Encephalopathy in Canada, 2007-2008.
Jaundice: a 10 year review of 41,000 live born infants.
Jaundice: clinical practice in 88,000 liveborn infants.
Late sepsis in a G-6-PD deficient newborn.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Mechanisms and Significance of Eryptosis, the Suicidal Death of Erythrocytes.
Metabolic Insight of Neutrophils in Health and Disease.
Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency.
Neonatal jaundice in Asia.
Neurological complications of kernicterus.
Omics markers of the red cell storage lesion and metabolic linkage.
Oxidative Stress and Suicidal Erythrocyte Death.
Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency.
Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice.
Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality.
Risk Assessment for Adverse Outcome in Term and Late Preterm Neonates with Bilirubin Values of 20 mg/dL or More.
Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria.
The Brief Case: Recurrent Chromobacterium violaceum Bloodstream Infection in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patient with a Severe Neutrophil Defect.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria.
[Clinical studies of neonatal hyperbilirubinemia treated with blood exchange transfusion]
[Complications of exchange transfusion in term and preterm newborns]
[Screening and identification of potential targets of carthamin against sepsis].
Severe Acute Respiratory Syndrome
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19.
Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
Severe Dengue
Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever.
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children.
Sickle Cell Trait
A hematological survey of preschool children of the United Arab Emirates.
A survey of the incidence of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Zambia.
Alpha-2-globin gene polyadenylation (AATAAA-->AATAAG) mutation in hemoglobin H disease among Kuwaitis.
An evaluation of concurrent G6PD (A-) deficiency and sickle cell trait in Malian populations of children with severe or uncomplicated P. falciparum malaria.
Anemia in pregnancy.
Antibody responses to P. falciparum Apical Membrane Antigen 1(AMA-1) in relation to haemoglobin S (HbS), HbC, G6PD and ABO blood groups among Fulani and Masaleit living in Western Sudan.
Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.
Beta thalassaemia trait in western Nigeria.
Blood pressure and other cardiovascular disease risk factors in black adults with sickle cell trait or glucose-6-phosphate dehydrogenase deficiency.
Campaign to control genetic blood diseases in Bahrain.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Correlation of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and sickle cell trait (Hb-AS).
Deficiency of erythrocyte glucose-6-phosphate dehydrogenase and sickle cell trait: a survey of Mahar students at Aurangabad, Maharashtra.
Dietary alterations modulate susceptibility to Plasmodium infection.
Effect of 4-HNE Modification on ZU5-ANK Domain and the Formation of Their Complex with ?-Spectrin: A Molecular Dynamics Simulation Study.
Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study.
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda.
Family analysis of malaria infection in Dienga, Gabon.
Fetal Hemoglobin Modulators May Be Associated With Symptomology of Football Players with Sickle Cell Trait.
Frequencies of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency differ in highland and nearby lowland malaria-endemic areas of Kenya.
Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
G-6-PD deficiency, sickle cell trait, and acute hemolysis after bronchography.
Genetic Blood Disorders Survey in the Sultanate of Oman.
Genetic resistance to malaria, oxidative stress and hemoglobin oxidation.
Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso.
Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Trait among Prospective Blood Donors: A Cross-Sectional Study in Berekum, Ghana.
Haematological study in Cabo Delgado province, Mozambique; sickle cell trait and G6PD deficiency.
Haemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait.
Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1.
Hematological profile of twenty-nine tribal compound cases of hemoglobinopathies and G-6-PD deficiency in rural Orissa.
Human genetics and malaria resistance.
Human red blood cell polymorphisms prevalent in Colombian population and its protective role against malaria.
Identification of Inflammatory Biomarkers for Pediatric Malarial Anemia Severity using Novel Statistical Methods.
Influence of hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency on diagnosis of diabetes by HbA1c among Tanzanian adults with and without HIV: A cross-sectional study.
Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon.
Membrane protein carbonylation of Plasmodium falciparum infected erythrocytes under conditions of sickle cell trait and G6PD deficiency.
NADH-methemoglobin reductase (cytochrome b5 reductase) levels in two groups of American blacks and whites.
Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review.
Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria.
Prevalence of classic erythrocyte polymorphisms among 749 children in southern highland Rwanda.
Prevalence of glucose-6-phosphate dehydrogenase deficiency and sickle cell trait among blood donors in Riyadh.
Red blood cell-derived microparticles: An overview.
Rhabdomyolysis and hemolysis associated with sickle cell trait and glucose-6-phosphate dehydrogenase deficiency.
Right Middle Lobe Collapse and Pleural Effusion in an 18-Year-Old Man.
Role of genetic factors and ethnicity on the multiplicity of Plasmodium falciparum infection in children with asymptomatic malaria in Yaoundé, Cameroon.
Sickle cell trait and G6PD deficiency in blood donors in eastern Saudi Arabia.
Sickle cell trait and glucose-6-phosphate dehydrogenase deficiency. Effects on health and military performance in black Navy enlistees.
Sickle cell trait, thalassaemia and glucose-6-phosphate dehydrogenase deficiency in the Bhil tribe of southern Rajasthan.
Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.
Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain).
The distribution of the parasitic fauna dictates the distribution of the haemochromatosis genes.
The role of red blood cell polymorphisms in resistance and susceptibility to malaria.
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children.
[Evaluation of the incidence of glucose-6-phosphate dehydrogenase deficiency in children with sickle cell anemia in Brazzaville (Congo)]
[Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in the sub-Saharan immigrant population of the Center and South Maresme region, Catalonia, Spain]
Siderosis
[Studies on the primary lesion of experimental retinal siderosis. IV. The primary lesion of experimental retinal siderosis from the viewpoint of histochemical studies on glucose-6-phosphate dehydrogenase]
Skin Diseases
Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus.
Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage.
Skin Neoplasms
The measurement of photodamage.
Small Cell Lung Carcinoma
Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines.
Spasm
[Could the understanding of racial differences prevent idiosyncratic anesthetic reactions?]
Spasms, Infantile
The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency.
Spotted Fever Group Rickettsiosis
Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency.
Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever.
Infection of human endothelial cells by Rickettsia rickettsii causes a significant reduction in the levels of key enzymes involved in protection against oxidative injury.
Rocky Mountain spotted fever and deficiency in glucose-6-phosphate dehydrogenase.
Squamous Cell Carcinoma of Head and Neck
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
Starvation
Age and thyroid hormone as factors in the responses of BHE rats to starvation-refeeding.
Dietary fatty acids on the control of glucose-6-phosphate dehydrogenase and malic enzyme in the starved-refed rat.
Dietary induction of hepatic glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and malic enzyme in lean and obese female Zucker rats.
Dietary regulation of liver glucose-6-phosphate dehydrogenase in the rat: starvation and dietary carbohydrate induction.
Effect of cold stress and starvation on the cerebral glucose-6-phosphate dehydrogenase activity of male garden lizards of three different age groups.
Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase, and glutathione peroxidase of rat RBC.
Effect of peptides of the insulin superfamily on glucose-6-phosphate dehydrogenase activity in skeletal muscles of river lamprey (Lampetra fluviatilis) during prespawning starvation.
Expression of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase isoform genes in suspension-cultured Arabidopsis thaliana cells.
Glucose dehydrogenase, glucose-6-phosphate dehydrogenase and hexokinase in liver of rainbow trout (Salmo gairdneri). Effects of starvation and temperature variations.
Glucose-6-phosphate dehydrogenase activity in adipose tissue from two types of obese mice during starvation.
In Vivo and in Vitro Studies of Glucose-6-Phosphate Dehydrogenase from Barley Root Plastids in Relation to Reductant Supply for NO2- Assimilation.
Independence of glycogen accumulation and glucose-6-phosphate dehydrogenase induction in rat liver.
Inhibition of carbon dioxide fixation by lead acetate in rat liver mitochondria.
Interactions of NADP-reducing enzymes across varying environmental conditions: a model of biological complexity.
Long-term effects of starvation-refeeding in the rat.
Long-term starvation in Xenopus laevis Daudin--III. Effects on enzymes in several tissues.
Metabolic responses to prolonged starvation, food restriction, and refeeding in the brown trout, Salmo trutta: oxidative stress and antioxidant defenses.
Oxidative stress and antioxidant defenses after prolonged starvation in Dentex dentex liver.
Pair-feeding in the dietary control of glucose-6-phosphate dehydrogenase.
Regulation of glucose-6 phosphate dehydrogenase and 6-phosphogluconate dehydrogenase in the meal-fed rat.
Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status.
Starvation actively inhibits splicing of glucose-6-phosphate dehydrogenase mRNA via a bifunctional ESE/ESS element bound by hnRNP K.
Starvation-induced impairment of metabolism in a freshwater catfish.
The effect of starvation and refeeding on lipogenic enzymes in mammary glands and livers of lactating rats.
The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation.
Transcriptional activation of glycogen catabolism and oxidative pentose phosphate pathway by NrrA facilitates cell survival under nitrogen starvation in the cyanobacterium Synechococcus sp. strain PCC 7002.
[Activity of hexokinase and glucose-6-phosphate dehydrogenase in hemopoietic cells of the bone marrow in normal rabbits and after hydrocortisone administration during starvation and alloxan diabetes]
[Intensity of pentose phosphate metabolism of carbohydrates in various brain areas in normal and starved animals]
Stevens-Johnson Syndrome
Acute reversible renal failure and Stevens-Johnson syndrome in a patient having glucose-6-phosphate dehydrogenase deficiency.
Still's Disease, Adult-Onset
Adult-onset Still's disease associated with G6PD deficiency: a case report and literature review.
Stillbirth
Is G6PD A- deficiency associated with recurrent stillbirths in The Gambia?
Stomach Neoplasms
Flow-cytometric determination of dehydrogenase activities in primary human gastrointestinal tumor cell lines.
G6PD-NF-?B-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2.
Glucose-6-phosphate dehydrogenase deficiency reduces susceptibility to cancer of endodermal origin.
LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis.
Modulatory effect of naringenin on N-methyl-N'-nitro-N-nitrosoguanidine- and saturated sodium chloride-induced gastric carcinogenesis in male Wistar rats.
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer.
Rev-erb? inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells.
Stomach Ulcer
The effect of low temperature on the enzyme activities and the level of SH groups in benign gastric ulcer and gastric carcinoma.
[Characteristics of the pentose phosphate pathway of carbohydrate metabolism in the gastric mucosa of persons with peptic ulcer]
Stomatitis, Aphthous
Diet in dermatology: revisited.
Stroke
A histochemical study of cerebral cortical vessels and ganglionic vessels of the caudatoputamen in aging normotensive rats.
A TIGAR-regulated metabolic pathway is critical for protection of brain ischemia.
Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.
Association of alpha-thalassemia and Glucose-6-Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia.
Community-acquired acute kidney injury in Asia.
G6PD deficiency and stroke in the CSSCD.
G6PD Mediterranean S188F codon mutation is common among Saudi sickle cell patients and increases the risk of stroke.
Genetic predictors for stroke in children with sickle cell anemia.
Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes.
Glucose-6-Phosphate Dehydrogenase Deficiency in Brazilian Children With Sickle Cell Anemia is not Associated With Clinical Ischemic Stroke or High-Risk Transcranial Doppler.
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.
Influence of the ?(s) haplotype and ?-thalassemia on stroke development in a Brazilian population with sickle cell anaemia.
Inhibition of Calcium/Calmodulin-Dependent Protein Kinase II? Suppresses Oxidative Stress in Cerebral Ischemic Rats Through Targeting Glucose 6-Phosphate Dehydrogenase.
Intravenous Thrombolysis for Stroke Patients with G6PD Deficiency.
Safety and efficacy of low-dose aspirin in ischemic stroke patients with different G6PD conditions.
[Value of the study of various erythrocyte enzymes in determining the nature of cerebral stroke in the acute period]
Stuttering
Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
superoxide dismutase deficiency
Growth on ethanol results in co-ordinated Saccharomyces cerevisiae response to inactivation of genes encoding superoxide dismutases.
Syncope
An unusual syncope cause in the ED: Favism.
Does amyl nitrite have a role in the management of pre-hospital mass casualty cyanide poisoning?
Severe methemoglobinemia and syncope in a patient with glucose-6-phosphate dehydrogenase deficiency.
Syphilis
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Teratoma
Endodermal origin of yolk-sac-derived teratomas.
Testicular Neoplasms
Chemotherapy in a Patient With G6PD Deficiency and Advanced Testicular Cancer.
Thalassemia
A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
A study of nine polymorphic systems in the population of the Po Delta.
Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.
Analysis of genotype distribution of thalassemia and G6PD deficiency among Hakka population in Meizhou city of Guangdong Province.
Anemia at Altitude: Thalassemia, Sickle Cell Disease, and Other Inherited Anemias.
Anemia in Patients with Coinherited Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
Anemia in pregnancy.
Apoptosis in blood diseases. Review new data.
Assessment of erythrocyte deformability with the laser-assisted optical rotational cell analyzer (LORCA).
Attitudes and impact among people with abnormal premarital screening test results in Muscat governorate's primary healthcare centers in 2018.
Atypical dengue Fever in a splenectomized boy with glucose-6- phosphodehydrogenase deficiency and thalassemia intermedia.
Autoimmune hemolytic anemia.
Blood cell parameters for screening and diagnosis of hereditary spherocytosis.
Burden of Hemoglobinopathies (Thalassemia, Sickle Cell Disorders and G6PD Deficiency) in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Caution is Needed in Interpreting Hemoglobin A1c Levels in the Muslim Bedouin Population of Southern Israel.
Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre.
Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.
Community Expansion and Gene Geography of Sickle Cell Trait and G6PD Deficiency, and Natural Selection against Malaria: Experience from Tribal Land of India.
Current prevalence of intestinal parasitic infections and their impact on hematological and nutritional status among Karen hill tribe children in Omkoi District, Chiang Mai Province, Thailand.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Differential fertility as a mechanism maintaining balanced polymorphisms in Sardinia.
Distortion of the ?-globin Chain of Hemoglobin Alters the Pathway of Erythrocytic Glucose Metabolism Through Band 3 Protein.
Effects of variant UDP-glucuronosyltransferase 1A1 gene, glucose-6-phosphate dehydrogenase deficiency and thalassemia on cholelithiasis.
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.
Erythrocyte glucose-6-phosphate dehydrogenase activity in thalassemia and in hemoglobin E.
Erythrocyte ion channels in regulation of apoptosis.
Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.
First report of co-morbidity of pantothenate kinase-associated neurodegeneration and three types of chronic hemolytic anemias.
Frequency of thalassemia and G6PD deficiency in five provinces of Spain.
Genetic and dietary adaptation to malaria in human populations.
Gilbert syndrome.
Glucose 6-phosphate dehydrogenase, hexokinase activities and ATP levels as a function of cell density in thalassemia and iron deficiency anemia.
Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum.
HAART has no major impact on hematological and plasma bilirubin changes in HIV-infected patients with congenital G-6-PD deficiency.
Hematological parameters and red blood cell morphological abnormality of Glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemia.
Hemoglobin S-mediated membrane oxidant injury: protection from malaria and pathology in sickle cell disease.
Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Hereditary red blood cell disorders in middle eastern patients.
Hereditary red cell disorders in Southeast Asian refugees and the effect on the prevalence of thalassemia disorders in the United States.
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
How malaria has affected the human genome and what human genetics can teach us about malaria.
Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia.
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area?
Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death.
Medical genetics in Thailand.
Molecular Epidemiological Survey of Glucose-6-Phosphate Dehydrogenase Deficiency and Thalassemia in Uygur and Kazak Ethnic Groups in Xinjiang, Northwest China.
Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE).
New considerations on the distribution of malaria, thalassemia, and glucose-6-phosphate dehydrogenase deficiency in Sardinia.
Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Oxidative Stress and Suicidal Erythrocyte Death.
Phenotypic effect of heterozygous alpha and beta 0-thalassemia interaction.
Plan and process for hematology laboratory standard in Thailand.
Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.
Premarital Screening and Genetic Counseling Program: Studies from an Endogamous Population.
Prevalence of anemia, iron deficiency, thalassemia and glucose-6-phosphate dehydrogenase deficiency among hill-tribe school children in Omkoi District, Chiang Mai Province, Thailand.
Prevalence of beta-thalassemia trait and glucose-6-phosphate dehydrogenase deficiency in Iranian Jews.
Prevalence of hemoglobin E, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency in 1,000 cord bloods studied in Bangkok.
Prevalence of thalassemia and G6PD deficiency in North Cyprus.
Prevalence of Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency in Newborns and Adults at the Ramathibodi Hospital, Bangkok, Thailand.
Prevalences of thalassemia/hemoglobinopathies and G-6-PD deficiency in malaria patients.
Red cell acid phosphatase: another polymorphism correlated with Malaria?
Red cell membrane protein in thalassemia and glucose-6-phosphate dehydrogenase deficiency anemia.
Sanfilippo syndrome, glucose-6-phosphate dehydrogenase deficiency and sickle cell/?(+) thalassemia in a child: The burden of consanguinity.
Sickle-cell trait, thalassemia, G-6-PD deficiency and puerperal pulmonary embolism.
Some roles of free radicals in malaria.
Studies on thalassemia, glucose-6-phosphate dehydrogenase deficiency, and sickle cell trait in the Province of Huelva (Spain).
STUDIES ON THE DISTRIBUTION OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, THALASSEMIA, AND OTHER GENETIC TRAITS IN THE COASTAL AND MOUNTAIN VILLAGES OF CYPRUS.
Thalassemia and G-6-PD deficiency in Chinese-Canadians: admission screening of a hospital population.
Thalassemia and G6PD deficiency in Spanish blood donors.
Thalassemia trait and G6PD deficiency in Thai blood donors.
THALASSEMIAS, ABNORMAL HEMOGLOBINS AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN THE ARTA AREA OF GREECE: DIAGNOSTIC AND GENETIC ASPECTS OF COMPLETE VILLAGE STUDIES.
The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.
The relations between G-6-PD deficiency, thalassemia and malaria. Further analysis of data from Sardinia and the Po Valley.
Therapeutic potential of manipulating suicidal erythrocyte death.
Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.
Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.
[Association of a triple genetic erythrocyte defect: thalassemia, sickle cell disease and glucose-6-phosphate dehydrogenase deficiency in a child of Calabro-Sardinian origin]
[Beta-thalassemia and glucose-6-phosphate dehydrogenase deficiency]
[CONGENITAL AND RECESSIVE METHEMOGLOBINEMIA. ITS ASSOCIATION WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THALASSEMIA MINOR.]
[Erythrocyte glucose-6-phosphate dehydrogenase deficiency--a study on its distribution in the province of Ferrara and its relation to malaria and thalassemia]
[Erythrocyte polymorphism in Mali: epidemiology and resistance mechanisms against severe Plasmodium falciparum malaria]
[GENETIC ASPECTS OF RESISTANCE TO MALARIA (REVIEW)].
[Genetic, biochemical, pathogenetic and laboratory aspects of thalassemia. Heterozygote thalassemia in Alghero]
[Imported case of malaria in Taiwan: analysis of 11 cases]
[Morbidity patterns in a non-German population (migrant workers) (author's transl)]
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency]
[RELATIONS BETWEEN DEFICIT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE AND THALASSEMIA AT THE POPULATION AND INDIVIDUAL LEVEL.]
[Triple erythrocyte disorders: thalassemia, hemoglobinopathy L Glucose-6-phosphate dehydrogenase deficiency in a girl from Polesine. First study]
Thiamine Deficiency
[Changes in the intracellular glucose-6-phosphate dehydrogenase metabolism in the rat liver during thiamine deficiency]
Thrombocythemia, Essential
Essential thrombocythemia: a clonal disorder of hematopoietic stem cell.
Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.
Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in a GdB/GdMediterranean subject.
Stem cell origin of human myeloid blood cell neoplasms.
Thrombocytopenia
COVID-19 infection triggering hrombotic thrombocytopenic purpura.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Intra-erythrocytary enzymes before and after splenectomy.
N-acetylcysteine overdose after acetaminophen poisoning.
[Glucose-6-phosphate dehydrogenase in the thrombocytes of patients with thrombopenia and thrombopathy]
Thromboembolism
[The biochemical and morphological changes in the myocardium of patients with an acute surgical vascular pathology (based on data from early autopsies)]
Thrombosis
COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients.
Deep vein thrombosis after hemolytic crisis in a glucose-6-phosphate dehydrogenase deficient boy with antithrombin-III deficiency.
Deep vein thrombosis in association with acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency: a unique case.
Fatal haemolytic crisis with microvascular pulmonary obstruction mimicking a pulmonary embolism in a young African man with glucose-6-phosphate dehydrogenase deficiency.
The mystery of 'saturation gap' and falsely normal G6PD: a case of primaquine-induced haemolysis in Plasmodium vivax malaria infection.
[Hematologic characteristics in Black Africa]
Thrombotic Microangiopathies
Drug-induced hemolytic anemia: Pharmacological aspects.
Etiology and Outcomes of Thrombotic Microangiopathies.
How I do in front of an hemolytic anemia of unknown etiology?
Thyroid Diseases
Assessment of potential donors for living related liver transplantation.
Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine.
Thyroid Neoplasms
Clonal origin of inherited medullary thyroid carcinoma and pheochromocytoma.
Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells.
Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells.
Thyroiditis
Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.
Thyrotoxicosis
Blood trasketolase and erythrocyte glucose-6-phosphate dehydrogenase activities in thyrotoxicosis.
[Glucose-6-phosphate dehydrogenase activities in erythrocytes in thyrotoxicosis and myxedema]
Toxoplasmosis
Cerebellar Toxoplasmosis in an Immunocompetent Patient with G6PD Deficiency.
Patient with toxoplasmosis and glucose-6-phosphate dehydrogenase deficiency: a case report.
Toxoplasmosis in a group of glucose-6-phosphate dehydrogenase deficient patients.
Transfusion Reaction
Intraoperative hemolysis. The initial manifestation of glucose-6-phosphate dehydrogenase deficiency.
Transfusion-Related Acute Lung Injury
Acute lung injury after exchange transfusion in two newborns with Glucose-6-phosphate dehydrogenase deficiency.
Tricuspid Valve Insufficiency
Perioperative challenges in a patient of severe G6PD deficiency undergoing open heart surgery.
Triple Negative Breast Neoplasms
Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Trypanosomiasis
Pharmacological targeting of glucose-6-phosphate dehydrogenase in human erythrocytes by Bay 11-7082, parthenolide and dimethyl fumarate.
Trypanosomiasis, African
16-Bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture.
Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites.
Tuberculosis
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression system.
Non-nutritional anemia: Malaria, thalassemia, G6PD deficiency and tuberculosis in Indonesia.
Role of Premycofactocin Synthase in Growth, Microaerophilic Adaptation, and Metabolism of Mycobacterium tuberculosis.
Study with glucose-6-phosphate dehydrogenase of guinea pig kidney in experimental tuberculosis.
[Clinico-immunologic characteristics of patients with pulmonary tuberculosis, psychic diseases and a congenital glucose-6-phosphate dehydrogenase deficiency]
[Effectiveness of lymphotropic therapy in patients with tuberculosis in relations to genetic markers]
[Features of disruption of certain components of carbohydrate metabolism in a combination of pulmonary tuberculosis and diabetes mellitus in people with haptoglobin phenotypes]
[Gene geography of hereditary glucose-6-phosphate dehydrogenase deficiency and pulmonary tuberculosis in Azerbaijan]
[One hundred and twenty-three cases of sickle-cell trait (author's transl)]
[Pulmonary tuberculosis in patients with hereditary glucose-6-phosphate dehydrogenase deficiency]
Tuberculosis, Pulmonary
Incidence of G6PD deficiency in patients of three different ethnic groups suffering from pulmonary tuberculosis.
[Clinico-immunologic characteristics of patients with pulmonary tuberculosis, psychic diseases and a congenital glucose-6-phosphate dehydrogenase deficiency]
[Gene geography of hereditary glucose-6-phosphate dehydrogenase deficiency and pulmonary tuberculosis in Azerbaijan]
[Pulmonary tuberculosis in patients with hereditary glucose-6-phosphate dehydrogenase deficiency]
[Red blood cell metabolic changes in patients with acutely progressive pulmonary tuberculosis]
[The oxidative metabolic indices of phagocytizing and immunocompetent cells in patients with pulmonary tuberculosis]
Tumor Lysis Syndrome
A perfect storm: Tumor lysis syndrome with rasburicase-induced methemoglobinemia in a G6PD deficient adult.
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Rasburicase-induced Hemolytic Anemia in an Adolescent With Unknown Glucose-6-Phosphate Dehydrogenase Deficiency.
Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem.
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Turner Syndrome
TURNER'S SYNDROME, TWINNING, AND AN UNUSUAL VARIANT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE.
Typhoid Fever
Co-trimoxazole in the treatment of typhoid fever in children with glucose-6-phosphate dehydrogenase deficiency.
Depression of erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in enteric fever.
Frequency of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency in Tanzanian males with typhoid fever.
Glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Haemolysis in typhoid fever in children with G-6-PD deficiency.
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura.
Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
Serum transcobalamin II level in glucose-6-phosphate dehydrogenase deficient subjects with typhoid fever.
Transient inhibition of glucose utilization by erythrocytes during the acute stage of typhoid fever.
Transient, acquired glucose-6-phosphate dehydrogenase deficiency in Thai children with typhoid fever.
Typhoid and paratyphoid fever in 192 hospitalized children in Thailand.
Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
Typhoid fever and viral hepatitis in a G6PD deficient individual.
[A case of typhoid fever in a visitor from India with glucose-6-phosphate dehydrogenase deficiency. Remarkable conjugated hyperbilirubinemia probably induced by an analgesic drug (author's transl)]
[Enzymatic activity in the lung cells to the intrapulmonary administration of antigen]
[Hemolytic anemia caused by glucose-6-phosphate dehydrogenase deficiency during typhoid fever]
[Modifications of the glucose-6-phosphate dehydrogenase activity in the granular leukocytes of guinea pigs poisoned by typhoid endotoxin]
[Typhoid fever, hemoglobinuria and glucose-6-phosphate dehydrogenase deficiency. (Apropos of 2 cases)]
Tyrosinemias
Diet in dermatology: revisited.
Uremia
Determination of erythrocyte superoxide dismutase, catalase, glucose-6-phosphate dehydrogenase, reduced glutathione and malonyldialdehyde in uremia.
Therapeutic potential of manipulating suicidal erythrocyte death.
Urinary Bladder Neoplasms
Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.
Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer.
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
[Histochemical investigations on human bladder cancer (author's transl)]
Urinary Tract Infections
Accessibility of pregnancy-related point-of-care diagnostic tests for maternal healthcare in rural primary healthcare facilities in Northern Ghana: A cross-sectional survey.
Investigation of prolonged neonatal jaundice.
Underlying etiologies of prolonged icterus in neonates.
Urticaria
Diet in dermatology: revisited.
Uterine Cervical Neoplasms
Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma.
MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD.
miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
[Study of glucose 6-phosphate dehydrogenase and its isozyme in patients with uterine cervical cancer]
[Study of glucose-6-phosphate dehydrogenase and its isozyme in the therapy of uterine cervical cancer]
Uterine Cervicitis
Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma.
utp-hexose-1-phosphate uridylyltransferase deficiency
Two novel glucose-6-phosphate dehydrogenase variants found in newborn mass-screening for galactosaemia.
Vascular Diseases
Antioxidant enzyme deficiencies and vascular disease.
Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases.
CRISPR-Mediated Single Nucleotide Polymorphism Modeling in Rats Reveals Insight Into Reduced Cardiovascular Risk Associated With Mediterranean G6PD Variant.
G6PD activity contributes to the regulation of histone acetylation and gene expression in smooth muscle cells and to the pathogenesis of vascular diseases.
Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice.
Oxidative enzymopathies and vascular disease.
Single Cell Cytochemistry Illustrated by the Demonstration of Glucose-6-Phosphate Dehydrogenase Deficiency in Erythrocytes.
Targeting the Pentose Phosphate Pathway in Syndrome X-related Cardiovascular Complications.
Vasculitis
Diet in dermatology: revisited.
Venous Thromboembolism
Prevalence of factor V Leiden and G6PD 1311 silent mutations in Dalmatian population.
Venous Thrombosis
Deep vein thrombosis after hemolytic crisis in a glucose-6-phosphate dehydrogenase deficient boy with antithrombin-III deficiency.
Deep vein thrombosis in association with acute intravascular haemolysis in glucose-6-phosphate dehydrogenase deficiency: a unique case.
Vesicular Stomatitis
Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer.
Vibrio Infections
Modulation of beta-actin, insulin-like growth factor 1 and glucose-6-phosphate dehydrogenase gene expression during vibriosis of sea bream, Sparus (=Rhabdosargus) sarba Forsskål.
Virus Diseases
Acute pancreatitis--complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency.
An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire.
Effect of hydroxychloroquine on prevention of COVID-19 virus infection among healthcare professionals: a structured summary of a study protocol for a randomised controlled trial.
G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).
Glucose-6-phosphate dehydrogenase (G6PD) deficiency in southern Italy: a case of G6PD A(-) associated with favism.
Glucose-6-phosphate dehydrogenase (G6PD)-deficient epithelial cells are less tolerant to infection by Staphylococcus aureus.
Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people.
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-?B Signaling.
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases.
Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency.
Hepatitis E virus infection in a 7-year-old boy with glucose 6-phosphate dehydrogenase deficiency.
Hexokinase activity as marker to assess time of harvest of foot-and-mouth disease virus in BHK(21) Cl(13) cell cultures.
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays.
Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018.
Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.
The metabolic and phagocytic activities of leukocytes from patients receiving corticosteroid and radiation therapy, and patients with bacterial infections.
Tolerability of tiaprofenic acid in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Two apparent glucose-6-phosphate dehydrogenase variants in normal XY males: G6PD Alabama.
Viral infections in G-6-PD deficiency.
What has passed is prolog: new cellular and physiological roles of G6PD.
[Hemoglobinuria in children hospitalized in Ouagadougou: short term inpatient care and prognosis].
Vitamin A Deficiency
Nutritional Status of Young Children with Inherited Blood Disorders in Western Kenya.
Vitamin B 12 Deficiency
Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
Vitamin D Deficiency
The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
Vitiligo
Association of glucose 6-phosphate dehydrogenase (G6PD) 3'UTR polymorphism with vitiligo and in vitro studies on G6PD inhibition in melanocytes.
Decreased glucose-6-phosphate dehydrogenase levels in vitiligo patients: Further evidence of oxidative stress.
Diet in dermatology: revisited.
Distribution of serum proteins, red cell enzymes and haemoglobins in vitiligo.
Study on the antioxidant status of vitiligo patients of different age groups in Baroda.
von Willebrand Diseases
22q and two: 22q11.2 deletion syndrome and coexisting conditions.
Dengue infection in hematologic-oncologic pediatric patients: aggravation of anemia and bleeding risk.
Warts
Oxidative stress in patients with nongenital warts.
Werner Syndrome
Low glucose-6-phosphate dehydrogenase activity in cultured skin fibroblasts from Werner's syndrome.
Whooping Cough
Bordetella pertussis extract induces increase in the activities of glycolytic enzymes in mouse liver.
Elevation of glucose-6-phosphate dehydrogenase levels in alloxan diabetic mice by Bordetella pertussis cell extract.
Wilms Tumor
Evidence for clonal development of Wilms' tumor.
Wiskott-Aldrich Syndrome
Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier.
Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection.
Xanthomatosis
Diet in dermatology: revisited.
Xeroderma Pigmentosum
A child with xeroderma pigmentosum and G6PD deficiency.
Heat-labile glucose-6-phosphate dehydrogenase in cultured fibroblasts from patients with De Sanctis-Cacchione Syndrome.
Yersinia pseudotuberculosis Infections
GLUCOSE-6-PHOSPHATE DEHYDROGENASE AND 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITIES OF PASTEURELLA PESTIS AND PASTEURELLA PSEUDOTUBERCULOSIS.